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Abstract 
ANALYSIS OF A NOVEL PHENAZINE ANTIBIOTIC GENE 
CLUSTER IN ERWINIA HERBICOLA EHI087: A 
BIOLOGICAL CONTROL AGENT FOR FIREBLIGHT 
Stephen Giddens 
x 
The present study advances genetic, molecular biology, and biochemical analyses of antibiotic 
production by Erwinia herbicola (syn. Pan toea agglomerans) strain Eh1087, a candidate for 
biological control of the Fire Blight pathogen Erwinia amylovora. Three research areas were 
investigated concurrently: i) the role of antibiosis in biological control by Eh1087, ii) the 
genetic basis of antibiotic production, and iii) the nature of the antibiotic. Antibiotic production 
was shown to be an important biological control mechanism since removal of an antibiotic 
synthesis gene cluster in Eh1087 significantly decreased the ability of this bacterium to suppress 
the colonization of apple blossom stigmas by E. amylovora strain Ea8862. 
A region of DNA sufficient for antibiotic production and resistance was identified and 
characterized by molecular genetic analyses. Evidence suggesting that this DNA region did not 
originate in Eh1087 is presented. The region was found to contain a cluster of 16 genes 
designated ehp (/irwinia herbicola Qhenazine) using a combination of DNA sequence analyses, 
minicell protein analyses, and the correlation of mutation with the production of coloured AGA 
intermediates by many ehp mutants. The function and regulation of the genes within the cluster 
were determined by the use of classical syntrophic and DNA-complementation experiments. 
Each biosynthetic gene was assigned to one of four Groups according to the function of their 
products in antibiotic biosynthesis, while a single gene was shown to provide antibiotic 
resistance. A pathway for antibiotic biosynthesis is proposed that involves intracellular 
synthesis of a phenazine nucleus, modification and translocation of this nucleus to the 
periplasm, and finally the activation and release of antibiotic from the producing cell. 
Purification and analysis of the Eh1087 antibiotic demonstrated that the ehp genes confer on 
Eh1087 the ability to produce the phenazine antibiotic D-alanylgriseoluteic acid (AGA). This is 
the first example of the isolation of a phenazine antibiotic from a species of Erwinia (or 
Pantoea), and only the second isolation of AGA as a natural product. The characterization of 
various AGA properties led to predictions about its mode of action. 
Chapter 1 INTRODUCTION 
Chapter 1. INTRODUCTION 
In many parts of the world, including the US, Europe, The Middle East, and New Zealand, 
apple and pear growers face a constant battle against a disease called Fire Blight (Bonn and van 
der Zwet, 2000). Fire Blight is a necrotic disease so-named because the tissues of badly 
infected plants become blackened, as if ravaged by fire. The infectious agent responsible for 
Fire Blight is the bacterium Erwinia amylovora (originally Bacillus amylovora), which was the 
first bacterium to be identified as a plant pathogen (Burrill, 1883). Over the intervening years 
the disease cycle of E. amylovora has been well established (Fig. 1.1). Recent studies have shed 
light both on the likely sites of infection (blossoms and shoots) and on E. amylovora-specific 
factors involved in the disease process (recently reviewed by Eastgate, 2000). Much of this 
research has been motivated by difficulties in the control of Fire Blight. These difficulties have 
become more troublesome with the use of most modem apple and pear cultivars, which are 
particularly susceptible to Fire Blight as they were developed for marketability and not for 
disease-resistance (Johnson and Stockwell, 1998). 
Fire Blight 
An understanding of the disease cycle of E. amylovora is essential for the development of 
methods to control Fire Blight. E. amylovora over-winters inside a host plant as a concentrated 
area of infection termed a 'canker' (Fig. 1.1). Once spring arrives, vectors such as insects or 
rain can transfer the bacterium to newly opened blossoms (Johnson et aI., 1993). This marks the 
start of an epiphytic phase during which E. amylovora multiplies to 106 - 107 CFU,blossom-1 in 
the moist, nutrient rich environment of the stigma (Gibbins, 1978; Johnson and Stockwell, 
1998; Wilson et aI., 1992; Wilson and Lindow, 1993). The high epiphytic population of E. 
amylovora on the stigma can provide inocula for transfer to new blossoms, enabling the 
bacterium to rapidly infect large areas of an orchard (Johnson et aI., 1993). E. amylovora does 
not survive well on flower parts other than the stigma (Rundle and Beer, 1987; Thomson, 1986), 
however it has to migrate from the stigma down the style to the hypanthium (nectaries) to infect 
plant tissue and initiate the blossom blight phase of Fire Blight. It is therefore likely that an 
epiphytic phase results in a population of E. amylovora sufficient to overwhelm the natural plant 
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defenses at the hypanthium (Thomson, 1986). Since infections usually follow rainstorms or 
heavy dew, the moisture from such events is thought to transfer E. amylovora from the stigma to 
the hypanthium and may also act to dilute out natural defenses, such as the high osmolarity of 
nectar, at the hypanthium (Johnson and Stockwell, 1998; Stockwell et aI., 1999; Thomson, 
1986). After infecting a plant, E. amylovora can rapidly spread throughout the host and 
eventually cause systemic disease, sometimes resulting in the death of a tree in a single season 
(Eastgate, 2000; Vanneste, 1996). 
Figure 1.1. The Fire Blight disease cycle 
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In the last two decades or so, a number of factors required by E. amylovora to cause Fire Blight 
has been elucidated. As recently reviewed by Eastgate (2000), E. amylovora has distinct 
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features that enable it to survive within the plant, and to cause disease. Survival factors include 
siderophores to scavenge iron in the low iron environment of the plant and the ability to 
metabolize sugars such as sucrose and sorbitol, a major transport sugar in pear. Disease factors 
have largely been uncovered by the analysis of E. amylovora mutants that lack the ability to 
cause disease. For instance, mutants unable to produce an extracellular polysaccharide named 
amylovoran were found to be unencapsulated and avirulent (Roberts and Coleman, 1991). The 
mutations responsible for the avirulence phenotype were located adjacent to a ca. 25 kbp region 
of DNA required for hypersensitive response and ~athogenicity (hrp genes) (Bogdanove et aI., 
1998). The product of hrpN, harpin is an intracellular protein that elicits a hypersensitive 
response in tobacco leaves and is a Fire Blight pathogenicity factor (Wei et aI., 1992). 
Expression of the hrp genes is influenced by carbon source, pH, temperature, and ammonium 
ion concentration, and no doubt by other environmental influences (Wei et aI., 1992). Weir et 
aI. (1992b) concluded that nutritional status is the over-riding influence on hrp gene expression 
rather than plant derived compounds. Also associated with Fire Blight are genes termed dsp, 
which encode gisease §Qecific factors. Of these, DspE is secreted by an HRP secretory pathway 
(Bogdanove et aI., 1998). In general, it is Clear that the molecular biology of Fire Blight disease 
is beginning to be unraveled, however few details of the process are currently known. 
Control of Fire Blight 
The control of Fire Blight is a difficult and multifaceted task. Tools available to the orchardist 
include rigorous prunmg regimes and the manual removal of over-wintering cankers, complex 
disease prediction models, and preventative chemical and biological treatments. Careful 
pruning can remove infected shoots if caught in time and if the severity of pruning is sufficient 
(Clarke et aI., 1991). The susceptibility of shoots to infection can be reduced by Apogee® 
(prohexadione calcium), very recently released by the agrochemical arm of the company 
BASF®. Apogee inhibits the biosynthesis of gibberellin and reduces the growth of vegetative 
shoots which are susceptible to infection. To predict the onset of disease, Fire Blight risk 
assessment models have been developed using data from long term studies of conditions in 
which Fire Blight develops. The most important factors are warm temperatures and wet 
periods, which readily induce disease. Two Fire Blight risk assessment models can be found on 
the internet; Cougarblight 98C, www.ncw.wsu.edU/fbsmith.htm; and Maryblyt, 
www.intrepid.net/afrs/fb8.htm (19 January 2002). When the likelihood of disease is high, 
orchardists have a limited arsenal of preventative control methods (reviewed by Johnson and 
Stockwell, 1998; and Vanneste 1996). Chemical controls are applied by spraying and generally 
aim to target the bacterial population present on blossoms where most infections occur. These 
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controls include copper sulphate, which is limited by phytotoxicity against blossoms, and 
antibiotics such as streptomycin (marketed by Novartis as Agri-Mycin 17) and oxytetracycline 
(marketed as Terramycin). Streptomycin has been the Fire Blight control of choice due to its 
good efficacy and bactericidal mode of action, however strains of E. amylovora with resistance 
against streptomycin have arisen on numerous occasions (recently reviewed by Jones and 
Schnabel, 2000). Significantly, the use of streptomycin appears to reduce the natural microflora 
present in flowers resulting in more severe disease outbreaks in areas with streptomycin 
resistant E. amylovora. An alternative, oxytetracycline, is less efficacious than streptomycin as 
it is bacteriostatic and has a shorter half life in the field. Additionally, the use of antibiotics for 
control of fireblight has been banned in many European countries. In response to these 
limitations a substantial research effort has focused on an alternative control mechanism, which 
involves the suppression of E. amylovora by saprophytic epiphytes isolated from the blossoms 
of Fireblight susceptible plants. This approach, known as biological control, has had a 
checkered history III vanous ecological systems, and is the subject of much debate and 
speculation. 
General aspects of biological control 
Biological control is often thought of in the 'classical' sense as the introduction of a natural 
predator to control an exotic pest. In this sense, biological control has existed as a scientific 
discipline for over 100 years (Thomas and Willis, 1998). More recently, the National Academy 
of Sciences (US) defined biological control as 'the use of natural or modified organisms, genes, 
or gene products to reduce the effect of undesirable organisms (pests), and to favor desirable 
organisms such as crops, trees, animals and beneficial insects and microorganisms' (reported by 
Thomashow and Weller, 1996). A definition of a biological control agent (BCA) was proposed 
by the U.S Environmental Protection Agency (EPA) as 'any living organism applied to or 
introduced into the environment that is intended to function as a pesticide against another 
organism declared to be a pest by the administrator' (reported by Cook, 1996). These 
definitions show the broad scope of biological control in the modem setting and encompass the 
use of microbes as BCAs, the use of a native BCA against a native pest, and approaches such as 
isolating a BCA from the same niche as the pest and reapplying the BCA to diseased sites. 
Unfortunately, spectacularly unsuccessful applications of BCAs, particularly with regard to the 
unanticipated detrimental effects on non-target flora and fauna, have led to widespread 
skepticism towards biological control. However, because a successful biological control 
operation will never make as much noise as a significant failure, Cook (1996) suggested that it 
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is important that the real risks are assessed and that the perceived risks are not given an 
excessive influence on biological control decisions. 
What does biological control offer that chemicals cannot? This comparison is particularly 
pertinent given that, in the US at least, a major hurdle in the development of BCA is licensing. 
Microbial BCA, but not other BCA such as insects or plants, are subject to the same rigorous 
and expensive registration process as chemicals. The use of chemicals to control pests is often 
(and sometimes realistically) perceived by the public at large as being unnatural and having 
undesirable side effects. Furthermore, Thomas and Willis (1998) suggest that chemical controls 
are usually short term, non-specific, and that alternatives are required to deal with the 
development of resistance (although the short half life of many agrichemicals can be desirable if 
non-target organisms are adversely affected). It has been suggested, somewhat controversially, 
that the use of microbial BCA for control of phytopathogens in agriculture and horticulture has 
many advantages over chemicals, including lack of resistance development and highly selective 
pathogen targeting (Dunne et aI., 1996). Even if this is not true in every case, the manipulation 
of artificial agricultural 'ecosystems' by the informed use of microbial BCA can be seen as a 
more natural control process than the use of toxic chemicals. 
Biological control is often hindered by incomplete pathogen suppression and on occasion by 
short term activity. Both usually result from mismanaged application, which itself results from 
a lack of research and development (Frecldeton, 2000). Biological control failures usually 
result from inadequate colonization of the target site and variability in the activity of pathogen 
suppression mechanisms (Thomashow and Weller, 1996). The lack of funding for research and 
development into these aspects of biological control, along with a lack of implementation and 
the perception of users, are seen as major drawbacks with biological control (Cook, 1996). On 
this basis, Cook (1996) proposed that the increased use of microbial BCAs will lead to more 
familiarity and greater public acceptance of the methodology. Furthermore, Thomas (1998) 
suggested that criticism of biological control is not constructive without comparative data about 
chemical alternatives or doing nothing. Perhaps a more pressing concern in the development of 
many BCAs is the efficacy of pathogen suppression in the field, particularly in cases where the 
alternatives are limited or ineffectual, such as Fire Blight. 
The suppression of a pathogen by another organism can result from one or more of three 
potential mechanisms; competition, predation, or the production of toxic chemicals (powell, 
1995). Both competition and the production of antibiotics by antagonistic microbes feature 
strongly in the suppression of the fireblight pathogen E. amylovora, as discussed below 
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(Johnson and Stockwell, 1998). In such cases, microbial biological control can ensure that toxic 
chemicals are produced in the same and often specialized niche as the pathogen, plus it offers 
the advantage of competitively excluding the pathogen from this niche. The synergistic effect 
of such an approach may require less chemical production for effective disease suppression than 
the use of chemicals alone. Furthermore, the use of a consortia of different antagonists with 
different suppressive activities in different conditions and the use of antagonists in combination 
with chemical controls are potential developments available to the biological control 
programme (Dunne et aI., 1996). 
Biological control of Fire Blight 
The control of Fire Blight by the use of antagonistic microbes has been unequivocally 
demonstrated by a number of research groups both in New Zealand (Keams, 1993; Vanneste et 
aI., 1995; Vanneste et aI., 1995), and elsewhere (Hattingh et aI., 1986; Johnson et aI., 1993; 
Rundle and Beer, 1987; Wilson et aI., 1992; Wilson and Lindow, 1993; Wodzinski et aI., 1994). 
Together with the fact that chemical treatments are of limited use, the control of Fire Blight by 
biological means is likely to play an important role in the future of apple and pear horticulture 
(reviewed by Johnson and Stockwell, 1998,2000). Over the past ca. 35 years, research into the 
biological control of Fire Blight has progressed far. Pseudomonas fluorescens A506 has now 
been registered as a biological pesticide as Blightban A506@ (Plant Health Technologies, Boise, 
ID), and Erwinia herbicola strain EhC9-1 is currently in the registration process. The history 
and development of the biological control of Fire Blight is an interesting model for biological 
control in general, and warrants a brief overview. 
In 1967, Goodman demonstrated that the infection of an avirulent E. amylovora strain into the 
stem of apple shoots provided some degree of resistance against further infection, as did the 
injection of a saprophytic 'yellow' bacterium similar to E. amylovora (presumably a strain of E. 
herbicola). McIntyre et al (1974) subsequently showed that cell free sonicates of these 
organisms also acted analogously to a 'vaccine' presumably inducing a systemic protective 
response against all invading microbes. Unfortunately the response was generally not 
permanent, limiting the usefulness of such an approach in the orchard. 
The use of a saprophytic antagonist of E. amylovora as a BCA was suggested by Erskine and 
Lopatecki (1975), after isolating a candidate organism, named E. herbicola 'Y' (yellow). They 
also suggested that E. herbicola strain Y prevents E. amylovora from accumulating a population 
sufficient to initiate and maintain a Fire Blight infection. This proposal was subsequently 
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supported by investigations that showed that E. amylovora multiplies exclusively on the stigma 
(Thomson, 1986), and that E. herbicola (Hattingh et aI., 1986; Rundle and Beer, 1987; Wilson 
et aI., 1992) and P. fluorescens A506 (Wilson and Lindow, 1993) multiply and occupy this 
same niche. For instance, Hattingh et al (1986) observed that E. amylovora and E. herbicola 
both grow on the stigma in the space between papillae, and proposed that both space and 
nutrients are a limited resource in this environment. In fact, competitive exclusion is a 
mechanism common to all Fire Blight biological control microbes isolated to date. For P. 
fluorescens A506 this is the only mechanism for E. amylovora suppression clearly demonstrated 
to date. The possibilities that A506 modifies the blossom environment to produce less nectar or 
modifies the plant compound arbutin to a toxic inhibitor of the pathogen (see below) have also 
been proposed (Wilson and Lindow, 1993). 
The production of toxic chemicals is often associated with the suppression of E. amylovora by 
strains of E. herbicola. An early proposition was that ~-glucosidase produced by saprophytic 
microbes such as E. herbicola caused the cleavage of arbutin to create hydro quinone, a 
compound shown to inhibit the growth ofE. amylovora in plate assays (Chatterjee et aI., 1969; 
Hildebrand and Schroth, 1964). Hildebrand et aI. (1964) developed this proposal when they 
found that E. herbicola strains had predominantly strong ~-glucosidase activity, whereas E. 
amylovora strains had only weak activity. Chatterjee et aI. (1969) subsequently showed that 
hydro quinone inhibits oxygen uptake by E. amylovora and thus inhibits the growth of the Fire 
Blight pathogen. 
More recent studies on the suppressive mechanisms of E. herbicola have demonstrated that the 
synthesis of toxic compounds, rather than the modification of plant compounds, is a common 
theme amongst strains of this species (El-Goorani and Beer, 1991; Hodges et aI., 1980; Keams 
and Hale, 1996; Wilson et aI., 1990; Wodzinski et aI., 1990; Wodzinski and Paulin, 1994; 
Wright et aI., 2001). As summarized by Vanneste (1996), of ca. 1500 putative E. herbicola 
strains isolated in three studies in the 1990's, 38 % produced one or more antibiotics (El-
Goorani and Beer, 1991; Wilson et aI., 1990; Wodzinski and Paulin, 1994). The association of 
antibiotic production with disease suppression was shown in orchard trails involving twelve E. 
herbicola strains, from which four out of five antibiotic producing strains were excellent 
antagonists of Fire Blight, whereas seven antibiotic non-producing strains were weak 
antagonists (Wodzinski et aI., 1994). Wilson et aI. (1992) proposed that the exclusion of E. 
amylovora by E. herbicola strain HL9M3 involves competition and antibiosis because the 
growth of E. amylovora was inhibited by HL9M3 before nutrients became a limiting factor. 
More specifically, Vanneste et al (1996) demonstrated that a peptide antibiotic isolated from E. 
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herbicola strain Eh252 was inhibitory to E. amylovora using a fruit slice model for assessing 
Fire Blight suppression. This claim was strengthened by the finding that an antibiotic-minus 
mutant of Eh252 could not inhibit E. amylovora in the same assay system. They also proposed 
that in situ colonization was essential after finding that a derivative of E. coli DH5a 
transformed to produce the antibiotic of Eh252 in vitro could not suppress E. amylovora using 
the fruit plug assay. Similarly, E. herbicola strain Eh318 produces two antibiotics thought to 
have a role in E. amylovora suppression since a spontaneous mutant of E. amylovora that was 
resistant to the two antibiotics was more weakly suppressed than the antibiotic-sensitive parent 
strain (Wodzinski et a1., 1990; Wright et a1., 2001). In summary, antibiotic production appears 
to have a role in the suppression of E. amylovora by E. herbicola; this is further discussed in 
Chapters 2 and 4. 
A common and important problem associated with BCAs is good pest suppression in different 
environments. The Fire Blight biological control model has a potential solution to this problem. 
Since the activity of microbes varies with environment, various researchers have experimented 
with combinations of microbes with different antagonistic mechanisms, and with different 
optimal suppressive activity in different conditions. P. fluorescens A506 is best suited to cool 
temperatures whereas EhC9-1 is a better antagonist in warmer climates; therefore a mixture of 
both would be expected to offer control in both conditions (Johnson and Stockwell, 1998; 
Johnson et a1., 1993). Similarly, A506 acts to colonize a stigma and exclude E. amylovora and 
as such needs to be applied two to three days prior to E. amylovora to offer control, whereas 
some E. herbicola strains produce one or more antibiotics that enable them to compete directly 
with E. amylovora for space and nutrients when co-inoculated (Wilson et a1., 1992; Wilson and 
Lindow, 1993). The co-habitation of A506 and Eh252 was successfully demonstrated by 
Vanneste, thus a combination of A506 and Eh252 should enhance the ability of A506 to 
colonize the stigma of blossoms in the presence of E. amylovora. In attempting to test this 
prediction Vanneste et al (1995) found that the suppression of E. amylovora by Eh252 was not 
enhanced by the presence of A506, however the hypothesis was not truly tested as A506 by 
itself did not offer significant control in these experiments, which were carried out in an orchard 
in Hamilton, New Zealand. In contrast, most other trials involving A506 have been carried out 
in the US and demonstrated Fire Blight suppression sufficient to warrant the registration of this 
strain as a biological pesticide (Johnson et a1., 1993; Lindow et a1., 1996). This observation in 
itself highlights the validity of using a multi-strain consortia of E. amylovora antagonistic 
bacteria to ensure that suppression of the Fire Blight pathogen can be guaranteed in different 
environments. 
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The potential for inhibition of E. amylovora at the hypanthium was suggested recently by Pusey 
(2000). He proposed that the biological control capability of an antagonistic microbe may be 
influenced by the ability to tolerate nectar at the hypanthium surface. Since yeasts possessed 
higher osmotolerance than E. amylovora, which was higher than E. herbicola, Pusey (2000) 
proposed that saprophytic yeast strains may be worth developing as part of a consortia BCA. 
Studies have also demonstrated that the integration of biological control agents with current 
control regimes may be a valid approach. As an example, Stockwell et al (1996) found that the 
establishment of A506 and EhC9-1 was not affected by co-application of streptomycin, 
although oxytetracycline treatment adversely affected the survival of these bacteria for several 
days. Lindow et al (1996) demonstrated that the application of A506 in combination with both 
streptomycin and oxytetracycline was additively better in reducing Fire Blight and frost damage 
than either treatment by itself. 
A final feature required for successful integration of a biological control programme into 
orchard management schemes is the development of application methods that preferably fit in 
easily with current orchard practices. Again, the biological control of Fire Blight offers a good 
model for the successful development of such a system. The preparation of bacterial inocula 
was found to have a large influence of the successful establishment of the applied microbes 
(Stockwell et aI., 1998). Stockwell et al (1998) found that lyophilized A506 established on 
significantly more flowers than bacteria suspended from agar plates. The reason for this was 
not clear, however the procedure reduces both variation in microbe establishment and provided 
an easily standardized method for preparation of a BCA that could potentially be stored long 
term. A second important aspect of orchard application is timing, for which complex disease 
forecast systems have been developed (Johnson and Stockwell, 1998; Eastgate, 2000). It has 
been shown that unopened blossoms rarely carry detectable populations of bacteria (> 1 00 
CFD.blossom-1), and that populations develop in most flowers within days of opening (Johnson 
et aI., 2000). According to Henis and Chet (1975), the introduction of potential antagonists is 
generally not successful because existing microflora prevent a new-comer from establishing. 
Thus, Johnston and Stockwell (1998) proposed multiple orchard applications from early 
blossom through to late blossom to ensure that populations of introduced saprophytes can 
colonize stigmas and exclude E. amylovora from becoming established. 
Future biological control programmes to combat Fire Blight will most likely involve the use of a 
consortia of microbes, possibly with chemicals, to create a highly effective control agent with 
multiple suppressive activities (Johnson and Stockwell, 1998; Johnson and Stockwell, 2000). 
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All new strains are therefore useful, but will have to be screened for usage with current control 
methodologies, Furthermore, knowledge of the suppressive mechanisms and the modification 
of strains for enhanced biological control are important research areas required for the 
development of biological control strains to be incorporated in an integrated biological control 
programme. 
The isolation and characterization of E. Iterbicola strain Ehl087 
Erwinia herbicola strain Ehl087 was isolated by Keams (1993) in 1989 during a survey of 
bacteria present on blossoms of apple trees (Malus domestica Borkh. cv, Golden Delicious) 
in Canterbury, New Zealand. It is worth noting that the species E. herbicola has been regrouped 
with some other Erwinia species as Pan toea agglomerans, however for continuity the name E. 
herbicola has been retained in the present study (Gavini et a1., 1989). Eh1087 displayed 
superior ability to suppress strains of amylovora using in vitro and fruit slice assays than 
other bacteria isolated from the same trees (Keams and Hale, 1995). Keams subsequently used 
an immature pear fruit assay to show that antibiotic-minus mutants of Eh1 087 did not suppress 
the ability of E. amylovora to produce Fire Blight symptoms (Keams, 1993; Keams and 
Mahanty, 1998). Once antibiosis was suspected of being involved in the suppression of E. 
amylovora by Ehl 087, investigations into the genetic basis underlying antibiotic production by 
Ehl087 (Keams and Hale, 1996), and the nature of the antibiotic were initiated (Keams, 1993; 
Kearns and Mahanty, 1998). Further details of these investigations are presented in Chapters 3 
and 4 respectively. 
Objectives of the present investigation. 
Control of Blight is an important issue for the pip-fruit industry both in New Zealand and 
worldwide as the disease causes significant economic losses. The isolation of the amylovora 
antagonist E. herbicola Eh1087 from a Canterbury orchard is particularly relevant to the 
potential biocontrol of Fire Blight in the dry, cool growing climates associated with New 
Zealand Coast orchards, Eh1087 is a good proposition as a biological control agent against 
amylovora as it appears to strongly inhibit the pathogen in planta, and it is adapted to New 
Zealand conditions. It is highly probable that the most effective biological control of Fire Blight 
will involve a consortia of various bacterial strains that possess different antagonistic properties 
(Johnson and Stockwell, 1998). Thus, the fact that Ehl087 has different properties to other 
potential Fire Blight control strains means that Eh1087 will be a useful strain to develop as part 
of such a consortia (Keams, 1993; Keams and Hale, 1996; Keams and Mahanty, 1998). An 
understanding of the disease control mechanisms of Ehl 087 at a fundamental level is essential 
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for such development. Once the signiflcance of a control mechanism is established, modem 
molecular biology technologies offer the means to make substantial improvements to a 
biological control agent at the genetic level. Furthermore, the purifled 'biocontrol metabolite' 
may itself have use in a Fire Blight control programme, and the characterization of such 
compounds may provide leads for the development of analogous active compounds. 
1. Preliminary investigations by Keams had indicated that the production of antibiotic was 
essential for suppression in a fruit slice assay (Keams, 1993; Keams and Mahanty, 1998), 
however there is evidence that this is a poor measure of efficacy in planta (Wilson et al., 1990). 
Therefore, a key objective of this investigation was to attempt to determine whether or not 
antibiotic production was an important mechanism for suppression of E. amylovora by Ehl087 
inplanta. 
2. The main objective of the present study was to investigate the genetic determinants required 
for antibiotic production by Eh1087. A locus involved in this process had been located, 
however no information regarding the extent of the locus, or the genes and their expression was 
lmown (Keams, 1993; Keams and Mahanty, 1998). 
3. Keams and Hale (1996) demonstrated that crude extracts of the antibiotic produced by 
Eh 1087 had different properties to antibiotics produced by other potential E. herbicola 
biological control agents, however the chemical structure of the antibiotic was not known. 
Thus, the flnal significant objective of this investigation was to purifY the antibiotic and 
determine its structure, for comparison with other E. herbicola antibiotics, and to relate 
chemical structure to the potential functions of genes involved in its synthesis. An additional 
part of this investigation was to investigate the properties of the antibiotic with a view to 
determining its mode of action. 
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Chapter 2. THE ROLE OF AGA IN SUPPRESSION OF THE FIREBLIGHT 
PATHOGEN 
Introduction 
The biological control of Fire Blight will most likely involve a consortia of numerous 
complementary microbes (Johnson and Stockwell, 1998; Vanneste, 1996). The isolation of 
microbes suitable for use in such a consortia requires a simple and reproducible laboratory assay 
that is predictive of Fire Blight suppression in the field. Since E. amylovora grows on slices of 
immature pear and apple fruits and produces a sticky exudate considered representative of Fire 
Blight disease, an assay was developed to assess the ability of antagonistic bacteria to inhibit 
exudate production (Beer and Rundle, 1983). This assay was used to demonstrate the 
suppression of E. amylovora byE. herbicola strain EhC9-1, and by crude preparations of 
antibiotic from cultures of this strain (Ishimaru et aI., 1988). The fruit slice was further 
developed as a quantitative assay based on the proportion of infected slices, and the severity of 
ooze production (Wilson et aI., 1990). However, Wilson et al (1990) reported that the fruit slice 
assay gave inconsistencies in measurement of strain efficacy from one assay to the next, and 
that the assay does not provide a measure of Fire Blight suppression in blossoms. For example, 
of 34 E. herbicola isolates assessed using a pear slice assay, the two most suppressive strains 
and a very poor suppressor chosen as a control strain were subsequently found to have similar 
efficacy in planta. Inconsistencies between the pear slice assay and in planta assays were also 
noted for a selection of potential Fire Blight control strains from different genera (McLaughlin 
and Roberts, 1993). Vanneste (1996) argues that the fruit slice assay is valid as a qualitative 
assay, if carried out with care. He has further developed the fruit slice assay using small plugs 
of pears which reduced between-assay variation, since many plugs could be obtained from a 
single fruit (a potential source ofvariation)(Vanneste et aI., 1996). 
The biological control of E. amylovora occurs when the stigmatic surface of a blossom is 
colonized by an antagonist resulting in the exclusion of the pathogen (Johnson and Stockwell, 
2000). There appears to be little information relating the environment of a fruit slice to the 
stigma of a flower where E. amylovora and antagonistic saprophytes interact (Hattingh et aI., 
1986). Because these environments are probably considerably different, and since the degree of 
antagonism in the fruit slice assay is not necessarily predictive of suppression in blossoms, 
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(Wilson et aI., 1990), the efficacy of each potential Fire Blight control strain currently needs to 
be assessed in planta (Johnson and Stockwell, 2000). Wilson et al (1992) used an assay that 
involved competition between E. amylovora 19 and E. herbieola EhHL9N13 on the stigma 
of hawthorn flowers on branches maintained in controlled conditions. They found that the 
population of Ea519 was significantly reduced when the stigma was pre-inoculated or even co-
inoculated with EhHL9N13. EhHL9N13 produces a broad-spectrum antibiotic that is active 
against E. amylovora on potato-dextrose agar plates, however since antibiotic-minus mutants 
were not competed against E. amylovora in the in planta assay, the influence of the antibiotic in 
Fire Blight suppression was not directly measured. Furthermore, Wilson et al (1992) did not 
assess the ability of EhHL9N13 to colonize flowers on which Ea519 had already established, 
which has relevance to the timing of orchard application. When resources are available, the 
efficacy of a biological control agent can be assessed in large scale orchard trials such as those 
carried out by Johnson et al (1993), who assessed the inhibition of E. amylovora spread by bees 
to flowers that had been pre-inoculated with P. jluoreseens A506 or E. herbieola EhC9-1. 
Large scale orchard assays are impractical for screening saprophytes for potential Fire Blight 
control strains. To simplify these assays, but maintain in planta realism, Pusey (1997) 
developed an alternative assay based on the competition between E. amylovora and an 
antagonist on the stigma of detached flowers. Pusey also manipulated the environment of pear 
trees to obtain blossoms almost year-round. Since the suppressive activity of twelve antagonists 
against E .amylovora on the detached flowers was not significantly different to that suppression 
in whole trees both in glass houses and in the field, this assay appears to be a good measure of 
the efficacy of a potential biological control strain (Pusey, 1997). Very recently, Mercier and 
Lindow (2001) developed an alternative method for rapidly assessing the populations of E. 
amylovora on numerous flowers. They created an E. amylovora derivative strain containing an 
ice nucleation gene (ieeC) from Pseudomonas syringae that caused chilled flowers to freeze at 
higher temperatures than they would otherwise. The number of flowers frozen at a set 
temperature provided an approximate measure of the E. amylovora population present on a 
flower, and therefore the influence of an antagonist on that population (Mercier and Lindow, 
2001). 
The current investigation was designed to test the hypothesis that antibiotic production by 
Ehl087 is important for suppression of E. amylovora strain Ea8862. Strong support for this 
proposition was provided by Keams (1993) who showed that, in contrast to Ehl087, antibiotic-
minus mutants of Eh 1 087 do not prevent the development of fireblight symptoms on immature 
pear slices. The first question that remained to be answered was whether or not Eh1087 
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produces antibiotic (AGA) in the environment provided by sliced immature fruit. If not, then 
this would suggest that AGA production is not required for Ea8862 suppression but is linked to 
some other factor that is required for such suppression such as competition. A second question 
was whether or not AGA production was important for suppression of Ea8862 on the stigma of 
apple blossom, a situation more relevant to the environment in which these organisms compete 
in nature. 
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Methods 
Extraction of AGA from apple slices 
Apple slices were inoculated with Eh1087 as described by Keams (1993), and sampled 
destructively every day for five days. At each sampling point, apple slices were suspended in 
five ml I-A minimal salts, vortexed for 30 s, and sonicated for 10 s with a Transon Ultrasonic 
Cleaner at the top setting (6), before a 10 III sample was taken to enumerate CFU. The 
remaining medium was centrifuged to remove solid debris, and extracted with 5 ml chloroform 
as described in chapter 4. The chloroform layer was removed and dried. The chloroform-
extracted solids were dissolved in 50 III I-A medium and assessed for antibiotic activity against 
a lawn of Ea8862 grown on LB. The efficiency and reliability of the procedure was calibrated 
using apple slices spiked with a measured amount of stock AGA extract. 
Blossom assays 
Blossom assays were carried out in a similar manner as that described by Pusey (1997). 
Unopened blossoms were collected from Malus x domestica during September 2000, and 
individually placed in eppendorf tubes containing 10 % sucrose (Fig. 2.1A). Bacterial strains 
Ea8862, Ehl087, and EMAGA (Table AI), were grown overnight in LB with full antibiotic 
selection, and resuspended to the following concentrations (CFU.mtl) in phosphate buffer (10 
mM, pH 7.0) containing 0.03 % Tween 20; Ea8862, 1 x 107; Ehl087, 1 x 108, EMAGA, 1 x 
108• One microlitre of suspended cell solution, containing 104 or 105 CFU, was placed on each 
stigma of a blossom using a Gilsen pipette (Fig. 2.IA). The blossoms were arranged in a rack 
placed on moist towels in an air tight container, and incubated at 25°C. After 0, 12, 24, 48, and 
72 h, 24 flowers from each treatment were sacrificed to enumerate bacteria. The sample size 
was subsequently reduced to eight groups of three flowers. For each blossom the stigmas and 
styles were aseptically removed from the remainder of the flower parts (Fig. 2.lB). The stigma 
and styles from three blossoms were placed in an eppendorf tube containing one ml of I-A 
medium with 10 % glycerol. Bacteria were separated from the stigma by 10-15 s vigorous 
vortexing and 60 s sonication, and immediately frozen at -80°C. To enumerate the bacteria 
present on the stigmas, each frozen sample was thawed, diluted and plated on LB media 
supplemented with the appropriate antibiotic as follows; Ea8862, Nal; Eh1087, Rf; and 
EhL1AGA, Rf and Sm. Blossom assay data was analyzed using S-Plus version 4.5 (Mathsoft 
hlC.) with assistance and expertise provided by Gary Houliston, P AMS Dept., University of 
Canterbury, New Zealand. 
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Results 
2.1. Ehl087 produces AGA when grown on apple slice 
Eh1087 was chosen from a pool of orchard isolates because it demonstrated consistently strong 
suppression of E. amylovora in an immature pear slice assay (Kearns and Hale, 1995). 
Antibiotic-minus mutants of Eh1087 did not inhibit E. amylovora strain Ea8862 in this assay 
demonstrating the importance of AGA for the suppression of Ea8862 in an accepted, albeit 
artificial, fireblight assay system (Keams and Mahanty, 1998). Two of the early goals of the 
present investigation were to confirm that Ehl087 produced AGA during the immature fruit 
assay, and to determine the timing of AGA production by Eh 1 087 in this environment. A 
simple procedure was developed for the recovery of AGA from an immature apple slice, which 
allowed the recovery of ca. 20 to 45 % of the AGA applied to an apple slice (see materials and 
methods). The extraction of AGA from apple slices inoculated with Eh1087 yielded AGA over 
the first 36 to 48 hours of the assay, as the Ehl087 population size increased (data not shown). 
Generally, greater than 108 Ehl087 cells per slice were required for AGA to be detected. After 
48 hours the Eh1087 population stabilized and no AGA could be detected. No antibiotic 
activity could be extracted from apple slices in which the AGA-minus Eh1087 derivative 
Eh~AGA was grown, confirming that AGA produced by Eh1087 was isolated by the extraction 
procedure. The timing of AGA production by Eh1087 grown on immature apple slices is 
similar to that of broth cultures (see section 4.1.1) and supports the proposal that periods of 
population increase or growth are required for AGA production by Ehl087. 
2.2. Competition between Eh1087 strains and Ea8862 on the stigma of apple blossoms 
2.2.1. Experimental design 
The stigma is the proposed site of interaction between E. amylovora and E. herbicola 
(Stockwell et al., 1998; Thomson, 1986; Wilson et al., 1992). To investigate the role of AGA in 
the suppression of Ea8862 by Eh1087 in a situation more representative of the real world than 
the fruit slice assay, an apple blossom assay similar to that described by Pusey (1998) was 
undertaken. Initially, a defined inoculum of two bacterial strains was applied to the stigma of 
apple blossoms that were individually maintained in 10 % sucrose in the laboratory. Recovery 
and enumeration of the bacteria from the blossoms at various time points gave a measure of the 
outcome of competition between the two strains. Eh 1087 was expected to produce AGA in the 
conditions of the blossom assay since the populations ofEhl087 on apple blossoms were shown 
to multiply rapidly during petal drop (Kearns and Hale, 1995), and antibiotic production had 
coincided with Eh1087 growth in vitro (see Chapter 4). Additionally, petal drop was induced 
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early in c ut flowers in which senescence is sped up, which could have enhanced the growth of 
Eh 1087. 
During the first season, a preliminary blossom assay was curried out that retrospec tive ly served 
to demonstrate the large va riation in bacterial populations between flowers. On the busis of the 
data ge nerated in the first assay, a second ussuy was designed and carried out in which each 
sampling point was composed of eight repl icates of three flowers (24 flowers total) for each 
treatment. Flowers were sampled as desc ribed in materials and methods (Fig. 2.1). The 
influence of AGA on the growth of b8862 was asscs,~ed by comparing populations of Ea8862 
that had competed against Eh 1087 with populations of Ea8862 that had competed against 
Eh~AGA. The importance of stigma colonization in the interactions between Ea~~62 and 
Eh IOK7 or Eh~AGA was also assessed by varying the time at which flowers were inocu lated 
with each strain. Three concurrent assays were carried out: A) Eh 1087 or Eh~AGA were 
applied 24 hours hefore Ea8~62 ; B) all bacteria were app lied together; C) Ea8862 was applied 
24 hours before Eh 1087 or Eh~AGA. Binomial data generated from these experiments is 
presented in Appendix AS. The binomi a l data generated by thi s experiment were analyzed 
using a generalized linear model to compare the influence of AGA production (Eh 1(87) and 
comp tilive exc lusion only (Eh~AGA) on the proportion of bactelial cells on the stigma thaI are 
Ea8862 (over time). 
A) B) 
Figure 2.1. Stigma inoculation and sampling 
A) One Illicrolitre of a hactcrial suspension was placed on the stigma of apple hlossol11s 
maintained in an eppendorf tube containing 10 eli sLicrose. B) Separation of the sti!,!ll1as and 
styles from other flower parts. 
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2.2.2. AGA production does not disadvantage the growth of Ehl087 on stigma 
Before the influence of AGA production on Ea8862 suppression was detennined it was 
necessary to compare the population growth rates ofEhl087 and EMAGA to assess whether or 
not the production of AGA is disadvantageous in planta. The increase in populations of 
Ehl087 and EMAGA did not vary significantly over the 72 hour course of the experiment, 
indicating that AGA production did not influence the growth rate ofEhl087. 
2.2.3. AGA production by Ehl087 has a significant role in the suppression ofEa8862 
The ability of Ea8862 to colonize stigma already populated with Ehl087 was significantly 
lower (P < 10'6, slope -3.6) than the colonization of a stigma colonized with the AGA-minus 
mutant Ehl1AGA. Furthennore, there was no significance difference in the effect of antibiotic 
production over time (P = 0.3). Interestingly, Ea8862 still struggled to get established on stigma 
populated with EhAAGA, suggesting that once established Eh1087 may exclude competing 
strains by antibiosis and competitive exc~usion (Fig. 2.2). When Eh1087 strains and Ea8862 
were co-inoculated onto stigmas (Assay B), AGA production was again found to playa 
significant role in the suppression of Ea8862 (P < 10-7, slope = -3.7). Assay B contrasted with 
Assay A in that there was a significant positive effect of AGA production over time (P < 10.7,), 
although this effect was weak (slope +0.05). This finding indicates that AGA production is 
particularly influential when Ea8862 and Ehl087 are competing to establish in the same niche 
and is clearing illustrated in Figure 2.2 (Assay B). 
2.2.4. Ehl087 cannot rapidly colonize a stigma populated with Ea8862 
When stigmas were inoculated with Ea8862 24 h before the introduction of Ehl087 or 
Ehl1AGA (Assay C), the population of Ea8862 increased only slightly once these strains were 
added (Fig. 2.2). In this situation, the influence of AGA production was not significant (P = 
0.4), demonstrating that once Ea8862 is established on the stigma, the potential to produce AGA 
does not give Ehl087 any advantage over EhAAGA in colonizing the stigma. Because two 
lines of evidence suggest that Ehl087 produces AGA during periods of growth (sections 2.1, 
4.1.1), it is possible that the population of Eh 1087 increases too slowly during colonization of 
an already populated stigma to produce sufficient AGA for significant reduction of the Ea8862 
population. This is particularly likely given that the population of Ehl087 increases more 
slowly and to a smaller final size during Assay C than in either Assay A or B in which 
unpopulated stigma offered a niche for greater Ehl087 population increase (Fig. 2.2). 
Unfortunately, AGA production by Ehl087 during growth on the stigma was not assessed due 
to experimental difficulties. 
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Figure 2.2. Competition between bacteria on the sti gmas of apple blossom 
The change in populations of LaXX62. I: h 1087, and ~hb.AGA grow n in competition on the 
stigma of apple tlowers. Data is repurted in Appendix AS . Each data point represents the 
average of eight replicates of the hacterial population prese nt on stigmas fro m three di f ferent 
bl()ss()llls. 
Assay A: Eh I OX7 or Ehb.AGA were inoculated 24 h before ~aX X62. 
Assa y 8: hoth COIll peting bacteri a were eo-i nocu I ated. 
A ssay C: Ea8X62 was inoculated onto sti gma 24 h before Eh 1087 or Ehb.AGA . 
Assays A and C were sampled once the sti gma were inoc ulated with the second bacterial 
speci es. whereas Ass ay 8 \hlS assayed from 12 h after both bacterial spec ies \\'l:rc plilced on 
the stigma . 
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Discussion 
Fruit slice assays may be inappropriate for the analysis of Ehl087 efficacy 
The efficacy of Eh1087 as an antagonist of E. amylovora strain Ea8862 was previously 
measured using plate assays, and an immature fruit assay (Keams, 1993; Keams and Hale, 
1995). Eh1087 was shown to produce an antibiotic that formed large clear zones of inhibition 
against lawns of Ea8862 grown on nutrient media plates (for example see Fig. 4.5), and Eh1087 
antibiotic-minus mutants ofEh1087 did not suppress the development offireblight symptoms in 
immature pear slices treated with Ea8862. However, the production of AGA by Eh1087 
cultured on fruit slices was not assessed. During this investigation the development of methods 
to isolate and concentrate AGA led to the demonstration that this bacteria does produce AGA 
when grown on immature apple slices. However, antibiotic was only detected during periods of 
growth similar to the production of AGA by Eh1087 grown in broth cultures (see section 4.1.1). 
Ea8862 that were not killed during the growth period of Eh 1 087 can readily re-establish on the 
fruit and eventually cause disease symptoms, such as oozing tissue, to develop. For this reason 
data from an immature fruit assay needs to 'be interpreted carefully with relation to the timing of 
AGA production and E. amylovora suppression. For instance, on the basis of a similar 
immature fruit assay, Vanneste et aI, (1996) proposed that Eh 1 087 was significantly worse at 
suppressing E. amylovora than two other strains of E. herbicola, EhC9-1, and Eh252. However, 
given that the flesh of fruit is not the probable site of interaction between Ea8862 and Eh1 087, 
and that the fruit tissue appears to poorly support the growth ofEh1087, this assay offers no real 
advantage over the plate assay to assess the suppression of E. amylovora by E. herbicola. 
The role of AGA production in Ea8862 suppression assessed using a stigma-based assay 
The role of AGA production by Eh1087 in the suppression of Ea8862 was assessed in a 
blossom assay more representative of the niche in which these bacteria compete in the orchard 
than the fruit slice assay (Pusey, 1997; Thomson, 1986; Wilson et aI., 1992). The stigma is a 
moist, nutrient rich environment that supports the growth of many bacteria, whereas few 
bacteria are found on other flower parts (Stockwell et aI., 1999). It is here that E. amylovora are 
thought to multiply, before moving down the style to the hypanthium to initiate a fireblight 
infection (Thomson, 1986). The multiplication of E. amylovora on the stigma can, however, be 
inhibited by competition from other epiphytic bacteria, particularly species of E. herbicola 
(Hattingh et aI., 1986; Rundle and Beer, 1987; Wilson et aI., 1992). Since the stigma is the 
probable site of interaction between E. amylovora and E. herbicola, it was a logical 
environment in which to assess the role of AGA in the suppression of E. amylovora Ea8862. 
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As with other bacteria investigated for their fireblight biocontrol potential, Eh1087 was found to 
multiply rapidly and fully populate a stigma with ca. 107 cells within 24 h (Fig. 2.2). AGA 
production was not assessed on blossoms. However, since Eh1087 multiplies readily on 
stigmas it is likely to produce AGA since AGA production correlated with periods of growth 
both in broth cultures (section 4.1.1.) and in immature fruit (section 2.1). Additional evidence 
for AGA production in planta is provided by the significant difference in suppression of Ea8862 
by Eh1087 and Eh,1AGA (see below), which are isogenic except for the presence of the AGA 
gene cluster in Eh1087. 
To detennine whether or not the production of AGA was necessary for suppression of Ea8862 
in planta, populations of Ea8862 competed against the potential AGA-producer Eh1087 were 
compared with Ea8862 populations competed against the AGA-minus mutant EMAGA. In this 
regard the tenn suppression refers to the population of Ea8862 and not to the development of 
disease symptoms, however it is generally accepted that the risk of fireblight infection increases 
as the population of E. amylovora on stigma increases (Johnson and Stockwell, 1998). The role 
of AGA production was also compared with all other suppressive influences (including 
competitive exclusion), by enabling either the pathogen or the antagonist to populate the stigma 
for 24 h before introducing the competing bacteria. Two findings suggest that primary 
succession of a new stigma is a crucial process in detennining the efficacy of biocontrol by 
Eh1087. Firstly, stigma populated with Eh,1AGA were poorly colonized by Ea8862, and 
secondly, stigma populated with Ea8862 were poorly colonized by Eh1087. AGA production 
significantly improves the antagonistic properties of Eh1087 relative to Eh,1AGA, but only 
when competing to populate new stigmatic surfaces, or for the exclusion of invading bacteria 
once a stigma is colonized. Similarly, the antibiotic-producing E. herbicola strain EhHL9N13 
also suppressed E. amylovora during pre-emptive and competitive stigma colonization (Wilson 
et al., 1992). In contrast, the suppression of E. amylovora strain Ea8R was only significantly 
reduced by if stigma were pre-inoculated and not co-inoculated with P. fluorescens A506 
(Wilson and Lindow, 1993). By implication, antibiotic production may give E. herbicola an 
advantage during competition for colonization of the stigma. AGA production does not enable 
Eh1087 to colonize Ea8862-populated stigma significantly better than EMAGA, but Ea8862 
suppression can happen in the absence of AGA production (Fig. 2.2), competitive exclusion 
appears to be more a more important factor in Ea8862 suppression than AGA production. 
A common proposal that has emerged from competition experiments involving E. amylovora 
and antagonistic epiphytes is the need to populate the stigma with the antagonist as soon after 
anthesis (flower opening) as possible (Johnson and Stockwell, 1998; Johnson et al., 2000; 
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Stockwell et al., 1999; Wilson et al., 1992). When blossoms first open there is little indigenous 
micro flora present on the stigma. The microflora eventually become established when vectors, 
such as bees, come into contact with newly opened flowers. However, rather than relying on 
natural vectors to transfer bacteria applied to early opened flowers to late opened flowers, 
Johnson and Stockwell (1998) recommended application of antagonistic bacteria at least twice 
during flowering. It is expected that effective fireblight suppression by Ehl087 would also 
require application of Eh1087 to flowers as soon as possible after anthesis, since AGA 
production by Ehl087 gives a significant competitive advantage when pre- and co-inoculated 
with Ea8862, but does not enable Ehl087 to out-compete Ea8862 that are already established on 
a stigma. The ability of Ehl087 to suppress co-inoculated Ea8862 may increase the period in 
which the bacteria can be applied to orchards and offer effective protection against fireblight 
relative to the commercially available fireblight control strain, Pseudomonas fluorescens strain 
A506 (BlightBan A506, Plant Health Technologies, Boise, ill) which inhibits E. amylovora 
when pre-inoculated but not when coinoculated (Wilson and Lindow, 1993). 
There remains the untested possibility that isolated and concentrated AGA, applied with 
Ehl087, may kill the indigenous microflora present on a flower, and enable Eh1087 to become 
established. This approach could potentially reduce orchard treatments to one application 
reasonably late in the bloom. Similarly, Johnson et al (2000) found that the co-application of 
streptomycin and E. herbicola strain C9-l S (SmR) increased the proportion of C9-l S relative to 
the indigenous flora, however this effect was lost in orchards that had been treated with 
streptomycin for many years. The increasing emergence of streptomycin resistance amongst 
bacterial species present in the orchard, both in E. amylovora (Lindow et al., 1996; Stockwell et 
al., 1996; and references therein) and in other indigenous microflora (Johnson et al., 2000), is a 
major issue in the control of fireblight. In this regard, Ehl087 and AGA, a new antibiotic that 
has not been used artificially to control the Fire Blight pathogen, could offer a useful alternative 
to the currently used control measures. The combined application of Ehl087 with purified 
AGA to remove bacterial competitors and aid the establishment ofEhl087 during flowering is a 
logical approach but one that requires further investigation. 
The current investigation confirmed the significance of antibiosis as a mechanism for the 
suppression of E. amylovora by Ehl087 in situ. Thus, further investigation of the antibiotic and 
the genes required for its synthesis were warranted. The development of Ehl087 as a BCA 
however, requires further investigation. The efficacy of EHI 087 has not been demonstrated in 
orchard trials, and the strain has not been assessed for ice-nucleation activity or induction of 
fruit russeting, features that may exclude Ehl087 as a useful BCA (Johnson and Stockwell, 
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1998). Assuming Eh1087 has favorable properties and good efficacy in the orchard, its use as a 
BCA would also require the assessment of methods for orchard application involving current 
orchard practices. Furthermore, the use of Eh1087 with other Fire Blight antagonists, and the 
isolation of strains able to resist current chemical Fire Blight controls needs to be assessed 
(Vanneste et al., 1995; Vanneste et al., 1995). The findings presented in the following Chapters 
indicate that Eh1087 is suitable for development by molecular methods for enhanced and 
extended antibiotic production in various conditions. 
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Chapter 3. A GENETIC ANALYSIS OF AGA PRODUCTION By EHI087 
Introduction 
Modification of a biological control agent by molecular methodologies may be of particular use 
in the development of a Fire Blight control regime, in which it is proposed that a consortia of 
different agents with different suppressive mechanisms will be the most successful approach 
(Johnson and Stockwell, 1998; Johnson and Stockwell, 2000; Vanneste, 1996). As stated by 
Dunne et al (1996) 'the cloning and characterization of genes involved in the production of a 
biocontrol metabolite offers possibilities for the improvement of biocontrol agents'. However, 
before a biological control strain can be improved by genetic manipulation, the genetic basis 
underlying the suppression mechanism needs to be fully characterized. Pathways that have been 
sufficiently described may have the potential to be manipulated to increase antibiotic 
production, or the range of environments in which the organism produces antibiotic, or even to 
create novel antibiotics. 
The antibiotic produced by Eh 1 087 has different properties to all other currently described 
antibiotics produced by E. herbicola strains (discussed in Chapter 4). Keams (1998) had also 
found that four putative linked genes were involved in antibiotic production by Eh1087 
suggesting that a cluster of genes are involved in this process. Therefore, as this chapter 
presents an investigation into the genes required for antibiotic production by Eh1087, it is useful 
to look at antibiotic production by micro-organisms in general to find common features of 
antibiotic gene clusters. Almost all known naturally synthesized antibiotics are produced by 
prokaryotic actinomycetes or eukaryotic fungi, and the antibiotic biosynthesis pathways in these 
organisms have received considerable attention due to the pharmaceutical value of their 
products (Kirby, 1992). General themes in the organization of genes for antibiotic synthesis 
have emerged. Such genes are usually organized in clusters, and in some cases as subclusters; 
both arrangements offer a mechanism to temporally coordinate the production of appropriate 
enzymes or enzyme complexes as they are required (Martin and Liras, 1989). Others have 
suggested that the structure of gene clusters arises from the evolutionary processes that created 
them (Lawrence and Roth, 1996). It has also been proposed that the ordered expression of the 
genes within a cluster enables each enzyme to act on the synthesized product of each earlier 
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enzyme, thereby reducing the randonmess by which an enzyme locates its substrate (Martin and 
Liras, 1989). One or more resistance genes are often found within antibiotic biosynthesis gene 
clusters and are coordinately expressed with the biosynthesis genes to prevent the suicide of the 
organism producing the antibiotic. Finally, antibiotic production is usually affected by 
environmental conditions; for instance many antibiotics and other secondary metabolites are 
produced as resources for growth become exhausted and unwanted metabolites accumulate. 
Thus, the expression of antibiotic synthesis genes is often regulated by environmental signals, 
particularly during entry into stationary phase when there are insufficient resources for 
continued population increase. 
Many antibiotic gene clusters have been isolated from species of Streptomyces (for examples 
see Bormann et aI., 1996; Hong et aI., 1997; Kakavas et aI., 1997; McHenney et aI., 1998). The 
first steps in characterizing an antibiotic gene cluster are to locate and clone it, and to attempt 
expression of the entire gene cluster in a heterologous host. A common approach is to screen a 
library of large, 20-50 kbp clones representing all the genomic DNA from an antibiotic 
producing organism, for the ability to produce antibiotic in a heterologous host. Because a gene 
cluster may not be correctly expressed in a new host organism, alternative approaches may be 
needed. McHenney et al (1998) located the Daptomycin gene cluster by determining the 
position of transposon insertions responsible for an antibiotic-minus phenotype in Streptomyces 
roseosporus. Bormann et al (1996) used a reverse genetics approach to clone a section of DNA 
required for the expression of two proteins involved in Nikkomycin synthesis. The similarities 
between at least some components of antibiotic pathways in species of Streptomyces enabled 
Kakavas et al (1997) to successfully isolate a polyketide synthase (PKS) from a Niddamycin 
gene cluster using a pair of degenerate primers based on PKS genes in other antibiotic gene 
clusters. Even more simply, Hong et al (1997) hybridized a PKS gene from Streptomyces 
coelicolor A3(2) to genomic libraries of various Streptomyces species to isolate clones 
containing cluster of PKS genes responsible for the synthesis of Tetrangulol and 
Tetrangomycin. Once gene cluster clones are isolated from a genomic library, they can often be 
expressed in a genetically tractable heterologous host such as E. coli, making further 
characterization and manipulation of these clusters far easier than it would otherwise be in 
Streptomyces species. 
Of the antibiotic-producing Erwinia herbicola species with potential as Fire Blight antagonists, 
there is very little information about the genes involved in antibiotic synthesis. Examples of 
preliminary investigations into the genes involved in antibiotic production by E. herbicola are 
provided by Vanneste and Yu (1996) for strain Eh252, and by Wright et al (2001) for strain 
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Eh318. The DNA region required for antibiotic production by Eh252 was cloned and localized 
to a 2.4 kbp fragment (Vanneste and Yu, 1996). Therefore, it is unlikely that there are more that 
one or two genes involved in the production of this antibiotic, and since it is susceptible to 
protease, it may be a peptide antibiotic encoded by a single gene (Vanneste et aI., 1992). Eh318 
was originally thought to produce a single antibiotic (Wodzinski et aI., 1990), however two 
different cosmids recently isolated from a genomic library of this strain each transformed E. coli 
DH5a to produce antibiotics with different properties (Wright et aI., 2001). These antibiotics 
were given the trivial names, Pantocin A and Pantocin B. Wright et al (2001) created a double 
mutant of Eh318 that could not produce Pantocin A or B. This mutant was not inhibitory to E. 
amylovora, but was inhibitory to a selection of different bacteria, demonstrating that Eh3l8 
produces at least three antibiotics. However, for both Eh252 and Eh318, no genes or gene 
clusters required for antibiotic production have been characterized in any detail as far the author 
is aware. An Erwinia species for which an antibiotic gene cluster has been described is E. 
carotovora strain GS101. GS101 contains a cluster of eight car genes that are responsible for 
the synthesis of a f3-lactam antibiotic, 1-carbapen-2-em-3-carboxylic acid (McGowan et aI., 
1997). Two of these genes, carF and' carG, provided some resistance to the antibiotic 
(McGowan et aI., 1996). As with other antibiotic gene clusters, each of these genes are 
transcribed in the same direction. This gene cluster was of particular interest at the beginning of 
the present investigation because Keams and Hale (1996) had previously observed that the 
antibiotic of Eh1087 was inactivated by relatively high concentrations of f3-lactamase, and 
predicted that it may have been a f3-lactam antibiotic. However, since it is now lmown that 
Eh1087 produces a phenazine antibiotic (Chapter 4), a brief overview of phenazine gene 
clusters is warranted. 
hwestigations into the genetic and biochemical mechanisms responsible for phenazine 
production have so far focused on Pseudomonas spp., in which phenazine production is often 
important for the specificity and efficacy of these organisms as biocontrol agents. For instance, 
the production of phenazine-1-carboxylic acid (PCA) by P. fluorescens 2-79 is required for 
suppression of a variety of fungal diseases including take-all, a wheat-root disease caused by 
Gaeumannomyces graminis var. tritici (Thomashow and Weller, 1988; Thomashow et aI., 
1990). Similarly, phenazine-1-carboxamide (PCN) produced by P. chlororaphis PCL1391 
suppresses tomato root rot caused by Fusarium oxysporum f. sp. radicis-lycopersici, however 
PCA produced by P.fluorescens 2-79 does not inhibit this disease (Chin-A-Woeng et aI., 1998). 
A cluster of seven genes (phzA - phzG) cloned from P. fluorescens 2-79 by Mavrodi et aI. 
(1998) was shown to be sufficient for PCA production. The transformation of P. fluorescens 
SBW25 with this gene cluster resulted in a strain that could produce PCA and was more 
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effective at reducing damping-off disease of pea seedlings caused by Pythium ultimum (Timms-
Wilson et aI., 2000). In a recent screening of phenazine-producing Pseudomonads, the seven-
gene PCA operon was found in strains of P. aeruginosa, P. aureofaciens, P chlororaphis, and 
P. fluorescens but not in isolates of Burkholderia cepacia, Burkholderia phenazinium, or 
Brevibacterium iodinum, suggesting that a second genetic mechanism may exist for the 
synthesis of the phenazine nucleus in these phenazine producers (Mavrodi et aI., 2001). P. 
aeruginosa possesses two functional and nearly identical copies of the PCA gene cluster in 
different areas of the chromosome. 
Mavrodi et aI. (1998) proposed a biochemical model for the synthesis of the phenazine nucleus 
by the products of the PCA gene cluster that was supported, with some modifications, by the 
recent findings of McDonald et aI. (2001). Initially PhzE catalyses the transfer of an amide 
nitrogen from glutamine to chorismic acid, creating 2-amino-2-deoxyisochorismic acid, which 
is converted to trans-2,3-dihydro-3-hydroxyanthranilic acid (DHHA) by the protein PhzD. 
PhzF and PhzG are absolutely required for dimerization of two molecules of DHHA to create a 
phenazine nucleus in the form of PCA.· The mechanism of this dimerization is currently 
unlmown, although the data of McDonald et aI. (2001) indicates that the dimerization reaction is 
enhanced by both PhzA and PhzB. An alternative mechanism was considered likely for 
synthesis of the phenazine nucleus in Streptomyces spp., although at this stage the genetic basis 
for this conversion has not been investigated (Van't-Land et aI., 1993). 
The PCA operon is present in many Pseudomonas species, however these species can produce 
many different types of phenazine antibiotics. These phenazines arise from modification of the 
common intermediate, PCA, by the product of one or more genes located outside the cluster of 
genes that make up the PCA operon. For instance, the P. chlororaphis phzH gene is required 
for the conversion of PCA to phenazine-1-carboxamde (PCN) (Chin-A-Woeng et aI., 2001). 
Similarly, phzO, encoded immediately downstream of the PCA operon in P. aureofaciens 30-
84, and phzS, encoded downstream of PCA operon 1 in P. aeruginosa PA01, are responsible 
for the hydroxylation of PC A to create 2-hydroxyphenazine-carboxylic acid (2-0H-PCA) and 1-
hydroxyphenazine (1-0H-PHZ), respectively (Delaney et aI., 2001; Mavrodi et aI., 2001). In 
addition, the protein PhzS is required for the conversion of PCA to pyocyanin by P. aeruginosa 
PA01 in association with the product ofphzM, located immediately upstream of PC A operon 1. 
P. aeruginosa P AO 1 also possesses a homolog of the P. chlororaphis phzH gene some distance 
from either of the PCA operons. Mavrodi et aI. (2001) showed that P. aeruginosa PA01 genes 
phzH, phzS, or both phzS and phzM, conferred on E. coli JM109 the ability to convert 
exogenous PCA into PCN, 1-0H-PCA, or pyocyanin, respectively. The potential for altering 
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phenazine production and therefore the range of organisms able to be suppressed by 
Pseudomonas spp. was demonstrated by Chin-A-Wong et al (2001) who transferred phzH from 
p. chlororaphis PCL1391 to P. fluorescens 2-79 creating a strain that could convert PCA to 
PCN and thereafter suppress tomato root rot. 
During the present investigation Eh1087 was found to produce the phenazine antibiotic, D-
a1anylgriseoluteic acid (AGA, see Chapter 4). AGA was found to be active against a broad 
range of Gram-negative and Gram-positive organisms, including the Fire Blight pathogen E. 
amylovora. The finding that antibiotic production by Eh1087 was required for suppression of E. 
amylovora in fruit slice assays led to investigations into the genetic basis for antibiotic 
production by Eh1087 (Keams, 1993). Initially, Keams (1993) isolated six mutants defective 
for antibiotic production from 800 TnphoA insertion mutants. DNA adjacent to the TnphoA 
insertion in one of these mutants, EhA17g, was cloned and hybridized to a library of Eh1087 
genomic cosmid clones. Of 13 cosmids that hybridized to this probe, six restored antibiotic 
production to EhA17g, however some variability in antibiotic production among the 
transformants was observed. Further variation in antibiotic production was observed in the 
remaining five mutants, EhAllg, EhA12e, EhA19f, EhA20f, and EhA46a, harboring cosmids 
pLA272, pLA215, or pLA255 (Fig. 3.1). Hybridization analyses also showed that the mutated 
locus was located on a ca. 200 kbp plasmid in Eh1087 (Keams and Mahanty, 1998). Analysis 
of the DNA sequence in and around the locus revealed four potential open reading frames that 
had been interrupted by transposon insertions in various mutants. During the present study 
these ORFs and other genes associated with antibiotic production by Eh1087 have been 
designated ehp, for lirwinia llerbicola 12henazine, to differentiate them from the phenazine genes 
(Phz) described in Pseudomonas species. 
Initial research into the genetic basis for antibiotic production by Eh1087 by Keams provided a 
good starting point for elucidating and describing the genetic region involved in antibiotic 
production. At the start of the present investigation, very little was known about the following: 
i) the extent of the region involved in antibiotic production, ii) the function, and regulation of 
expression of genes within this region, iii) whether this region is sufficient for antibiotic 
production or if genes outside this region are required for antibiotic production, or even iv) how 
Eh 1087 protects itself from the antibiotic that it produces. These questions formed the basis for 
the investigations reported in this chapter. 
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Methods 
Creation of Ehl087 mutants with defined transposon insertions 
DNA from the region to be mutated was ligated into a suitable vector, usually pBR322, and 
subjected to random insertional mutagenesis with transposons mini-TnIO-LK, mini-Tn5phoA, 
or miniMudII [Kleckner et al., 1991; Casti1ho et al., 1984; de Lorenzo et al., 1990). The 
resulting transposon insertions were mapped by analysis of restriction enzyme fragments, and 
p1asmids containing appropriate insertions were introduced to Eh1087. Recombinant 
derivatives of Eh1087 were screened for loss of the plasmid-encoded antibiotic resistance 
marker and for maintenance of the transposon-encoded antibiotic resistance marker following 
homologous recombination between the introduced plasmid and the Eh1087 genome. When 
recombination was not successful using these p1asmids, insertions were transferred, again by 
homologous recombination, to an appropriate cosmid in an E. coli recA+ host. Recombination 
between the cosmid carrying the transposon insertion and the genome of Eh1087 occurred at a 
high frequency because the large region of DNA either side of the transposon insertions enabled 
recombination to initiate readily. For all strains created by these processes, the predicted 
alterations in the restriction enzyme patterns due to transposon insertion were verified by an 
appropriate Southern hybridization (Appendix A1.5), and in some cases by restoration of the 
original Eh1087 genome by homologous recombination between the mutant genome and a 
plasmid containing the relevant region of wild-type Eh1087 DNA. 
Creation and isolation of random Ehl087 AGA-minus mutants 
Mini-Tn5lacZ2 transposon mutants of Eh1087 were generated using a simplified version of a 
published method (de Lorenzo et al., 1990). Briefly, miniTn5kmlacZ2 was introduced to 
Eh1087 on a suicide plasmid (pUT) by conjugation with E. coli S 17 -1 which possesses Apir to 
enable plasmid replication and RP4 mob function for conjugative transfer of the plasmid to 
Eh1087 RfZ recipient cells. Liquid cultures of E. coli S17-1 (pUT::mini-Tn5IacZ2) and Eh1087 
were grown overnight, the cells rinsed twice in fresh liquid media, mixed, and plated on LB-
agar plates supplemented with Rf, Km, and Xg. Because Rf has a bacteriostatic mode of action 
the E. coli donor cells were not killed and were able to donate pUT::mini-Tn5IacZ2 to the 
recipient Eh1087 (Rt-) on the selective media. No more than 50 Eh1087 mutants from each 
conjugation were screened for loss of AGA production to ensure independent transposon-
insertion mutants were isolated. If more than one mutant was isolated from a single 
conjugation, only those with obvious differences in colony morphology, AGA-production, or f3-
galactosidase activity were retained. Eh1087 transconjugants were transferred to Ea8862 lawns 
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grown on agar composed of rich media (LB) or defined minimal media (l-A), to isolate mutants 
unable to produce antibiotic when cultured on one or both one media types and to enumerate 
auxotrophic mutants. Antibiotic-minus mutants were subsequently purified on selective LB 
media. Each purified mutant was then cultured overnight in broth culture with full antibiotic 
selection and reassessed for antibiotic production. The remainder of each culture was divided; 
half was used to prepare genomic DNA, and half was stored at -80 DC in LB with 10 % 
glycerol. 
Insertion point cloning 
To clone the section of DNA containing mini-Tn5lacZ2 and the adjacent DNA from an Eh1087 
mutant, genomic DNA prepared from each mutant was digested with Pst1 or Sail, which do not 
cut within the transposon, ligated to pB1uescriptKS, and used to transform E. coli DHSa to ApR 
KmR. On occasion, the cloned DNA was further subcloned to provide suitable clones for DNA 
sequence determination. 
Transposon insertion mapping 
The position and orientation of transposon insertions within the ehp gene cluster was mapped by 
hybridizing cloned ehp gene cluster fragments to digested genomic DNA prepared from Eh1087 
ehp mutants. Genomic DNA prepared from each Eh1087 mutant was digested to completion 
with restriction endonucleases EcoRI, BamHI and EcoRI + BamHI, separated by agarose gel 
electrophoresis and transferred to a Hybond N+ membrane. To screen for mutants with single 
transposon insertions the fixed DNA was hybridized to a 3.2-kbp Not1 DNA fragment 
containing the kanamycin resistance gene present in mini-Tn5IacZ2. To localize the position 
and orientation of insertions in the Eh1087 ehp gene cluster to within SO-lOa bp, cloned DNA 
fragments from pBB7, pBESa, and pBESb (Table 1) were hybridized to the fixed genomic DNA 
to detect differences in fragment sizes between Eh1087 and the ehp mutant derivative strains. 
Minicell analysis 
The sizes of the Ehp proteins were assessed by E. coli minicell analysis. Homologous 
recombination was used to transfer 01 transposon insertions from mutants EhehpA-EhehpE to 
pBB7, from EhehpG-EhehpK to pBESa, and from EhehpM-EhehpO to pBESb. The derived 
recombinant p1asmids were introduced to the E. coli minicell strain P678-S4T. Each strain was 
cultured in 400 m1 LB for S - 6 h to an optical density of 1.0 at A6oo . Vegetative cells were 
sedimented by centrifugation (1000 g, 10 min, 4 DC) and discarded, and the remaining cells 
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were collected by further centrifugation (10000 g, 10 min, 4 QC). The cell pellet was 
resuspended in 2 ml BSG buffer (150 mM NaCl, 20 mM KH2P04, 40 mM Na2HP04, 0.1 gX1 
gelatin, adjusted to pH 7.4 with 2M KOH), and carefully laid on a linear sucrose gradient 
prepared by freeze-thawing 35 ml sterile BSG containing 20 % sucrose (Gibco BRL ultraPure) 
in clear 50 ml plastic centrifuge tubes. Sucrose gradients were centrifuged in an IEC model B-
22M centrifuge using swing out rotor no. 960 to obtain a linear gradient (5000 g, 15 min, 4 QC). 
A 10 ml sample of the top band was carefully removed using a Jencons Powerpette Plus 
autopipettor and diluted with 10 ml BSG, and the cells were collected by centrifugation (10000 
g, 10 min, 4 QC). The cells were resuspended in 2 ml BSG, and the cell separation process was 
repeated, before cells were finally resuspended to an optical density of 2.0 at A600 in sterile 
minimal medium containing 30 % glycerol and stored at -80 QC as 100 f!l aliquots. To 
radiolabel the proteins synthesized by the minicell strains, each 100 f!l aliquot was added to 900 
fll of M63 labeling buffer (M63 salts (Miller, 1972) containing all amino acids with the 
exception of cysteine and methionine) and incubated at 30 QC for 30 min, before two f!Ci Pro-
Mix L-esS] (Amersham Pharmacia Biotech) was added and the incubation continued for a 
further 30 min. The labeled cells were collected by centrifugation (10000 g, 10 min, 4 QC) and 
resuspended in 60 f!l buffer (70 mM NaCl, 20 mM KH2P04, 50 mM Na2HP04, and 1 mM 
MgS04) for storage at -80 QC. Radiolabelled proteins were separated by electrophoresis 
through either 12.5 % linear or 8 - 16 % gradient SDS-polyacrylamide gels, and protein sizes 
were estimated by comparison with a BioRad broad range protein standard. 
Creation of EhLlAGA 
To create EMAGA a 7 kbp BamHIIEcoRI fragment of pLA272 DNA from upstream of the 
AGA gene cluster and a 5 kbp EcoRIIHindIII fragment of pLA267 DNA from downstream of 
the AGA gene cluster were ligated to a 1.8 kbp EcoRI fragment of DNA from pHRP315 
containing a n cassette (SmR) (Parales and Harwood, 1993). This construct was ligated to 
BamHIIHindIII digested pLAFR3 to create pLMAGA. pLA~AGA was introduced to EhehpA 
(which contains an active lacZ fusion) and recombinants were screened for loss of ~­
galactosidase activity, loss of the vector pLAFR3 (TcR) , and maintenance of SmR. Southern 
hybridization analysis of two resulting recombinant EMAGA strains demonstrated that the 
AGA-resistance and biosynthesis regions were missing whilst the flanking fragments of DNA 
and the SmR cassette were present in the predicted order (data not shown). 
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Colour production and complementation 
To qualitatively assess the production of coloured AGA precursors, each ehp mutant was 
cultured in a microtitre dish well containing 100 J.ll of 2 % King's A medium as previously 
described (Carson and Jensen, 1974). Precursor feeding was carried out by placing 20 J.lg of 
API isolated from Ehi'lAGA(pBB7) or AP3 isolated from EhehpO onto a 6 mm $ antibiotic 
disk, impregnating the disk with ca. 107 cells of an Eh 1 087 ehp mutant, and assessing antibiotic 
production on an Ea8862 lawn. Mutant-mutant complementation was carried out either by 
mixing overnight cultures of each ehp mutant combination and placing one micro litre on a lawn 
of Ea8862, or by placing one micro litre of each mutant 1-2 mm apart on a lawn of Ea8862. To 
assess DNA complementation, pLA272 or 02 mini-Tn51acZ2 insertion derivatives of this 
plasmid were introduced to representative Ehehp recA strains and antibiotic production was 
measured. 
Isolation and characterization of the Ehl087 recA gene. 
A cosmid encoding the Ehl087 recA gene was isolated from an Eh1087 genomic library by 
transforming coli DH5a with cosmid clones and selecting transformant with restored RecA-
dependent DNA-repair mechanisms. Conditions sufficient for differentiation between recA+ 
and recA- cells, were exposure to 0.125 mM MMS (methane sulfonic acid methyl ester), or 20 
seconds UV irradiation in a Gelman Sciences Australia Biohazard using a Philips TUV 
30W/630T8 lamp at 50 cm. To localize the recA gene for subsequent manipulations, recA-
cosmid DNA (pLArecA) was digested with Pst!, ligated to pBluescriptKS-, and used to 
transform DH5a. Transformants were again selected for the ability to complement DH5a recA. 
A 1.8 kbp Pstl fragment had the complete recA gene (plasmid pKSrecA). DNA sequence was 
determined from each end of the cloned DNA in plasmid pKSrecA using T3 and T7 primers. 
Creation of Ehl087 recA strains 
To mutate the Ehl087 recA gene, a chloramphenicol resistance marker was transferred into the 
EcoRl site between bases 777 and 778 of the predicted Ehl087 recA gene to create 
pKSrecA777. The marked, interrupted Ehl087 recA gene was confirmed by its inability to 
complement DH5a recA. Because of the high copy number of pKSrecA777 and the short 
sections of DNA either side of the nCm cassette, the mutated recA gene was transferred to an 
Ehl087 recA cosmid by homologous recombination in E. coli MC4100 recA+. Plasmid DNA 
prepared from this culture was introduced to DH5a and transformants were selected for TcR and 
CmR to isolate a recA- recombinant cosmid (pLArecA777). To interrupt the recA gene of 
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Eh1087 strains, a process was developed for transfer of the QCmR marker from pLArecA777 to 
the relevant Eh1087 genome. Because the cosmid vector pLAFR3 has an oriT site, 
pLArecA777 was introduced to E. coli S 17 -1 by electroporation, for subsequent RP4-mediated 
conjugal transfer to Eh1087 strains. Eh1087 recA777 mutant-recombinants were initially 
screened for Tcs indicating loss of the pLARF3 vector, and then for increased MMS and UV 
sensitivity relative to the parental strain to ensure that recA was inactivated. To check that the 
QCmR cassette was present in the recA gene ofEh1087 recombinants, genomic DNA from these 
strains was digested with Pst1, hybridized to the 1785 bp Pst1 recA fragment of pKSrecA, and 
assessed for an increase in size of 3.2 kbp due to the presence of the QCmR cassette. 
Chapter 3 A'IIALYSIS OF THE AGA~GENE CLUSTER 34 
Results 
3.1. Antibiotic production and immunity are conferred by Ehl087 cosrnids 
One of the underlying goals of this investigation was the characterization of the genes and their 
role in the production of antibiotic by Eh1087. Four candidate antibiotic-production genes had 
already been implicated in antibiotic production in a previous investigation by Keams (1993) 
who found that mutations within a 2.2 kbp region (region 1, Fig. 3.1) on a ca. 200 kb plasmid 
present in Eh 1 087 abolished antibiotic production. However, little was known about these 
genes or the extent of this region (Keams and Mahanty, 1998). A resource for detennining the 
extent of this region was a collection of 13 cosmid clones containing genomic DNA from 
Eh1087, created and isolated by Keams (1993). During the present investigation, the mapping 
of restriction endonuclease fragments of cosmid DNA demonstrated that the 13 cosmids isolated 
by Keams comprised nine different overlapping cosmids (Fig. 3.1). To detennine whether or 
not the cosmids encoded sufficient infonnation for AGA-production (hereafter referred to as the 
AGA-gene cluster) all nine cosmids were introduced to E. coli MC4100. MC4100 containing 
the cosmids pLA272, pLA305, pLA214, 'pLA215, or pLA424 produced antibiotic, however 
antibiotic production was detected when these strains were grown on minimal media but not on 
rich media (e.g. LB), varied from strain to strain, and was always less than Eh1087. In contrast, 
E. herbicola field isolate Eh262 harboring cosmid pLA214 produces a similar amount of 
antibiotic as Eh1087, both in rich and minimal media, suggesting that there may be Envinia-
specific factors or expression mechanisms that overcome the rich media suppression observed in 
coli MC4100. The finding that cosmids pLA255, pLA367, pLA179, and pLAI01 do not 
confer antibiotic production on MC4100, demonstrated that the AGA-gene cluster must extend 
beyond the Ehl087 DNA region covered by these cosmids (Fig. 3.1). Additionally, cosmids 
pLA272, pLA305, and pLA214 provide MC4100 with resistance to AGA. These data 
demonstrated that infonnation upstream of cosmid pLA255 was required for antibiotic 
production, and infonnation upstream of cosmids pLA215 and pLA424 was required for AGA 
resistance (Fig. 3.1). 
3.2. Boundaries of the region required for antibiotic production in Ehl087 
The analysis of cosmids with sufficient infonnation for antibiotic production and resistance 
demonstrated that the AGA-gene cluster was more extensive than the 2.2 kbp region (region 1, 
Fig. 3.1) reported previously (Keams, 1993; Keams and Mahanty, 1998). Therefore, the next 
logical step in the characterization of the AGA gene cluster was the detennination of its 
boundaries. 
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Figure 3.1. The DNA region required for AGA production and resistance. 
Alignment of cosmids encoding all (+), or part (-), of the information required for AGA 
synthesis (AGA) and AGA resistance (RY in a heterologous host. Heavy dotted lines indicate 
that cosmid DNA extends beyond the region illustrated here. The recognition sites for BamHI 
(B) and EeaR! (E) are shown. Arrows highlight: (1), the region of DNA in which TnphaA 
insertions resulted in antibiotic-minus mutants (Keams, 1993; Keams and Mahanty, 1998); (2), 
the region common to cosmids that confer AGA production to a heterologous host; and (3), the 
region common to cosmids that confer AGA resistance on a heterologous host (discussed in 
section 3.8) 
3.2.1. Left boundary ofthe AGA-gene cluster. 
I I 
The search for the left-most boundary was initiated in a 7.4 kbp fragment of DNA bordered by 
BamHI sites and located adjacent to region I (Fig. 3.1). To specifically manipulate this piece of 
DNA, it was transferred from pLA272 to pBR322, creating pBB7 (Fig. 3.2). Numerous mini-
Tnl 0-LK transposon insertions were introduced into pBB 7. Twelve were located within the 
7.4 kbp BamHI fragment, and four (UI - U4), were transferred to the genome of EhI087 by 
homologous recombination (Fig. 3.2). UI-U4 were chosen because they were located upstream 
of, and progressively further away from, the EhI087 DNA cloned in cosmid pLA367 which 
does not confer AGA production on a heterologous host, and thus, could not possess the left-
most boundary of the AGA gene cluster. UI to U3 inactivated AGA-production in EhI087 and 
demonstrated that information encoded in this region was required for antibiotic production. 
The insertion furthest from pLA367, U4, had no apparent effect on antibiotic production or 
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AGA-resistance. On this basis, U4 was assumed to lie outside the AGA-gene cluster and 
therefore defined the known left-most boundary. 
3.2.2. Right boundary of the AGA-gene cluster. 
The right-most boundary of the AGA-gene cluster was determined by a similar process, 
however this time DNA downstream of region 1 (depicted in Fig. 3.1) was disrupted by 
transposon insertions to determine which portion was required for antibiotic production. 
Initially, insertion Dl was isolated from a collection of pBESa derivatives containing mini-
TnphoA insertions (pBESa includes region 1). When introduced to the Eh1087 genome, 
insertion D 1 created a mutant that was unable to produce antibiotic indicating that information 
further downstream of this point was involved in antibiotic production. During this investigation 
a S kbp EcoRI fragment of DNA from pLA272 that had been ligated to pBR322 to create 
pBESb (Keams, 1993) was found to lie adjacent to the DNA cloned in pBESa (Fig. 3.2). Since 
all cosmids that confer AGA production on a heterologous host possess the DNA contained in 
pBESb this DNA region was expected to contain information required for antibiotic production. 
Mutant derivatives ofpBESb were obtained by mutagenesis with mini-TnphoA, and the position 
of five insertions determined. From these, insertions D2 and D3 were selected for transfer to the 
Eh1087 genome because they were located furthest from insertion Dl. Insertion D2 interrupted 
antibiotic production, whereas an Ehl087 mutant with insertion D3 could still produce 
antibiotic (Fig. 3.2). This experiment demonstrated the region in which the AGA gene cluster 
terminated and thereby defined the extent of the AGA gene cluster. 
3.2.3. The region between the proposed boundaries is sufficient for AGA production 
To confirm that the region between the boundary insertions was sufficient for antibiotic 
production, the complete IS.S kbp region was reconstructed, via a multi-step cloning process 
(data not shown), in pBluescriptKS- creating plasmid pAGA (Fig. 3.2D). pAGA was found to 
confer antibiotic production on E. coli hosts DHSa and MC4100. These strains produced a 
moderate amount of antibiotic on minimal media, and a small amount on rich media (LB), 
demonstrating for the first time that the suppression of AGA production in E. coli by some 
component(s) of rich media is not absolute. 
3.3. Isolation of Ehl087 AGA-minus mutants. 
In order to identify all, or at least the majority of the genes involved in antibiotic production by 
Ehl087, new transposon mutants were generated, screened for loss of antibiotic production, and 
the genes disrupted in the AGA-minus mutants were characterized. A second mutant screen 
was deemed necessary for two reasons. Firstly, the original screen for Ehl087 mutants unable 
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to produce antibiotic was considered insufficient as discussed below (Kearns, 1993; Kearns and 
Mahanty, 1998). Secondly, antibiotic expression by coli strains harboring cosmids with the 
entire AGA-gene cluster (Fig. 3.1) was found to be repressed greatly in rich media in contrast to 
Eh1087 or other Erwinia herbicola isolates harboring these clones suggesting that additional 
'Erwinia-specific' factors encoded outside the AGA gene cluster are required for full antibiotic 
production by Eh1087 in rich media. 
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Figure 3.2. Creation of defined Ehl 087 transposon insertion mutants 
(A) The AGA-gene cluster regions described in Fig, 3.1 
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(B) A selection of trans po son insertions into cosmid 3272 subclones pBB7, pBESa, and pBESb 
(see Table AI). The solid arrows indicate the positions ofUI-U4 (insertions gpstream of the 
TnphoA insertions) and DI-D3 (insertions Qownstream of the TnphoA insertions) as 
determined by restriction mapping. 
(C) dashed arrows represent transfer of the transposon insertions to the genome of Ehl 087 by 
homologous recombination to create Ehl087 derivatives that either cannot produce antibiotic 
(-) or retain the ability to produce antibiotic (+) and therefore define the AGA- gene cluster 
boundaries in Eh1087. TnphoA insertions created in a previous study cover a region of 2.2 kbp 
in which transcription was found to proceed left to right as illustrated by the horizontal arrow. 
(Keams, 1993; Keams and Mahanty, 1998). Recognition sites for BamBI, B, and EcoRI, E, 
are shown for comparison with Figure 3.1. (D) The insert DNA for pAGA, covering the region 
between transposon insel1ions U4 and D3. 
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Figure 3.3. Positions of transposon insertions within the AGA gene cluster 
(A) Regions 1, 2, and :1 are shown for comparison with Figure 1.1. 
(B) The positilln and orientation of X2 mini-Tn5lacZ2 insertions that maplxt.! within the AGA 
gene c luster of Eh I OH7 AGA-minus mutants. and of four mini-Tn !O/w·i:" insertions in ant.! near 
the resistance gene encoded on plasmid pBB7. The positions or AGA+ insertions lI4 and Dl 
are silown at each end of the gene cluster ant.! t.!elineate the gene cluster bount.!ari.es. 
Tr<lnsj111S11n inser1ions in orientation I are shown above the gene cluster. and insertions in 
orientation 2 below the gene cluster. Blue arrows represent insertions tilat are in the correct 
orientation ant.! reat.!ing frame to produce ,5galactosidase whilst white arrows represent 
insertions that do not produce ,5galactosidase. The direction of transcription derivecJ from 
these active J(/eZ fusions is generally from left to right. howt'ver insertions to pBB7 that result 
in loss of the AGA resist<lnce factor cJemonstrate that the resi stance gene is divergently 
transcribed from the rest of the AGA-gent' cluster. 
(C) Arrows are coloured to illustrate the colour of compounds produced by the AGA-minus 
mutants. Transposon insl'l"tions were dil·idcd into four groups based on the colour of tile 
compound produced by ulch resulting mutant. 
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Initially, 1000 b:h 1087 mini-Tn5lacZ2 mutanls were screened to establish protocols for the 
assessment of antibiotic activity and for the mapping of transposon insertion points. Of the 
[000 mutants screened, ten could not grow on minimal media. Since ca . J Iii of the bacteriul 
genome is gennally dedicated to the metabolism of amino acids. the rate of uuxotrophy found 
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here indicated that the mutagenesis screen was sufficiently random. A procedure to determine 
the positions of transposon insertions within the AGA gene cluster was developed to 
discriminate between insertions within the gene cluster and those outside it, and to map each 
insertion point within the cluster to 50-100 bp resolution (see materials and methods). A total of 
5000 Eh1087 mutants were screened for the loss of antibiotic production, from which 83 
mutants with single insertions were altered in their ability to produce antibiotic (l.7 %). Of 
these 83 mutants, 81 possessed insertions within the 14 kbp of AGA gene cluster (Fig. 3.3B), 
and 2 mutants contained insertions outside this region'. Insertions within the AGA gene cluster 
were distributed evenly throughout this region, in both possible orientations (Fig. 3B, Appendix 
A3). 
3.4. Gene functions 
3.4.1. Coloured AGA intermediates produced by many eltp mutants. 
During the screening of Eh1 087 mutants for loss of antibiotic production, a number of insertion 
points were cloned and the DNA sequence of the insertion points determined. A subset of these 
cloned insertion points was found to lie within a region of the Eh1087 genome with sequence 
similarity to genes involved in phenazine production by Pseudomonas spp., suggesting that the 
Eh1087 antibiotic is a phenazine antibiotic. Since some phenazine biosynthesis mutants of 
Pseudomonas spp. accumulate coloured phenazine precursor molecules when cultured on 
Kings-A medium, all 82 AGA-gene cluster mutants were cultured on this medium and assessed 
for the production of coloured compounds (Fig. 3.3C). Mutants with insertions in close 
proximity to each other usually produced compounds with similar colour, probably because the 
antibiotic biosynthesis pathway was inactive at the same modification step resulting in 
accumulation of the same-coloured antibiotic precursor. Intermediates of the same colour were 
assumed to have the same or very similar chemical structures and therefore used as a basis to 
divide the mutants into four groups (Fig. 3.3C). A yellow intermediate was named antibiotic 
precursor one (AP1), a red intermediate was named AP2, and an orange intermediate was 
named AP3. The colour of the intermediate(s) released by each mutant is listed in Appendix 3, 
and the properties of these intermediates are described in section 4.3.3. 
• One of these mutants was found to have an insertion in gInA, which is responsible for the final step in glutamine 
synthesis (Appendix A2.4). The second mutant carries an insertion in an undefined gene that appears to be immediately 
upstream of a potential homologue of the E. coli sensor protein gene, barA (Appendix A2.5). Both mutants have 
subsequently become the focus of a separate investigation. 
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3.4.2. Precursor-feeding experiments. 
To determine whether a mutant could convert an AGA precursor into AGA, isolated precursor 
compounds were provided exogenously to a representative mutant from each group (Fig. 3AA). 
Griseoluteic acid (GA) was also assessed because it was a phenazine breakdown product of 
AGA present in the supernatant ofEh1087 cultures (as discussed in Chapter 4), its structure was 
known, and it was found to have similar properties to AP3 (see chapter 4). Only mutants with 
transposon insertions in orientation 1 (01), and not those with orientation 2 (02) insertions, are 
able to convert API, AP3, or GA into AGA. Figure 3AA demonstrates that API can be 
converted to AGA by Group I mutants, which cannot synthesize their own API but can carry 
out all subsequent modifications. AP3 can be converted to AGA by Group 1,2, and 3 mutants 
which are able to carry out the final conversion step, but not by Group 4 mutants, which 
produce AP3 but lack a gene required for conversion of AP3 to AGA. GA is also converted to 
AGA by Group 1, 2, and 3 mutants but not by Group 4 mutants, therefore the Group 4 gene 
products are required for the addition of a D-alanine group to GA to create AGA. It is worth 
noting that mutants representing insertions in each of the predicted gene cluster genes were 
subsequently assessed for precursor conversions and all mutants within a particular group 
possessed similar precursor conversion abilities (for example, see Figure 3.7); exceptions are 
discussed below. 
3.4.3. Sharing of resources, AGA production by mixed eltp mutants 
An alternative approach was required to investigate whether or not AP2 could be converted to 
AGA, because AP2 could not be separated from culture supernatant and concentrated by 
extraction with solvents such as chloroform or dichloromethane, unlike API, AP3 and AGA. 
Since Group 2 mutants release AP2 and Group 3 mutants release AP3, these mutants were used 
as donors of exogenous precursors. To do this, a selection of mutants representing transposon 
insertions in both orientations (01 and 02) from each of the mutant groups was crossed pair-
wise with each other mutant, as well as with the AGA gene-cluster deletion strain EMAGA. 
No individual mutant could complement EMAGA. In contrast, antibiotic production was 
observed when various combinations of mutants were crossed pair-wise (Fig. 3AB). It was 
found that colonies composed of orientation 1 (01) transposon insertion mutants from Group 4 
and either Group 1, 2, or 3 produced antibiotic (Fig. 3 AB, plate 1). Similar antibiotic 
production was noted by colonies consisting of a Group 3 mutant and a Group 1 or Group 2 
mutant. This result indicated that the gene Groups downstream of an 01 transposon insertion 
retained activity. In contrast, colonies composed solely of mutants with orientation 2 (02) 
transposon insertions produced no antibiotic (Fig. 3AB). 
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Group 3 Crosses Group 4 Crosses 
Figure 3.4. Conversion of intermediates to AGA by ehp mutants 
(A) The conversion of exogenous API and AP3 to AGA by mutants representative of each 
functional Group. Each six mm diameter filter disk contains 20 ~g of crude API or AP3 and 
ca. 107 cells of the relevant mutant. In this diagram, antibiotic activity resulting from the 
conversion of API or AP3 to AGA is demonstrated by a dark zone around a disk resulting 
from the death of Ea8862 cells spread over the plate (Griseoluteic acid (GA) gave the same 
result as AP3). 
(B) Antibiotic production by colonies composed of two different ehp mutants. Gl (Group 1) -
G4 (Group 4); 01, 02, transposon insertions in orientation 1 or 2. 
(e) The relative conversion of AP2 and AP3 to AGA by mixed and separated colonies of ehp 
mutants. The Group 3 crosses are representative of a Group 3 mutant (AP2 donor, D) crossed 
with a Group 1 or Group 2 mutant (AP2 recipient, R), either as mixed, or separated colonies. 
Similarly, the Group 4 crosses are representative of crosses between a Group 4 mutant (AP3 
donor) and a Group 1,2, or 3 mutant (AP3 recipient). 
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To further assess the influence of transposon orientation on crossfeeding ability, 01 and 02 
mutants were crossed pair-wise. 02 mutants only complemented 01 mutants that possessed 
insertions in a group upstream (relative to the direction of transcription throughout the AGA-
gene cluster, as illustrated in Fig. 3.3). For instance, mutants with an 02 insertion in a Group 3 
gene release AP2 (which is converted to AGA by a mutant with an 01 insertion in a Group 1 or 
2 gene), but cannot convert AP2 or AP3 into AGA. Similarly, Group 1 or 2 mutants with an 
02 insertion are not able to convert AP2 or AP3, donated by 01 mutants, into AGA. These 
results concur with the inability of the 02 mutants to convert exogenous API, AP3, or GA, to 
antibiotic,-as described in section 3.4.3, and indicate that all genes downstream of an 02 
transposon insertion are either not expressed, or expressed at a far lower level than normal. 
To confirm the mutant responsible for donation and the mutant responsible for precursor 
conversion, colonies of each mutant were separated by ca. 1-2 mm and assessed for antibiotic 
production (Fig. 3.4C). This experiment demonstrated that AP3 is donated by Group 4 mutants, 
and converted to AGA by Group 1, 2 or 3 (01) mutants which must therefore produce 
functional Group 4 gene products to carry out this conversion. Similarly, Group 3 mutants 
were shown to donate AP2 under the same conditions to Group 1, 2, or 3 (01) mutants, which 
express functional Group 4 gene products and can convert AP3 to AGA. Colonies receiving 
exogenous AP3 were able to convert it to AGA at a faster rate than those receiving exogenous 
AP2. Because the rate of conversion of the two precursors was similar in mixed colonies, and 
since the red-coloured AP2 diffuses through the agar media at least as well as AP3, it appears 
that the transfer of AP2 from one mutant to another is facilitated by cell-to-cell contact, whereas 
the equivalent transfer of AP3 is less dependent on such contact. The low rate of AP2 to AGA 
conversion by adjacent colonies of mutants meant that this experiment could not demonstrate 
whether Group 4 mutants can convert AP2 to AGA, however this is improbable because Group 
4 mutants lack one of the genes required for the conversion of AP3 to AGA. 
3.5. Description of the AGA-gene cluster genes 
3.5.1. DNA sequence ofthe AGA gene cluster. 
Mutants with transposon insertions in the AGA-gene cluster could be divided into Groups 
depending on the colour of the AGA intermediate(s) that they produced (Fig. 3.3C). To begin 
characterizing the number and function(s) of genes within these groups the DNA sequence of 
the entire region between insertions U4 and D3 was determined and assessed for sequence 
determinants characteristic of genes using the GeneMark algorithm (Lukashin and Borodovsky, 
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199R). From the 15497 bp of seque nce data ana lyzed, GeneMark predicted 16 genes within a 
conti g. uo us 14924 bp section o f the DNA sequence, designated ehpR, and ehpA-rjJ.£!O Clirwil7io 
fierbiro/a Qhcnaz ine) (Fi g: . 3. 5, Ta ble ]. 1). The re a re like ly to be 5 genes , named ehpC-chpK 
present in the 5061 bp regio n of DN A prev io us ly re ported to contain 6 ORFs (Kearns and 
Mahanty, 199R). ehpl , ehpJ, a nd ehpK we re forme rl y designated ORr's 4, 5, and 6, 
respec tive ly, while ehpC , a nd ehpH are new predic ti o ns arising from the change in seque nce 
contex t. Most impo rtantl y, the predicted genes agreed we ll with the divi s ion of mutants into 
g ro ups, as reported in Appe ndi x A]. 
mini-TnSlacZ: Orientation 1 (01 ) 
F+ lacZ • KmR I 
-.t ~ it t *+ + + t + t ~ ' ~~I C---+ 10011&IF-+IG+IHI/.1 J--+IK.IL---+I!M--+ (lA o-+1 
KmH~ lacZ ~ 
mini-Tn SlacZ: Orientation 2 (02) 
Figure 3.5. The eh" ge ne cluster 
Locati on, Sill'. and d irl'c ti lln of transc ription of the chI) genes predicted by (,l'neMark analysis 
of the DNA sequence be twee n insertions U4 and DJ. Blue arrows indicate the position of in -
fram e I({(Z fusions. 
3.5.2. Evidence in support of the ehp gene predictions 
Three lines of ex pe rime nta l ev ide nce suppo rt the predic ted properti es of the genes illu strated in 
Fi g ure ].5 . Firstl y, mutants with tra nsposon insertions in the same sequence-predic ted gene 
excrete the same colo ured compo unds whe n grow n on Kings-A media ( li s ted in A ppendi x Al). 
Secondl y, the predicted directi on o f transc riptio n for each of the ge nes conc urs with the 
o ri entati o n of ac ti ve foeZ fu s ions to the ehp gcnes A , E, C, D, F, C , H, I , L, and M (Fi g. ].5). 
Fin a ll y, the s izes o f many of the predic ted trans lation products of the ehp genes were confirmed 
by mini ee ll ana lys is of these ge ne products as outlined below, 
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E. coli mini cell strain P678-54 was transfonned with one of three p1asmids that collectively 
contain all the DNA of the AGA gene cluster, pBB7, pBE5a or pBE5b, or derivatives of these 
p1asmids into which mini-Tn5lacZ2 insertions had been transferred (see methods and materials, 
Table 3.1). To relate a single gene product to a transposon insertion, 01 insertions were used to 
ensure that genes downstream of the insertion point were expressed via initiation of 
transcription for the kanamycin resistance gene of mini-Tn5IacZ2, which does not possess 
transcriptional or translational stop signals (de Lorenzo et aI., 1990). 
E. coli minicells containing pBB7 produced radio1abelled EhpR (15 1illa), EhpA (19 1illa) , 
EhpB (26 kDa), EhpD (32 1illa) , EhpE (28 1illa) and EhpF (48, 52 kDa) (Fig. 3.6). In most 
cases these products are similar in size to the predicted gene product (Table 3.1). A range of 
minicell strains containing pBB7 derivatives with an 01 transposon insertion in an ehp gene 
demonstrated the size of each gene product (Fig. 3.6). The products of ehpB and ehpE are 
slightly different in size to the sequence predictions, whilst insertion to ehpF resulted in the loss 
of 2 proteins, both larger than predicted from sequence data, suggesting that these proteins may 
undergo post-translational modifications ifthe sequence predictions are accurate. It is unknown 
why insertion to ehpC, which has a predicted 70 kDa product, did not result in the 
disappearance of any detectable proteins. E. coli minicells containing pBE5a and pBE5a::ehpI 
demonstrated clear products for EhpI (26 kDa) and EhpK (291illa), but not for EhpG (33 kDa), 
EhpH (17.5 1illa) or EhpJ (55 kDa) (Fig. 3.6). The three proteins not detected by this procedure 
are thought to be bound to the inner membrane as described in sections 3.6.2 and 3.6.3. As such 
they are likely to be hydrophobic and may have not have dissolved in the protein loading buffer 
prior to electrophoresis. E. coli mini cells containing pBE5b and pBE5b: :ehpM demonstrated a 
clear product for EhpM (56 1illa) , and a second 12 kDa protein that may EhpN, however this 
was not confinned with an ehpN 1mockout (Fig. 3.6). No EhpO candidate protein was seen, 
probably because the predicted 34kDa protein was concealed by a highly expressed protein that 
is probably the kanamycin resistance protein (31 kDa) since it is present in cells containing only 
the plasmid vector. Finally, EhpL was not observed in these analyses because ehpL spans 
between pBE5a and pBE5b. 
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(.\) Proteins Inn)] minin'lls harhllurin~ pBS7 and various ~cnc-knockllut dnivati\cs Wl're 
resolved hv S[)S-I'A(;E in a 12 'X linl'ar gel. 
(13) 1'Illteins Irum l11inicclls harbuuring piI ESa. pBI.Sa::dlfll. pBLSh. pBL5b::ciIIJ.V1 WLTe 
rl~s()I\L'c1 by S[)S· PAGE in a X '"i; . In'''; gradient gel. Bands tll till' ri~ht 01 an asterisk arl' 
prl'suillahly I .aci.: :Lhp Iusion pillteins. 
3.6. Gene functions derived f.-om sl'quence predictions and l'xperiml'ntal eyidence 
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A BlastN scarch for similarity hctween the DNA sequcnce of the I'hp ,l'ene cluster and other 
rcported DNA sequenccs indicatcd that the DNA scqul'nec.s of thl' ('hp gencs arc novel (/\Itschul 
ct dl.. Il)97). HO\\C\CL as discussed helm\, B laslX denlOnstraled that the trdllslatinn products 
of some genl's within the cluster werL' simildr to the prl'dicted products oj genl's frum variuus 
soun.:es. In addition. thl~ predicted sequenecs of thc I~hp prukins were assessed fur conserved 
domains using RPS-BLAST, for si g nal sequellces using Si,l'n,tlP, ,1Ild for membranl' associated 
regions usin,l' i)AS and TMHMM. JS outlined in Appendix A 1.7.2 (Tahle -'1.2). 
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Table 3.1. Properties ofthe ehp genes 
10roup (Colour) 2Intermediate Oene 3Position 4AA 5kDa (6est.) 
ehpR 918-529 129 14.6 (15) 
01 (none) ehpA 1337-1813 159 18.6 (19) 
01 (none) ehpB 1944-2576 261 29.4 (26) 
G1 (none) ehpC 2644-4473 635 70.2 
01 (none) ehpD 4473-5336 288 31.8 (32) 
01 (none) ehpE 5470-6000 209 23.7 (28) 
02 (yellow) API ehpF 5981-7081 367 40.9 (48,52) 
02 (yellow) API ehpG 7081-8016 312 33.3 
02 (yellow) API ehpH 8013-8489 159 17.7 
03 (red) AP2 ehpI 8534-9217 228 25.0 (26) 
03 (red) AP2 ehpJ 9241-10677 479 50.8 
03 (red) AP2 eIJpK 10677-11465 263 29.3 (29) 
03 (red) AP2 ehpL 11476-12612 379 40.3 
04 (orange) AP3 ehpM 12683-14164 494 55.9 (56) 
04 (orange) AP3 ehpN 14154-14381 76 8.5 (12) 
04 AP3 14352-15452 310 34.0 
1. Mutant groups derived from the production of coloured AOA intermediates 
2. AOA intermediates API, AP2 and AP3 were differentiated on the basis of colour, and 
could consist of a group of similarly coloured compounds 
3. Position of each predicted ehp gene (including start and stop codons) within the 15524 bp 
AOA-gene cluster DNA sequence between transposon inseliions U4 and D3. 
4. Number of amino acid residues in the predicted translation product of each ehp gene. 
5. The predicted molecular weight of the ehp gene products in kilodaltons 
6. The estimated molecular weight of Ehp proteins derived from mini cell analysis of the 
where known. 
3.6.1. The Group 1 genes products. 
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Two lines of evidence indicate that the group 1 genes are responsible for the synthesis of API. 
Firstly, exogenously supplied API partially restores antibiotic production to Group I mutants, 
demonstrating that these mutants lack the ability to synthesize API but possess the capability of 
subsequent conversion of API into AGA (Figure 3.7). Secondly, API is produced by cells 
harbouring the Group I genes but no other ehp genes. The predicted protein sequences of the 
Group 1 genes, ehpA-ehpE, show many identities to the products of five out of seven genes that 
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form a core operon required for synthesis of phenazine-l-carboxylic acid (PCA) by 
Pseudomonas spp. (Table 3.1). The arrangement of the phenazine synthesis genes in the PCA 
operons is also similar to the Group 1 genes (Fig. 3.8A), however in Eh1087 the Group 1 gene 
products synthesize API, a probable phenazine compound that was shown by HPLC analysis to 
have a similar absorbance spectrum, but different solubility in water than PCA (see Fig. 4.7). 
Table 3.2. Properties of the predicted ehp translation products 
Product Role Domain l Residues2 Score4 TM5 
EhpR AGAR none No 
EhpA ~AP1 none No 
EhpB ~AP1 Isochorismatase family 27 -207 (261) 97.8% 4e'46 No 
EhpC' ~AP1 Chorismate binding enzyme 11i~379 (635) 100.0% No 
Glutamine amidotransferase class-I 441-621 (635) 98.4% 
EhpD ~AP1 Phenazine biosynthesis-like protein 6-277 (288) 98.0% No 
EhpE ~AP1 Pyridoxamine 5'-phosphate oxidase 5-208 (209) 93.2% No 
EhpF AP1~AP2 AMP-binding enzyme 44-315 (367) 60.5% ge,07 No 
EhpG AP1~AP2 Aldehyde dehydrogenase family 155-294 (312) 32.0% 4e,08 l*(D) 
EhpH APl~AP2 none 2 (D) 
EhpI AP2~AP3 ubiE/COQ5 methyltransferase family 51-214 (228) 70.5% No 
EhpJb AP2~AP3 none 14*(T) 
EhpK AP2~AP3 Short chain dehydrogenase 6-223 (263) 90.0% No* 
EhpL AP2~AP3 none No 
EhpM AP3~AGA AMP-binding enzyme 42-420 (494) 100.0% k 52 1 (T) 
EhpNb AP3~AGA none No 
AP3~AGA none No 
1. Conserved domains of the predicted ehp translation products detected by RPS-BLAST. 
Note: a) EhpC has two domains, b) PRO SITE detected motifs for EhpJ (transmembrane 
transport protein), and EhpN (acyl carrier protein domain) that were not detected by RPS-
BLAST). 
2. Residues within the Ehp protein that comprise the conserved domain. The total size of the 
Ehp protein is shown in brackets for comparison. 
3. Percentage of the conserved domain present in the Ehp protein. 
4. Significance scores for the likelihood that each sequence similarity or conserved domain 
occurred by chance (only proteins with scores above 1 e'6 are shown). 
5. TM, transmembrane sections predicted by DAS (D) with a cutoff value of 2.2, or by 
TMHMM (T); an asterisk indicates that the protein is predicted to have a prokaryotic 
membrane ",,,,,,r,,'tp,,'1 attachment site 
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Figure 3.7. AP I conversion by representative ehp mutants 
Six mm filter disks with 20 flg API (+API) and without API (negMive control) were 
supplemented with 107 cells of each Ehehp Illutant and assessed for antibiotic activity on a 
lawn of La8R62 grown on a I-A minimal media agar plate. A disk with API only, or with API 
and the chp gene cluster deletion strain Ehf,AGA (f,), show no antibiotic activity in this a.ssay. 
All mutants possess 0 I transposon insertions. and an 02 chpA mutant (02) is shown for 
comparison EIIIOH7 supplemented with 20 flg AP I (EI1+) produces slightly more antibiotic 
than non-supplemented Eh I 087 (Eh-). 
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The predicted translation products of the Group I genes ehpB-ehpE possess conserved domains 
that concur with the preJicted functions of the PCA operon analogs (Fi g. 3.8, Table 3.2). The 
sequence of EhpS indicates that it belongs to the isochorismatase family of enzymes, of which it 
is most similar to the PhzA-PhzD proteins required for phenazine synthesis in Pseudolllonas. 
and next most similar to anthranilate synthetase which catalyzes the exchange of the amide 
nitrogen of glutamine for the side group of chorismic acid converting it into anthranilate. The 
predicted sequence of EhpC aligns closely to the PhzS-PhzE phenazine synthesis pilltcins. 
PhzC possesses two domains, one is characteristic of chorismate binding enzymes, and the other 
is a member of the glutamine amidotranst"erasc cla.ss-J family. FhpD shane's sequence similarity 
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with PhzC-PhzF. A recently report by McDonald et al. (2001) indicates that PhzF acts with 
PhzG in the dimerization of two molecules of 2,3-dihydro-3-oxoanthranilic acid (DHOA) to 
form PCA. EhpD may possess two DAP-epimerase motifs (weak similarity), which concur 
with the prediction that the Pseudomonas analog, PhzF, holds two DHOA molecules in the 
correct orientation to control dimerization. Finally, EhpE is similar to PhzG, and both have 
sequence characteristics of pyridoxamine 5' -phosphate oxidases. This domain is predicted to 
enable PhzG to oxidize trans-2,3-dihydro-3-hydroxyanthranilic acid (DHHA) to DHOA as part 
of the dimerization process (McDonald et al., 2001). By comparison with the Pseudomonas 
model (Fig 3.8B), EhpC is expected to transfer an amide group from glutamine to chorismic 
acid, while EhpB removes a pyruvate moiety to create DHHA. DHHA is most likely converted 
to a molecule very similar to PCA by EhpD and EhpE, and EhpA may help to stabilize a 
hypothetical multienzyme complex and thereby enhance the rate of phenazine synthesis 
/ 
(Mavrodi et a1., 1998). 
3.6.2. The Group 2 gene products. 
Group 2 mutants are unable to convert API to AP2 (Figs. 3.4, 3.7). The DNA and predicted 
protein sequences of the Group 2 genes did not show similarity to the sequences of genes or 
gene products with known function(s). Therefore, to begin characterizing each gene involved in 
the conversion of API to AP2, the DNA and translated protein sequences of the Group 2 genes 
were analyzed for conserved functional domains or motifs using RPS-BLAST and PROSITE. 
The protein sequence between residues 72-124 of EhpF has a weak similarity to ca. 60% of a 
conserved domain characteristic of AMP-binding proteins. EhpG has a weak similarity to the 
middle ca. 30% of a conserved domain found in aldehyde dehydrogenases. EhpG and EhpH 
both possess features that suggest these proteins are localized to the cytoplasmic membrane. 
Specifically, residues 275-285 of EhpG are characteristic of a prokaryotic membrane lipoprotein 
lipid attachment site, for which a signal peptide at the C-terminus is cleaved by signal peptidase 
II and a glyceride-fatty acid lipid is bound to a cysteine residue for membrane attachment. This 
prediction is strengthened by the analysis of EhpG with the Dense Alignment Surface method 
(DAS) (Cserzo et al., 1997) which indicates that EhpG has a single, potentially membrane-
bound, section located between residues 274-285. Similarly, the DAS method predicted that 
EhpH has two hydrophobic regions, benveen residues 68-76 and 86-96, that could interact with 
a membrane. While the mechanism for conversion of AP 1 to AP2 is currently unknown, the 
potential for membrane interactions by EhpG and H suggests that it takes place on or near the 
cytoplasmic membrane. 
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(ADIC) 
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Figure 3.8. Analysis ofthe Group 1 genes 
(A) Comparison of genes required for synthesis of the phenazine nucleus in: 
(i) Eh1087 
(ii) P. aureofaciens 30-84 
(iii) P. chlororaphis PCL139l, P.jluorescens 2-79, andP, aeruginosa PAOI 
(pAOl possesses two phz operons,phzAl-phzGl, andphzA2-phzG2). 
The black boxes highlight the similarity between the translation product of ehpA and the 
translation products of both phzX and phzY (or phzA and phzB), The white box highlights the 
plzzC/ phzF gene specific to the phenazine gene clusters found in Pseudomonas spp., and grey 
boxes indicate genes from each bacteria that have similar translation products and are in the 
same relative location. 
(B) The predicted role of the PCA operon gene products (Phz) in the synthesis ofthe phenazine 
nucleus by P. jluorescens 2-79 (adapted from McDonald et al., 2001), and the probable roles of 
Ehp analogs from Ehl087. Phz proteins in brackets are not essential, however PhzF may act 
with PhzG in the oxidation ofDHHA, and PhzA and PhzB are known to increase the efficiency 
of the conversion of DHHA to PCA. The conversion of all intermediates to phenazine has 
been demonstrated with the exception of 2,3-dihydro-3-oxoanthranilic acid (DHOA). 
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3.6.3. The Group 3 gene products. 
The Group 3 genes are required for conversion of AP2 to AP3 (Fig. 3.4, Table 3.2). Analysis of 
the protein sequence of the predicted translation products of the Group 3 genes provided 
information about the activities of EhpI, EhpJ, and EhpK, but not about EhpL. EhpI contains 
ca. 70% of a methyltransferase motif between residues 51-215, which may direct the transfer of 
a methyl group from S-adenosyl-L-methionine to the antibiotic precursor AP2. Because no 
other AGA-gene products appear to have this motif EhpI is currently the best candidate to 
catalyze the addition of the methoxy group present in AGA (see Fig. 4.6). EhpK may also be 
involved in direct modification of AP2 because it has a protein sequence containing 90 % of a 
motif characteristic of short chain dehydrogenases, a family that includes NAD- and NADP-
dependent oxidoreductases. 
The predicted protein sequence of EhpJ is similar to transmembrane efflux proteins found in a 
variety of bacterial species. PRO SITE analysis of the EhpJ sequence indicates that it belongs to 
a group of proteins involved in the transmembrane transport of various compounds including 
sugar transporters, the FecCD transport family, and the Xanthine / Uracil permease family. 
Support for the transmembrane localization of EhpJ is provided by the predicted presence of a 
region rich in the hydrophobic amino acid leucine (residues 209-288), and the prediction by the 
transmembrane hidden Markov model (TMIIMM) that EhpJ has 14 transmembrane sections. 
To establish the EhpJ membrane topology experimentally, random mini-Tn5phoA fusions were 
generated throughout clone pBE5a, which contains the genes ehpG-ehpK. Active PhoA fusions 
indicate fusions to part of a protein that is localized extracytoplasmically because alkaline 
phosphatase is not active in the cytoplasm (Michaelis et al., 1983). Active fusions only 
originated from insertions within ehpJ, suggesting that EhpJ does indeed have periplasmic 
domains, and that the products of the other ehp genes encoded by pBE5a are located in the 
cytoplasm. The exact location of a selection of active mini-Tn5phoA insertions in ehpJ was 
determined by DNA sequence analysis. Five different insertions were obtained. The five 
hybrid proteins predicted to result from these mini-Tn5phoA insertions were composed of a 
fusion between PhoA and 21, 88, 148, 221, or 271 amino acids from the N-terminus of EhpJ, 
confmning the first five out of seven predicted periplasmic domains (Fig. 3.9). TMIIMM-
analysis of EhpJ predicted that for each of these hybrid proteins PhoA would be fused to a 
section of EhpJ that either transverses from the inner to outer sides of the membrane, or is 
located on the periplasmic side of the membrane. Analysis of the amino acid sequence of EhpJ 
with SignalP indicates that the first transmembrane domain may be a N-terminal signal peptide 
that is cleaved between residues 20-21 or 43-44, resulting in a mature EhpJ protein with 12 or 
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13 transmembrane domains. Because PhoA::EhpJ fusion data agree with analyses of the 
predicted protein sequence of EhpJ, it is likely that I::hpJ is a transmembrane protein. 
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Figure 3.9. Predicted membrane topology for EhpJ 
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The TMHMM-predicted probability of regions of .:. hpJ protein to be cytoplasmic. periplasmi'c 
or membrane-localized is shown in the top section of the illustrat.ion, and the proposed 
membrane localization is shown below. Each coloured dot represents two amino acids, Black 
dots indicate the positions of potential signal sequence cleavage points. and blue arrO\vs show 
the p()sition 01 active PhoA fusions, 
Comparison with other transpolt proteins suggest that the role of EhpJ in the conversion of AP2 
to AP3 is likely to involve controlled transport across the cytoplasmic membrane, AP2 is only 
released by Group 3 mutants presumably due to lack of a transmembrane complex required for 
controlled release, Group 4 mutants or Eh 1 087 do not release AP2. as evidenced by the absence 
of red compounds in the culture media of the latter strains after most AP3 and AGA was 
removed by numerous chloroform extractions, indicating that AP2 is always converted to AP3 
and released by cells with functional Group 3 genes. 
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(A) G4 no cross G1 G2 G3 (8) Strain Strain only +AP3 
Figure 3.10. Prope rties of the G roup 3 mutants 
(A) The conversion of AP2 donated by 01 Group 3 mutants to AGA by representative 01 
Group 1 - Group 4 mutants (G I - G4). 
(B) The con version of exogenous AP3 to AGA by Group 3 mutants. Each 6 mm filter disk 
contains ca. 5 x 107 CFU of Ehehp/, J, K or L with or without 10 flg AP3, 
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A close r inspection of AGA production by 0 I and 02 Group 3 mutants crossed with 
representatives from other groups enabled the Group 3 genes to be further subdivided according 
to the specific role of each gene product in the conversion of AP2 to AP3 (Fig. 3, 10), All Group 
3 mutants export a red coloured compound, designated AP2, when cultured in Kings-A media, 
with the exception of EhehpL (0 I ), which releases a red / brown compound. The red compound 
released by Ehehp/ (0 I) is taken up and converted to AGA by Group I or Group 2 mutants rar 
less proficiently than the red compound(s) released by all other Group 3 mutants (Fig. 3. 10). 
On the hasis of this and other properties (listed in Table 3.3), the red compound (APi') 
produced by Ehehp/ (0 I) is clearly different from the red compounds produced by other 
mutants (AP2 / AP2'). Furthermore, since there is a good chance that Ehpl catalyst's the 
addition of a methyl group to AP2, the red compound produced by Illutants expressing EhpI was 
tentatively termed APi, to differentiate it from the red compound released by Ehehp/ (02) 
which lacks EhpI and all other Group 3 gene products. However, there is no experimental 
evidence to indicate that AP2 and APi are different at this stage, In summary, different Group 
3 mutants produce one of at least two different red compounds; Ehehp/ (0 I) produces APi l , 
and all other Group 3 mutants produce AP2 / APi. Important properties of AP2 / APi and 
APi' are listed in Table 3,3. 
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Table 3.3. Origin and properties of coloured compounds produced by Group 3 mutants. 
Insertion l Activity of the Group 3 Media colour3 
Gene Ori. ehp/ ehpJ ehpK ehpL sealed opened Convert.4 Name5 
ehp/ 02 off off off* off* red yellow yes AP2 
ehpJ 02 on off off* off* red yellow yes APi 
ehpK 02 on on off off red yellow yes APi 
ehpL 02 on on on off red yellow yes APi 
ehp/ 01 off on on on red red no APi! 
ehpJ 01 ou off on on red yellow yes APi 
ehpK 01 on on off on red yellow yes APi 
ehpL 01 on on on off brown brown APi? 
1. The iuterrupted Group 3 gene and the orientation (OrL) ofmini-Tn51acZ2 within that gene. 
2. Activity of the Group 3 genes predicted from transposon orientation and demonstrated by 
DNA complementation (see section 3.4). *ehpK and ehpL are expressed at a low level 
when ehp/ or ehpJ are intelTUpted (see section 3.7). 
3. The colour of compound(s) excreted to Kings-A media by each mutant cultured in sealed 
(oxygen limited) or opened (unlimited oxygen) microtitre dishes. The colours present in 
sealed microtitre dishes changed from red to yellow within hours of opening. 
4. Shown to be converted (Convert.) into antibiotic by Group 1 and 2 mutants (a measure of 
the activity of Group 3 and Group 4 genes). 
5. The division of red compounds according to different properties. The brown compound 
(APi?) produced by EhehpL (Ol) presumably arises from mini-Tn51acZ2-induced 
expression of the neighbouring Group 4 gene ehpM, as the equivalent 02 mutant, EhehpL 
54 
Since AP2II is only released by a mutant expressing ehpJ, ehpK, and ehpL, but not ehpI, it is 
apparent that one or more of the proteins EhpJ, EhpK, and EhpL (EhpJKL), convert AP2 into a 
form that either cannot be taken up by a Group 1 or 2 mutant or cannot be further modified into 
AGA by the Group 3 and Group 4 gene products. Either way, EhpTI(L can modify AP2. 
Whenever EhpI is present, or whcn all Group 3 gene products are missing a red compound is 
released that can be modified to AGA. Therefore, EhpI is either inactive in the absence of 
EhpJ-L and AP2 is the same as AP2\ or EhpI modifies AP2 in such a way that it can still be 
converted to AGA, in which case AP2 and AP2I would be different. Sequence analysis suggests 
that EhpI is a methyltransferase and EhpK is an oxidoreductase, thus EhpI and EhpJKL 
probably catalyze different reactions. Interestingly, it was noted that the red compound AP2 / 
APi released by the appropriate mutants grown in sealed Universal bottles became 
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yellowlbrown once opened, in contrast to AP2Il. Once the bottles were resealed the culture 
media again became red after many hours, and the conversion from yellow to red started at the 
bottom of the culture medium. These observations indicate that exposure to some component in 
air, presumably oxygen, is in part responsible for the colour change of AP2 I APi. It is likely 
that AP2II is not susceptible to these changes because it has been modified by the EhpJKL 
complex, of which EhpK is a potential oxidoreductase that may alter the redox state, or at least 
the oxygen-reactivity, of AP2. 
Figure 3.10 also illustrates how EhehpJ (01) cannot convert exogenous AP3 to AGA, in 
contrast to all other Group 3 mutants. This observation enables at least one function of EhpJ to 
be differentiated from EhpK and EhpL. As described section 3.7.4, the Group 4 genes ehpM, 
ehpN, and ehpO, cloned in pBR322 to create pBE5b, cdnfer on a host bacterium the ability to 
convert AP3 to AGA in the absence of all other ehp genes, including ehpJ. The Group 4 genes 
in pBE5b are orientated so that they are likely to be expressed under control of the promoter of 
the TcR gene present in the vector, pBR322, probably overriding the normal regulatory 
mechanisms that control expression of the' Group 4 genes in Ehl 087. Therefore, the Group 4 
gene products do not need to interact with EhpJ to function. However, in the context of the 
complete ehp gene cluster, ehpJ must not be interrupted for full expression of the Group 4 
genes. Given that 02 ehpK and ehpL mutations do not affect expression of the Group 4 genes 
the influence of ehpJ is unlikely to be cis-acting, and therefore probably involves a trans-acting 
mechanism. 
A diagram of the predicted activities of the Group 3 gene products in different Group 3 mutants 
is presented in Figure 3.11. The complete Group 3 system present in Ehl087 (panel 1), 
converts AP2 to AP3, and releases AP3 on the periplasmic side of the inner membrane. Panel 2 
illustrates the release of AP2 by EhehpI (02), a mutant which effectively lacks all Group 3 gene 
products. Panel 3 shows the release of AP2II by EhehpI (01), a mutant that lacks EhpI, but 
possesses EhpJ, EhpK, and EhpL, and modifies AP2 to AP2Il. Panels 4, 5, and 6 illustrate 
strains in which EhpI is present and AP21 is released. Determination of the structurcs of the red 
compounds released by different Group 3 mutants would strongly support or discredit this 
model. 
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Figure 3.11. Proposed modification and release of AP2 by Group :I Illutants. 
Each panel illustrates the predicted scenario resulting from mutation to a Group :I gene. The 
Group :I gene cluster is drawn at the bottom of each pane), in which inactive genes are 
highlighted in red. In panel 2 the genes with reduced expression (chpK and ehpL) <lre 
highlighted in pink, and the translation products of these genes are coloured grey to represent 
<lbnOl'm<llly low concentr<ltion. The Group :I gene products arc arbitr<ll-ily drawn as polygons, 
with the e xcl~ption of EhpJ, which is depicted as a tr:.lJlsmembrane protein spanning the inner 
membrane (1M). AP2, APi, and APi ' are all red compounds re k ased by Group :I mutants as 
discussed in the text. 
3.6.4. The Group 4 gene products. 
The Group 4 gene products are responsible for the conversion of AP3 to AGA as evidenced by 
the inability of Group 4 mutants to carTY out the final conversion of AP3 to AGA (Fig. 3.4) and 
because the Group 4 genes confer the ability to convert AP3 to AGA on a host cell in the 
abse nce of all other ehp genes (Fig. 3.12). The products of this group are also car~lhle of 
cata lyzing the addition of a D-alanine residue to GA, the compound created by hydrolysis of 
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AGA (Figs. 3.4A, 3.12). The predicted protein sequences of both EhpM and EhpN are similar to 
non-ribosomal peptide synthetases. The sequence of EhpM is most similar to SyrB I. a 
threonine-bi ndi ng component of s yri ngomyci n synthetase found in Pseudomonas .Iyringa(' pv. 
syringae (Guenzi et al. . 1998). PROSITE analysis of EhpM suggests that it belongs to the 
AMP-dependent synthetase and ligase protein family (residues 42 - 420). In addition, the 
TMHMM program predicts that EhpM is composed of a cytoplasmic 75 residue N-terminal 
region. followed by a transmembrane helix of 19 residues, and that the final 397 residue C-
terminal region is peripiasmic. This topology is suppor1ed by the activity of lacZ fusions within 
ehpM (Fig. 3.13). Because ~-galactosidase is only active in the cytoplasm, the lower activity of 
a hybrid EhpM::LacZ protein containing 281 amino acids predicted to be periplJsmically-
localized. compared to a similar fusion with only 80 predicted periplasmic amino acids, 
suggests that the greater the length of the periplasmic region. the greater the chance that the 
EhpM protein section can mobilize the fused LacZ protein into the periplasm where it is not 
active. Alternatively, the ~-galactosidase activity of the two EhpM::LacZ proteins may result 
from structural constraints on LacZ. Additional EhpM :: LacZ fusions, particu lady to the 
predicted cytoplasmic region of EhpM, are required to strengthen or discredit this proposal. 
Figure 3.12. The Group 4 genes are sufficient for the com'Cfsinn of AP3 to AGA 
Each antibiotic disk contains 20 J.lg of 
AP] and ca. 107 cells of e ither E. 
heriJico/a Eh~AGA or E. coli MC4100 
(controls). or these strains harbouri ng 
plasmid pBE5b (encodes all Gn)up 4 
genes . clzpM. ehpN. and chIlO). Viable 
ce lls were rec()vered from the control 
disks but not from disks in which AP3 
hac! hL'l:n converted to AG 
Gri sl:oluteic acid (GA) W;,iS s imilarly 
converted tLl AGA by tlll' .'" strain s. 
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Figure 3.13. Support for localization of the C-terminus of EhpM to the periplasm 
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fJ-galactosidase activity of lacZ fusions to the 
approximate N-terminal and C-terminal regions 
of the predicted periplasmic region of EhpM. 
The N-terminal fusion creates a hybrid protein 
consisting of LacZ fused to 174 EhpM amino 
acids, ofwruch the fITst 75 are cytoplasmic, the 
next 19 span the inner membrane, and the last 
80 are periplasmic. The C-terminal fusion 
consists of LacZ fused to 375 EhpM amino 
acids, of which the last 281 are predicted to be 
periplasmic. Error bars for two standard 
deviations from three experimental replicates 
are shown. 
3.7. Operon structure and regulation within the e/tp gene cluster 
3.7.1. A system for the creation of Eh1087 recA mutants 
58 
Complementation studies of Ehl087 (Ant-) mutants and various subclones from the region 
involved in antibiotic production have produced inconsistencies probably as a result of RecA-
mediated homologous recombination between the introduced plasmid DNA and the genome of 
the host Ehl087 strain (Keams, 1993). To overcome these problems and accurately assess 
clones for their ability to complement Ehl087 (Ant-) mutants, a system for marked mutation of 
the recA gene in Eh 1087 was developed. Initially, cosmid pLArecA, encoding the Eh 1 087 reeA 
gene, was isolated from the Eh1087 genomic library by complementation of DH5a reeA. 
Because the reeA+ allele is normally dominant over most mutant alleles, DH5a recA+ 
strains can be differentiated from reeA- strains by selection for MMS or UV resistance, which 
requires RecA induction of the SOS response to counter the effect of DNA damage caused by 
MMS or UV (Owttrim and Coleman, 1987). This selection was used to isolate a 1.8 kbp EeaRl 
fragment of cosmid DNA containing a functional recA gene (pKSrecA). DNA sequence of this 
fragment was determined for one strand (Appendix Al.6), which was sufficient to demonstrate 
very high sequence similarities to the translated recA gene products from Yersinia pestis 
(299/331 identities), Serratia marcescens (297/330 identities) and Pantaea agglamerans 
(296/331 identities), amongst others. The GeneMark algorithm predicted a gene between an 
ATG start codon at base 134 and a TGA stop codon at base 1201 (1068 bp) of the 1784 bp 
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insert DNA in pKSrecA (Fig. A 7). This sequence data, and the complementation of the recA 
mutation in DH5a, indicated that clone pKSrcr!\ encodes a 1068 bp recA ge ne from Eh 1087. 
A rc('/I-mutant deri vati ve of pLAr('(/I, pLArcc!\ 777 was created by i nserti ng an nCmR cassette 
between bases 777 and 778 of the Eh 1087 recA gene to create the mutant recA allele recA 777. 
The transfer of pLArec!l777 from an E. coli S17-1 donor to Ehl087 strains by conjugation was 
can-ied out in the presence nf em to select for maintenance of recA 777, and in the absence of Tc 
to ensure that the cosmid vector was not maintained by selection. Under these conditions, 90-
95 % of all transconjugants were found to be recA recombinants that had lost (or never 
established) the cosmid vector. If the cosmid vector was allowed to establish, recombination 
occurred at a very low rate and was often difficult to detect. All Eh 1087 rccA strains created by 
this process were killed by 0.125 mM MMS, or a brief dose of UV irradiation, conditions that 
differentiate between recA+ and recA - strains (Fig. 3.14). All recA strains were confirmed by 
Southern hybridization (data not shown). 
Figure 3.14. MMS sensitivity of Eh IOS7 recA strains 
Qualitative assay for RecA activity. The following bacterial strains were streaked on LB agar 
medium supplemented with 0.125 mM MMS; I, E. coli MC4100 I'('cA-; 2, MC4JOO recA+; 3, 
EhlOS7 I'cc;\-; 4, Ehl087 rC(f\+, 5. Eh~AGA rec;\-, 6, Eh~AGA r('c;\+. Strains 2, 4, and 6 
have grown without inhibition by MMS, whereas strains J, 3, and 5 are all inhibited. 
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3.7.2. The Ehl087 recA mutatiou is dominant 
coli MC4l00 recA+ possessing plasmid pKSrecA777 was more sensitive to UV than cells 
without this clone or than cells possessing pKSrecA. This indicated that the introduced recA777 
anele was overriding the effect of the functional recA gene present in MC4100, and may have 
been the reason behind the low recombination frequency of Ehl087 strains in which 
pLArecA777 had become established. The chloramphenicol resistance cassette used to create 
the recA777 allele contains numerous translation and transcriptional stops at each end. 
Therefore, it is likely that the 777 bp 5' region of the recA gene upstream of the nCmR cassette 
may be expressed as a truncated 259 residue protein that can compete with or inhibit the activity 
of functional RecA monomers. 
3.7.3. Recombination rates in Ehl087 l'ecA+ and l'ecA- strains 
The creation of recA strains was undertaken to prevent homologous recombination occurring 
between the Eh1087 genome and introduced plasmids. To compare homologous recombination 
in recA+ and recA- strains of Eh1087, the frequency of recombination between recA+ and recA-
strains of mutants EhehpA or EhehpC and pLA272, cosmid with DNA complementary to the 
mutation points, was compared. . Plasmid DNA prepared from each of these strains was 
introduced to E. coli, and plasmid-containing transformants were isolated on media 
supplemented with Tc. These transformant were subsequently assessed for the presence of the 
transposon mini-Tn5lacZ2 by selection on media supplemented with Km. TcR, KmR co-
transformants could only conceivably have arisen from homologous recombination between the 
Ehl087 mutant genome and the complementary pLA272 DNA. Of 100 TcR transformants 
arising from the introduction of plasmid DNA from one of the four strains, KmR recombinant 
plasmids were only isolated from DNA derived from the recA+ strains, and at a frequency of 16 
% for both strains. This frequency was shown to be coincidently the same, since recombination 
between pLA272 and other ehp mutants ranged from 1.3 % to 17 %, presumably depending on 
how soon after inoculation a recombination event occurred in each culture. 
3.7.4. Complementation of EhehpA. 
The inability of mutants with 02 transposon insertions to convert exogenous AGA 
intermediates to AGA suggested that the interruption of any AGA synthesis gene affects 
expression of all genes transcribed downstream. On this basis it was possible that the 15 AGA-
synthesis genes are transcribed solely as a single operon subject to polarity (the single operon 
hypothesis). An alternative, but not mutually exclusive, explanation is that regulation of gene 
expression within the AGA-gene cluster could involve trans-acting mechanisms. The direction 
of transcription throughout the 15 ehp synthesis genes, and the fact that 02 mutants could not 
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cany out any functions involving genes downstream of the insertion point, supported the former 
proposal. 
To test the single operon hypothesis, a classical DNA-DNA complementation approach was 
undertaken, in which a second copy of the ehp gene cluster (pLA272) harbouring 02 transposon 
insertions in one of the ehp genes was assessed for ability to transform Eh1087 02 mutants into 
antibiotic producers. 02 inseltion mutants were used because the transposon orientation 
ensures that transcription initiated from within the transposon is directed against transcription of 
the el/p genes, creating mutations that demonstrate the influence of an insertion in a particular 
gene on expression of all downstream genes. In contrast, transcription presumably continues 
under a KmR promoter for genes downstream an 01 transposon insertion and polar effects are 
avoided. Therefore, for all genes downstream of the insertion point in 02 mutants those 
controlled by the same promoter will not be active, whereas those controlled by a separate 
promoter will be active. Activity can be detected as antibiotic production if a second copy of 
the ehp gene cluster harbouring a transposon insertion in another ehp gene is provided in trans 
(Fig. 3.15). For this investigation, a selection of 02 transposon insertions in each ehp gene, 
except ehpE and ehpO, were transferred to cosmid pLA272 by homologous recombination. 
Each cosmid derivative created by this process was initially introduced to an EhehpA 02 mutant 
that had been modified to be recA to prevent homologous recombination between the introduced 
DNA and the mutant genome. It was anticipated that if the single operon hypothesis was 
correct then no cosmid derivative should complement EhehpA (02) because no strain would 
have all the gene products required for AGA synthesis. In contrast, pLA272 with 02 insertions 
in ehpF-ehpO did complement EhehpA indicating that these genes are expressed independently 
of the Group 1 genes (Fig 3.15). 
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Mutant: ~ Qj+ ®+ ~ 
EhehpA ... ~~=:>~==:::,.....=;. 
ehp gene: ABC 0 E F G H I J I<. L M N 0 
Complementary pLA272 derivative: 
AGA 
Production 
pLA272::ehpA-D ...... • 
pLA272::ehpl-L q~~",-",.~",,,,-,,. ~ 3-4 mm 
pLA272::ehpM q c:;c. =~~~=:>~~ 5-8 mm 
pLA272::ehpN 9-12 mm 
Figure 3.15. Eh ch/JA comple mentation by pLA272 transposon-inse rtion derivatives 
Black arrows represent genes interrupted by mini-Tn5/({cZ2, and white arrows represent genes 
for which expr ' ssion is unknown. Gene activity (either ge ne expression or functionalit y of the 
gene product) is colour coded: yellow arrows represcnt low activity, through to red arrows, 
which re present high activity. A ntibiotic production was meas ured as 2 x radius of ha lo from 
edge of colony, and in all cases results from fralls complementation of the genomic eh/iA 
mutation. Five predicted promoters, P"" Ph Ph PM, and P,, , are shown at the top of the 
diagram. 
Strains of Eh<'hpA harboring a second copy of the AGA-gene cluster mutated in a Group I gene 
(pLA272::ehpA. B, C, or D) do not produce antibiotic, Since all of these strains are lacking at 
le'lst one Group I gene product, the genes ehpA-ehpD must be expressed as an ope ron from a 
sin g le promoter. Plasmids pLA272::ehpF, pLA272::ehpC, or pLA272::ehpH partially 
complemented EhehpA, resulting in low level antibiotic production. Therefore, a second 
promoter controls expression of ehpF, ehpC, and ehpH as an operon, and e xpression from this 
promoter is either secondary to read-though from the ehpA promoter, or is reduced when the 
preceding genes are interrupted. Further analysis of the EhehpA complementation data 
indicated that the expression of all genes tested, except ehpN, is reduced when any upstream ehp 
gcne is interrupted. the 0 I mutations re-initiate This observation sugge sts that most genes 
required for AGA synthesis have an underlying operon structure, with additional promoters 
controlling each functional gene group over and above, or in the absence of, the underlying 
transcription of the complete' AGA synthesis operon'. 
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Table 3.4. Complementation of Lh I OS7 02 mutants 
pLA272 deri vati lies I contro ls" 
pLA A B C D F C H J K L M N I~g Eh 
Lilt' IzI}A II 0 0 0 0 2 2 ] ] ] J 6 II 4 
Eh ehfi F 12 2 3 3 2 0 0 0 5 II .5 
Eh ehv t 12 6 6 6 5 2 2 2 2 0 5 II .5 
Eh ehfiM 12 9 9 t o 9 7 7 7 7 7 > J 0 7 4 . J 
Antibioti c production by rnA mutants of Eh ehl'A, L hehl'F, Ehehl'J <wd Ehehl'M harbouring 
pL A272 deri vati ves (measured, in mm, as diameter of c learing [one minus co lony d iameter). 
Oat:.! in italics is artificiall y high due to the effect of plasmid copy number as illustrated in 
f igure ]. 16. I pLA272 (pLA) and recombinant deri vati ves of pLA272 contain ing a t ransposon 
inserti on in the ehl } gene li sted (no te: exc luding ehfJE and ehl' 0 ). 2Cont rn ls to assess va ri ati on 
be t we~n plal\:S were I !Jf' ,\GA ( in a si x mill ¢ di sk) and Ehl 087 ce ll s cultured and applied as 
per test strains. 
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A) Eh1087 native plasmid copy Production 
EhehpA .. ~~=>~~ 
A B C 0 E F G H I J I<. L M N 0 5-6 mm 
pLA272: :ehpM ..... • .... ....... .... .~Introduced plasmid copy 
B) Eh1087 native plasmid copy 
EhehpM ..... • .... • . ...... . ... .~ 
A B C 0 E F G H I J I<. L M N 0 9-10 mm 
pLA272:: ehpA .. C::::::> :>C==>~=>~~
Introduced plasmid copy 
Figure 3.16. The effect of copy number on complementation. 
Com plemen tati on of an Lhehfi mutant by a plasmid w ith a second copy of the ('hI' gene c luster 
containing a diffe rent ('hI' mutation. The genomic gene cluster copy is shown above the 
plasmid copy. Coloured alTOWS represent genes w ith the fo llowing propert ies ; green. genes that 
are subject to normal ex pression contro l mechanisms: blac k, genes harbouring a mutati on; 
white, genes downstream of a mutated gene and suhject to ex press ion independent of ehl'A: 
red, the copy of ehpM that prov ides a measure or the ehl}M express ion that is independent o f 
cis intluences from the ex press ion of ('hl}A . A) Antibioti c producti on by a stra in contai ning 
both a genom ic mutati on in ehl}A and an elil)j\1 mutation in a pla ~ mjd copy o f the gene clustL:r 
prov ides a measure of ehl}A-indef1endent exprc~si()n of the genomic ehl )!'v! . B) ehfiA-
independent (c is) eX f1rcss ion of the pl asmid-encoded ehfiM. 
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3.7.5. Gene cluster copy number limits complementation analysis 
The copy number of the introduced plasmid containing the AGA gene cluster has an important 
influence on the interpretation of complementation data. As an example, the complementation 
of EhehpA by pLA272::ehpM (A), and EhehpM by pLA272::ehpA (B) is compared in Figure 
3.16. In both situations the Group 1,2, and 3 genes (ehpA-ehpL) are expressed under control of 
the regular ehp gene cluster promoters on either the introduced plasmid (A) or the Eh1087 
genome (B), whereas ehpM is provided in trans by expression from a promoter independent 
(mostly) of these influences (red arrows). The AGA gene cluster is encoded on a ca. 200 kbp 
plasmid of unknown copy number in Ehl087. However, since the provision of ehpMin trans is 
the limiting factor for antibiotic production by these strains, and antibiotic production is lower 
when the functional ehpM is encoded by the Eh1087 genome rather than the plasmid 
pLA272::ehpA, it appears that the copy number of pLA272 is higher than the native Eh1087 
plasmid. In strain EhehpM harboring pLA272::ehpA, the introduced plasmid presumably 
supplies artificially high amounts of EhpM, and disguises the true effect of an ehpA insertion on 
expression of ehpM. For this reason the activity of the ehp genes present on the native Ehl087 
plasmid was scored to assess complementation, rather than the activity of the ehp genes on the 
introduced plasmid. Unfortunately this approach is limited to assessing the influence of a 
particular gene on the expression of downstream genes, and does not differentiate between cis-
and trans-acting regulatory mechanisms. 
3.7.6. Complementation of Group 2, 3, and 4 mutants. 
Since the Group 1, Group 2, and Group 3 genes appeared to be controlled as individual operons, 
complementation of a representative mutant from each group by pLA272 derivative-plasmids 
was used as an approximate measure of the influence that each group had on the expression of 
downstream genes. The plasmid pLA272, and transposon insertion derivatives of pLA272, 
were introduced to recA mutants of EhehpF (Group 2), Ehehpl (Group 3), and EhehpM (Group 
4), and all strains were assessed for antibiotic production (Table 3.4). For unknown reasons the 
amount of antibiotic produced by mutants harbouring pLA272 was markedly less than Ehl087, 
however because pLA272 complemented all mutants equally it is likely that this difference 
would have an consistent influence on the complementation analyses reported here. The data 
presented in Table 3.4 again indicates that the functional Groups 1, 2, and 3, are expressed as 
individual operons with dedicated promoters, and that expression or activity of most genes is 
influenced, in varying degrees, by the expression of all genes encoded upstream. This influence 
provides further clues about the relative strength of the regulatory mechanisms controlling the 
AGA synthesis gene cluster. For instance, the lower the amount of antibiotic produced by a 
strain containing two copies of the AGA gene cluster, each with an insertion in different genes, 
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the stronger the co-regulation of the two mutated genes (as an operon or by other mechanisms), 
or the greater the likelihood that those gene products act together (Fig. 3.17). 
It is proposed that the Group 3 and Group 4 operons are not only preceded by promoters, but 
also contain the 'intra-operon' promoters, PK, and PN, respectively (Figs. 3.15, 3.17). Promoter 
PK is present within the Group 3 operon as evidenced by EhehpJ harbouring pLA272::ehpK. 
This strain demonstrates that PK can drive the expression of ehpK and ehpL at a low level when 
transcription through ehpJ is interrupted. also appears to influence the expression of ehpM 
since antibiotic production by EhehpM harbouring pLA272::ehpK / L is far lower than other 
EhehpM strains. If the expression of ehpM was not linked to ehpK, surplus ehpM would be 
provided in trans (due to the higher plasmid copy number), and this strain would produce a 
similar amount of antibiotic as EhehpM harbouring pLA272. The Group 4 genes ehpM and 
ehpN have separate promoters as demonstrated by antibiotic production by EhehpM harbouring 
pLA272::ehpN, and by the increased production of all strains harbouring pLA272::ehpN 
compared to strains harbouring pLA272: :ehpM. The relatively large amount of antibiotic 
produced by this strain indicates that the ehpN promoter is reasonably active in the absence of 
ehpM, in contrast to the low activity of the ehpK promoter in the absence of ehpJ. However, 
because mutants EhehpA-EhehpL harbouring pLA272::ehpN produce more antibiotic than 
EhehpM (pLA272::ehpN), full expression of ehpN must require a functional ehpM gene. 
Therefore, the Group 4 genes probably have an underlying operon structure, much like the other 
functional groups, and the expression of ehpN is also controlled by a secondary 'intra-operon' 
promoter (PN). 
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Figure 3.17. The polar effect of ehp mutations on the expression of downstream genes. 
Gene activity is colour coded as per Fig. 3. 15. Dotted red lines represent operons, and the 
black crosses hi ghlight the point at which transcription is interrupted by an 02 transposon 
insertion in the gene co loured black. The influence of one gene on the 'activity' of another 
(blue arrows) was graded as follows: 
+++ strong dependence of one gene on another; for example EhehpA is on ly weakly 
complemented by a second copy of the gene cluster with an insertion in ehpF, ehpG, or 
ehpH. Strains produce a 1-2 mm <D antibiotic halo (ye llow arrows). 
++ moderate dependence, stra ins produce a 3 mm <D antibiotic halo ( li ght orange arrows) . 
+ weak dependence, strains produce a 5-7 mm <D antibi otic halo (dark orange arrows) . 
(red arrows depict genes that are not influenced by a mutation in an upstream gene) 
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3.7.7. An assessment of post-transcriptional regulation 
Complementation studies indicated that there are six promoters driving expression of the ehp 
g:cnes, and that if transcri ption from PA is interrupted, the acti vity of all promoters downstream 
of Group I is very low (Figs . .3.15 - 3.17). Therefore, the ehp genes appear to be expressed 
predominantly as a single operon (excluding ehpN and presumably ehpO) under control of PA. 
If ehp gene expression is regulated solely at the level of transcription, then expression of all 
genes should be similar or greater for genes further from ehpA as additional promoters could 
potentially enhance the transcription of such genes. To quantify the expression of the ehp gene 
translation products, and determine whether the expression of these products is subject to 
regulation at the level of trans lation, the activity of in-frame, {aeZ fusions to these ge nes was 
measured. This approach enabled the expression of the translation products of ehp genes from 
different groups (inler-group), and from within the same group (infra-group), to be compared 
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Figure 3.18. ,B-galacLOsidase activity of Eh ehfi mutants with active lacZ fusions. 
Mutants were grown in l -A minimal media to an optical density (A = 600 nm) of 0.4-0.6 (mid-
log phase. L). or for 24 hours (stationary phase. S). and ~-galactosjdase activity \-Ias measured 
by the method of Miller. 
The expression of representative genes from Groups 2, .3. and 4. werc all lower than EhpA. 
indicating that the ehp gene cluster is subject to transcriptional and translational regulation. and 
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that the activity of the secondary promoters upstream of each of these groups is insufficient to 
override the translational regulation (Fig. 3.1 XA). Furthell11ore, the regulatory mechanism(s) 
controlling the rate of translation are highly influential even within the Group I genes (Fig. 
3.18B). There are also examples of intra- and inter-group variation in the suppression of gene 
expression during entry to stationary phase. The production of most gene products decreases in 
varying degrees during this period, except EhpC and EhpM, indicating that there is a second 
post-transcriptional regulatory mechanism. Thus, tr~mslation 01 the AGA-gene cluster transcript 
is differentially regulated for each gene during exponential-phase growth, and the magnitude of 
the suppression of translation during entry to stationary phase is also differentially regulated for 
each gene tested in this study. 
To determine whether or not these translation-regulating mechanisms are speci fie to Eh I 087 
and could affect the amount of AGA produced by EhlOX7 relative to E. coli, the expression of 
LacZ::Ehp fusion proteins was measured in both bacteria. To assess the expression of these 
fusions in E. coli, the appropriarc mini-Tn5lacZ2 insertion derivatives of pLA272 were 
introduced to E. coli MC4100, a strain that produces AGA when it contains pLA272, although 
with far lower effi 'iency than Eh 1087. The copy number of pLA272 is likely to be higher than 
the copy number of the native Eh 1087 plasmid, and this may result in an over-estimation of ehp 
gene product expression in E. coli relative to Eh1087. As shown in Figure 3.19, even with a 
copy number effect, the expression of the gene fusions is far lower in F. coli MC41 00 than in 
Eh1087. For instance, the expression of EhpA during log phase is ca. SO % less in MC4100 
than in Eh 1087, and the expression of EhpF, Ehpl and EhpM is 80-90 Cir less in MC41 00. 
Figure 3.19. Relati ve expression of Ehp proteins in Eh IOX7 and E. co/i. 
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3.8. The AGA-gene cluster contains a resistance gene 
3.8.1. Localization of the AGA-resistance gene 
69 
Three cosmids, pLA272, pLA203, and pLA214, conferred AGA-resistance on an E. coli host 
cell as shown in Figure 3.1. The plasmid pBB7, containing a 7 kbp DNA fragment from 
pLA272 (Fig. 3.2) also provided coli with AGA resistance. To localize the resistance gene(s) 
random insertions of mini-TnlOlacZ' in pBB7 were isolated and screened for loss of AGA-
resistance in an coli host. Such insertions were mapped by restriction enzyme fragment 
analysis to within a 400 bp region upstream of ehpA (Fig. lB). Active lacZ fusions that resulted 
in a resistance-minus phenotype were orientated so that lacZ was divergently transcribed from 
the rest of the ehp genes (Fig. 3.5). Analysis of the DNA sequence surrounding these 
transposon insertions using GeneMark indicated that they interrupted a 390 bp gene, designated 
ehpJ1 (AGA resistance), which possessed no similarity to any DNA or protein sequences in the 
databases (December, 2001). The translation product of ehpR was predicted to be a protein of 
14.6 kDa, which agrees with the size of the EhpR protein expressed in E. coli mini cells (Fig. 3. 
6). 
3.8.2. ehpR is necessary and sufficient for AGA-resistance in Ehl087 and in E. coli 
Three lines of evidence suggest that immunity is necessary for Eh 1 087 survival during 
antibiotic production. Firstly, no insertions to the resistance gene were isolated during the 
screening of 5000 Ehl087 mini-Tn51acZ2 mutants. Secondly, although transposon insertions 
either side of ehpR could be transferred from pBB7 to the Eh1087 genome by recombination at 
a frequency of 1-2 % no recombination was detected for equivalent insertions within the 
resistance gene (data not shown). Thirdly, and perhaps most convincingly, E1u\AGA cells 
containing the Group 4 genes on a plasmid can convert exogenous AP3 to AGA, but die in the 
process due to sensitivity to AGA (Fig. 3.12). Based on the assumption that the resistance 
factor is essential for Eh1087 survival, and therefore that ehpR could only be mutated if 
antibiotic synthesis was first inactivated, both the AGA-resistance and biosynthesis regions 
were deleted from EhehpA to create EhLlAGA. All four resulting E1u\AGA strains were 
sensitive to AGA (minimal lethal concentration (MLC), 1.6 ~g.mrl), and were transformed to 
be antibiotic resistant by pBB7 or pBB7::ehpA (MLC >51.2 ~g.mrl), but not pBB7::ehpR. 
Similar results were obtained with E. coli strains harbouring these plasmids, demonstrating that 
the resistance factor is sufficient for antibiotic resistance in Eh 1087 and E. coli. Furthermore, 
the provision of resistance to E. coli demonstrates that EhpR acts independently of the AGA-
synthesis gene cluster and any other Eh1087-specific factors. 
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3.8.3. EhpR may prevent AGA from entering an otberwise susceptible cell 
The predicted amino acid sequence of EhpR does not have features found in membrane-
localized proteins such as transmembrane a-helices or hydrophobic regions, thus it is unlikely 
to associate with a cell membrane and function as a drug efflux pump. As discussed in Chapter 
4, AGA has redox potential and could be oxidized to a semiquinone free radical (see Fig. 4.11), 
a compound that would have the potential to react with many cell components and cause wide 
ranging cellular damage. If this is the case then it is unlikely that EhpR protects or alters a 
specific AGA target. To test whether EhpR acts to inactivate AGA or prevent AGA uptake, 
AGA was exposed to Ea8862 and Ea8862 (ehpR), re-extracted after various exposure periods, 
and assessed for activity (Fig. 3.20). After 60 min., all Ea8862 cells exposed to excess AGA 
(25 times MLC) were killed, and all AGA activity was lost, demonstrating that AGA loses 
activity in the presence of Ea8862. This result suggests that AGA reacts with some cell 
component(s), losing activity in the process. Furthermore, AGA appears to react with and 
become inactivated by even dead cells, because AGA inactivation continued when an Ea8862 
cells had died (For example, see Fig. 4.7). Live cells, for instance Ea8862 (PEhpR), appear to 
degrade AGA at a slightly faster rate than dead cells suggesting that recently killed cells, in 
which metabolism is reduced but still potentially active, are less reactive to AGA. In contrast, 
the reactivity of a bacterium with intrinsic resistance to AGA, Pseudomonas aureofaciens 
PA147-2, was found to be considerably less than either Ea8862 or Ea8862 (pEhpR), 
3.8.4. The AGA synthesis and resistance genes are not necessary for plasmid maintenance 
ill piallta 
The AGA gene cluster contains genes for AGA synthesis and resistance, thus it was possible 
that the gene cluster could act as a plasmid maintenance system whereby all cells that 
segregated without the plasmid would also lack AGA resistance and may be killed by 
neighbouring AGA-producing cells. It was hypothesized that interruption of the AGA-gene 
cluster would result in loss of the native plasmid over time, This hypothesis was tested by 
assessing the loss of SmR in strain Ehi\AGA, which was created by replacing the AGA gene 
cluster with an SmR marker. To enhance the selection pressure for cells that had lost the 
metabolic burden of the native plasmid, plasmid loss was assessed in cells of EMAGA that had 
been competing with Ea8862 for the stigma of an apple blossom (see chapter 2 for experimental 
details). Strains isolated from blossoms after 24, 48, and 72 h were enumerated on selective 
media, and each Rf'R EMAGA colony was assessed for loss of the plasmid marker, SmR , It was 
assumed that the establishment of Ea8862 on stigmas before inoculation with Ehi\AGA would 
provide a difficult environment for EhL\AGA to grow, and therefore increase the selection 
pressure for loss of excess metabolic burdens, such as a plasmid, even further. However, no Rf'R 
strains isolated from blossoms after 24 h (95 colonies), 48 h (120 colonies), or 72 h (106 
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colonies) were Sms, indicating that the Eh1087 plasmid is maintained by some mechanism other 
than the provision of AGA synthesis and resistance to a host cell. 
A) T Exp (min.): 5 10 30 60 
LB 
control 
Ea8862 
Ea8862 
(pEhpR) 
B) 
PA147-2 
Figure 3.20. The influence of EhpR on AGA degradation by bacterial cells 
LB media supplemented with 10 Ilg.mr1 AGA and either no bacteria (LB control), Ea8862, 
Ea8862 (pEhpR), or PA147-2 were incubated at 30 °C and AGA was extracted to chloroform 
from 200 III (0.2 Ilg AGA) of culture supernatant at the designated times. Over the 60 min 
period of the assay the Ea8862 population decreased from 1.2 x 109 to < 10 cfu.mr1, whereas 
the Ea8862 (pEhpR) population did not decrease (6.5 - 5.8 x 108 cfu.mrl) and the PA147-2 
population decreased by an intermediate amount (2.2 x 109 to 5.2 X 107 cfu.mr1). MIC data 
for these strains: Ea8862, 0.25 Ilg.mr1; Ea8862 (pEhpR), >51.2 Ilg.mrl; PAI472 >16 Ilg.mr1 
(see section 4.5). 
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3.9. Origin of the AGA gene cluster. 
3.9.1. Amongst E. Izerbicola the AGA gene cluster may be unique to Ehl087 
Twelve E. herbicola strains isolated from various field locations in New Zealand were 
investigated for the presence of all or part of the DNA region responsible for antibiotic 
production (strains were obtained from the International Collection of Micro-organisms from 
Plants, Landcare Research / Manaaki Whenua New Zealand Ltd., Auckland, New Zealand). 
Genomic DNA from these strains failed to hybridize to the DNA of cosmid 3272, or subclones 
pBB7, pBE5a, and pBE5b which cover the AGA-gene cluster region indicating that neither the 
AGA gene cluster, nor part thereof, is present in the Erwinia spp. investigated (data not shown). 
Since it has been shown that the AGA-gene cluster is located on a large plasmid (Keams, 1993; 
M. Galbraith, pers. comm., 2001) there is a good chance that the entire plasmid may be unique 
to Eh1087. 
3.9.2 DNA sequence characteristics suggest that the AGA gene cluster did not originate in 
Pseudomonas spp. 
The lack of similarity between the DNA sequences of the AGA gene cluster and the described 
PCA operons is at least partly due to the considerable difference in GC content between them, 
as illustrated in Figure 3.21. The AGA gene cluster has a GC content of 43.7%, whilst the PCA 
operons vary from 61.2-68.8 % (accession numbers: Pseudomonas aeruginosa. AF005404; 
aureofaciens 30-84, L48339; P. chlororaphis PCLl391, AF195615; P.jluorescens, L48616). 
3.9.3 Evidence that the AGA-gene cluster is a transposon 
Analysis of the DNA sequence of the regions upstream and downstream of the AGA gene 
cluster suggests that the cluster may be part of a transposon. In both regions there are 
similarities of varying significance to transposase-type genes (see Appendices A2.2 and A2.3). 
The probable transposase encoded in the region upstream of ehpR has a far higher GC content 
than the remainder of the gene cluster, suggesting that it is of different origin (Fig. 3.21). The 
DNA sequence of a possible transposase-encoding region downstream of ehpO is short (ca. 
1000 bp) but also appears to mark a transition to higher GC content. The sequence of DNA 
beyond this region is required to strengthen or refute this proposal. 
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Figure 3.21. DNA sequence properties of the AGA gene c luster and neighbouring DNA. 
The DNA sequence of the region illustrated in grey has been determined. including the ehll 
genes (yellow). The boundary-defining insertion s LJ4 and 0 3 are shown for comparis()n with 
Figure 1.2. and the direction of transcription within the DNA region is shown by arro ws below 
tiK' gene cluster. The variation in GC content throughout the sequenced reg ion is shown in the 
top scction. in which short black lines represent the GC content of overlapping 500 bp sL'c tiol1s 
of DNA scquence. The average "It- GC content of the ellll gene cluster is shown by a dashed 
red line (AGA). The dotted red lines indicate the average GC content of the phena/.ine 
nucleus genes in Ps. aemgil10sa PAOI (PCAI). in Pol . fluore .\(·('l/s 2·79, Ps. ch/oruraphi., 
PCL 1191 . and P,. ollJ'co(acims 30-:-\4 (1'(',\2) , and in E. herhico/a Eh 1087 (AP I) Regions 
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Discussion 
The characterization of antibiotic gene clusters provides infonnation that is useful for the 
manipulation of antibiotic biosynthesis pathways to alter the ability of an organism to produce 
different amounts of antibiotic in different environments, or even to produce antibiotic variants. 
The genetic modification of an antibiotic gene cluster in such a way offers enonnous potential 
for the development of superior biological control agents for which antibiosis is important for 
pathogen suppression. Given that antibiosis is recognized as important for suppression of the 
Fire Blight pathogen, E. mnylovora, by many strains of herbicola, it is somewhat surprising 
that there is so little data about the molecular genetics of antibiotic production in these strains. 
In this regard, the present study breaks new ground in characterizing a substantial 16-gene 
cluster required for synthesis of AGA by Ehl087, an antibiotic that is involved in the 
suppression of E. amylovora (see chapter 2; also Keams, 1993; Keams and Mahanty, 1998). 
Just as irr;tportantly, this is the first description of genes required for synthesis of the phenazine 
nucleus outside of the Pseudomonas genus. The results presented in this chapter also 
demonstrate the general roles of sub-clusters of genes in the modification of the phenazine 
nucleus (PCA); in contrast, the modification of PCA in Pseudomonas spp. appears to involve 
single genes, each involved in a particular PCA modification (Chin-A-Woeng et al., 2001; 
Delaney et al., 2001; Mavrodi et a1., 2001). Also of significance is the finding of a dedicated 
phenazine antibiotic resistance gene associated with the AGA-gene cluster in Ehl087, since to 
the authors knowledge no such gene has been described previously. 
Previously, transposon mutants of Ehl087 were isolated that could not produce antibiotic 
(Keams, 1993). Characterization of the transposon insertion points demonstrated that a region 
of DNA required for antibiotic production in Ehl087 was located on a plasmid, and concluded 
with the cloning and sequencing of four putative genes within the region that were essential for 
antibiotic production (Keams, 1993; Keams and Mahanty, 1998). These data and tools 
provided a good starting point for the characterization carried out in the present study. The 
limited number and distribution of transposon insertions isolated in the previous investigation 
indicated that the original mutagenesis screen not only underestimated the AGA-gene cluster 
size, but may also have missed additional genetic elements required for antibiotic production in 
Ehl087. In the present investigation, the use of defined insertion points, cloning, and a second 
mutagenesis screen has now demonstrated the extent of a gene cluster sufficient for antibiotic 
production, and revealed two non-gene cluster loci that may be involved in this process. 
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Characterization of the AGA-gene cluster genes 
Characterization of the AGA gene cluster is the predominant theme of this thesis. A primary 
goal was the elucidation of the genes and their respective role(s) in the production of AGA. 
Gene predictions were based on DNA sequence data, and supported by empirical evidence in 
the form of expressed gene protein products. Preliminary investigations into the function of 
each gene were helped enormously by the production of coloured AGA intermediates by 
various Eh1087 AGA-minus mutants, a feature also noted for phenazine mutants in other 
bacteria (Byng et aI., 1979; Byng and Turner, 1976; Carson and Jensen, 1974). This 
observation led to the use of classical syntrophism tests, as outlined by Hayes (1968), in which 
the ability of mutants to 'cross feed' each other and to convert antibiotic intermediates into 
AGA demonstrated the role of each gene (product) in the process of AGA synthesis (Figs. 3.4, 
3.7). Complementation analysis provided information about the operon structures within the 
gene cluster, and thus the probable site of promoters for the initiation of transcripts, and the 
comparison of this data with the expression of active lacZ fusions to various ehp genes gave 
clues about the transcriptional and translational expression of the AGA-biosynthesis genes. In 
summary, the AGA gene cluster in Eh1087 has been comprehensively described, and 
preliminary information about the function and expression of each gene has been obtained. 
Several studies have established that a seven-gene operon is necessary for the synthesis of the 
phenazine nucleus (PCA) by fluorescent Pseudomonas spp., and predicted or demonstrated 
authentic roles for each gene in the process (Fig. 3.8). In contrast, the AGA gene cluster of 
Ehl087 is composed of 16 ehp genes, of which five genes have similar products to the PCA 
operon. The AGA gene cluster contains an additional eleven genes required for modification 
and export of the phenazine nucleus, and a final gene whose product provides resistance against 
the antibiotic activity of AGA. The analysis of individual ehp mutants for the production of 
AGA intermediates, and for the ability to convert intermediates to AGA, enabled the genes 
responsible for AGA synthesis to be divided into four functional groups (Groups 1-4). 
The Group 1 genes (ehpA-ehpE) are probable analogs of five of the seven genes required for 
synthesis of PCA by Pseudomonas spp. (Fig. 3.8). In Ehl087 these genes are required for the 
synthesis of the first coloured AGA precursor, AP 1, which has an absorbance spectrum similar 
to PCA (see Fig. 4.7). The low yield of API and the poor conversion of API to AGA by Group 
2 mutants, suggest that API is synthesized within the cytoplasm. Because API and PCA have 
very similar absorbance spectra and only slightly different solubility in water, it is likely that the 
chemical structures of these compounds are very similar. The difference between PCA and API 
could be due to the notable absence in the AGA gene cluster of an apparent gene duplication 
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responsible for the nearly identical phzA and phzB (orphzX and phzY) genes encoded in the 
PCA operons (Fig. 3.8). PhzA and PhzB influence the relative amounts and types ofphenazines 
produced by P. aureofaciens 30-84 and P. fluorescens 2-79 (Mavrodi et aI., 1998; McDonald et 
aI., 2001), therefore the single analog (ehpA) present in Ehl087 may specify the synthesis of 
API rather than PCA as the first AGA precursor. The AGA Group 1 genes also lack phzC 
(phzF) , whose product is similar to plant 3-deoxy-D-arabino-heptulosonic acid 7-phosphate 
(DAHP) synthases. DAHP synthases carry out the first step of the shikimic acid pathway and 
are regulated by numerous mechanisms, for instance bacterial DAHP synthases are often subject 
to feedback inhibition by aromatic amino acids (Jensen et aI., 1967) whereas plant variants of 
this enzyme are apparently not (Mavrodi et aI., 1998). PhzC is more similar to plant DAHP 
synthases, and as such could maintain shikimic acid synthesis and ensure a constant supply of 
the phenazine precursor, chorismic acid, in the presence of aromatic amino acids (Mavrodi et 
aI., 1998). The partial suppression of AGA production in Ehl087 by exogenous tyrosine (data 
not shown) supports the prediction that Ehl087 lacks a functional equivalent of PhzC (PhzF) 
and cannot override feedback inhibition of the native DAHP. This difference between the PCA 
operon and the Group 1 genes may affect the relative amount of the phenazine nucleus 
synthesized by Ehl087 compared to Pseudomonas spp. in some environments. 
Genes comprising Groups 2, 3, and 4 of the AGA gene cluster encode products responsible for 
the conversion of the phenazine nucleus (API) to AGA by a process that involves at least two 
coloured intermediates (Fig. 3.23). The equivalent region immediately downstream of the PCA 
operon in some Pseudomonas spp. encodes phzS, phzO, or phzH for the conversion of PCA to 
1-0H-PHZ, 2-0H-PCA, or PCN, respectively (Chin-A-Woeng et aI., 2001; Delaney et aI., 
2001; Mavrodi et aI., 2001). Since AGA differs from PCN by a carboxamide group, and from 
1-0H-PHZ and 2-0H-PCA by a hydroxyl group attached to the phenazine nucleus, it is not 
surprising that the Ehl087 AGA gene cluster does not appear to possess analogs of phzH, phzO 
or phzS. It is proposed that the genes in Groups 2, 3, and 4 are responsible for novel phenazine 
modifications. The only other organism currently lmown to produce AGA is Vibrio strain 
SANK 73794 which presumably has a similar biochemical pathway for modification of the 
phenazine nucleus (Sato et aI., 1995). However, neither this pathway nor the genetic basis for 
this pathway in strain SANK 73794 have been investigated as far as the author is aware. 
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Figure 3.22. Comparison of the genes immediately downstream of the PCA operon 
Comparison of genes immediately downstream of the phenazine nucleus operon in 
Pseudomonas spp, and Eh1087. The proposed modification carried out by the products of 
these genes are shown on the right (adapted from Delaney et at, 2001; Mavrodi et a1., 2001), 
EhpF acts in association with EhpG and EhpH for the conversion of API to AP2. The product 
of phzS (P. aeruginosa PAOl) also acts to convert PCA to pyocyanin in association with the 
product of phzM. PCA, phenazine-I-carboxylic acid; l-OH-PHZ, I-hydroxy-phenazine; 2-
OR-PCA, 2-hydroxy-phenazine-l-carboxylic acid; PCN, phenazine carboxamide. 
77 
Chapter 3 ANALYSIS OF THE AGA-GENE CLUSTER 78 
The three Group 2 gene products, EhpF, EhpG, and EhpH, carry out the conversion of API to 
AP2. The first member of this group, EhpF, has an AMP-binding domain motif found in 
proteins that catalyze reactions requiring ATP. Although the direct involvement of ATP in the 
synthesis of AGA has not been clearly demonstrated, EhpF may act as a sensor of cellular 
energy levels and limit AGA synthesis during stationary phase when ATP becomes less 
available, and when antibiotic production by Ehl087 stops (see Figure 4.1). The lack of active 
phoA fusions to ehpG and ehpH indicates that their translation products are predominantly 
cytoplasmic. Furthermore, the predicted protein sequences of EhpG and EhpH possess short 
hydrophobic regions suggesting that these proteins are bound to the inner membrane, 
presumably to localize API in preparation for additional modifications and translocation to the 
periplasm. The cytoplasmic conversion of API to AP2 is supported by the fact that AP2 is only 
released from an ehp mutant lacking a Group 3 gene. 
The Group 3 gene products, EhpI, EhpJ, EhpK, and EhpL, collaborate to convert the red 
compound, AP2, to the orange compound, AP3. Data presented in Table 3.3 indicates that 
different Group 3 mutants release at least two and possibly three different red compounds that 
are crudely categorized as 'AP2' (Fig. 3.11). Thus, the products of the Group 1 and 2 genes 
synthesize a red compound that is subsequently modified in at least two different ways by the 
Group 3 gene products without altering the colour or hydrophobicity of the chromophore. As 
illustrated in Figures 3.10 and 3.11, EhpJKL appears to catalyze a reaction that creates a red 
AP2 derivative named AP21I that is not amenable to conversion to AGA by Group 1 or 2 
mutants. Of these gene products, EhpK is a putative oxidoreductase that could potentially alter 
the redox state of AP2 and perhaps lowering the reactivity of AP2 so that it cannot be taken up 
or converted to AGA by Group 1 or Group 2 mutants. This is supported by the observation that 
the product of EhpJKL, AP21I, does not change colour on exposure to air, in contrast to AP2/ 
APi, which are apparently more labile in the presence of oxygen. In contrast, EhpI either 
converts AP2 into a compound that can be modified to AGA by Group 4 gene products, or EhpI 
is not active in the absence of EhpJ or K or L. Ehpl is thought to bc a methyltransferase (Table 
3.2) and as such is probably responsible for the only methyl group present in AGA (excluding 
the methyl group present in D-alanine), at position 9 of the phenazine nucleus (see 4.6). On 
this basis, it appears that Ehpl and EhpJKL catalyze different reactions, that are carried out 
either simultaneously or sequentially (the EhpI reaction occurring first) since the EhpJKL 
modification results in a compound that cannot be converted to AGA by Group 3 and 4 gene 
products (Fig. 3.l0). Alternatively, EhpI may alter the activity of EhpJKL rather than modify 
the structure of AP2; in this scenario the Group 3 gene products are likely to function as a single 
complex. 
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A red compound is also produced by phzS mutants of P. aeruginosa PAOI (Mavrodi et a1., 
2001). Investigations in E. coli demonstrated that phzM gene is responsible for the conversion 
of PCA into this red pigment, which is further converted by PhzS into a blue phenazine 
compound, pyocyanin. Because the red product of PhzM is strongly hydrophilic it did not 
extract to solvents from culture supernatants and its structure has not yet been determined. 
Interestingly, the extraction of the red precursor AP2 / APi from EhehpJ (01) failed for the 
same reasons (no other mutants have been assessed, see Chapter 4). PhzM is predicted to be a 
methy1transferase responsible for the addition of a methyl group to the nitrogen at position 5 of 
the phenazine nucleus (see Fig. 4.6). Because AGA has a methyl group at position 9 of the 
phenazine nucleus, it is probable that the red phenazine intermediates isolated from mutants of 
Ehl087 and P. aeruginosa PAOI are structurally different. Alternatively, the red product of 
PhzM could be the same as the red compound produced by EhehpI, if the conversion of API to 
AP2 includes the addition of a methyl group to the nitrogen at position 5 of the phenazine 
nucleus and the function of EhpI is to subsequently transfer the methyl group to position 9 of 
the phenazine nucleus. It would be interesting to test these predictions by introducing phzS to 
an Eh1087 Group 3 mutant to see whether PhzS can convert AP2 to pyocyanin. 
The second Group 3 gene product, EhpJ, is a transmembrane protein with similarity to protein 
families involved in the transport of a diverse range of compounds across membranes (Fig. 3.9). 
Taken with the findings that the Group 3 mutants release AP2, and that AP3 is found in culture 
supernatants of Ehl087, it is proposed that the mechanism by which AP2 is converted to AP3 
includes the controlled export of AP3 by EhpJ (Fig. 3.11). Since AP2 is only released when any 
of the Group 3 gene products are missing, it is likely that these gene products also function 
together to prevent the premature release of AP2 from Ehl087. The lack of an ehpJ analog in 
or near PCA operons in Pseudomonas spp. indicates that the AP3 export mechanism in Ehl087 
may be different to the phenazine-re1easing mechanisms in Pseudomonas spp. 
The conversion of AP3 to AGA is carried out by the products of the three Group 4 genes ehpM, 
ehpN, and ehpO, independently of all other ehp gene products (Figs. 3.4 and 3.12). The Group 
4 gene products are also able to convert griseo1uteic acid (GA, resulting from the loss of a D-
alanine moiety by AGA), into AGA, and this reaction presumably occurs when Ehl087 grows 
in a moist environment, such as the stigma of blossoms. It is therefore possible that this 
reaction enables Ehl087 to convert hydrolyzed AGA back into active antibiotic on the stigma of 
blossoms where antibiosis is influential in the ability of Ehl087 to compete for niche 
colonization against the Fire Blight pathogen, E. amylovora. Although the exact mechanism by 
which AP3 is converted to AGA is not known, the conversion of GA to AGA by the Group 4 
Chapter 3 ANALYSIS OF THE AGA-GENE CLUSTER 80 
gene products strongly suggests that the mechanism involves a condensation reaction between 
AP3 or GA and D-alanine. Similarly, Yagishita (1960) showed that sonicated mycelia of S. 
griseoluteus possess an enzyme (or complex) that was capable of reacting glycolic acid and GA 
to create griseolutein A. Taken together, these findings indicate that the 6-hydroxymethyl group 
of GA may be commonly substituted with various side groups to produce different antibiotic 
active derivatives (Imamura et aI., 1997; Sato et aI., 1995; Singh et aI., 1997; Yagishita, 1960). 
How do EhpM, EhpN, and EhpO carry out this final antibiotic synthesis step? EhpM is a 
member of the AMP-dependent synthetase and ligase family of proteins. It shares greatest 
protein sequence similarity with the amino acid-binding domains of peptide synthetases such the 
threonine-binding SyrB 1 protein involved in the synthesis of syringomycin by Pseudomonas 
syringae pv. syringae (Guenzi et aI., 1998; Zhang et aI., 1995). EhpM is therefore a good 
candidate to sequester and activate D-alanine for incorporation to AP3 in association with EhpN 
and EhpO. It is likely that EhpM specifically binds D-alanine, and that similar proteins in 
Pelagiobacter variabilis may exclusively bind valine and glycine for the synthesis of 
valylgriseoluteic acid and glycylgriseoluteic acid, respectively (Imamura et aI., 1997). Because 
EhpN is similar in sequence to acyl-carrier proteins, it is likely to juxtapose the sequestered D-
alanine and AP3 (or GA) and thereby catalyze the condensation reaction between them. 
Investigations with ehpO mutants demonstrated that EhpO is also necessary for the conversion 
of AP3 to AGA, however its mechanism of action cannot be predicted at this stage. 
Indirect evidence suggests that the conversion of AP3 to AGA takes place in the periplasm. 
Firstly, Figure 3.4A clearly illustrates that exogenous AP3 is more efficiently converted to AGA 
by Ehl087 mutants with functional Group 4 gene products than exogenous API, supporting the 
proposal that AP3 only needs to enter the periplasm for conversion to AGA, whereas API 
would also have to cross the cytoplasmic membrane for conversion to AGA via AP2 and AP3. 
Secondly, no active antibiotic has been isolated from lysed Ehl087 cells, indicating that the 
final antibiotic synthesis step is unlikely to occur within the cytoplasm. Thirdly, the predicted 
translation sequence of the Group 4 gene product EhpM indicates that it has a transmembrane 
helix that would transverse the inner membrane to position ca. 80% of the protein in the 
periplasm, indicating that much of its activity is likely to be carried out within the periplasm 
(Fig 3.13). Finally, the release of a D-alanine moiety in the periplasm during the 
transpeptidation reaction that links peptidoglycan chains during synthesis of the bacterial cell 
wall would provide a natural reservoir ofD-alanine for the final AGA-synthesis step. 
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Recombination deficient Ehl087 strains: A prerequisite for complementation analyses 
In a previous investigation homologous recombination was reported to be a rare event, 
occurring at a frequency of 0 - 0.4 % (Keams, 1993). However, in that study recombination 
was scored as cells that had lost both the plasmid, to become Tcs, and the transposon insertion 
complemented by the plasmid, to become Kms. This is an inadequate measure of 
recombination, as its relies on plasmid loss and cannot account for recombination without loss 
of the plasmid, which could be high given that the vector pLAFR3 was reported to be stable in 
Eh1087 in the same study. During the present study the true frequency of recombination was 
assessed by measuring the frequency that a plasmid containing the AGA gene cluster acquired a 
transposon insertion from an Eh1087 ehp mutant. By this methodology the frequency of marker 
exchange (via recombination) between cosmid pLA272 and Eh1087 mutants ranged from 1.3 % 
to 17 % for 24 h cultures. Thus, all complementation experiments involving Eh1087 mutants 
and cosmids have to be interpreted very carefully, given that recombination may have occurred 
in up to 17 % of the cosmid molecules after 24 h. Since RecA is absolutely necessary for 
homologous recombination through the pairing and exchange of homologous ssDNA 
(Kowalczykowski et aI., 1994), a system w~s developed for the creation of CmR marked Eh1087 
recA mutants (recA777) to prevent recombination during DNA complementation experiments. 
Recombination between pLA272 and recA777 mutants of EhehpA or EhehpC and was not 
detected. Since recombination in Eh1087 recA 777 mutants is, if anything, a very rare event (not 
detected in this investigation), plasmid integrity should be maintained during complementation 
analyses involving these strains. 
The recA777 allele exhibited dominance over recA in two ways. Firstly, once pLArecA777 was 
established in an Eh1087 strain, loss of the plasmid vector and maintenance of the recA777 
allele (CmR) was very rarely detected. Because of this, recombination was routinely carried out 
without selection for the plasmid vector. Secondly, during the creation of pLArecA777, it was 
noted that pKSrecA777, but not pKSrecA, induced MMS sensitivity in E. coli MC4100 recA+. 
Studies of nearly identical RecA proteins from other bacteria indicate that the 95 aa missing 
from the C-terminus of the truncated Eh1087 RecA mutant protein (RecA777) are required for 
NTP binding, RecA monomer binding, and the alignment of RecA-filaments for exchange of 
complementary ssDNA strands (Kowalczykowski et aI., 1994). The domains required to bind 
ssDNA (between residues 156-165 and 194-210) would be present in RecA777, and could 
enable this protein to bind ssDNA if sufficient RecA structure is maintained. RecA 777 proteins 
bound to ssDNA would not be able to catalyze reactions that require NTP, such as denaturation 
of complementary strands, or LexA cleavage, and would effectively lower the concentration of 
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ssDNA not associated with RecA and inhibit the activity of normally functional RecA 
monomers. Similar effects were noted in E. coli in which truncated RecA proteins supplied in 
trans interfered with the activity of the native RecA protein by 'codominant 
inhibition'(Yarranton and Sedgewick, 1982). Observations like these lead to the proposition 
that RecA functions as a protein filament that can be influenced by the composition of its 
monomer components (Kowalczykowski et al., 1994). Such a scenario is attractive because it 
offers an explanation for the low frequency of recombination between established pLArecA 777 
cosmids and the Eh1087 genome. In such strains, there are more copies of the plasmid-encoded 
mutated recA gene than the single functional genomic recA gene, and therefore more potential 
inhibitors of RecA-mediated homologous recombination. Before pLArecA777 becomes 
established in a new host cell and recA777 is expressed, functional native RecA proteins could 
carry out homologous recombination between the genomic recA and the introduced recA777 
without interference from RecA 777. 
Regulation within the AGA-gene cluster 
The present study has uncovered many of the factors controlling expression of the AGA-gene 
cluster. Initial information was provided by gene predictions from DNA sequence, and the 
orientation of transposon insertions that formed active lacZ fusions to an AGA-biosynthesis 
gene demonstrated the orientation of genes as illustrated in Figure 3.5. A different feature of 
mini-Tn51acZ2 was utilized to find out information about the size and expression of operons 
within the AGA gene cluster using classical complementation experiments. mini-Tn51acZ2 
possesses a kanamycin resistance gene under control of its own promoter and the transcript 
initiated by this promoter is not terminated within the transposon. Instead the process of 
transcription continues along the DNA into which the transposon has inserted. For this reason, 
transposon insertions in orientation 1 (01) were aligned within the direction of transcription of 
the AGA-gene cluster; the lacZ gene of these insertions was under control of the gene into 
which the transposon had inserted, and all genes downstream of the insertion point were under 
the transcriptional control of the kanamycin resistance gene promoter in the transposon. Thus, 
orientation 2 (02) insertions interrupted not only the gene into which the transposon had 
inserted, but all genes downstream that were under the same transcriptional control (i.e., part of 
the same operon) as the interrupted gene. The influence of this polarity is particularly notable in 
Figure 3.4, which illustrates how 01 mutants can express downstream genes and convert 
exogenously supplied intermediates into AGA, whereas 02 mutants can donate an intermediate, 
but lack the expression of one or more groups of genes required to convert an intermediate into 
AGA. The polarity of the 02 insertions was further utilized to determine the size(s) of the 
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operons within the AGA gene cluster. For instance, an Ehl087 ehp mutant is complemented by 
a plasmid containing a second copy of the AGA gene cluster in trans and therefore produces 
antibiotic. However, if the second copy of the gene cluster also contains a transposon insertion 
in a different gene, and no antibiotic is produced then the genes must be subject to 
transcriptional control by tbe same promoters; they are therefore part of the same operon, and 
vice versa. Furthermore, the amount of antibiotic produced by a mutant complemented in such 
a way offers a measure of the level by which the expression of one gene influences the 
expression of another, as illustrated in Fig 3.17. 
The copy number of the introduced DNA relative to the copy number of the host DNA has an 
important influence on complementation. In the case of the AGA gene cluster this was 
complicated by the fact that it is located on a ca. 200 kbp plasmid of unknown copy number, 
although two lines of evidence suggest that the native Ehl087 plasmid is present in more than 
one copy per cell. Firstly, AGA-gene cluster insertions were isolated at a far higher frequency 
(1.7 %) during this investigation than would be expected for a 15.5 kbp region of DNA, 
assuming the chromosome of Ehl087 is 'similar in size to other Enterobacteriaceae (3 4 
Mbp). Because insertions were spread evenly throughout the gene cluster region, and because 
auxotrophic mutants arose at ca. 1 %, it appears that mini-Tn5lacZ2 inserted randomly 
throughout the Ehl087 genome. Two possibilities arise. Either the genome of EHI078 is ca. 
880 lcbp if the frequency of insertions to the AGA gene cluster is extrapolated, or, more 
plausibly, the genome size of Ehl 087 is 3-4 Mbp and the plasmid on which the gene cluster is 
located is present at 3-5 copies per cell. A second finding that suggests the native plasmid is 
multicopy is the greater strength of signal from hybridizations to the gene cluster relative to 
chromosomal genes such as rpoS and recA (data not shown). Even so, the initial 
complementation results indicated pLAFR3 was present in more copies per cell than the native 
Ehl087 plasmid, since antibiotic production was lower when the gene that was limiting for 
antibiotic production was contained on the Ehi087 plasmid rather than the introduced, 
pLARF3-based plasmid (Fig. 3.16). Because complementation analyses wcre restricted to 
assessing the expression of genes within the gene cluster located on the native Ehl087 plasmid, 
they could only be used to determine the effect of a mutation on downstream genes, and not to 
differentiate between cis and trans acting factors. 
The major finding of the gene cluster complementation experiments is that the gene cluster has 
an underlying operon structure that extends from ehpA to ehpM. Therefore all Groups are 
linked in cis. The expression of ehpN is independent of the Group 1, 2, and 3 genes, however it 
is influenced by expression of ehpM, which is dependent on expression of the upstream genes. 
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Within the ehpA-ehpM operon, exist alternative promoters for the Group 2 and Group 3 genes, 
and for ehpK and ehpM (Figs. 3 .IS, 3.17). These promoters probably have a very minor role in 
expression of the ehp genes since 02 mutants cannot sufficiently express genes downstream of 
the mutation point for conversion of AGA intermediates to AGA (Fig. 3.6). In fact, these 
promoters may only be active in the absence of expression of the overall ehp operon. If the ehp 
gene cluster is a mosaic of genes from various sources as predicted by contemporary 
evolutionary models (see below), these internal gene cluster promoters may be relicts of 
promoters that integrated into the gene cluster with a cognate gene or operon, but have since lost 
activity by mutation over time in the new environment of the gene cluster. This is particularly 
enticing given that each gene group appears to be preceded by independent, albeit weak, 
promoter. In summary, it is proposed that an overall operon structure is the most influential 
mechanism regulating transcription of the ehp gene cluster. 
The finding that the AGA-gene cluster has an underlying operon structure provides an answer 
for an apparently anomalous observation of Kearns and Mahanty (1998) who found that plasmid 
pAH8, which contains all the Group 2 genes and most of the Group 3 genes, complemented 
what is now described as an EhehpG mutant poorly, unless pBESb was also present in trans 
(Kearns, 1993; Kearns and Mahanty, 1998). The reason for this is now apparent; the transposon 
insertion in ehpG has a cis-acting polar effect on downstream genes, including the Group 4 
genes, thus pAH8, which contains only the Group 2 and Group 3 genes, cannot complement 
EhehpG. However, sufficient genes are provided in trans by pAR8 (Group 2 and 3 genes) and 
pBESb (Group 4 genes under control of the pBR322 TcR promoter) to complement the EhehpG 
mutant and create a strain that can produce AGA. 
Complementation experiments could not differentiate between cis and trans acting regulatory 
influences, however indirect evidence from precursor-feeding experiments suggests that at least 
one trans acting factor may operate to control expression of the AGA-gene cluster. Ehehpl 
(01) does not convert exogenous AP3 into AGA and therefore does not express the Group 4 
genes, in contrast to EhehpK and EhehpL (01) (Fig. 3.10). Since pBESb confers on a cell the 
ability to convert AP3 to AGA in the absence of any other ehp gene (Fig. 3.12), the influence of 
EhpJ on the Group 4 gene products is not due to interactions between the Ehp proteins. Thus, in 
Ehl087, ehpJmust positively influence the expression of the Group 4 genes. This influence is 
presumably not necessary in a heterologous host containing pBESb because the Group 4 genes 
are under the independent control of a TcR promoter present in the vector. Furthermore, the 
influence of EhpJ on the Group 4 genes must be trans acting rather than cis acting, as both ehpK 
and ehpL are expressed in Ehehpl (01). Also, this influence is not observed for EhehpK or 
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EhehpL mutants in which ehpJ is active (Fig. 3.10). This proposition could be tested by 
inverting the Group 4 gene fragment in pBE5b so that the Group 4 genes are only expressed 
under control of their own promoter( s), creating a plasmid that should not enable a host cell to 
convert AP3 to AGA, if the prediction holds true, unless the regulatory influences of ehpJ are 
restored in trans. 
The transcription of the majority of the AGA gene cluster as a single unit provided a means to 
assess whether or not regulatory influences acted at the level of translation. As shown in Figure 
3.18, the expression of LacZ: :Ehp fusion proteins varied from group to group and even within a 
group, indicating that each gene is subject to post-transcriptional regulation. Of the genes with 
active LacZ fusions, the expression of six gene products, EhpA, B, D, F, I, and L, was 
significantly (2 SD) reduced in stationary phase relative to log phase, whereas the expression of 
EhpC, G, and M did not drop during this transition (data not shown). The change in expression 
during entry to stationary phase offers a mechanism to explain the drop in antibiotic production 
after Ehl087 reached stationary phase (see Fig. 4.1). Perhaps more importantly, the expression 
of these genes may berate limiting for antibiotic production, and therefore make a logical target 
for modification to enhance the amount of antibiotic produced by Ehl087 and to extend the 
period of antibiotic production. The production of antibiotic in growth-limited environments 
may improve the ability for Ehl087 to compete against E. amylovora that have already 
colonized a stigma, a feature that is currently lacking in Eh1087 and other potential Fire Blight 
control strains. 
Differential gene expression can also account for the observation that antibiotic production by 
E. coli harboring the AGA-gene cluster was considerably lower than antibiotic production by 
Ehl087. Expression of the LacZ fusions to EhpA, F, I, and M, in coli demonstrated that 
expression of EhpA was only half that of Ehl087, whereas the expression of EhpF, I, and M, 
was only 10 20% that of Eh 1087. Although the underlying transcription of the ehp gene 
cluster may be only reduced by half in E. coli as evidenced by 50 % ehpA expression, the 
positive regulatory influence( s) acting on the translation of the ehpF, ehpI, and ehpM transcripts 
in Ehl087 is (are) either missing or less active in E. coli. The lower expression of the ehp genes 
in E. coli relative to Ehl 087 correlates well with the lower amount of AGA produced by E. coli 
relative to Ehl 087. Another interesting finding from this experiment was that the expression of 
ehpA, ehpF, and ehpI, reduced during entry to stationary phase in Eh 1087 but not in coli (Fig. 
3.19). The simplest account for these observations is that a positive post-transcriptional 
regulatory mechanism specific to Eh1087 is turned off during stationary phase, and this is not 
seen in MC4100 because it does not possess this mechanism. Alternatively, a second negative 
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regulatory factor present in Eh1087, and missing in MC4100, may specifically down-regulate 
ehp gene expression in stationary phase. 
A observation of Keams (1993), considered in the context of what is now known about the 
AGA-gene cluster, suggests that the expression of ehpR may influence the expression of the 
AGA-biosynthesis genes. Keams (1993) had noted that cosmid pLA255 fully complemented an 
EhehpG mutant, whereas pLA424 did not, in apparent contradiction of the fact that pLA424 
possessed more of the AGA-gene cluster than pLA255 (Fig. 3.10). During the present study, 
DNA sequence was determined for the terminal section of the AGA-gene cluster cloned in each 
cosmid (data not shown). pLA255 was found to contain DNA downstream ofbp 5404 (between 
?hpD and ehpE), and pLA424 possessed DNA downstream of bp 563 (interrupts ehpR). Since 
pLA424 could not complement an ehpG insertion mutant, it is probable that expression of ehpR 
affects expression of at least the Group 2 genes, perhaps via some mechanism that co-regulates 
AGA synthesis with expression of the resistance factor. In contrast, ehpG encoded by pLA255 
is expressed, suggesting that any mechanism linking expression of ehpR with the biosynthesis 
genes is missing in pLA255, or that the section of the AGA-gene cluster cloned in this cosmid is 
artificially expressed under control of a vector promoter. 
Resistance to AGA. 
The translation product of a single gene, ehpR, divergently transcribed from the 15 ehp genes 
involved in AGA-synthesis, was found to confer AGA resistance on an otherwise AGA-
sensitive host bacterium. For instance, E. coli MC4100 and EMAGA (ehpR-), which have 
similar AGA-sensitivity, are both transformed to be AGA-resistant by a plasmid encoding ehpR. 
EMAGA harbouring pBE5b can be induced to 'suicide' by supplying exogenous non-toxic 
AP3, which is converted into toxic AGA by the products of the Group 4 genes on plasmid 
pBE5b. Unlike Eh1087, EMAGA dies in the production of AGA as it is sensitive to the 
antibiotic (Fig. 3.12). These observations suggest that ehpR is necessary and sufficient for 
AGA-resistance both in an AGA-producing bacterium such as Ehl087, and in a heterologous 
host such as E. coli. 
Three lines of evidence provide clues about the probable location of EhpR activity. Firstly, no 
intracellular antibiotic activity has been detected, secondly, the intracellular AGA intermediates 
API and AP2 have no antibiotic activity, thirdly, conversion of AP3 to active AGA most likely 
takes place in the peri plasm or on the outer membrane. On the basis of this data it is tentatively 
proposed that EhpR somehow prevents AGA from acting either on or inside the cytoplasmic 
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membrane. This is common theme amongst antibiotics, such as AGA, that are activated from 
inert precursors during export, presumably because it is energetically more efficient than drug 
uptake, inactivation, export and reactivation (Cundliffe, 1989). An alternative mode of 
resistancc, alteration of the antibiotic target, is also unlikely on the grounds that this mode of 
action usually operates for antibiotics with single targets, and AGA is probably reactive against 
numerous targets (see Chapter 4) (Spratt, 1994). Thus, it is tempting to speeulate that EhpR acts 
in a similar manner as the colicin V immunity protein, Cvi, which prevents periplasmically 
presented colicin V from re-entering the producing cell (Zhang et a1., 1995). 
The mode of action by which EhpR protects a cells from AGA is not fully understood, although 
some clues were provided by the degradation of AGA during exposure to bacteria. AGA 
degrades slowly in LB, but rapidly in LB containing bacteria, demonstrating that bacterial cells 
reaet with AGA (Fig. 3.20). However, the antibiotic activity of AGA does not detectably 
deerease during the first ten minutes of exposure to either Ea8862 or Ea8862 (pEhpR). Since 
many bacteria within a culture are killed or mortally wounded within 10 minutes of exposure to 
AGA (for instance, see Fig. 4.7), EhpR does not appear to inactivate AGA otherwise antibiotic 
activity would decrease immediately on exposure to Ea8862 (pEhpR). Additionally, the 
reaction between AGA and Ea8862 cells, which results in loss of antibiotic activity, is either not 
part of the killing process because it occurs whether bacteria die or not, or the reaction generates 
toxic by-products that EhpR protects against. 
There are probably at least two different types of AGA-resistance, intrinsic AGA-resistanee as 
displayed by Pseudomonas aeruginosa PA147-2, a bacteria isolated from the rhizosphere 
(MLCAGA > 16.0 Ilg.mr1), and the dedicated resistance conferred by EhpR. When ehpR is 
absent, the rate of the reaction between AGA and a bacterial cell relates to the AGA-sensitivity 
of that cell, for instance PA147-2 is less reactive and more AGA-resistant than Ea8862. ehpR 
transforms Ea8862 bacteria into an AGA-resistant bacteria, but does not decrease the AGA-
reactivity of these bacteria. This data supports the proposition that the resistance of PA147-2 
involves poor recognition of AGA, whereas Ea8862 possesses outer membrane properties that 
enable it to recognize and react with AGA, perhaps as part of the uptake process, and EhpR 
presumably prevents further uptake of AGA by inhibiting translocation across the inner 
membrane. This hypothesis could be tested assessing the AGA reactivity of a large number of 
AGA-sensitive and resistant bacteria to see if intrinsic resistance always correlates with low 
reactivity. Furthermore, the activity of EhpR in a gram-positive bacteria would demonstrate 
whether or not it acts in the periplasm or outer membrane, as both are absent in these bacteria. 
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To ensure that sufficient EhpR is available to prevent self-poisoning of an AGA-producing cell, 
it is likely that expression of ehpR would be regulated in unison with the AGA synthesis genes. 
Within the 419 bp region between ehpR and ehpA, two potential ehpR promoters have been 
identified by sequence analysis that could initiate transcripts that converge and overlap with 
transcripts initiated by two potential ehpA promoters (promoter predictions scored the highest 
possible likelihood). Such an arrangement could offer a mechanism for co-regulation of the 
AGA-resistance and synthesis genes, similar to that of the well-characterized Mu phage system 
in which competition between the converging promoters PcM and PE is used to regulate the 
lytic and lysogenic pathways (Krause and Higgins, 1986). 
A resistance mechanism may be associated with the PCA operon of P. aureo/adens 30-84. 
Pierson et al. (1992) reported that matings between E. coli and strain 30-84 were only 
successful in conditions in which phenazine production was suppressed, whereas E. coli 
harbouring the PCA operon could produce PCA and remain viable. However, the PCA 
resistance mechanism, or the gene(s) responsible for it, were not identified. Taken together with 
the fact that EhpR shows no similarity to' known protein sequences or motifs, it appears that 
EhpR is a novel antibiotic resistance protein and that this is the first clear demonstration of a 
resistance gene associated with a phenazine antibiotic gene cluster. 
Origin and features of the AGA gene cluster. 
Recently, Mavrodi et al (2001) detected by DNA-hybridization at least part of the PCA operon 
in phenazine-producing fluorescent Pseudomonas spp., but none of this operon was detected in 
several phenazine-producing isolates of Burkholderia cepacia, Burkholderia phenazinium, or 
Brevibacterium iodinum. The lack of similarity between the DNA sequence of the AGA gene 
cluster and the PCA operon found in Pseudomonas spp. demonstrates that although phenazine 
synthesis genes may not be dctectable at the DNA level, the products of analogous or diverged 
genes may be similar, in sequence and function, and this may be the case in phenazine-
producing bacteria that appear to lack the PCA operon. The lack of sequence similarity between 
the AGA gene cluster and the described PCA operons is at least partly due to the considerable 
difference in GC content between them, at 43.7 % for the AGA cluster, and 59.4 - 67.7 % for 
the PCA operons. This indicates that the AGA gene cluster is unlikely to have arisen in 
Pseudomonas, and that the relationship between the described Pseudomonas PCA operon and 
the AGA gene cluster is more likely to be analogous than homologous (Fitch, 2000). 
Furthermore, since thc GC content of 21 described Pantoea agglomerans (syn. E. herbicola) 
strains is 55.1 56.8 %, the AGA gene cluster is unlikely to have originated in this species 
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(Gavini et aI., 1989; Ochman et aI., 2000). So what is the origin of the AGA gene cluster? It is 
tempting to speculate that the genetic basis for AGA production in Ehl087 and SANK 73794 
originated in the same organism as the GC content of the AGA gene cluster falls within the GC 
content range of Vibrio spp. at 38-51 %, and AGA has only been isolated from Ehl087 and the 
marine Vibrio spp. SANK 73794 to date. 
Currently, the origin of the AGA-gene cluster is inadequately estimated because it is based on 
comparisons with the DNA sequence of phenazine gene clusters characterized in only a handful 
of Pseudomonas species. The characterization of phenazine gene clusters in many other 
organisms is required to substantiate any evolutionary claims regarding their origin and 
relatedness. In addition, the characterization of phenazine gene clusters may provide useful data 
about the evolution of gene clusters in general. Recently, Lawrence and Roth (1996) proposed a 
'selfish operon model of gene clustering' based on the fact that horizontal gene transfer is a 
potent evolutionary mechanism that enables gene clusters to be exposed to a large variety of 
hosts and environments. Therefore, even gene clusters with weak selective advantages are more 
likely to find a host in an environment that benefits from the gene cluster, than if the gene 
cluster was only transferred vertically. Since genes scattered around the chromosome cannot be 
transferred as a 'going concern' to a new host, they are not subject to the same selection 
pressure. Thus, the evolution of gene clusters able to provide a new host with a complete and 
functional metabolic pathway is favoured. On the basis of this theory, the AGA-gene cluster 
could have resulted from multiple gene clustering events. The observation that each gene 
Group is preceded by weak promoter activity suggests that each Group (see Table 3.1) may 
have been subclustered as separate operons prior to incorporation in the AGA gene cluster. For 
instance, the Group 1 genes, responsible for the synthesis of a PCA-like compound, may confer 
an advantage to a host in certain environments, an advantage sufficient for clustering of these 
genes. Presumably the addition of the Group 4 genes would have coincided with the resistance 
gene, to prevent death of the host in which the gene cluster evolved. In support of this the GC 
content of ehpR and ehpMNO are somewhat lower than the rest of the gene cluster, although the 
significance of this difference is unknown. Again, a measure of the relatedness of the AGA-
gene cluster (or the sub clusters within it) to phenazine genes in other organisms is required to 
test this proposition. 
The complete AGA-gene cluster may be a horizontally-mobile element. Horizontally mobile 
genetic elements are ubiquitous in nature and are believed to have an important role in the 
evolution of bacteria (Miller, 1998; Ochman et aI., 2000), and perhaps higher organisms (de la 
Cruz and Davies, 2000) although this is a source of conjecture (Kurland, 2000). Not only is the 
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AGA-gene cluster located on a plasmid (Keams and Mahanty, 1998), which may itself be 
transmissible, but the cluster appears to be bordered by sequences with similarity to 
transposases and integrases (Fig. 3.21). As such the AGA-gene cluster has many (but not a1l) 
features of pathogenicity islands involved in the virulence of pathogenic bacteria (Hacker et a1., 
1997). Pathogenicity islands are normally associated with disease causing bacteria, however the 
physical features of these islands, as defined by Hacker et al (1997), have parallels in the AGA-
gene cluster. The AGA-gene cluster is present in Eh1087 but not other species of E. herbicola 
(even from similar environments), it has different G+C content to the chromosome of Ehl087, it 
is a compact, distinct genetic unit, and it is bordered by potential 'mobility' genes. A key 
pathogenicity island feature that the AGA-gene cluster lacks is chromosomal location, although 
Mecsas and Straus (1996) suggested that location was irrelevant in view of the fact that genetic 
elements are in a constant state of flux. Ehl087 appears to be saprophytic, thus the AGA gene 
cluster cannot be termed a pathogenicity island per se, however as more AGA-type gene 
clusters are discovered it may become necessary to define a new set of 'islands', that are not 
directly involved in pathogenesis but have similar physical features to pathogenicity islands. In 
this regard, Hacker etal (1997) coined the 'term 'metabolic islands' to define pathogenicity-like 
islands involved in the physiology of microorganisms. 
There is some evidence that suggests that the AGA-gene cluster is unique to Ehl087 amongst 
other E. herbicola isolates. Many New Zealand E. herbicola isolates possess plasmids similar 
in size to the native Ehl087 plasmid, however the genomic DNA of all twelve species that were 
tested did not hybridize to the AGA gene cluster. Since there is a good chance that at least some 
of these plasmids have a similar origin but the AGA-gene cluster is a feature specific to the 
Ehl087 plasmid, and since the GC content of the gene cluster is different to the Ehl087 
genome, it is likely that the gene cluster has been acquired by horizontal transfer from some 
unlmown source. 
Plasmid maintenance often involves a mechanism termed post-segregational killing (PSK), in 
which plasmid-free daughter cells lack a plasmid-encoded antitoxin that provides protection 
against a diffusible plasmid-encoded toxin (recently reviewed by Gerdes, 2000). Thus, a gene 
cluster that is responsible for the production of an antibiotic and for resistance against that 
antibiotic could conceivably act as a PSK-system. The possibility that the AGA-gene cluster 
provided a mechanism for the stable maintenance of the native Ehl087 plasmid was crudely 
tested by assessing the maintenance of an AGA-gene cluster deletion derivative of this plasmid 
over three days in planta. The AGA-deletion plasmid was stably maintained in planta indicating 
that other plasmid-maintenance mechanisms must exist. Given that the AGA-gene cluster may 
Chapter 3 ANALYSIS OF THE AGA-GENE CLUSTER 91 
be a mobile element and therefore may be a recent addition to the native Ehl087 plasmid, it is 
not surprising that it is not required for plasmid maintenance. 
Many of these propositions are highly speculative, but lead to interesting questions that warrant 
further investigation. Is the AGA-gene cluster part of a transposon or is it coincidently located 
between two putative transposases? If it is part of a transposon, does it still function, and if so 
what induces it to jump? Is the plasmid containing the gene cluster mobilizable under certain 
conditions? And how was the AGA-gene cluster created in the first place? Investigations into 
the putative mobility genes at each end of the AGA gene cluster, and the ability of this gene 
cluster to be transferred to various hosts under a variety of conditions would provide useful data 
about the likely spread of the gene cluster in nature. Not only does this have relevance to the 
use of Ehl087 as a biological control agent, but perhaps more significantly it relates to the 
biology of 'metabolic islands' in general. 
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Chapter 4. CHARACTERIZATION OF THE Al~IBIOTIC PRODUCED BY 
ERWlNIA HERBICOLA STRAIN EH! 087 
Introduction 
Biological control agents operate via one or more of three general mechanisms; predation, 
competition, or the production of toxic chemicals. herbicola strains act invariably by 
competitively excluding E. amylovora from the stigmas of flowers (Johnson and Stockwell, 
2000); for many strains the competitiveness of E. herbicola is enhanced by the production of 
antibiotics. Knowledge of the antibiotic structure and mode of action are necessary to fully 
understand the mechanism(s) involved in suppression of E. amylovora by candidate biological 
control strains, especially if these strains are to be deployed as biological control agents. This is 
particularly important in the United States, where the registration of microbial biological control 
agents requires the same rigorous testing as chemical agents. Characterization of biologically 
active natural products can also lead to the discovery of novel compounds and provide leads for 
the development of important new compounds with potential uses in agriculture and 
pharmacology (Powell, 1995). 
In general, very little is known about the antibiotics produced by E. herbicola, which is 
surprising given their importance in E. amylovora suppression, A particularly well-
characterized exception is pantocin B. Pantocin Band pantocin A and at least one other 
antibiotic are produced by Eh318 (Wright et aI., 2001), The importance of antibiotic production 
by Eh318 in control of the Fire Blight pathogen was demonstrated in an immature pear fruit 
assay in which both Eh318 and crude antibiotic preparations from this strain suppressed the 
development of Blight symptoms (Wodzinski et aI., 1994), The genetic requirements for 
pantocin A and B synthesis are located in different regions of the Eh318 genome and a strain in 
which both genetic determinants are interrupted produces a third antibiotic, but it is the 
pantocins that are required for inhibition of E. amylovora (Wright et aI., 2001). The chemical 
structure ofpantocin B has been determined as (R)-N-[((S)-2-amino-propanoylamino)-methyl]-
2-methanesulfonyl-succinamic acid (Brady et aI., 1999; Sutton and Clardy, 2000), The structure 
of pantocin A is yet to be determined, possibly because pantocin B is a more potent inhibitor of 
E. amylovora and therefore of greater importance in biological control (Wodzinski et aI., 1990). 
The targets of pantocin A and B are likely to be different as their antibiotic activity is 
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suppressed in the presence of excess histidine and arginine, respectively (Brady et al., 1999). 
Preliminary experiments demonstrated that pantocin B inhibited N-acetylornithine transaminase 
(Acorn) in the arginine pathway (Wodzinski et al., 1990). This was confirmed by Brady et al. 
(1999) who tested all arginine biosynthetic intermediates for suppression of antibiotic activity 
and found that no intermediates before N-acetylornithine inhibited by pantocin B activity. They 
further showed that pantocin B competes with N-acetylornithine, but not glutamine, to bind 
Acorn. Thus, pantocin B binds Acorn and prevents it from transferring an amine group from 
glutamine to N-acetylornithine during the synthesis of arginine. The activity of pantocin B has 
been further defined in a very recent study by Sutton et al (2001) who observed that pantocin B 
is similar to a tripeptide. They tested its activity in the presence of excess L-ala-gly-gly and 
found that it was reduced, presumably due to competition for uptake by a peptide transporter 
(Sutton and Clardy, 2001). To relate structural features of pantocin B to antibiotic activities, 
Sutton et al (2001) synthesized pantocin B variants and found that the stereochemistry at the N-
terminal end influences uptake. They also demonstrated that the chemical structure of the 
central and C-terrninal regions of pantocin B are highly specific for Acorn binding. Further 
characterization of pantocin B activity awaits the determination of the 3-D structure of Acorn. 
Antibiotics from cultures of E. herbicola strains EhC9-1, Eh112Y, and Eh252 have shown 
suppressive activity against E. amylovora using overlay plate and pear slice assays (Hodges et 
al., 1980; Ishimaru et al., 1988; Vanneste et al., 1996). Unlike pantocin B, the detailed 
characterization of these antibiotics has not been published. A common property of antibiotics 
produced by E. herbicola is the inhibition of activity in the presence of particular amino acids, 
which has been used to differentiate between different strains of E. herbicola (Wodzinski and 
Paulin, 1994). Of the amino acids, histidine is most often inhibitory of the antibiotic activity of 
E. herbicola strains (Wodzinsld and Paulin, 1994). Antibiotics that are ineffective in the 
presence of histidine include pantocin A, herbicolin 0 (but not herbicolin 1) produced by EhC9-
1, and a protease-sensitive antibiotic produced by Eh252 (Ishimaru et al., 1988; Vanneste et aL, 
1992). The activity of a second antibiotic produced by EhC9-1, herbicolin I, and the antibiotic 
produced by Eh112Y was reduced in the presence of yeast extract (Ishimaru et al., 1988). It is 
unclear whether antibiotic production in these strains is inhibited by yeast extract, or if one or 
more of the amino acid constituents of yeast extract negates the activity of these antibiotics. 
Preliminary investigations into the antibiotic produced by Eh1087 indicated that it was different 
from antibiotics produced by other E. herbicola strains. In particular, antibiotic activity was not 
inhibited by essential amino acids unlike many E. herbicola antibiotics (Keams, 1993; Keams 
and Hale, 1996). The antibiotic was classified as bacteriocidal because no viable E. amylovora 
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were recovered from zones of inhibition surrounding colonies of Ehl087. The antibiotic 
activity in cell-free Ehl087 culture supernatants was not inactivated by proteases indicating that 
it is not a peptide antibiotic, or by exposure to pH 4.0 or 9.0 for one hour, and was able to pass 
through dialysis membrane (10 lilla cut-oft) demonstrating that it was smaller than 10 lilla. 
Antibiotic activity was inactivated by 1 ~g.ml-1 Type 1 Bacillus cereus f3-lactamase suggesting 
that the antibiotic possesses a fi-lactam ring (Kearns and Hale, 1996). Further purification for 
characterization of the antibiotic was hampered by unreliable production in broth cultures 
(Kearns, 1993). 
The overall objectives of the research reported in this chapter were to purify the antibiotic 
produced by Eh1087, determine its chemical structure, and characterize properties of the 
antibiotic with a view to elucidating its mode of action. Preliminary research involved 
maximizing the production of antibiotic, a problem noted in a previous investigation (Kearns, 
1993). To optimize antibiotic yield, the time of antibiotic production and the influence of 
different carbon sources were assessed. Once conditions were established for reliable antibiotic 
production, a simple three stage purificatio'n process was developed. The chemical structure of 
the antibiotic was determined, as was the structure of an inactive compound that arose from 
storage of the antibiotic in aqueous solution. Chemical properties of the antibiotic and three 
precursors were compared with each other enabling predictions about the function(s) of the ehp 
gene groups. The antibiotic was subject to further investigations leading to speculation about its 
mode of action. 
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Methods 
Extraction of AGA and precursor compounds. 
EhI087, EhehpM, or EMAGA (PBB7) were cultured in 500 ml of I-A broth supplemented with 
0.2 % glucose and 1 mM MgS04 in a 2 L Fernbach culture flask for 48 h (or 120 h for 
Eh~AGA(pBB7)) at 22°C, with shaking at 200 rpm. Cells were removed by centrifugation at 
15000 g for 10 min., and the culture supernatant was either extracted directly with 2 volumes of 
dichloromethane (DCM) , or for Eh~AGA(pBB7) the broth was adjusted to pH 2.5 with HCI 
prior to extraction. The DCM extract was filtered through 0.45 ,.IM HA MpM-Membrane filters 
(Millipore) and dried by rotary evaporation. The soluble dried compounds were dissolved in 1-
A salts adjusted to pH 2.5 with HCI. Insoluble material (predominantly GA) was removed by 
centrifugation, the media neutralized with 2M NaOH, and compounds that partitioned to 
chloroform were dried. Dried material was either dissolved in chloroform and stored at 4°C, or 
dried onto 6 mm diameter filter disks (Schleicher & Schuell) for storage at ambient temperature. 
Compounds were separated and analyzed by C 18 reverse-phase high-performance liquid 
chromatography (HPLC) by gradient elution in 10 - 100 % acetonitrile in water over 25 minutes 
using a Shimadzu SPD-M10A Diode Array Detector, SIL-lOD Auto injector, and a SCL-10A 
Controller. To determine whether active antibiotic was present within Ehl087 cells, the cells 
removed from I L culture supernatant were rinsed with 5 rnl fresh media, twice extracted with 
an equal volume of DCM, and the DCM fraction was concentrated by evaporation and assessed 
for antibiotic activity. 
Antibiotic Susceptibility Tests 
MIC and MLC determination by microbroth dilution was performed essentially as per the 
National Committee for Clinical Laboratory Standards (NCCLS) protocol as reported by Woods 
and Washington (1995). Microtitre wells containing 100 Jll LB medium with 5 x 105 cells, and 
antibiotic at logz serial dilutions, were incubated at the appropriate temperature for cell growth, 
and wells were visually assessed for cell growth after 24, 48 and 72 hr. LB medium was used, 
rather than Cation-Adjusted Mueller-Hinton Broth, to provide MIC and MLC values for 
organisms grown under standard laboratory conditions. Disk diffusion tests were also carried 
out as recommended by the NCCLS. An overnight culture of each strain to be tested was 
adjusted to a McFarland standard of 0.5 (ca. 1 x 108 CFU.mrl ) and cross-streaked three times 
across the surface of an LB plate. Six mm filter disks containing one or ten Jlg of the compound 
to be tested were placed on the surface of the lawn, plates were incubated under the appropriate 
conditions, and the diameter of the inhibition zone was measured. Plates containing obligate-
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anaerobes were incubated in a two litre air-tight plastic container with a single 
AnaeroPack™oAnaero sachet (Mitsubishi Gas Chemical Co., Inc.). The removal of oxygen was 
confirmed using an Anaerobic indicator code no. BR (Oxoid), and by comparing growth of 
obligate aerobes such as Ea8862 and Pseudomonas aeruginosa, to growth of the obligate 
anaerobe. 
ill vivo mutagenecity testing 
Mutagenicity of AGA was assessed by measuring the frequency of lacZ- to lacZ+ reversions in 
a collection of E. coli tester strains containing different base substitutions at codon 461 of the 
lacZ gene. The assay was carried out as described by the strain developers (Ohta et aL, 1998; 
Ohta et a1., 1999), or with minor modifications (as outlined below) that did not affect the 
frequency of revertants when tested with known mutagens. The twelve E. coli tester strains are 
listed in Table AI, and the lacZmutation in each strain is shown in Table 4.1. Each strain was 
grown overnight in MGT liquid medium (1 x VBE salts', 0.5 % glucose, 50 Ilg.mf' L-
Tryptophan) supplemented with 10 Ilg.mrIAp for the WP3101P-WP3106P tester strains. Cells 
were collected by centrifugation, and resuspended in an equal volume of 10 mg.mr1 nutrient 
broth. 100 III of eaeh cell suspension (containing ca. 2 x 108 CFU, 1 mg nutrient broth) was 
spread on an ML agar plate (1 x VBE salts", 0.5 % lactose, 1.5 % agar, 50 Ilg.ml-l L-
Tryptophan) supplemented with various concentrations of the test compound, and incubated at 
37°C for 48 h. Data was scored as total number of lacZ revertants per plate. 
Table 4.1. Base substitutions detected by lacZ reverter strains 
Strain Reversion event detected at lacZ codon Glu-461 Base substitution 
WP3101 AAT TAG TCA 0 AAT GAG TCA (Stop 0 Glu) A:T 0 C:G transversion 
WP3102 AAT GGG TCA 0 AAT GAG TCA (Gly 0 GIu) G:C 0 A:T transition 
WP3103 AAT CAG TCA 0 AAT GAG TCA (GIn 0 GIu) G:C 0 C:G transversion 
WP3104 AAT GCG TCA 0 AA T GAG TCA (Ala 0 GIu) G:C 0 T:A transversion 
WP3105 AAT GTG TCA 0 AAT GAG TCA (Val 0 GIu) A:T 0 T:A transversion 
WP3106 AAT AAG TCA 0 AAT GAG TCA (Lys 0 GIu) A:T 0 G:C transition 
• '1 x VEE salts are composed of 1 mM MgSO.J, mM citric acid monohydrate, 57 mf..1 K2HPO.j, and 25 mM NaNH.HP04 
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ill vitro mutagenesis ofpUC19 DNA by AGA. 
Ten micrograms of pUC19 dsDNA was exposed to four micrograms of AGA in 250 J..lI 
phosphate buffer (PH 7.0) at 37°C for 24 hand 72 h. Plasmid DNA was also treated with 
hydroxylamine (0.4 M) as a positive control for in vitro DNA mutagenesis. Five microgram 
samples were taken at both time points and purified by phenol-chloroform extraction, followed 
by ethanol precipitation and rinsing with 70 % ethanol. Purified DNA was introduced to DH5a, 
recA+ and recA- cells prepared for DNA uptake by treatment with CaCI2• Transformants were 
selected on LB supplemented with Ap and Xg. 
Oxidation of hemoglobin by AGA. 
AGA and AP3 were dissolved to saturation in 50 mM phosphate buffer (pH 7.4), and 
standardized to equivalent OD364, usually 2.0 or 4.0 for a stock solution. Fresh red blood 
cells were separated from plasma by centrifugation (10000 g, 10 min., 4°C), rinsed twice 
in 50 mM phosphate-buffered saline (PBS) (centrifuged at 500 g, 5 min., RT) and rinsed 
cells were lysed in 5 mM phosphate buffer (pH 7.4), and centrifuged for 3 min. at 9250 g to 
remove solid material. The red blood cell lysate was equilibrated to an OD577 of 0.5 - 0.7 
before being exposed to standardized AGA or AP3 at 37°C. At 0, 120,240 and 360 min, 
100 J..lI samples were taken and diluted 1: lOin phosphate buffer before the absorbance of 
the solution at 560, 577, 630 and 700 nm was measured to calculate the change in redox 
state of hemoglobin. Additionally, at each time point A306 and A364 were measured and the 
difference between them gave a measure of the concentration of AGA and AP3. One mM 
acetylphenylhydrazine (APH) was used as a positive control for hemoglobin oxidation, and 
reactions were carried out in the presence or absence of azide to inhibit catalase. The 
concentration of oxyhemoglobin and the oxidized derivatives methemoglobin and 
hemichrome were derived from the spectral measurements as described previously 
(Winterboum, 1985). Van den Berg modifications of these equations were used when it 
was apparent that ferryl-Hb (methemoglobin-H20z complexes) may have been forming (c. 
Winterboum, pers. comm.). 
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Table 4.2. Equations to calculate the concentration of haemoglobin oxidation products 
Original Winterboume Equations 
[Oxyhemoglobin] = 119Am 39A630 
[Methemoglobin] = 28Am + 307 A630 
[Hemichrome] = -133Am 114~30 
89As60 
55As60 
+ 233As60 
Van den Berg modification using correct figures of 
Whitbum (for HzOz adducts) 
[Oxyhemoglobin] 
[Methemoglobin] 
[Fenyl-HB] 
= 536Am 104A63o 472As60 
= 430Am + 1500A63o 784A560 
= -536Am - 476A630 + 976A560 
Reduction of cytochrome C by AGA 
98 
The redox activity of AGA was assessed in vitro by measuring the reduction of cytochrome C in 
the presence ofNADPH. Reactions containing one or more of the components listed in Table 
4.3 were made up to 1 ml with 50 mM phosphate buffer (PH 7.4), and the rate of cytochrome C 
reduction in IlM.min-l was calculated by measuring the change in Asso over 3-5 min. at 25°C, 
where production of Cyt,Cred = slope I 10, and 10 (Cyt.Cred) 21100 M.cm-1• All chemicals except 
AGA and AP3 were purchased from Sigma Chemical Co .. 
Table 4.3. Components of cytochrome C reduction reactions 
Component Stockconc. Working Conc. 
Cytochrome C 2mM 20 IlM (est.) 
AGA saturated 0.5, 1.0, 2.0 Ilg.rn1-1 
AP3/GA saturated 0.5, 1.0,2.0 Ilg.rn1- 1 
NADPH 10mM 50,100 IlM 
NADH lOmM 50,100 IlM 
NADPH Reductase 2 Urn1-1 0.02 Urn1-1 
Superoxide Dismutase 30 mg.rn1-1 300 Jlg.rn1-1 
Catalase 35 mg.rn1-1 350 Ilg.rn1-1 
Menadione 20mM 200 IlM 
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Results 
4.1. Optimization of antibiotic )'ield from Eh1087 cultures 
4.1.1. The innuence of growth phase on antibiotic production by Eh1087 
To determine the optimal time for antibiotic extraction in small scale cultures, the production of 
antibiotic by Eh 1087 cultured in minimal-I A medium wa~ quantified over twelve days (Fi g 
4.1). These data demonstrate that Eh I 087 produces maximum antibiotic as the growth media 
becomes exhaust~d, after which time anti biotic activity decreases to barely detectable levels and 
the Eh 1087 population drops dramatically. After five days the population of Eh I 087 recovers 
and antibiotic activity is partially restored. To determine whether the antibiotic was involved in 
the changing pllpulation s ize of Eh 1087 over time, similar data was collected for EhehpA 
(AGA-) (rig. 4.1) . Because EhehpA does not exhibit these same population dynamics , it is 
likely that either the metabolic load of antibiotic production, or the activity of the antibiotic 
compound, causes the Eh I 087 population to decline. Since the yield of antibiotic from Eh 1087 
cultures was found to be greatest at the first sampling point. 24 h after the inoculation of fresh 
media, it was pertinent to check that greater antibiotic yields could not be achieved in less than 
24 h. In order to assess thi ', cultures of Eh I 087 were sampled for antibiotic activity and 
population size at hourly intervals (Fig. 4.2). This experiment showed that although antibiotic is 
produced by l::h 1087 soon after subculturing to ca. 106 cells .ml", the besr yield per culture 
volume was achieved when cultures entered stationary phase. 
Figure 4.1. Antibiotic yield and population s ize of Eh I 087 cultures over time 
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Antibiotic was partitioned from the 
supcrnal<lnt of l~h1087 cultures to 
chloroform, dried to maintain activity , 
and all samples were assessed for 
relative activity on the same lawn of 
ca88()2 . No antibiotic was obtained 
from EhehpA cultures. Population s izcs 
of both s trains were determined by 
dilution scries. Data is the avcrage o f 
twO replicates and error bars represent 2 
standard deviations. 
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4.1.2. Influence of carbon I energy source on antibiotic production by Ehl087 
AGA production by Ehl087 cultured in minimal medium with glucose as a sole carbon source 
was compared with sucrose and fructose because these sugars are reported to be the most 
common sugars found in nectar, and therefore their presence in blossoms was thought to be 
relevant to the production of AGA by Eh1087 in planta (Fig. 4.2). Eh1087 produced more 
antibiotic on glucose than other carbon sources, and the timing of production varied between 
each medium. Compared to minimal medium, in rich medium (LB) antibiotic production 
appeared to be both delayed and reduced. Antibiotic production by Eh1087 did not vary 
detectably when grown on minimal medium agar plates containing a range of glucose 
concentrations from 0.1 % to 2.0 %. On the basis of these findings Ehl087 was routinely 
cultured in I-A with glucose as the sole carbon source to prepare antibiotic for purification and 
further analyses. 
4.2. Purification of antibiotic from Eh1087 cultures 
4.2.1. Solvent extraction of Ehl087 culture supernatants 
Evidence presented in chapter 3 suggested that Eh1087 produces a phenazine antibiotic (Table 
3.1). Since the first step in phenazine isolation from the culture supernatant of other organisms 
commonly involves extraction with a solvent such as chloroform (Byng and Turner, 1976; 
Chang and Blackwood, 1969; Gerber, 1969), this was attempted for Eh1087 cultures. The 
free supernatant of Ehl087 cultures was extracted with chloroform, the solvent phase was 
collected and dried. The dried compounds were redissolved in sterile media and assessed for 
antibiotic activity. Although there was variation in the extraction of antibiotic from one culture 
to the next, up to 80-90 % of the antibiotic activity partitioned to the chloroform phase (Fig. 
4.3). This could be increased by further chloroform extractions. The phenazines that have been 
described in the literature are usually coloured and possess two absorbance maxima, between 
250 - 290 urn and 350 400 nm (Turner and Messenger, 1986). The crude chloroform extract 
from Eh1087 culture supernatant was yellow, and possessed a strong absorbance maximum at 
264 nm and weaker maximum at 364 urn, providing the first experimental evidence that Eh1087 
produces a phenazine antibiotic. 
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Figure 4.2. Intluence of growth phase and media composition on antibiotic production 
EhlOS7 was grown overnight in U:l o r I-A minimal media supplemented with 0.2 '}', g lucose . 
sucrose. or fructose . and s ubcu ltured to the same medium to ca. 10(' cfu .ml· l . At each tim e 
point. 500 ~I samples were taken fo r rfu.m)"i e numeration and antibiotic ntraction. Antibiotic 
was usually e xtracted from 100 ~I of culture supernatant. howevL'r sa mples marked w ith a 
white asteri s k show antibiotic extrac ted from J () ~J of c ulture supernawm. Samples were take n 
every h for 10 h .• lJld again at 24 and 32 h. The population s ize of Lh IOX7 grown in l'ac h 
media type (colour-coded) is shown at to p. and the relative antibiotic activity of each culture is 
shown be low as clearings in a lawn of Eal:ll:l62. Circled population s~lIl1ple points indi cate thL' 
approximate time when antibiotic prod ucti o n is similar in each media type: the figure nex t to 
each circle is the popul at ion s ize at th~tt s;tmpling point. 
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4.2.2. Secondary purification by acid solubilization 
In an earlier report the activity of the Eh1087 antibiotic was retained after exposure to pH 4.0 
and 9.0 for 30 min. (Keams and Hale, 1996). In the present study the activity of the antibiotic 
produced by Eh1087 was found to be maintained in acidic conditions but to rapidly decrease 
above pH 9.5 within 30 min (Fig. 4.3). Activity also decreased over a number of hours at 
neutral pH and the decrease was more rapid in basic conditions. Figure 4.3 also illustrates how 
antibiotic activity only partitions into chloroform from aqueous solutions that are near neutral 
pH. When the chloroform extract was dried and redissolved in I-A media at pH 2.5, only 10-20 
% of the material dissolved, whereas at pH 7.0 nearly all material dissolved. However, when 
the acidified solution was neutralized with NaOH, re-extracted to chloroform and antibiotic 
activity assessed, it was found that nearly all antibiotic activity was retained. This simple 
procedure separated AGA from nearly all other compounds, particularly AP3, which is a major 
component of chloroform extracts from Eh1087 culture supernatants (Fig. 4.4C, panels I and 4). 
Control 
Neutralized 
pH 2.0 2.5 3.0 3.5 4.0 5.0 6.0 7.0 8.0 9.0 9.5 10.0 
Figure 4.3. The pH sensitivity and chloroform extractability of AGA 
The differential partitioning of antibiotic from pH-adjusted solutions to chloroform (control) or 
from neutralized solutions to chloroform. 40 ~g of crude chloroform-extracted material from 
Eh1087 culture supernatant was redissolved in 200 ~l I-A medium adjusted to a pH between 
2.0 and 12.0, and maintained for 30 min at room temperature. The dissolved material was 
transferred to a new container and either directly extracted with 200 III chloroform (control) or 
neutralized before extraction with chloroform. Antibiotic compound(s) only transferred to 
chloroform from aqueous solution near neutral pH. Although only ca. 10 - 20 % of the 
material dissolved below pH 4.0, full antibiotic activity was retained. Of the original 40 Ilg 
material per treatment, eight Ilg was assessed for antibiotic activity on a lawns of Ea8862. 
Photographs of the appropliate section of each lawn were aligned using Photoshop 5.0 and 
although there is some variation in lawn sensitivity to the extracted antibiotic, the overall trend 
is clear. 
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4.2.3. Final antibiotic purification by LH-20 size exclusion chromatography 
The proportion of non-antibiotic compounds present after acid solubilization of the antibiotic 
was variable. This contamination was subsequently shown to be predominantly griseoluteic 
acid (GA) formed by hydrolysis of the antibiotic during extraction in aqueous buffer (Figure 
4.4B shows an extraction in which an standard amount of GA was present). Therefore a third 
purification step was used in which the acid-soluble compounds were extracted to chloroform 
and fractionated through a Sephadex LH-20 column. Two yellow fractions eluted at nearly the 
same time from the column, and were followed some time later by GA, which formed a red 
precipitate when dried. The first yellow compound had ca. 2.5 % of the antibiotic activity of the 
second. Furthermore, because mass spectrometry data indicated that the first yellow compound 
to elute from the column was likely to be composed of antibiotic-detergent adducts, it was 
discarded (Y. Feng, pers. comm.). The second yellow compound was sufficiently pure for ID 
and 2D nuclear magnetic resonance spectroscopy and mass spectrometry. 
4.2.4. Properties of the purified antibiotic 
As expected, the relative activity by weight of the purified compounds increased with each step 
of the purification process (for example see Fig. 4.4A). Purification was also demonstrated by 
HPLC analyses of the material present at each stage of the purification process (Fig. 4.4C). 
Analysis of the HPLC fractions demonstrated that a compound eluted at 6.9 minutes with 
antibiotic activity, in contrast to AP3 (10.7 min.) and GA (11.9 min.) (Fig. 4.4B). Subsequent 
discussions with S. Devenish (Dept. Chemistry, Univeristy of Canterbury, NZ) suggest that 
such comparisions must be judged carefully since the HPLC machine used in these studies was 
known to have leaking valves that could comprise the reproducibility of one run relative to the 
next. Antibiotic was purified from many Ehl087 cultures using this three-step process, which 
was sufficient to isolate antibiotic with the same activity and absorbance (see below) per weight 
on each occasion. Because dried antibiotic did not lose activity over three days when exposed 
to -20 DC, 4 DC, 18 DC, 30 DC, 37 DC or 65 DC, but lost nearly all activity within an hour in water 
at 65 DC, the antibiotic compound was routinely stored dried in a desiccator at ambient 
temperature. 
Using this three-step purification process, approximately one milligram of antibiotic was 
obtained from a one litre Ehl087 culture grown in minimal medium. Antibiotic activity could 
be detected from as little as 50 ng AGA per 6 mm diameter filter disk on a lawn of Ea8862. 
Antibiotic dissolved in minimal media or water has absorbance maxima at 262 and 362; at a 
concentration of 10 flg.mr1 an antibiotic solution has an OD262 of ca. 0.53 - 0.54. 
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A) 
C) 1) Crude AGA 2) Acid soluble 3) Final preparation 
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-
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0.0 
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4) Crude AP3 5) Acid insoluble 6) AGA hydrolysate (GA) 
1.0 AP3 GA GA 
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1\1 0.4 Qj 
a: 0.2 
0.0 
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~ AGA L rJ AGA 
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Elution Time (min.) 
Figure 4.4. The purification of AGA from minimal media cultures of EhlO87 
A) Antibiotic activity of 6 mm filter disks containing either (i) lO f.lg crude culture supernatant 
extract or (ii) 10 f.lg of material after acid-solubility purification. B) Assessment of antibiotic 
activity for samples eluting at the indicated times (min) from a water / acetonitrile gradient; 
samples start at 2.25 min and go from left to light. Samples were collected every 25 s, dried, 
redissolved in chloroform and absorbed onto six mm filter disks. Fractions tested for antibiotic 
activity correspond to the HPLC traces shown in part (C). C) HPLC traces for the antibiotic 
preparations listed in part (A), and for (4) antibiotic precursor 3 (AP3) extracted from the 
culture supernatant of EhehpN, (5) the acid insoluble material, and (6) the phenazine 
compound, Griseoluteic acid (GA), resulting from hydrolysis of AGA. 
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4.2.5. Properties of the coloured AGA intermediates 
To compare the coloured intermediates produced by different Ehehp mutants, the extraction of 
all coloured intermediates from culture supernatant to chlorofonn was attempted. API and AP3 
partitioned to chloroform, whereas AP2 did not, indicating that AP2 is more polar than API, 
AP3 and AGA (the antibiotic was found to be D-alanylgriseoluteic acid (AGA) as described in 
section 4.3.2). Since API is released in very small amounts from Group 2 mutants, it is likely 
to be convelted to AP2 intracellularly. Therefore, API was extracted from cultures of EhAAGA 
(pBB7) which enhanced the yield of AP 1 because pBB7 is a multicopy plasmid that contains 
the Group I genes ehpA-ehpE. API could be extracted to chloroform from the culture 
supernatant in which this strain had grown only after the medium was acidified, in a similar 
manner to the isolation of phenazine-l-carboxylic acid (PCA) from the culture supernatants of 
by P. jluorescens 2-79 and P. aureofaciens 30-84 (Thomashow et al., 1990). Since AP2 could 
not be extracted from culture supernatant to chloroform comparison with AGA, API AP3 and 
PCA was not possible. The final precursor (AP3) was isolated from a culture of the Group 4 
mutant, EhehpN. HPLC analysis was used to compare API, AP3, AGA and PCA (Hg. 4.5). 
The different elution times of these compounds indicate that they have different solubility in 
water and confmns that they are different molecules (Fig. 4.5A). However, all four compounds 
possessed absorbance spectra with characteristics common to phenazines (Fig. 4.5B) indicating 
that they all possess the phenazine nucleus (Turner and Messenger, 1986). Notably AP3 and 
AGA possessed similar absorbance spectra and Aula x, whilst AP 1 and PCA have very similar 
absorbance spectra and the same "max. Thus, API and PCA are probably more closely related to 
each other than to AP3 or AGA. 
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Comparison of solubility and UV-visible absorbance spectra of phenazine-l-carboxylic acid 
(PCA), AGA precursors API and AP3, and AGA separated on a water / acetonitrile gradient 
by CIS reverse-phase HPLC. 
A) Chromatograms illustrate the different elution times for each compound (measured at 265 
urn). For the chromatograms of PC A, API, and AP3 only the compound(s) responsible for the 
dominant peak (indicated) have the absorbance spectra common to phenazines (Turner and 
Messenger, 1986). The small peak at 11.9 minutes in the AGA chromatogram also has 
phenazine characteristics and was found to be GA (see section 4.3.1). 
B) Comparison of the ultraviolet-visible spectra for the major peak in each chromatogram. 
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4.3. Structure of the antibiotic produced by Ehl087 
4.3.1. Structure of the antibiotic-breakdown prodnct 
107 
Purified antibiotic is yellow and breaks down water or alcohol to a red compound that 
possessed no detectable antibiotic activity against Ea8862. Eventually it was found that the 
active yellow compound was stable in chloroform, however before this was known the structure 
of the red compound was determined as it was expected to provide clues about the structure of 
the active compound. The structure of the inactive red compound was elucidated as griseoluteic 
acid (GA) by nuclear magnetic resonance (NMR) and mass spectrometry. All data were 
obtained and interpreted by Yunjiang Feng, Department of Chemistry, University of 
Canterbury. GA was the first knmvn phenazine compound to be isolated from Eh1087, and 
indeed any Erwinia or Pantoea spp. as far as the author is aware (Fig. 4.6). The breakdown of 
the Eh 1 087 antibiotic into GA strongly suggested that the active compound was also a 
phenazine, with side group(s) that are easily hydrolysed in aqueous solution. 
4.3.2. The chemical structure of AGA 
The finding that the Eh1087 antibiotic was stable in chloroform enabled the structure to be 
determined by 1D and 2D NMR and mass spectrometry. NMR data are presented in Appendix 
A4 for completeness. The antibiotic produced by Eh1087 was indeed related to GA, but 
possessed an alanyl ester at position 6 (Fig. 4.6). The stereochemistry of the alanine group was 
determined by derivatizing an AGA hydrolysate with I-fluoro-2,4-dinitro-5yl-L-alanine amide 
(FDAA), and analysing the derivatives by LC-MS relative to FDAA derivatives of D-alanine 
and L-alanine (Y. Feng., pers comm.). This experiment demonstrated that hydrolysis of the 
Ehl087 antibiotic released D-alanine, and therefore the antibiotic was D-alanylgriseoluteic acid 
(AGA). Interestingly, D-alanine is an amino acid found almost exclusively in bacteria where it 
forms a key component of the cell wall. The chemical structures of AGA and GA indicate that 
GA could easily arise by hydrolytic cleavage of the D-alanyl moiety from AGA (see also 
section 3.4.2). To determine the concentration of purified AGA from spectral data, the molar 
extinction coefficient (8) was estimated from the absorbance (0.54) of a 10 Ilg.rnl-1 solution of 
AGA (Mw 355.35) in water: D-alanylgriseoluteic acid, Amox 262 nm (8 19200). Therefore, the 
concentration of a solution of AGA in water with an absorbance of 1.0 at 262 nm is ca. 52 iJM 
(18.5 Ilg.mrl). 
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D-Alanylgriseoluteic acid (AGA) 
Figure 4.6. The chemical structures of AGA and GA 
4.4. Spectrum of AGA-susceptible organisms 
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Once AGA was found to have no detectable impurities (by NMR analysis), the minimal 
concentrations required for inhibition and killing (MIC and MLC, respectively) of various 
organisms could be measured. It was anticipated that commonality amongst organisms with 
similar susceptibility to AGA could provide clues about antibiotic activity. To measure MIC 
and MLC, bacteria were cultured in microtitre dish wells containing LB media supplemented 
with a logz dilution series of AGA. In broth dilution, no antibiotic activity was retained after 48 
h. Thus, a dilution series could be scored at 72 h for MLC since any bacteria that had survived 
the initial AGA exposure would repopulate the media by 72 h. MIC values were often the same 
or a single dilution lower than MLC values (for example see Table 4.4). The broth dilution 
method could be used to quantify antibiotic activity measured by the disk diffusion method, a 
simpler technique which involves measuring the diameter of a killing zone on a lawn of 
sensitive bacteria. Comparison between the broth dilution method and the disk diffusion 
method indicated that the latter was an accurate and reproducible method for estimating the 
MIC for a particular organism. 
The MIC of many of the strains used throughout this investigation was assessed and this data is 
presented in the relevant sections. The MIC values for six E. coli strains are presented in Table 
4.4 because they demonstrate i) the variation in AGA-susceptibility amongst strains of the same 
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species, and ii) that MIC values can indicate general trends, in this case that recA mutants are 
more sensitive to AGA than isogenic recA+ strains. For a collection of different bacteria with 
MIC values ranging from 0.2 to 16 !!g.mt\ a strong correlation was noted between the 
measured MIC and the halo size of a filter disk containing AGA on a lawn of the test organism. 
Subsequently, a range of Gram+ and Gram- organisms were tested using the disk diffusion 
assay, and estimated MIC values are reported in Table 4.5 (strains and technical expertise were 
kindly provided by David Bean, Dept. Plant and Microbial Sciences, University of Canterbury). 
The cutoff point for insensitive organisms was arbitrarily chosen as 2: 8.0 !!g.mr\ because disks 
containing 10 !!g AGA either produce no clearings, or very small clearings (7 - 8 mm diameter, 
where 7 mm is the detection limit for 6 mm disks), on organisms with this level of sensitivity. 
Ten !!g disks produce substantial clearings on sensitive organisms (10 36 mm diameter), 
however it should be noted that this is not a clinically relevant measure of sensitivity as 
described by Woods and Washington (1995). Both Gram+ and Gram- bacteria exhibited a 
range of AGA-sensitivities. The data reported in Table 4.5 also demonstrate that AGA is active 
in an micro-anaerobic environment as it has good activity against the obligate anaerobes, 
Bacteriodes jragilis, and Clostridium perfringens cultured anaerobically. In summary, it is clear 
that there is no obvious rule by which the sensitivity of bacteria to AGA can be predicted; this 
data has to be determined empirically for each strain. 
Table 4.4. Sensitivity of recA+ and recA- E. coli to AGA 
MIC MLC 
E. coli strain recA+ recA- recA+ recA-
DH5a 1.6 0.8 1.6 1.6 
MC4100 3.2 OA 3.2 0.8 
DE880 0.8 0.8 
DE1491 0.4 0.4 
MIC and MLC data were determined by the broth dilution method 
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Table 4.5. Screen of gram- and gram+ bacteria for AGA sensitivity. 
SeIJ.sitive Organisms (NZRM#) Gram-/+ lZone Est. MIC 
Arcanobacterium haemolyticum (816) 31 <0.2 
Bacillus subtilis (698) 18 0.8 
Branhamella catarrhalis (2565) 23 0.4 
Campylobacterjejuni subsp.jejuni (3242) 20 0.4 
COlynebacterium diptheriae (23) + 18 0.8 
Escherichia coli (916) 15 1.2 
Haemophilus injluenzae (3315) 30 0.2 
Helicobacter pylori (8823) 36 0.2 
Neisseria gonorrhoeae (1036) 31 0.2 
Neisseria lactamica (2590) 25 0.2 
ShigellaJlexneri (3476) 20 0.4 
Staphylococcus aureus subsp. aureus (1056) + 22 0.4 
Streptococcus sp. Lancefield's group B (3250) + 21 0.4 
Streptococcus pneumoniae (3399) + 23 0.4 
Streptococcus pyogenes (2723) + 25 0.2 
Vibrio parahaemolyticus (820) 14 1.2 
Yersinia enterocolitica (2603) 20 0.4 
2Bacferiodesfragilis 25 0.2 
2Clostridium pelji'ingens + 23 0.4 
Insensitive Organisms (NZRM#) Gram-/+ 1 Zone Est. MIC 
Aeromonas hydrophila (3205) 8 ;::: 8.0 
Candida albicans (2228) (yeast) 0 > 8.0 
Enterococcl/S faecalis (2244) + 8 ;::: 8.0 
Klebsiella pneumoniae subsp. pneumoniae (3407) 0 > 8.0 
Pseudomonas aeruginosa (918) 0 > 8.0 
Staphylococcus saprophyticus subsp. saprophyticus (1010) + 7 ;::: 8.0 
ISix mrn <D disks containing 10 J.lg.m1-1 AGA were placed on standardized lawns of each strain 
on Mueller-Hinton Blood agar, or LB agar, incubated under appropriate conditions for each 
strain, and the diameter of the zone of inhibition caused by AGA was measured in mrn. MIC 
estimations (Est.) are derived from disk diffusion data. 
20bligate anaerobes were assayed under anaerobic conditions. C. pmfringens was tested by 
staff in the Dept. Microbiology, Wellington Medical School. 
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4.5. Preliminary investigations into the mode of action of AGA 
4.5.1. AGA is bacteriocidal 
111 
Previously, the antibiotic produced by Eh1 087 was reported to be bacteriocidal on the basis that 
no viable cells could be recovered from the zone of inhibition around a colony of Eh1087 on an 
Ea8862 lawn. During this investigation purified AGA was found to have the same property. 
Furthermore, cultures of Ea8862 grown to exponential phase or to stationary phase were found 
to be killed by AGA, indicating that the killing activity is independent of growth-phase. Even 
sub-MIC doses of AGA killed Ea8862 cells within 30 min (Fig. 4.7). When the dose was 
greater than the MIC, most cel1s were killed within five min (data not shown). Interestingly, 
when AGA-killed and untreated Ea8862 cells were fixed, stained with crystal violet, and viewed 
with a light microscope at 1000 x magnification, no morphological differences were observed. 
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Ea8862 cells from an overnight culture were suspended to ca. 1 x 109 CFU.ml-1 in minimal 
media salts and treated with 0.08 /lg.ml- l AGA (ca. 50 % MIC). Samples were taken at the 
time intervals indicated, immediately rinsed twice with ice-cold minimal medium and 
enumerated by serial dilution. Data points were measured in triplicate. 
4.5.2. AGA indnces an SOS response 
Many stress stimuH, particularly those that cause DNA damage, induce a regulon of genes that 
are normally repressed by LexA but become derepressed by the co-protease activity of RecA 
that has been exposed to single-stranded DNA (the DNA-damage signal). Collectively, these 
genes are known as the SOS regulon, and the induction of these genes can be assessed by 
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measuring the expression of the appropriate in-frame lacZ fusions (Walker, 1984). For instance, 
isogenic E. coli strains DE880 (recA+) and DE1491 (recA-) carry a fusion of lacZto sulA which 
is induced as part of the SOS regulon to inhibit cell division. Under SOS conditions the activity 
of SulA is thought to stop the formation of DNA-replication induced DNA lesions and provide 
time for cell repair mechanisms to fix DNA damage. Measurement of f)-galactosidase activity 
in DE880 is indicative of SOS induction, whereas DE1491 cannot induce an SOS response 
unless recA is provided in trans (Ennis et a1., 1989). To test whether AGA induced sulA, and by 
inference an SOS response, these strains were treated with varying concentrations of AGA. 1.0 
flg.mr1 AGA (ca. the MIC of AGA for this strain) induced the expression of sulA in DE880 to a 
similar level as 0.5 flg.mr1 mitomycin C, a wel1lmown inducer of the SOS response (Wei et a1., 
2001). The expression of sulA in response to AGA exposure by DE880 but not DE1491 
demonstrates that AGA causes recA-dependent sulA induction (Fig. 4.8A). The recA-dependent 
induction was confirmed when pKSrecA (a clone of the Eh1087 recA gene) was introduced to 
DE1491 and transformants were treated with AGA. In this strain sulA expression was induced 
to a similar level as AGA-treated DE880 cells. Cells treated with GA did not induce sulA 
expression, thus the SOS response correlates with antibiotic activity (data not shown). Also of 
significance, the induction of sui A by AGA was found to occur in a concentration dependent 
manner, and provides a very sensitive and accurate measure of antibiotic activity for AGA 
concentration well below the MIC for these strains (Fig. 4.8). sulA is the only member of the 
SOS regulon that has been assessed for induction by AGA, however because this induction is 
recA-dependent it is likely to represent an SOS response and will therefore be referred to as 
such from this point. 
EhpR provides a cell with protection from AGA. If the SOS response in E. coli exposed to 
AGA corresponds to the antibiotic activity of AGA then it was hypothesized that the provision 
of antibiotic resistance by EhpR would reduce or eliminate the SOS-response of antibiotic 
treated E. coli cells. This hypothesis was supported by the finding that the SOS response was 
not observed in DE880 that had been transformed to AGA-resistance with pBB7::ehpA (Fig. 
4.8B). The elimination of the SOS response by EhpR indicates that the EhpR-mediated AGA-
resistance mechanism inhibits antibiotic activity before an SOS response is induced, and must 
therefore prevent even sub lethal amounts of AGA from acting on a target cel1. 
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Figure 4.8. SOS induction in E. coli in rc,ponse to AGA 
A) AGA causes RecA-dependent induction of su/A. E. coli DEXSO (r('(A+) and DE 14YI 
(rc('A -) ce lls grown to an OD,,(~( of 0.5 in minimal media were treated with various amounts of 
crude Eh IOX7 antibiotic extract for 1 hour at -"7°C, in a water bath shaklllg at 250 rpm, and jJ 
galactw;idase activity was measured as described previously (Miller, 1972). 
B) su/A induction is prevented by EhpR. E. coli DJ:: XXO and derivatives harbouring 
pBB7::elzpR (EhpR-) or pBB7::ehpA (EhpR+) were grown in LB to an ODwll of 0.5, and 
treated with I f-lg.ml'l ACiA. Backgrtlund jJgalactosida,e activity conferred by pBB7::l'hpR is 
100-200 units, and for pBB7::ehpA is 200-300 units. MIC data for these \trains: DEXXO and 
DEX 80 (pBB7:: ehpR), 0.4 f-lg.m l" l; DEf.:XO (pBB7::ehpA), > 16 f-lg.mll; DE1491, O.S f-lg.ml'l. 
4.5.3. AGA is an indirect mutagen 
A common stress known to induce the SOS response is DNA damage. Since AGA induced an 
SOS response and many phenazines are mutagenic (Kato et aI., 1994; Martinez et aI., 2000; 
Watanabe et aI., 1989; Watanabe et aI., 19R9). the mutagenicity of AGA was as.scssed. 
Preliminary in v stigations into E. coli strains dosed with varying concentrations of AGA 
suggested that resistance to RfR and Nail" but not SmR, arose at significantly higher ralL's than in 
untreated cclls (data not shown). When isogenic recA+ and recA- strains were dosed 
sufficiently to reduce the population si ze by an order of magnitude and then allowed to fully 
recover, Rf and NaiR mutants arose independently of recA, thereby excluding the error-prone 
repair mechanism that forms part of the SOS response from involvement in the mutagenesis. 
However, Rf' and NaiR mutants could have arisen because of DNA base alterations caused by 
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AGA, or because such mutants may already have existed in the population and possessed some 
advantage that enabled them to out compete their non-resistant peers when exposed to AGA. 
To confinn whether or not AGA has in vivo mutagenic activity, a collection of six E. coli lacZ 
reversion tester strains (WP310 1-WP31 06) were obtained from Dr Toshihiro Ohta (School of 
Life Science, Tokyo University of Phannacy and Life Science, Japan). These six strains are 
derived from E. coli Blr WP2 [F-, uvrA155, tlpE65, malBIS, lon-II, sulAl] and possess a F' 
plasmid carrying one of six possible unique lacZ mutations at codon Glu-461 resulting in a 
lacZ- phenotype (Table 4.1). Reversion of these mutations is required for a lacZ+ phenotype, 
which can be assayed by plating bacteria on minimal media with lactose as the sole carbon 
source. If the frequeny of reversion increases after exposure to a compound, then that 
compound is deemed mutagenic and the nature of the reversion indicates the type of mutation 
caused by the mutagen. It is worth noting that these strains are uvrA- and therefore lack the 
ability to activate the excision repair pathway that would otherwise repair many mutations. The 
addition of plasmid pKMIOl carrying mucAB to these six strains resulted in the creation of 
strains WP3101P-WP31 06P. mucA and mucB are probable homologs of umuD and umuC and 
increase the rate of error prone repair under conditions in which DNA is damaged. Therefore 
different mutation rates between strains with and without mucAB indicates that the error-prone 
repair pathway is involved in the mutagenic process, and vice versa. The twelve E. coli lacZ 
reversion strains were exposed to OJ ~g per plate AGA or 20 ~g per plate sodium azide (as a 
positive control) at 37°C for 20 min as described by Ohta (1998), plated on defined minimal 
media with lactose as the sole carbon source, and incubated at 37°C for 48 h. After incubation, 
colonies that could be clearly seen by eye were counted Crable 4.5). In this initial experiment, 
AGA increased the rate of transition from G:C~A:T by approximately 10 times background, 
but caused no other base pair changes above background level. Since the frequency of 
revertants was lower in cells containing mucAB, it is apparent that the mutagenic process 
involving AGA does not depend on error-prone repair. This experiment was repeated using 
concentrations of AGA and AP3 from 0.05 ~g to 32 )lg per plate (data not shm.vn). The 
mutagenic effect of AGA was concentration dependent, with the greatest number of revertants 
occurring at between 0.25 and 1.0 )lg AGA per plate. Most bacteria were killed by ?:4 )lg AGA 
per plate (0.16 ~g.ml"l media). It was also noted that the number of revertants varied greatly 
from experiment to experiment, and that on most occasions the greatest reversion frequency 
after exposure to AGA was only 4-5 times greater than that of the untreated control. No 
increase in reversion was noted for bacteria cultured on plates supplemented with AP3 at 
various concentrations, suggesting that the antibiotic activity of AGA is related to mutagenicity. 
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Table 4.6. Reversion of lacZ point-mutations in E. coli strains exposed to AGA 
Strain Reversion Control NaN3 AGA 
WP3101 A:T---+C:G 0 
WP3102 G:C---+A:T 6 113 73 
WP3103 G:C---+C:G 0 0 0 
WP3104 G:C---+T:A 3 4 
WP3105 A:T---+T:A 1 4 7 
WP3106 A:T---+G:C 0 0 
WP3101P A:T---+C:G 2 3 
WP3102P G:C---+A:T 4 102 36 
WP3103P G:C---+C:G 0 0 0 
WP3104P G:C---+T:A 3 10 4 
WP3105P A:T---+T:A 0 3 7 
WP3106P A:T---+G:C 5 1 6 
Data from one representative experiment. is reported, in which the reversion of E.coli tester 
strains to lacZ+ in the presence of AGA ofNaN3 was assayed. 20 Ilg per plate NaN3 was used 
as a positive control for G:C---+A:T transitions (Ohta et aI, 1998). AGA was used at 0.3 Ilg per 
plate. Strains WP3101-WP3106 grew more quickly and formed colonies with less size 
variation than WP31 01P-WP3106P after exposure to AGA. 
115 
Does AGA act directly on DNA or does it require cellular components or physiological 
processes for mutagenic activity? To crudely test this question, purified DNA of the plasmid 
pUC19 was exposed to AGA for 24 and 72 hours, the pUC19 DNA repurified and assessed for 
ability to complement the a-fragment of lacZ in E. coli DH5a. Most mutations to the p-
fragment of lacZ carried on pUC19 should inactivate l3-galactosidase activity. AGA did not 
increase the proportion of lacZ mutations above background, whereas exposure to 
hydroxylamine did (Table 4.1). Therefore AGA does not cause mutation of DNA in the in vitro 
conditions tested, suggesting that AGA does not act directly on DNA, at least not in the absence 
of certain cellular component(s). Evidence presented in the next section suggests that the AGA 
may need an electron acceptor/donor such as NADP, an oxidoreductase, to effect its activity, 
however this has not been assessed in vitro against a target DNA molecule such as pUC19. 
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Table 4.7. Mutagenesis ofpUC19 by AGA in vitro 
Treatment 
Control (buffer only) 
Antibiotic 
Hydroxylamine 
Colonies per plate (DH5a recA+) 
blue (wild type) white (mutant) 
ca. 4000 
ca. 4000 
ca. 1000 
2 
2 
70 
DNA was exposed to AGA or hydroxylamine for 24 hours (similar results were obtained after 
72 hours). 
4.5.4. AGA has redox activity 
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The antibiotic activity of phenazine compounds is thought to occur by one of two common 
mechanisms, either by binding DNA and inhibiting various DNA-dependent processes, or by 
the generation of damaging oxidative compounds (Baron and Rowe, 1981; Behki and Lesley, 
1972; Hassan and Fridovich, 1980; Hollstein and Van Gernert, 1971; Hori et a1., 1978). AGA 
was shown to be weakly mutagenic against E. coli, causing G:C-+A:T transitions, possibly via 
the oxidative deamination of cytosine to uracil (and the subsequent pairing with adenine rather 
than guanine). On this basis, an investigation into the ability of Eh 1 087 to cause free radical or 
oxidative damage was carried out in association with the Free Radical Research Group at the 
Christchurch School of Medicine, under the guidance of Dr Christine Winterbourne. Redox 
activity was assessed using two assays; an 'in vivo' assay in which the oxidation of 
haemoglobin released from lysed red blood cells was measured (all red cell components were 
present), and an 'in vitro' assay in which the reduction of commercially prepared cytochrome C 
was measured. 
Oxyhemoglobin oxidizes to methemoglobin, and in some circumstances to other compounds 
such as hemichrome, or a methemoglobin::H202 complex known as ferryl-hemoglobin. The 
relative concentrations of these compounds can be derived from spectral changes as described 
by Winterbourne (1985). To assess whether or not AGA could oxidiZe hemoglobin, red blood 
cell lysate was treated with AGA and the change in absorbance spectra over time was measured. 
It is worth noting that high concentrations of AGA (32 or 64 Jlg.ml-1) were required to observe 
clear hemoglobin oxidation, relative to concentrations sufficient to kill many bacterial spp. (0.2 
- 4.0 Jlg.mf 1) From the spectra data the change in oxidation state of oxyhemoglobin was 
determined (Fig. 4.1 0). The treatment of red blood cell lysate with AGA or AP3 resulted in a 
decrease in the oxyhemoglobin fraction over time; concurrently an increase in the oxidized 
oxyhemoglobin derivative methemoglobin is observed and in the absence of catalase activity it 
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appears that the ferryl-hemoglobin (methemoglobin: :H202) complex also formed. Because the 
rate of these changes increases when the concentration of AGA or AP3 is increased, and since 
no hemoglobin oxidation was observed in reactions lacking AGA or AP3, it appears that these 
compounds are acting as oxidants. Originally the data was treated with the Winterbourne 
equations (see materials and methods) which indicated that no hemichrome was formed (data 
not shown), but the oxidized hemoglobin products could not account for the decrease in 
oxyhemoglobin concentration. However, the Van den modified equations using the correct 
figures of Whitburn (for HZ02 adducts) suggested that ferryl-hemoglobin was forming rather 
than hemichrome. Hemichrome formed when the red blood cell lysate was treated with the 
oxidant acetylphenylhydrazine, confirming that the lack of hemichrome formation is a specific 
feature of the hemoglobin oxidation involving AGA (data not shown). Two lines of evidence 
suggest that the oxidation of hemoglobin by AGA and AP3 involves the generation of reactive 
H202 ; firstly, the formation of ferryl-hemoglobin, and secondly, the finding that in the presence 
of azide to inactivate catalase and maintain H202, oxyhemoglobin was oxidized at a higher rate 
and methemoglobin was not detected (Fig. 4.9). Thus, the oxidation of hemoglobin by AGA 
appears to cause the formation of a methemoglobin-H202 complex. It is also apparent that AP3 
oxidizes oxyhemoglobin at a lower rate than AGA by a small but consistent margin, for reasons 
that remain to be determined. 
Once it was established that AGA and AP3 caused haemoglobin to become oxidized to 
methemoglobin in the presence of catalase and probably to ferryl-hemoglobin in the absence of 
catalase (Fig. 4.9), the next step was to determine if AGA and AP3 could reduce cytochrome C 
in the absence of the cellular components present in red cell lysate. The rate of cytochrome C 
reduction was measured as the change in AS50 over time in reaction mixtures containing one or 
more of the following; cytochrome C, varying concentrations of AGA and AP3, the electron 
donor NADPH (or NADH), and ferredoxin-NADP+ reductase to recycle electron donors. The 
results of this assay are presented in Table 4.8. Reactions 1-6 (Table 4.8) demonstrate the 
relationship between AGA or AP3 concentration and the rate of cytochrome C reduction. 
Reactions involving equivalent concentrations of AGA and AP3 proceed at a very similar rate. 
As the concentration of either AGA or AP3 doubles, the rate of cytochrome C reduction almost 
doubles, although when the concentration of AGA or AP3 is 32 ~g.mrl other factors appear to 
limit the reaction rate. Consequently, it can be concluded that, at least for 8 ~g.mrl and 16 
~g.mrl, the reaction rate is directly proportional to the concentration of AGA and AP3, which 
are therefore involved in the reduction of cytochrome C. This conclusion is supported by the 
finding that the reaction does not proceed in the absence of AGA or AP3. 
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Figure 4.9. OxiJation of hCllloglobin by AGA and AP3. 
The concentrations of oxyheillogiobin. methemoglobin, ;.IIld fcrryl-hemuglobin (assumed) were 
derived from spectral measu re ment s of red ce ll lysa te exposed to 32 )1g.m l-1 and 64 )1 g.m i"1 
AGA or AP3 at 37°C. Samples were taken at 2 h intervals for 6 h . Reactions \\·crc carried out 
with az.iJe absent (top three gr<lphs) or in the presence of a7.ide (bottom threc graphs). Azide 
inactivates catalase and inhibits the degradation of H ~(),. hence H,(j, is ahscnt in the assay 
reported in the top three graphs anJ present in th e assay reported in the bottom thrl'l' )2 raph s. 
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The effect of limiting NADPH or ferredoxin-NADP+ reductase on the rate of cytochrome C 
reduction is dcmonstrated by reactions 7 - 13. Lowering NADPH conce ntration by 50 0'< 
decreased the rate of cytochrome C reduction by ca. 35 % for reactions containing either AGA 
or AP3. indicating that the concentration of NADPH has a strong influence on the reaclion 
dynamics (reactions 7 and 8). In compalison. the presence of 30 ~g.ml·1 superoxide dismutase 
(to remove superoxide) or 35 ~g.ml -I catalase on 1 y decrease the reaction rate by ca. 12 o/c or ca. 
8 %. respectively, indi ating that sliperoxide and H202 have only a minor role in the reduction of 
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cytochrome C mediated by AGA or AP3 (data not shown). It has been proposed that 
superoxide acts in the auto-oxidation of fully reduced phenazine derivatives, restoring their 
electron-accepting potential (Davis and Thornalley, 1983). 
Table 4.8. Cytochrome C reduction by AGA and AP3 
Reaction lAGA JAP3 2NADPH 3Reductase 4Slope 5Rate 
(Jlg.m1,I) (Jlg.m1'I) (JlM) (units) (IlM •min• ,1) 
1 8 100 0.02 0.0571 2.71 
2 16 100 0.02 0.0987 4.68 
3 32 100 0.02 0.1481 7.02 
4 8 100 0.02 0.0544 2.58 
5 16 100 0.02 0.0969 4.59 
6 32 100 0.02 0.1464 6.94 
7 8 50 0.02 0.0370 1.75 
8 8 50 0.02 0.0364 1.73 
9 8 100 0.01 0.0275 1.30 
10 16 100 0.00 0.0315 1.49 
11 32 100 0.00 0.0529 2.51 
12 16 100 0.00 0.0052 0.25 
13 32 100 0.00 0.0088 0.42 
Reactions showing cytochrome C reduction only are reported; no reduction was observed if 
either NADPH or AGA I AP3 were absent. The concentration of reduced cytochrome C at the 
end point of each reaction was calculated to be 28 mM (Asso 0.6). 
1 AGA and AP3 were extracted from cultures of Eh1087 and EhehpO respectively, 
equilibrated for A364, and standardized by measuring the antibiotic activity of the AGA 
sample relative to purified AGA. 
2 NADH produced similar results when substituted as the electron donor. 
3 One unit offerredoxin-NADP+ reductase reduces 1.0 JlM NADP per min at pH 7.6,25 C. 
4 The plot of Asso change over time in min (reactions proceeded for up to 12 min). 
5 The rate of cytochrome C reduction. In these conditions a positive control, 200 JlM 
menadione (a redox-cycling agent), reduced cytochrome C at 20.9 JlM.min,1. 
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Ferredoxin-NADP+ reductase is a limiting factor in the reduction of cytochrome C since 
lowering the concentration of this enzyme by 50 % decreases the reduction rate by ca. 50 % 
(reactions 1 and 9). Removing the enzyme altogether reveals an important difference between 
AGA and AP3 (reactions 10-13). The rate of reactions without reductase and in the presence of 
AGA, is decreased by ca. 65 % initially and the reaction rate slows rapidly after 1 min (data not 
shown). In contrast, reactions containing AP3 and no reductase proceed at ca. 5 % of the rate of 
reactions containing reductase. Because the rate at which reductase replenishes NADPH is too 
low to affect the reaction rate (one unit will reduce 1.0 IJ.mole NADP per min), the reductase 
probably mediates redox reactions between cytochrome C and AGA or AP3 (Fig 4.11). The 
most likely scenario is that NADPH-reduced ferredoxin-NADP+ reductase reduces AGA and 
AP3, which are subsequently able to reduce cytochrome C. Additionally, it is likely that the 
redox potential of AGA is sufficiently high to oxidize NADPH and reduce cytochrome C in the 
absence of reductase, at least for a short period, whereas AP3 does not have the appropriate 
redox potential for this reaction. The end product of AGA / AP3 oxidation is likely to be the 
semiquinone free radical illustrated in Figure 4.10, a molecule that can react with either two-
electron or one-electron donor-acceptor pairs in a similar manner to the flavins involved in 
pyruvate oxidation. 
4.5.5. Catalase does not protect bacteria against the antibiotic activity of AGA 
The presence of catalase prevented the formation ofmethemoglobin::H20z complexes during the 
oxidation of hemoglobin by AGA, but had little effect on the rate of cytochrome C reduction. 
To determine whether or not H20Z could be involved in the antibiotic activity of AGA, the 
potential for a potent catalase from S. entomophila (Giddens, 1995) to provide bacteria with 
protection against AGA was assessed using the disk diffusion assay (Table 4.7). S. entomophila 
is intrinsically resistant to AGA (MIC and MLC, 16.0 IJ.g.mr1). A catalase-minus mutant of S. 
entomophila (BC4BCR) is as resistant to AGA as the catalase-producing parent strain indicating 
that catalase is not involved in the high inherent AGA-resistance of S. en tom oph ila. 
Furthermore, E. coli HBIOI harboring a plasmid containing the catalase gene (PSEC1) was 
equally as sensitive as HB I 0 I harbouring either no plasmid or a plasmid with an inactive 
catalase gene (pSECI-l), demonstrating that the S. entomophila catalase does not provide a 
heterologous host with any level of AGA-resistance. This data suggests that the antibiotic 
activity of AGA is not dependent on the presence ofH20z. 
Chapter 4 CHARACTERIZATION OF AGA 
AGAred or AP3red 
H 
NADPH""X 
NADP+ox 
Reductaseox 
Reductasered 
yO:;D 
/IAGAOrAP3 
y Cyto,hmme C. 
l~ Cytochrome Cred 
CCNX)~ AGAox or AP30x I .# N";;: .# cc~ f:lX)~ Semiquinone .# . ,.;;: .# free radical N 
NADPH., XAonlY H 
NADP+ox (Yt;I~ ~N~ 
if Cytochrome Cred 
A Cyto,hmme c~ 
. H 
AGAred 
Figure 4.10. Proposed redox reactions of AGA and AP3 during cytochrome C reduction 
AGA or AP3 can reduce cytochrome C when ferredoxin-NADP+ reductase is present (top 
section), whereas only AGA can mediate this reaction in the absence of the enzyme (bottom 
section). All reactive AGA and AP3 derivatives are currently theoretical, and all reactions are 
in equilibrium. 
Table 4.9. Sensitivity of bacteria to AGA in the presence of catalase 
Strain Catalase MIC 1 IOllg.ml-1 
S. entomophila BC4B + 16 0 7 
S. entomophila BC4BCR 16 0 7 
E. coli HB101 0.4 13 22 
E. coliHBI01 [pSECl] + 0.4 13 22 
E. coliHBlOl [pSECl-l] 0.4 13 22 
MIC data was measured for BC4B and estimated for all other strains. Six nun disks containing 
1 or 10 Ilg.ml-1 AGA were placed on standardized lawns of each strain, which were incubated 
at 30°C (8. entomophila strains) or 37 DC (E. coli strains). Clearing zones were measured after 
18 hr, and catalase activity was confirmed by placing a drop of 100 v/v HzOz on the lawn 
surface and observing the vigorous release of O2• 
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Discussion 
Ehl087 produces antibiotic during periods of growth in minimal and rich media, with maximum 
production during entry to stationary phase as illustrated in Figures 4.1 and 4.2. Similarly the 
production of AGA by Ehl087 in planta also correlated with periods of growth (Chapter 2). 
This extends the previous observations of Keams and Hale (1996) who detected antibiotic in the 
supernatants of cultures entering stationary phase. In contrast, many microbes do not produce 
antibiotics in medium supporting rapid growth (Malik, 1979). It has been noted that phenazine 
production in P. phenazinium reduces the maximal population size relative to a non-producing 
mutant derivative, SP2 (Messenger and Turner, 1981). Whereas for SP2 the non-producing 
mutant lost viability more quickly than the phenazine producing strain during stationary phase, 
the opposite is observed for Ehl087. The population decrease of Eh1087 relative to EMAGA 
could be caused by AGA toxicity, or the metabolic burden of producing AGA. Either way, 
once the concentration of AGA drops sufficiently, Ehl087 multiplies again and produces 
antibiotic. This experiment did not demonstrate the point during growth that Ehl087 produces 
the most antibiotic per cell, but it did identify the optimal time to harvest Eh1087 cultures and 
maximize the antibiotic yield for subsequent investigations. 
Antibiotic production by Ehl087 initiates during early-log phase in defined minimal media and 
in mid-log phase in rich media (Fig. 4.2). In contrast, phenazines are usually synthesized after 
exponential phase, and this has been associated with an increase in aromatic amino acid 
synthesis (Byng and Turner, 1975; Turner and Messenger, 1986). It also appears that some 
constituent(s) of rich media causes inhibition of antibiotic production by Ehl087 during early 
exponential phase growth. A comparable situation occurs in coli harbouring the AGA gene 
cluster, although in these strains the effect is far more severe, and AGA production is often not 
detected at all in rich media. These observations agree with ehp gene expression patterns in E. 
coli and Eh 1087 (section 3.7). It is therefore probable that rich media suppression does operate 
in Ehl087, although to a lesser degree than in E. coli, and that Ehl087 possesses a mechanism 
to overcome rich media suppression that is additional to the AGA gene cluster. 
The partial suppression of antibiotic production by Ehl087 grown in nutrient-rich media may be 
caused by aromatic amino acid feedback inhibition of the shikimic acid pathway thereby 
reducing synthesis of the common phenazine precursor, chorismic acid (Carson and Jensen, 
1974; Longely et al., 1972). This hypothesis is supported by the fact that Ehl087 produces less 
antibiotic in the presence of excess tyrosine (data not shown). Such feedback inhibition may act 
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on the first dedicated step in the shikimic acid pathway, catalyzed by 3-deoxy-D-
arabinoheptulosonate-7-phosphate (DAHP) synthase. DAHP synthase repression of aromatic 
amino acids in phenazine producing Pseudomonads has been demonstrated by Jensen et a1. 
(1967) and Levitch (1970) who found that of the aromatic amino acids only tyrosine was 
inhibitory in 16 different phenazine-producing strains, and Byng and Turner (1975) who found 
that only phenylalanine significantly inhibited this enzyme in P. phenazinium. Conversely, the 
PCA operons now characterized in a number of Pseudomonads (see Fig. 3.8) have a putative 
DAHP synthase isozyme, PhzBlPhzE, that may not be susceptible to feedback inhibition by 
aromatic amino acids, although this prediction has yet to be tested empirically. The lack of a 
potential homologue of DAHP synthase in the AGA gene cluster could explain why tyrosine 
inhibits AGA production in Eh1 087. 
The chemical structure of the antibiotic produced by Ehl087 
The antibiotic produced by Eh1087 was extracted from culture supernatant to chloroform in 
much the same way as phenazine antibiotics are initially purified from other organisms (Byng 
and Turner, 1976; Chang and Blackwood, 1969; Gerber, 1969; Imamura et a1., 1997). 
Extraction procedures are usually based on a protocol developed by Chang and Blackwood 
(1969) in which the culture supernatant is acidified prior to chloroform extraction. This process 
is suitable for the extraction of most phenazines, however the antibiotic produced by Ehl087 
does not partition to chloroform from acidified culture supernatant (Fig. 4.3). An acid-
extraction step was found to be useful however, as many other compounds that co-partition 
from Ehl087 culture supernatant to chloroform are insoluble at low pH, conditions in which the 
Eh1087 antibiotic is soluble and loses activity at a slow rate. This information led to the 
development of a simple antibiotic purification process as outlined in Section 4.2. In fact, 
antibiotic purified by this method was usually suitable for NMR analysis. Further purification 
of the Eh1087 antibiotic by filtration chromatography yielded antibiotic with no detectable 
contaminants that was suitable for structural elucidation and quantification. 
The antibiotic produced by Eh1087 was determined to be the phenazine compound l-carboxy-6-
D-alanyl-9-methoxy-phenazine (D-alanylgriseoluteic acid (AGA), 4.6). An extensive 
screen of the literature indicates that phenazine compounds have not been isolated from the 
Erwinia (Pan toea) genus before, and that AGA has only been isolated on one previous 
occasion, from a species of marine Vibrio, SANK 73794 (Sato et al., 1995). Therefore, to the 
authors lmowledge this is the first report describing the isolation of the phenazine compound 
AGA from a terrestrial organism. Similar compounds, containing 3-hydroxyvalyl (HVGA), 
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valy1 (VGA), or glycyl (GGA) esters in the same position as the D-a1any1 ester in AGA, have 
recently been described (Imamura et al., 1997; Sato et al., 1995; Singh et a1., 1997). These 
antibiotics were given the common name Pelagiomycin A, B, or C respectively, due to their 
isolation from another marine bacterium, Pelagiobacter variabilis (Imamura et a1., 1997). The 
pelagiomycins and a11 analogues containing an amino acid ester-bound to the 6-hydroxymethyl 
group of griseo1uteic acid (see Fig. 4.6), are protected by Japanese patent Toku-Kai-Hei 9-
48764 (18 February 1997) held by Nobutaka Imamura, Hiroshi Sano, and Takahide Takadera 
(see Imamura et al., 1997), of the Marine Biotechnology Institute, Shimizu Laboratories, Japan. 
This patent specifically excludes HVGA, presumably because it was described in the literature 
near to the time that the patent was lodged (Singh et a1., 1997). Curiously, the patent does not 
specifically exclude AGA, however since this compound was described in the literature prior to 
patent application (Sato et a1., 1995), it is unlikely that AGA is subject to patent protection. 
AGA is unstable in water or alcohol and degrades to a red, non-polar compound, determined to 
be 1-carboxy-6-hydroxymethyl-9-methoxy-phenazine (griseoluteic acid, GA). GA is therefore 
the fITst known phenazine compound to be isolated from an Erwinia (Pantoea) species, and it 
arises from the loss of the D-alanine residue from AGA (Fig. 4.6). GA was also isolated from 
bacteria producing griseoluteins and pelagiomycins, suggesting that this reaction is common to 
other GA-derived compounds (Imamura et a1., 1997; Sato et a1., 1995; Singh et a1., 1997). GA 
was original1y isolated from Streptomyces griseoluteus as a breakdown product of griseo1uteins 
A and B (Nakamura, 1958). Griseo1utein A has a glycolic acid moiety at the 6-hydroxymethyl 
group of GA, which is thought to be hydrogenated to create griseolutein B (yagishita, 1960). 
Both compounds are easily hydrolyzed to reform GA. Because GA has very low antibacterial 
activity relative to the griseo1uteins, the modifications at the 6-hydroxymethyl group were 
considered important for antibiotic activity (Yagishita, 1960). This prediction has been 
strengthened by similar findings with more recently discovered GA derivatives modified at the 
same position, such as AGA (this study; Sato et al., 1995), HVGA (Imamura et a1., 1997; Singh 
et a1., 1997), and glycylgriseo1uteic acid (Sato et a1., 1995). In particular, to account for the 
higher antibiotic activity of HVGA relative to griseoluteic acid, both isolated from culture LL-
141352, Singh et al. (1997) proposed that the amino acid residue facilitated the transport of the 
antibiotic across the cytoplasmic membrane. The amino acid group may enable these GA-
derivatives to be taken up by transporters similar to the non-specific di- and tripeptide 
transporters that are present in bacteria and higher organisms. For instance, PEPTI is the model 
peptide transporter found in the mammalian intestine that has affinity for compounds with 
amino-terminal and carboxyl-terminal groups separated by 500-650 pm or the approximate 
equivalent of four CH2 units (Doring et aL, 1998). Doring et al (1998) proposed that one 
Chapter 4 CHARACTERIZATION OF AGA 125 
charged group is sufficient for anchoring and that a second oppositely charged group is required 
for transport by PEPTl. Phenazines may be too long to be taken up by this transporter, however 
the same principle could apply to other non-specific transporters and offer a mechanism to 
differentiate between GA, which has only a single charged carboxyl group, and the amino acid 
substituted derivatives. Furthermore, the ubiquity of these transporters would provide an 
explanation for the broad spectrum of organisms that are susceptible to the GA-derived 
antibiotics. These propositions could be tested by assessing the sensitivity of different transport 
mutants to the GA-derivative antibiotics that have been recently described. 
Properties of the AGA intermediates provide clues about the AGA biosynthetic pathway 
The coloured AGA precursors could be differentiated from each other and from AGA by their 
differential partitioning between chloroform and culture supernatants at acid or neutral pH. The 
first AGA phenazine precursor, API, only extracts to chloroform from acidified supernatant 
medium. The second precursor AP2, does not extract to chloroform at neutral pH and 
precipitates out of solution at low pH, while the third AGA precursor, AP3, is insoluble at low 
pH but does extract to chloroform at neutral pH. These data demonstrate the varied chemical 
properties of each of the AGA intermediates and can be used with other data such as colour, 
solubility, and absorbance maxima, to estimate the type of phenazine present at each stage of 
AGA synthesis even though the chemical structures of these intermediates are not yet 1rnown 
(Fig. 4.7). For instance, API has similar properties to PCA, and AP3 has similar properties to 
GA. The minor additions to the phenazine nucleus predicted for API, and the more substantial 
modifications predicted for AP3 agree well with the proposed anabolic nature of the gene 
products responsible for the intervening modifications. The properties of AP2 were less well 
defined because this compound did not extract to chloroform for similar analyses. 
Antibiotic activity and cytotoxicity of GA-derived antibiotics 
The potency of AGA purified from a culture of Eh1087 against a range of Gram+ and Gram-
organisms is shovm in Table 4.4. Sato et al. (1995) reported that AGA purified by a different 
method from a different bacterium (Vibrio SANK 73794) had similar activity and inactivity 
against S. aureus and P. aeruginosa, respectively. They also showed that the MIC of AGA and 
GGA against a range of organisms were generally the same or varied only slightly. Imamura et 
al. (1997) found that HVGA was less active against S. aureus and more active against P. 
aeruginosa, but was inactive against the yeast Candida albicans, as observed for AGA in this 
study. In contrast, Singh et al (1997) reported that HVGA was only weakly active (MIC> 16 
flg.mr 1) against five unspecified Gram- isolates. Only AGA purified from Ehl087 has been 
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tested against anaerobic organisms, however it is likely that all GA-derived antibiotics have a 
similar mode of action, and therefore all would be similarly active against obligate anaerobes. 
Additionally, another phenazine antibiotic, pyocyanin, is active both aerobically and 
anaerobically (Baron and Rowe, 1981). ill summary, all GA-derived antibiotics that have been 
reported possess a range of antibiotic activities against bacterial isolates, and this activity varies 
with respect to the susceptibility levels of these isolates. However, given the variation in 
reported potency for HVGA, these data should be considered tentative until all compounds are 
tested against the same isolates under the same conditions. 
As with many other phenazine compounds the GA-derived antibiotics are cytotoxic. HVGA 
showed strong cytotoxic activity against HeLa, BALB373 and BALB3T3/H-ras cell lines (0.04-
0.2 J.lg.mr1), and weak but unspecified activity against the murine P388 leukemia cell line in 
vivo (Imamura et al., 1997). Singh et al (1997) tested HVGA against another five different 
tumor cell lines and found it to be less active than Imamura et al (1997), reporting LDso values 
of 0.12 to 0.7 J.lg.mr!, but also noted that a normal endothelial cell line was less sensitive (LDso 
= 2.7 J.lg.mr l ). They also reported that HVGA concentrations up to 8 mg.kg,l were inactive 
against a P388 murine leukemia model. In contrast, AGA purified from Eh1087 showed some 
activity in an in vitro test against the P388 cell line, (IDso 0.43 J.lg.ml'l), and therefore further 
cytotoxic tests with AGA may be warranted (Y. Feng, pers. comm.). Unfortunately the 
therapeutic use of these compounds as anticancer agents may be limited by their relatively high 
acute toxicity, which is a measure of the dose sufficient to kill a mouse (LDlOo). Singh et al. 
(1997) reported an LDlOo value of 16 mg.kg'! for HVGA, and Sato et al. (1995) reported the 
LDlOo of GGA as less than 12.5 mg. kg'! , but provided no data for AGA. The efficacy of these 
compounds in vivo is also questionable, as 8 mg.kg'] HGV A did not protect mice against a 
lethal infection of S. aureus. illterestingly, most published data relates to HVGA, which is not 
protected by patent. Given that the potency of different GA-derived antibiotics varies between 
different bacterial isolates and between different cell lines, it is possible that other GA-
derivatives such as AGA may be therapeutically useful. 
Properties of AGA that are involved in antibiotic activity 
The targets of most antibiotics produced by E. herbicola strains are potentially easy to detect 
because the antibiotic activity is inhibited by the presence of amino acids (EI-Goorani and Beer, 
1991; Ishimaru et aI., 1988; Vanneste et al., 1992; Wodzinski et al., 1990; Wodzinski and 
Paulin, 1994). ill contrast, the target of AGA is more difficult to determine as it is not inhibited 
by essential amino acids (Kearns and Hale, 1996), although this has not been reassessed with 
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purified AGA. Since little data regarding the mode of action of GA-derived antibiotics have 
been published, a number of general properties of AGA were investigated with the intention of 
determining the mode of action by which AGA kills a target organism. 
Previously, it has been demonstrated that the phenazines PCA, PCN, pyocyanin, iodinin and 
myxin, among others, bind DNA (Hollstein and Van Gernert, 1971). This led to the proposition 
that at least part of the antibiotic activity of phenazine antibiotics was caused by DNA 
intercalation, which would result in the inhibition of RNA synthesis and presumably the 
inhibition of DNA replication. It was subsequently proposed that myxin inhibits DNA synthesis 
and causes breaks in single stranded DNA, eventually leading to general DNA degradation and 
cell death (Behki and Lesley, 1972). Behki and Lesley (1972) also found that myxin-induced 
DNA damage was incurred far more quickly if protein synthesis was inhibited by 
chloramphenicol, and proposed that the DNA damage is normally repaired by a repair 'enzyme' 
that is not expressed when protein translation is inhibited by chloramphenicol. The antibiotic 
griseolutein, which is structurally very similar to AGA, was shown to inhibit DNA replication, 
but not to affect the stability of synthesized DNA or the synthesis of RNA or protein molecules 
(Hori et a1., 1978). The DNA repair 'enzyme' hypothesis of Behki and Lesley (1972) is still 
valid, as it is now well established that the inhibition of DNA replication at damage-induced 
lesions leaves gaps of ssDNA, which induce an SOS regulon comprised of numerous genes 
involved in repairing DNA and restoring cell health (Sassanfar and Roberts, 1990; Walker, 
1984). DNA damage is quickly recognized by RecA, which associates with ssDNA and 
enhances the cleavage of the SOS regulon repressor, LexA. One member of the SOS regulon, 
SuIA, interacts with FtsZ and prevents formation of the FtsZ ring to inhibit cell division and 
provide a damaged cell with time and resources to mend (Bi and Lutkenhaus, 1993). In support 
of the DNA intercalation model for phenazine antibiotic activity, AGA caused the recA-
dependent induction of sulA expression in E. coli (Fig. 4.8). On this basis it is likely that AGA 
induces an SOS response, although the induction of further SOS-response genes would 
strengthen this claim. Also in support of this model was the finding that recA strains of E. coli 
are slightly more sensitive to AGA than isogenic recA+ strains. In comparison, the sensitivity 
of recA - strains to agents that specifically act to damage DNA, such as 4-nitroquinoline-l-oxide 
or mitomycin C, is far greater than isogenic recA+ strains; the relative difference in sensitivity 
can be used to isolate recA genes based on the complementation of recA mutants for resistance 
to these compounds (K.eener et a1., 1984) (see also section 3). Thus, because recA+ strains are 
still relatively sensitive to AGA it is likely that DNA damage is not the primary antibiotic 
activity of this compound. Furthermore, because the SOS response is induced by generalized 
DNA damage it does not demonstrate the target of AGA or the processes by which AGA 
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generates DNA damage. Since any property of AGA that contributes to antibiotic activity 
warrants investigation and to obtain further information about the specific effect(s) of AGA on 
DNA, experiments were carried out to determine if AGA is mutagenic. 
It has been demonstrated that many, but not all phenazines are mutagenic (Watanabe et al., 
1989). In the course of general experimental work it was observed that AGA increased the 
frequency of rifampicin-resistant E. coli. Further testing demonstrated that the frequency of R:f 
consistently increased ca. 30 fold in the presence of AGA (data not shown). The mutagenic 
property of azide was discovered by the similarly fortuitous observation that it increased the 
frequency of penicillin- and streptomycin-resistant mutants in Staphylococcus aureus 
(rccounted by Owais and K1einhofs, 1988). Subsequently, AGA was shown to be weakly 
mutagenic, causing G:C-j>A:T transitions at 5-10 times background. The weak mutagenicity of 
AGA could be due in part to the position ofphenazine ring substitutions at carbons 1,6, and 9 
(Fig. 4.6), because Watanabe et al (1989) found that only phenazines substituted at positions 2 
and 7 are extremely mutagenic. AP3 was not mutagenic, indicating that without antibiotic 
activity these compounds are not mutagenic. However, the frequency of mutation caused by 
expsure to AGA was very low. Thus, both D~ damage and the associated mutagenesis are 
unlikely to make a major contribution to the mechanism by which AGA causes cell death. 
The lack of direct DNA mutagenesis by AGA in vitro suggests that the process is indirect and 
requires one or more cell components. As discussed below, the mutagenic property of AGA 
may need to be 'activated' by the donation of an electron from a redox-active compound such as 
NAD(P)H. To compare the mutagenic activity of AGA in vitro with activity in vivo, E. coli 
cells harboring pUC19 could be SUbjected to antibiotic treatment and assessed for mutation. If 
pUC19 mutations do arise under in vivo conditions, it is anticipated that in vitro experimental 
conditions could be modified by the addition of cell lysate to determine whether cell metabolism 
or certain cell component(s) are required for mutagenesis resulting from AGA exposure. It may 
also be possible to show this under in vivo conditions by treating E. coli cells harboring pUC19 
with bacteriostatic antibiotics that inhibit various cell functions, such as the expression of redox-
cycling enzymes. 
Does mutagenicity have any role in the antibiotic activity of AGA? Even if the mutagenic 
effect of AGA is an indirect resu1t of the reactions that occur when a cell is exposed to AGA, it 
may influence the efficacy of AGA. An example of a defined G:C-j>A:T transition is the 
chemical modification of cytosine by nitrous acid. Nitrous acid converts cytosine to uracil by 
oxidative deamination and uracil then pairs with adenine rather than guanine during the 
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subsequent DNA replication round. Under 'normal' intracellular conditions when a catalyst like 
nitrous acid is not available, the oxidative deamination of cytosine occurs at a low background 
rate and the resulting uracil moieties are removed in E. coli and many other organisms by uracil-
DNA-glycosylase (Dunean and Miller, 1980; Dunean et at, 1978; Duncan and Weiss, 1982). 
Thus, if the G:C-1>A:T transition induced by exposure to AGA is involved in antibiotie activity, 
an E. coli uracil-DNA-glycosylase mutant (ung-) should be hypersensitive to AGA due to an 
inability to remove uracil bases from its genome. Alternatively the induction of uracil DNA 
glycosylase activity by AGA could be assessed directly (O'Grady, 2000). Given that recA 
mutants are marginally more sensitive to AGA than recA+ isogenic strains, it could be useful to 
further test the relationship between mutagenesis and antibiotic activity by comparing the AGA-
sensitivity of a range of DNA-damage repair mutants. The correlation between the oxidative 
deamination of uracil by nitrous acid and the weak G:C-1>A:T transition mutagenesis involving 
AGA was strengthened by the next series of experiments, which demonstrate that AGA is redox 
active. 
Assuming that the mutagenic activity of AGA is insufficient for bacterial ldlling, what is the 
property of AGA that gives it antibiotic activity? The phenazine nucleus in AGA has two 
nitrogen that can be reduced (resulting in a semiquinone free radical, Figure 4.11) and could 
therefore potentially interfere in the electron transport chain (Crawford et aI., 1986). It has been 
proposed that pyocyanin is directly reduced by NADH, producing a pyocyanin radical that 
diverts the normal electron flow in E. coli to generate toxic O2 and H20 2 species (Hassan and 
Fridovich, 1980). Baron and Rowe (1981) demonstrated that pyocyanin was toxic in the 
absence of oxygen, and suggested that pyocyanin has sufficient redox potential to compete for 
electrons at several points in the electron transport chain itself. They also hypothesized that the 
antibiotic activity of pyocyanin could simply arise from the interruption of the electron 
transport chain. To compare the activity of AGA with these findings and to see if antibiotic 
activity correlated with redox activity, AGA and the non-toxic precursor AP3 were assessed for 
redox activity. 
AGA and AP3 are redox active. Both were capable of mediating the oxidation of hemoglobin, 
however because this reaction required a high concentration of AGA and AP3 and took place 
over a number of hours it is unlikely to be a primary factor in antibiotic activity. Conversely, 
the reduction of cytochrome C in the presence ofNADPH and ferredoxin NADH reductase was 
far more rapid, suggesting that the redox activity of AGA could be involved in antibiotic 
activity. NAD(P)H cannot directly reduce cytochrome C, but in reactions similar to those 
reported here, it was shown to reduce phenazine methosulphate (PMS), which can then reduce 
Chapter 4 CHARACTERIZATION OF AGA 130 
cytochrome C rapidly (Picker and Fridovich, 1984). Superoxide was not detected in this 
reaction, presumably due to the direct activity of PMS on cytochrome C, and possibly also 
because phenazines such as PMS and 1-hydroxyphenazine can scavenge superoxide (Muller, 
1995; Picker and Fridovich, 1984). The rate of cytochrome C reduction by AGA or AP3 is also 
not greatly affected by the removal of superoxide, probably for the same reasons. In contrast to 
PMS, when ferredoxin NADH reductase is absent the rate of cytochrome C reduction by AGA 
is considerably reduced and is almost non-existent for AP3. The reductase presumably mediates 
the redox activity between NADPH and AGA or AP3. Thus, the redox potentials of PMS, 
AGA, and AP3 are all different. Determination of the redox potentials of AGA and 
intermediate compounds would be interesting given that phenazines with more positive 
reduction potentials are reported as having the highest antibiotic potency (Crawford et al., 
1986). 
How is the redox activity of AGA involved in antibiotic activity given that both AGA and AP3 
can reduce cytochrome C under suitable conditions? Two explanations, not necessarily 
exclusive, are apparent. The first has alre<fdy been discussed; that the D-alanine group of AGA 
enables this compound to be taken up by a susceptible cell to react at some undefined site, 
whereas AP3 possesses similar reactivity but cannot access the target. Alternatively, the 
proposed difference in redox potential between AGA and AP3 may be sufficient to account for 
the toxic and non-toxic properties of these closely-related phenazine derivatives. For instance, 
phenazine methosulphate has a standard reduction potential (Eb) of +0.08 V and is able to 
accept electrons from cytochrome B (Eb = +0.07 V) but not from cytochrome C (Eb +0.25 V). 
The ability of AGA to spontaneously oxidize NADPH but not cytochrome C indicates that 
AGA could accept electrons from one or more of the electron carriers between NADPH and 
cytochrome C in the electron transport chain, this diversion of electrons would interrupt the 
respiration chain, and compromise the cells ability to generate energy. In contrast, AP3 appears 
to be a weaker oxidant than AGA and cannot spontaneously draw electrons from NADPH, 
which has the lowest Eb (-0.032 V) and is therefore the strongest reductant of all the respiratory-
chain electron carriers. This finding suggests that AP3 would not interrupt the electron 
transport chain unless a suitable intermediate such as a redox cycling oxidoreductase was 
present. It is on this point that the former hypothesis is again invoked. Reductases are present 
in living organisms, and are even required for the activation of some redox active antibiotics 
such as metronidazole (Tally et a1., 1981). Metronidazole resistance in Helicobacter pylori 
arises from the mutation or reduced expression of two genes encoding nitroreductases (Jeong et 
al., 2001; Sisson et al., 2000). In an analogous situation oxidoreductases present in a target 
organism could meditate the antibiotic activity of AGA and AP3 via redox activation as 
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illustrated in Figure 4.10. Thus, it is likely that within a cell both AGA and AP3 would be able 
to draw electrons out of the respiration chain, however it is proposed that AP3 cannot enter a 
cell to take part in such reactions. 
Assuming that redox activity is an important aspect of the antibiotic activity of AGA, what 
types of reactive species are involved in the process? At least two possibilities exist. The first 
possibility, that AGA can interfere with normal electron transfer processes has been discussed. 
A second possibility is that AGA could abstract an electron from a substrate such as an 
oxidoreductase to become reduced; the resulting cation could be resonance stabilized due to the 
conjugated nature of the phenazine nucleus and subsequently donate electrons to an acceptor 
such as oxygen to create toxic reactive oxygen species. However, because obligate anaerobes 
are highly sensitive to AGA it is clear that the generation of reactive oxygen species is not 
absolutely necessary for antibiotic activity. Additionally, catalase significantly reduced the 
oxidation of hemoglobin but not the reduction of cytochrome C by AGA, thus it appears that at 
least two different reactions are possible (Table 4.8). Not only is the oxidation of hemoglobin 
by AGA slow, but a potent catalase from S. entomophila did not provide any detectable degree 
of resistance against AGA for S. entomophila or E. coli, suggesting that the antibiotic activity of 
AGA does not involve H20 2• Superoxide did not appear to significantly alter the rate of 
cytochrome C reduction, and this has been observed elsewhere for phenazine methosulphate 
(Picker and Fridovich, 1984). In agreement with this, Davis et al (1983) detected superoxide in 
a system involving NADH reduction of pyocyanin but not phenazine methosulphate. This 
demonstrates that the generation of reactive oxygen species varies for different phenazines and 
that superoxide cannot be discounted as a factor in the antibiotic activity of AGA until it has 
been assessed. 
To further assess the influence of reactive oxidative compounds in the antibiotic activity of 
AGA, the suppression of antibiotic activity by antioxidant compounds could be measured (this 
could be carried out inE. coli strain DE880 which carries a sulA::lacZ fusion and responds with 
great sensitivity to antibiotic aCtivity). For instance, hemoglobin oxidation by 
acetylphenylhydrazine is almost completely inhibited by the antioxidant ascorbate 
(Winterboum, 1985). Alternatively, the generation of oxygen radicals by AGA could be 
detected and measured using genetic means, In E. coli, the induction of specific regulons in 
response to hydrogen peroxide (oxyR,;;:: eight genes) and superoxide (;ioxRS,;;:: 15 genes), can be 
detected and measured via the expression of lacZ gene fusions to promoters from different 
oxidative-stress induced genes (Gaudu et aL, 2000; Kogoma et a1., 1988; Michan et aL, 1999). 
Interestingly, the soxRS regulon includes nftA, which encodes an oxygen-insensitive 
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nitroreductase, and fpr, which encodes NADPH ferredoxin reductase, both with potential to 
increase the activity of AGA (Bianchi et al., 1993; Liochev et al., 1994; Paterson et al., 2002). 
ill the presence of oxygen the production of even small amounts of superoxide may lead to the 
reduction of AGA, which could then react with a member of the electron transport chain. 
All of the current physicochemical data on AGA suggests that it has a similar antibiotic mode of 
action to that proposed for pyocyanine by Baron and Rowe (1982) who hypothesized that the 
'compound' diverts electron flow at some specific point in the respiratory chain, bypassing 
several necessary carriers and starving the cell of energy. Since AGA is only weakly mutagenic 
and it is active in the absence of oxygen, mutagenesis and the generation of reactive oxygen 
species probably have only minor roles in the potency of AGA. Thus, direct interaction with the 
electron transport chain is likely to be a more important factor. The prediction of possible 
targets from which AGA could divert electrons will require determination of its standard 
reduction potential. 
Chapter 5 SUMMARY AND FUTURE DIRECTIONS 133 
Chapter 5. SUMMARY AND FUTURE DIRECTIONS 
The occurrence of Fire Blight in New Zealand is lower than predicted by established disease 
forecast systems (Thomson and Hale, 1987). To account for the low incidence of discase it was 
proposed that the causative agent of Fire Blight, E. amylovora, was suppressed in New Zealand 
orchards due to competition with other organisms. On this basis, the current research program 
was initiated by Drs Khris Mahanty, Leah Keams and Chris Hale, and led to the isolation of a 
potent suppressor of amylovora, Erwinia herbicola strain Eh1087 from an apple orchard in 
Canterbury, New Zealand (Keams 1993, Keams and Hale, 1995). The production of antibiotic 
by Eh1087 was found to be important for disease suppression in an immature pear fruit assay 
and led to preliminary investigations into the genetic basis of antibiotic production by Ehl087 
and characterization of the antibiotic. These preliminary data provided the basis for the present 
study, an in-depth investigation into the molecular genetics of antibiotic production by Eh 1087. 
Research Summary 
ill this dissertation three key research areas on antibiotic production by Ehl087 have becn the 
advanced: i) the significance of antibiotic production in planta has been established, ii) a cluster 
of genes sufficient for antibiotic production has been substantially characterized, and iii) the 
chemical structure of the antibiotic has been determined and its mode of action is at least 
partially understood. Each of these areas has been presented as separate sections of research, 
however it is worth noting that these research areas were earned out concurrently. This has 
relevance to the evolution of the present investigation, for instance, results from molecular 
genetic experiments often provided the rationale and influenced the design of experiments to 
characterize the antibiotic produced by Ehl087 and vice versa. Thus, there are frequent cross-
citations from one chapter to the next. The integration of various scientific disciplines was 
essential since the results from different research areas are complementary and synergistic. 
Perhaps most importantly, relationships between antibiotic structure and putative gene functions 
led to a number of testable predictions - a prerequisite for continued investigation of antibiotic 
biosynthesis by Eh1087. 
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The biological significance of antibiotic production 
So what were the most significant findings of the present investigation? The present study 
demonstrates for the first time that the inhibition of E. amylovora by Ehl087 holds true in the 
real world - the stigma of blossoms where E. amylovora and antagonists compete for space and 
nutrients. Because the multiplication of E. amylovora on stigma is required for the development 
of a population sufficient for plant infection, the inhibition of stigma colonization is a potent 
mechanism for biological control. The significance of antibiotic production in amylovora 
suppression in planta and the novel structure of the antibiotic produced by Ehl087 indicates that 
this bacterium is an excellent biological control candidate that warrants further investigation and 
development, particularly for use as part of a microbial consortia of biological control strains 
with different suppression mechanisms. 
The AGA gene cluster: current knowledge and future possibilities 
A major goal of the current study was to characterize all the genes required for antibiotic 
syrithesis. A 15 kbp section of DNA was shown to be sufficient for AGA production by a 
heterologous host and became the major focus of the present study. Sixteen genes were 
characterized from within this region and each was shown to have a role in either antibiotic 
biosynthesis or resistance. Genes were grouped according to their involvement in the synthesis 
of a coloured intermediate. These assignments were useful for elucidating the role of each gene 
in the biosynthesis of antibiotic. Strong evidence suggests that the Group 1 gene products are 
involved in the synthesis of a phenazine nucleus, similar to the phenazine-l-carboylic acid 
(peA) operon found in some fluorescent Pseudomonads. It would be interesting to see whether 
Ehl087 mutants missing a Group 1 gene can produce AGA when transformed by a plasmid 
encoding genes for the synthesis of peA, and vice versa. This is the first time that genes for 
synthesis of the phenazine nucleus have been described for a non-Pseudomonad, and the first 
time that Groups of genes have been described that are required for modification of the 
phenazine nucleus. These modifications appear to involve the step-wise conversion of the 
phenazine nucleus (API) to a red intermediate, AP2, which is modified and transported across 
the inner membrane, where the periplasmic (or extracellular) AP3 is finally converted to AGA 
by addition of a D-alanyl moiety (Fig 5.1). In Pseudomonas spp. the products of different 
single genes are involved in the modification of peA to a variety of phenazines. Such genes 
may provide a useful resource for genetic manipulation of Ehl087 to produce different 
phenazine antibiotics and enhance the biological control capabilities of this strain, either against 
E. amylovora or against other pests such as fungi that Ehl087 cannot currently suppress. Since 
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orchard spray regimes often include antifungal sprays, an antibacterial and antifungal strain of 
Ehl087 could be of great utility to the orchardist (Keams, 1993). 
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Figure 5.1. Summary model of antibiotic p~oduction by Eh1087 
Overall model of the data and predictions arising from the present study. ehp genes are shown 
in boxes with heavy black arrows depicting significant transcripts required for antibiotic 
production. The reactions are given below the groups of genes required for each antibiotic 
synthesis step. Each modification is predicted to occur in the cytoplasm (Cyt.), across the inner 
membrane (lM) or in the periplasm I outer membrane (Peri.). The chemical structure of API is 
unknown but it has similar characteristics as PCA or PDC (shown); the structure of AP2 is 
unknown; the structure of AP3 is unlmown but is likely to be similar to GA (shown) as both 
can be converted into AGA by the Group 4 gene products; the stmcture of AGA is known. 
As a resource, the collection of ehp mutants will be invaluable for further elucidation of the 
antibiotic biosynthetic pathway. Comparison of the structures of intermediates purified from 
each mutant would categorically demonstrate the role of each gene product in the synthesis of 
AGA. Since many proteins with similar sequence to the predicted Ehp proteins are themselves 
predicted by sequence similarity, these experiments would provide empirical data to strengthen 
the predictive power of the sequence databases and thereby benefit research proj ects not directly 
related to this one. 
Information about the regulation of the AGA gene cluster is of great use in the manipulation of 
Ehl087 to enhance antibiotic production or to increase the range of conditions in which Ehl087 
can produce antibiotic. E. coli harbouring the AGA gene cluster produce far less antibiotic than 
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Eh1087. Additionally, expression of the gene cluster during entry to stationary phase decreases 
in Eh1087 but not coli. Thus, it is hypothesized that Eh1087 has a positive inducer of 
antibiotic production during periods of growth that is not present in E. coli, and this inducer 
does not function in stationary phase. Whatever the reason for the expression differences 
between E. coli and Ehl087 the mechanism(s) behind it could provide a good target for genetic 
manipulation. The manipulation of Eh1087 to produce antibiotic during periods of no or low 
growth would potentially enhance the ability of Eh1087 to compete against E. amylovora that 
have already colonized a stigma. This is a feature that all current Fire Blight biological control 
strains lack. In contrast to E. coli, the AGA gene cluster conferred on another herbicola 
strain the ability to produce nearly as much antibiotic as Eh1087. Thus, the expression of the 
gene cluster appears to be better in E. herbicola than in E. coli, perhaps due to general 
expression differences such as promoter recognition. The possibility that the gene cluster is 
well expressed in E. herbicola and that fact that AGA has different characteristics to antibiotics 
produced by other E. herbicola strains, means that the AGA gene cluster is potentially a good 
tool for the use in the development of potent new biological control strains. Given that the gene 
cluster may be horizontally mobile as discussed below it would be best to develop a system to 
'immobilize' the AGA gene cluster as far as possible on the chromosome of the new host strain. 
EhC9-1 is a good candidate for transformation with the AGA gene cluster, as it is currently 
undergoing licensing for use as a biological control agent. 
Origin of the AGA gene cluster 
Two interesting questions arise regarding the mobility and origin of the AGA gene cluster. It 
would be very difficult to design experiments to determine the origin of the AGA gene cluster, 
although this may become apparent as more phenazine antibiotic gene clusters are discovered. 
In contrast, it is possible to test the hypothesis that the gene cluster is a horizontally mobile 
element. Two pieces of evidence suggest that this may be the case; firstly, it is located on a 
large plasmid, and secondly, it is bordered by putative transposase / integrase genes. The 
stability of the AGA gene cluster in Eh1087 is an important consideration for the use of this 
strain as a biological control agent. It is therefore essential that the mobility of the AGA gene 
cluster between organisms is assessed. If transfer does occur, it would be useful to measure the 
transfer frequencies in different environments and to investigate the mechanisms involved. 
Future studies should focus on assessing the possibility of horizontal transfer from Eh1087 to E. 
amylovora, however many other saprophytic bacteria could potentially act as transfer mediators 
and should also be assessed. 
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Purification, structure, and properties of the antibiotic produced by Ehl087 
Chapter 4 presents data relating to the properties of the antibiotic produced by Ehl 087. Initially, 
media conditions and growth phase were assessed for optimization of antibiotic yield. 
Subsequently, a three stage antibiotic purification process was developed that enabled the 
chemical structure of the antibiotic to be determined. The antibiotic produced by Ehl087 was 
found to be a phenazine compound, D-alanylgriseoluteic acid (AGA). AGA was found to kill a 
wide range of Gram+ and Gram- bacteria, although some species demonstrated inherent 
resistance or tolerance. The results conclude with preliminary investigations into the mode of 
action of AGA which revealed that it has bacteriocidal activity, generates an SOS response in 
susceptible bacteria, is weakly mutagenic in vivo, and has redox activity. It was speCUlated that 
the redox potential of AGA would enable it to divert electrons from the electron transport chain 
and inhibit the ability of a cell to generate energy, whilst comparison with AP3 suggested that 
D-alanine is required for antibiotic uptake by a susceptible cell. Further investigations into the 
mode of action of AGA should test its ability to interfere with the electron transport chain. 
Determination of the standard reduction p~tential of AGA would provide clues as to whether or 
not this is likely to occur. Additionally, measurement of the change in redox state of the 
electron transport chain intermediates in the presence of AGA would show which electron 
carrieres), if any, can be reduced by AGA and hence the point at which AGA diverts electrons 
and prevents a cell from generating energy. Similar studies with AP3 would support or refute 
the hypothesis that the lack of antibiotic activity of this compound is the result of properties 
other than redox potential, properties that may, for instance, affect uptake by otherwise 
susceptible cells. The use of defined E. coli mutants would be useful to assess the influence of 
other AGA properties such as mutagenicity, the generation of oxidative species, and even AGA 
uptake by transport mechanisms. Since AGA is weakly mutagenic and could potentially 
generate free radicals, the phytotoxicity of Ehl087 in planta should be also assessed. In 
particular, it is important that blossoms inoculated with Eh1087 are not affected in their ability 
to produce normal fruit. 
The research presented in this dissertation provides fundamental information about the genetic 
basis for antibiotic production in Ehl 087, and in doing this opens up a number of interesting 
research areas. Notably, the origin of the gene cluster has wide implications for the evolution of 
organisms in general. In addition, the present study has provided the tools and necessary 
information for manipulation of the gene cluster to test hypotheses on gene function and 
regulation, to create new biological control strains, and potentially even new antibiotics. 
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ApPENDICES 
At. General Materials and Methods 
ALl. Bacteriological methods. 
The bacterial strains and plasmids used in this study are described in Table AI. coli strains 
were routinely grown at 37°C, and E. herbicola and amylovora at 30°C, Bacteria were 
cultured in Luria-Bertani (LB) medium or I-A minimal medium with 0.2% glucose as 
described (Miller, 1972). Antibiotics, 5-bromo-4-chloro-3-indolyl phosphate (XP), and 5-
bromo-4-chloro-3-indoyl-~-D-galactopyranoside (Xg), were obtained from Sigma Chemical 
Co. (St. Louis, Mo.) and were used at the following concentrations: ampicillin (Ap), 100 
Ilg.mr1; chloramphenicol (Cm), 30 Ilg.mn; gentamicin (Grn), 30 Ilg.mr1; kanamycin (Krn), 
50 Ilg.mr1; rifampicin (Rf), 50 Ilg.mr1; streptomycin (Sm), 50 Ilg.mr1; tetracycline (Tc), 15 
Ilg.mr1; XP and Xg, 25 Ilg.mr1. Enzymes for DNA manipulation were purchased fr'om BRL 
and used according to the manufacturers instructions. ~-galactosidase activity of whole cells 
was detern1ined as described previously (Miller, 1972). Viable cell counts were carried out by 
serially diluting bacterial cultures either in microtitre dishes (100 III per well) or in eppendorf 
tubes (1 ml per tube). 
Al.2. Antibiotic activity assays 
Antibiotic activity was routinely assayed on a lawn of Erwinia amylovora strain Ea8862 as 
follows. LB or I-A minimal medium (supplemented with niacin (Sigma) to 50 Ilg.mr1) agar 
plates were overlaid with 2 rn1 of 0.75 % 1-A or LB agar containing 20 III of an overnight LB 
broth culture of Ea8862. Strains to be tested for antibiotic activity were placed directly on the 
lawn ofEa8862, whereas test compounds were dried onto 6 rnrn 4> antibiotic disks (Schleicher 
& Schuell) which were placed on the lawn. Activity was assessed as zones of Ea8862 
inhibition after overnight incubation at 30°C, 
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Table AI. Bacterial strains and plasmids 
Strain or plasmid 
E. coli 
DE880 
DE894 
Ea8862 
Eh1087 
EhehpA-EhehpO 
EMAGA 
HB101 
bMC4100 
P678-54 
Relevant Genotype or description 
HfrH fi(lac-argF)U169 relAl thi-l cps-3 malF55::Tn5 
sulA::Mu d(lac Ap) XCam (Mu+) srlC300::TnlO 
HfrH fi(lac-argF)UI69 relAl thi-l cps-3 malF55::Tn5 
sulA::Mu d(lac Ap) XCam (Mu+) fi(recA-srlR)301::TnlO 
supE44 filacU169( ~801acZAM15) hsdR17 thi-l relA 1 
Erwinia amylovora strain isolated from Malus x domestica 
Erwinia herbicola strain isolated from Malus x domestica 
Ehl087 AGA-negative derivatives each with single 
mini-Tn51acZ2 insertions in an ehp gene 
Ehl087 derivative in which the AGA-gene cluster has 
been deleted and replaced with a n SmR cassette 
supE44 hsdS20(rB-mB-) recAl3 a1'a14 rpsL20 proA21acYl 
galK2 xyl5 myl1 
araD139 fi(lacIPOZYA-grgF) U169 rpsL thi recA-56 supo 
Minicell-produeing mutant of E. coli K-12 P678 
Source or ref. 
Ennis et al. 
(1989) 
Ennis et al. 
(1989) 
Hanahan 
(1983) 
ICMp· 
Kcarns (1993) 
This study 
This study 
149 
Boyer and 
Rou1land (1969) 
Casadaban 
(1976) 
Adler et al. 
(1967) 
S17-1 thi pro hsdR- hsdM+ firecA ').pir RP4-2 . : Mu-KmR: :Tn7 Simon et al. 
(1983) 
WP3101-WP3106 uvrA155 hpE6511(lac-pro) malBl51on-11 sulAl 
F+(lacI-lacZ- proAB+): six lacZ reversion test strains 
WP3101P-WP3106P WP3101-WP3106 containing pKMlOl (mucAB, ApR) 
Plasmids 
pAGA 
pB lusecriptKS-
pBR322 
pBB7 
pBB7::ehpR 
pBB7::ehpA - ehpF 
pBE5a 
pBluescriptKS- containing a 15.5 kbp section of DNA 
encoding the entire AGA-gene cluster 
M13-, Coml ori lacZa KS-oriented MCS, ApR 
ColE! derivative, ApR, TcR 
BamHI 7.4 kbp subclone ofpLA272 inpBR322, contains 
ehpR, ehpA-E 
pBB7 canying a TnlO-LK insertion in ehpR 
Six derivatives of pBB7 each canying a mini-Tn51acZ2 
insertion in one of the genes ehpA - ehpF 
EcoRl5 kbp sub clone ofpLA255 inpBR322, contains 
Ohta et al. 
(1998) 
Ohta et al. 
(1999) 
This study 
Strata gene 
This study 
This study 
This study 
Keams and 
Mahanty (1998) 
This study 
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Table Al continued. 
Strain or plasmid 
pBE5b 
pBSECI 
pBSECl-l 
pEhpR 
pHRP315 
pJQ200mp18 
pLAAAGA 
pLAFR3 
pLA272 
Relevant Genotype or descdption 
EcoRl5 kbp subclone ofpLA272 in pBR322, contains 
ehpM-ehpO 
pBR322 with a 13 kbp DNA fragment from S. entomophila 
BC4B encoding a catalase gene 
pSECI containing a miniTnlO insertion within a catalase 
gene 
pBluescriptKS- containing a 1.8 kbp DNA fragment 
encoding ehpR 
IncQ plasmid containing an 0 SmR cassette 
GmR, MCS, contains sacE (sucrose sensitivity) 
Sections of DNA from upstream and downstream ofthe 
AGA gene cluster cloned either side of a 0 SmR cassette 
RP4 (IncP-l) ori, "Acos, pUC9 MCS and lacZ(/ TcR 
AGA+, AGAR cosmid from Ehl087 genomic library 
pLA272::ehpA-ehpO Derivatives ofpLA272 each carrying a mini-Tn5lacZ2 
insertion (01 or 02) in one of the genes ehpA-ehpO 
pLArecA A cosmid containing the Ehl087 recA gene 
pLArecA::OCmR As for pLArecA, however the recA gene is intenupted by 
a oCmR cassette 
pKSrecA A 1.8 kbp Pstl fragment of DNA containing the Ehl087 
recA gene cloned in pBluescriptKS 
pKSrecA::OCmR As for pKSrecA, however the recA gene is intenupted by 
a OCmR cassette 
pUT::mini-Tn5IacZ2 mobilizable suicide delivery plasmid containing tnp for 
transposition 
pUT::mini-Tn5phoA As for pUT::mini-Tn51acZ2; for transposition with 
mini-Tn5phoA 
150 
Source or ref. 
This study 
Giddens (1995) 
Giddens (1995) 
This study 
Parales and 
Harwood (1993) 
Quandt and 
Hynes (1993) 
This study 
Staskawicz, et 
al. (1987) 
Kearns (1993) 
This study 
This study 
This study 
This study 
This study 
de Lorenzo 
et al. (1990) 
de Lorenzo 
et al. (1990) 
"ICMP; International Collection of Micro-organisms from Plants, Landcare Research / Manaaki 
Whenua New Zealand Ltd., Auckland, New Zealand. brecA+ derivatives of these strains were created 
PI transduction of recA from E. coli W311 O. 
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A1.3. Manipulation of DNA 
A1.3.1. Total DNA Preparation 
151 
Genomic DNA was prepared by the method of (Pitcher et aI., 1989). Cells were collected in 
an eppendorf tube by centrifugation from one ml of a bacterial culture grown for 18 h. The 
cells were resuspended in 100 III TE buffer (10 mM Tris-HCI; 1 mM EDTA, pH 8), lysed 
with 0.5 ml GES reagent (5 M guanidium thiocyanate (Sigma), 100 mMll EDTA, and 0.5 % 
v/v sarkosyl), and vortexed until fully mixed. The cell lysate was cooled on ice and the 
denatured proteins precipitated by adding 0.25 ml 7.5 M ammonium acetate and placing the 
tube on ice for 10 min. 0.5 ml of a mixture of chloroform and isoamyl alcohol (24:1) was 
added, mixed thoroughly by vortexing, centrifuged (10000 g, 10 min.), and the aqueous phase 
was transferred to a new eppendorf tube. DNA was precipitated by the addition of 0.54 
volumes of cold isopropanol, and collected by centrifugation (10000 g, 1 min.). DNA was 
rinsed three to five times with 70 % ethanol, dried, and dissolved in 50 III TE buffer. 
A1.3.2. Plasmid DNA Preparation 
Generally, plasmid DNA was isolated from bacteria using the alkaline lysis procedure 
(derived from Bimboim and Doly, 1979; Sambrook et at., 1989). Cells cultured for 18 h were 
resuspended in an isotonic buffer (1 % glucose; 25 mM Tris-HCI; 10 mM EDTA, pH 8.0). 
The buffer was adjusted to 0.67 % SDS and high pH (0.67 M NaOH) to lyse the cells and 
denature proteins, before the lysate was neutralized with 1 M sodium acetate (pH 4.8) to 
precipitate the denatured components, which could then be sedimented by centrifugation 
(10000 g, 10 min.) and discarded. Plasmid DNA was precipitated from the lysate by the 
addition of two volumes of ethanol, and collected by centrifugation (10000 g, 5 min.). 
Plasmid DNA was rinsed twice with 70 % ethanol, and purified using one or more of the 
following steps if required. High Mw RNA was precipitated from the plasmid DNA solution 
after adjusting the solution to 2.5 M LiCI, and removed by centrifugation. The remaining low 
Mw RNA was digested with RNaseA (100 ng.mf1) at 37°C for 15 - 30 min., and removed 
along with other proteins still present in the plasmid DNA solution by phenol chloroform 
extraction. Plasmid DNA was collected from the aqueous phase after adjusting it to 0.25 M 
potassium acetate, adding two volumes of ethanol, and centrifuging the plasmid precipitate. 
Plasmid DNA was washed twice in 70 % ethanol, dried, redissolved in an appropriate volume 
of TE or dHzO and stored at -20°C. 
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A1.3.3. Restriction enzyme digestion of DNA 
DNA molecules were digested with restriction endonucleases (and Bal31 exonuclease) 
purchased from Gibco BRL according to the manufacturers recommendations. When more 
than one endonuclease was required, the reactions were either carried out in the most suitable 
buffer or the DNA was digested with one endonuclease, precipitated, digested with the next 
endonuclease, and so on. To partially digest DNA, restriction endonuclease were suitably 
diluted, and the reactions were incubated for 15 min. at the appropriate temperature and 
stopped by cooling on wet ice. Digested DNA was purified by phenol chloroform extraction 
before further manipulation. 
A1.3.4. Separation of DNA fragments by agarose gel electrophoresis 
Digested DNA fragments were separated by electrophoresis through a gel composed of 
agarose dissolved to an appropriate concentration in 1 x TAE buffer or in 0.5 x TBE for FIGE 
electrophoresis using a FIGE MapperTM (Bio-Rad). Separated DNA fragments were stained 
with ethidium bromide and visualized on a Sigma T2210 UV transilluminator (302 nm) or 
with an Ultralum KS3000 gel Visualization-Documentation and Analysis system. 
A1.3.5. Elutiou of DNA from an agarose gel 
DNA fragments were eluted from agarose gels using a Prep-A-Gene® DNA purification kit 
(Biorad) according to the manufacturers instructions. 
A1.3.6. Dephosphorylation of DNA to prevent self-ligation 
Linearized plasmid DNA molecules (usually vector) were treated with Calf Intestinal 
Phosphatase (CIP, (Boehringer Mannheim)) to remove terminal 5' phosphate groups and 
prevent self ligation. Generally 1 Ilg of linearized plasmid DNA was treated with 1 unit of 
CIP at 37°C for 30 min., before being purified by phenol-chloroform extraction. 
A1.3.7. Ligation of DNA fragments 
Linearized DNA molecules were ligated using T4 DNA ligase (Gibco BRL) in a ratio of ca. 1-
5 Ilg DNA to 1 unit ligase at room temperature for 2-16 hr. 
AI.4. Transformation of bacteria with plasmid DNA 
A1.4.1. Calcium chloride method. 
E. coli strains were grown in LB at 37°C with vigorous shaking to an O.D6oo of 0.4, and 
harvested by gentle centrifugation (5 min., 4000 rpm, 4 °C). The cells were rinsed once with 
10 mM NaCl, and twice with 100 mM CaCho Cells resuspended in CaCh were stored on ice 
APPENDICES 153 
for 20 min. before plasmid DNA was introduced and the cells stored for a further 30 minutes 
on ice. Cells were then exposed to 42°C for 60 - 90 s, placed on ice for 60 s, before ten 
volumes of LB was added and the cells elaborated for 60 min. 
Al.4.2. Electrotransformation. 
Generally E. coli strains were grown in LB with vigorous agitation to an OD6oo of 0,3 to 0.5, 
and herbicola or E. amylovora strains were grown overnight. Cultures were chilled on ice 
for 2-10 min., before cells were rinsed three times in cold sterile dH20 by the process of 
centrifugation (5 min., 4500 rpm, 4°C), supernatant removal, and resuspension in dH20. 
Cells concentrated ca. 100 times were divided into aliquots of 40 ,...,1 for immediate use, or 
were finally resuspended in 10 % filter-sterilized glycerol before storage at -80°C. 
Electroporation was carried out using a Gene Pulser™ (Bio-Rad) set with capacitance at 25 
,...,F, pulse-controlled resistance at 200 .0, and voltage at 1.8 kV for 0.1 em gap cuvettes 
(Dower et aL, 1988; Zabarovsky and Winberg, 1990). 
A1.S. DNA hybridization 
A1.S.1. Colony transfer 
Single colonies of an Eh1087 genomic library constructed in a previous study (Kearns, 1993) 
were transferred onto 2 % LB agar plates supplemented with tetracycline (15 ,...,g.ml-1) in grid 
formation using a numbered template, and overlaid with circular Hybond N+ membrane 
filters. After incubation at 37 overnight the titters were removed and the plates were 
stored at 4 °C until needed, Cells attached to the membranes were lysed by placing the 
membranes colony side up on Whatmann 3MM filter paper soaked with 10 % SDS for 3 min. 
To fix DNA to the membranes they were rinsed with freshly prepared denaturation solution 
(0.5 M NaOH, 1.5 M NaCI) for 5 min. The filters were finally rinsed twice with fresh 
neutralising solution (0.5 M Tris pH 8.0, 1.5 M NaCI), placed on a paper towel and air dried. 
Al.5.2. Southern transfer 
DNA was transferred from an agarose gel to a Hybond N+ membrane using a Pharmacia LKB 
VacuGene XL vacuum blotting system as described in the supplied instruction manual. The 
DNA was partially depurinated by covering the gel with a layer of 0.25 M HCI under a 
vacuum pressure of 50 mbar for 10 min. The HCI was removed by aspiration, the gel covered 
with 0.4 M NaOH, and the DNA was transferred at a vacuum of 50 mbar for 1 hr. After this 
period the membrane was rinsed in 2 x SSC and air dried on tissue paper, and the gel was 
restained in ethidium bromide to determine the efficiency of transfer. Membranes were either 
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probed immediately or WTapped In Glad Wrap ™ and stored at room temperature until 
required. 
A1.S.3. Hybridization detection using EeL TM (Amersham) 
Fragments of DNA to be used as probes were labeled with the Amersham Enhanced 
Chemiluminescence (ECL) direct nucleic acid labeling and detection system according to the 
manufacturers instructions. Hybridization was carried out using a rotary mini-hybridization 
oven (Hybaid) in which the membrane bound DNA was exposed to 20 ml of ECLTM gold pre-
hybridization buffer (0.5 M NaCl, 5 % w/v blocking reagent) containing labeled probe at 10 
ng.J.!r1• Following hybridization, unbound probe was removed by rinsing the membrane at 55 
°C for 20 min. with 50 - 100 ml of a solution containing OA % SDS and O.lxSSC, followed by 
two rinses with 100 - 200 ml2xSSC for five min. at room temperature. To detect hybridized 
probe DNA, the rinsed membranes were exposed to equal volumes of detection reagents 1 and 
2 for 1 min., WTapped in Glad WrapTM, and exposed to Amersham Hyperfilm-MP in an 
autoradiography cassette for 30 sec. to 16 hr depending on the strength of the signal. The 
films were then immersed in AGFA G-150 developer for 5 min., washed in running water, 
and immersed in AGF A G-334 fixer for a further 5 min. The autoradiographs were finally 
rinsed in water and air dried. 
A1.6. Protein Electrophoresis 
Protein preparation and polyacrylamide gel electrophoresis (pAGE) was carried out 
essentially as described by Hames and Rickwood (1990). Denaturing polyacrylamide gels 
(0.75 mm thickness) for SDS-PAGE, and molecular weight standards (Biorad) were prepared 
according to the manufacturers instructions. Gradient gels were prepared using a gradient 
former (BRL). SDS-PAGE was carried out using a Biorad protean II gel apparatus, a Biorad 
Buffer recirculation Pump, and a Biorad PowerPac 1000. Protein samples for separation were 
resuspended in an equal volume of 2 x treatment buffer (0.125 M Tris-HCL (pH 6.8), 4 % 
SDS, 20 % glycerol, 10 % J3-mercaptoethanol, and 0.25 % w/v bromophenol blue), boiled for 
3 min., loaded onto a polyacrylamide gel and separated by electrophoresis with a constant 
current set at 13 rnA per 0.75 mm gel until samples reached the boundary between the 
stacking gel and the resolving gel, and then at 18 rnA per 0.75 mm gel until the run had 
completed. Gels were stained with Coomassie G-250 blue for 90 min., de stained in 50 % 
methanol : 10 % acetic acid for 1 hour, and then destained overnight in 5 % methanol : 7 % 
acetic acid : 3 % glycerol. Destained gels were either photographed, or, for radiolabelled 
proteins the gels were exposed to 500 m1 Amplify Fluorographic Reagent (Amersham) for 30 
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min., before being rinsed in dHzO, placed on a sheet of Whatmann no. 1 chromatography 
paper and dried under vacuum at 65 DC using a Model 443 slab drier (Biorad). Dried gels 
were exposed to Amersham Hyperfilm-MP in an autoradiography cassette at -80 DC for 1-7 
days depending on the strength of the signal. 
At.7. Sequence Data 
At. 7.1. DNA Sequencing 
DNA sequence determination and analysis. DNA sequence was determined by the Sanger 
method using chain terminating dideoxynucleoside triphosphate; infrared dye (IRD40) labeled 
sequencing reactions were resolved on a Licor 4000LD IR2 automated sequencer, and 
Rhodamine-dye terminator labeled sequencing reactions were resolved on an ABI 377XL 
automated DNA sequencer. Primer sites throughout the regions to be sequenced were 
provided either by transposon insertions, by subcloning of the regions to pBluescript KS-
(Stratagene), or by designing specific primers to known DNA sequence. For the ehp gene 
cluster, the DNA sequence of both strands was compiled manually, and both strands were 
aligned for authentication. 
Al.7.2. DNA sequence analysis 
Gene predictions were created using the Heuristic GeneMark.hmm gene prediction program 
(15 June 2001, http://dixie.biology.gatech.edulGeneMarklheuristic.cgi)(Lukashin and 
Borodovsky, 1998). DNA sequence was compared with the GenBank DNA sequence 
database using the BLASTN and BLASTX programs (http://www.ncbi.nlm.nih.govlhlast) 
(Altschul et al., 1997). The predicted gene products of the AGA gene cluster were analyzed 
for conserved domains using PROSITE (25 July 2001, http://www.expasy.chltoolsl) 
(Hofmann et al., 1999) and Reverse Position Specific (RPS) BLAST version 2.2.1 (28 August 
2001, http://www.ncbi.nlm.nih.gov/Structure/cddlwrpsb.cgi) (Altschul et a1., 1997), for signal 
sequences and their cleavage sites using the SignalP V2.0 program (28 August 2001, 
http://www.cbs.dtu.dklservices/SignalP)(Nielsen et a1., 1997), and for membrane regions 
using the Dense Alignment Surface (DAS) method (25 July 200 I, 
http://www.sbc.su.se/~rniklosIDASI) (Cserzo et al., 1997), and the transmembrane hidden 
Markov model (TMHMM) version 2.0 program (28 August 2001, 
http://www.cbs.dtu.dklservices/TMHMMI) (Sonnhammer et a1., 1998). Promoter predictions 
were carried out using the Neural Network Promoter Prediction for prokaryotes (23 October 
2001, http://www. fruitt1Y,91:g[§W.JQols/promoter.html) 
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A2. DNA Sequence Data 
A2.1. DNA sequence and predicted translation products of the AGA gene cluster 
DEFINITION: D-alanylgriseoluteic acid 
ACCESSION: AF451953 (bankit434340) 
gene cluster, complete cds. 
ORGANISM: 
SOURCE: 
Db-xref: 
REFERENCE: 
AUTHORS: 
TITLE: 
JOURNAL: 
Pan toea (Erwinia herbicola) strain Ehl087 
Bacteria; Proteobacteria; gamma subdivision; Enterobacteriaceae; 
taxon: 549 
1 (bases 1 to 14924) 
Giddens, S. R. 
Characterization of a novel antibiotic gene cluster in 
Erwinia berbicola Ehl087 
Submitted (27-NOV-2001) Plant and Microbial Sciences, University 
of Canterbury, Ilam Road, Christchurch, Canterbury 8004, New 
Zealand 
Translated sequence data: 
156 
For each gene the start codon 
as the gene. 
I, and the product has the same name 
Gene: ehpR 
CDS: reverse complement [390 11 
translation: 
MTDLAGPTITPNLQLVYVSNVERSTDFYRFIFKKEPVFVTPRYVAFPSSGDALFAIWSGGEEPVAEIPRFSEIGIMLP 
TGEDVDKLFNEWTKQKSHQIIVIKEPYTDVFGRTFLISDPDGHIIRVCPLD 
Gene: ehpA 
CDS: complement [809 - 12851 
translation: 
MYLTDEDAIRIREINRQVVSQYLSSTRGIARLKRHELFAEDGEGGLWTTETGEPIIIRGIENLEKHAKWSLECFPDWE 
WYNIKIFTTDNPDHVWVECDGRGLIRFPGYPESYYENHFIHSFELRNGLIVRNREFMNPVTQLKCLGIDVPRIKREGI 
PS 
Gene: ehpB 
CDS: complement [1419 - 2048J 
translation: 
MYRTLKSESYSLSNII IPDEQPLAWNIEPQRSALLVHDMQRYFVDALPCEPVDTVIHS ISLILKWARINEI PVFYSAQ 
PGGMTPEQRGLLNDLWGPGMRTTEDERKII TELTPSPGDTVLTKWRYSAFYRSPLAEMLKNDQRDSLIITGIYASVGI 
SATAIDAFTQDIKPFVTADGIADFSLAGHQQAINYLADNCAKIISTDGVVNNV 
Gene: ehpC 
CDS: complement [2041 - 3945) 
translation: 
MSDSLTHILSQPHKPYALLYRPAVSMDSVEI LHLTCGKTHSLDKALSADSHHGKLLVVPFCQVAKRGYHAINDETPIL 
TMPITARQSLPLSEVISRLPDLPISVTNTNFNLDDIQFGQRISQLIEHEIGQGAGSNFVLHRKLRTSLVDYHPEQLLS 
LFRRLLQTESSAYWCFLINTGDEAFIGVSPELHASLDNGEMCMNPISGTLRYPEQGETIEALLEFLTNQKETNELYMV 
VDEELKVMSRLCERGAQVSDLRLKQLSQVIHTEYVLKGKTKASISDILTETLPAPTIIGSPVQNACQVIARYEPEGRR 
YYSGVVALVDGTHDNPRLDSAICIRTAEVTADGKVEIGVGATIVRDSVPLDEAEETRSKAQSLYAALTQDSLPAKKKV 
TPASLKKLKLGDNPKVRPLLNERNNRISKFWLSDPEKRHNRIYSFADKKILILDGNDAFTAMFKTLFSSLGALAHVEK 
VCSGIDLQGWDLVVAGPGPGNPLDVNDFRVNAMREAIIKMRATGQPFFAVCLSHQLLCLQLGLPVARLSPPNQGVQKE 
ILLDRNLETAGFYNTFCASINAVTHSQMRQRGIEVYSDPDNGNVHALRAHSFSSVQFHLESVLTLNGQALLERFVAPL 
FQKNYSGMAS 
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Gene: ebpD 
CDS: complement [3945 - 4808] 
translation: 
157 
MEGYQVDYTVLNAFTHSPLEGNPVAVFHDTEKLSEAVMQAlARQLQLSESTFISEKTVDGQARVRlFTPVNELPFAGH 
PLMGTASAYSRRHGLDQFVFHTALGAVSlSVEHHTETLSTVKIEVPLARTVPFKEEKRLLKALGLEQSVLPVEMYDAG 
ARHVLVSVDSIETLRELRPDHQVLAEFENLAVNCFAWCGFQAENRMFSPAYGVKEDAGTGSVVGPlALHLMKHGQLKA 
NEKlMlEQGlLLNRRCVMYGElKQENElASHlELSGQVTLFSDCRALLSNSGK 
Gene: ebpE 
CDS: complement [4846 5472] 
translation: 
VKRLESLTGITDLPFPQYDAPPVVPYElLHNWMQLAHHENVREPDAWTLATRSDAGMISMRTI FPVRMNGEDLWCATH 
LGSRKSLDMCANKAVSCHIYWRELGRQVSLTGNAKLLSDDlADQlWHSRASAYDPVSVASHQSEPLNDLTTLQAKlAG 
IGCGKLERPERFVV~mLAFDTYEFWSASSSRIHKRLLYTRNELGWKHERLQP 
Gene: ebpF 
CDS: complement [5453 6553) 
translation: 
MKDYSLElDAVMKAAQlNDTNNFVQALMRWHFSKETGSPFWLGMREQLNFDPlKDVKTlNDLRQFSDlSHCLRQEPVA 
NLVPQGLPADSHPQVYESGGTTGAPKYVVAYDAWlEALlSWRMSGYQHRPGRPSGNTLAAlPTGPHlVGAlNKERALR 
LGGMFFSlDlDPRWVKRSLSEGDTATVRKYTHHLVDQVQNTLMNQDlRFLVTTPPVLRELLKRPEVVLQMKQSLAQlT 
LGGTELNLDElKFlASElLPDCEFSASYGSTSALGVSRSLLlTSESQQVIYDSFSPFlTYDVVDSlTAQTVEYGERGN 
VIVTHLSPWAFYPRVAERDTAlRLPGVSGFAGDRLADlEPLKlSEGRKVlEGVY 
Gene: ebpG 
CDS: complement [6553 - 7488] 
translation: 
MPNlAQSCPHVNANELPVl SAl TPLCSPQFLRQREVVNlYEKPlALLQQSPGVFADYVlAHLR KSPVLDRASRQKALQ 
QAGELFAGSVLCGMNLTEYNTKVSSLTGLPRTVVENASDKIAQSlSHALTFALKGlPLQENQATDRYFCAQSVRRGDV 
LTVlAPGNGTGVHALWPQAIALGYRVVlRPSEREPFTAQRVVPAMVAAGLQDYVTLLPCNYDVVETLlDAADLSLlYG 
ADEITARYADRRNILVQGPGRSKVVlGADYPLEKALELlFTSVVGLGGAACVCASSVLVEGDAEALVGNSALFCPIK 
Gene: ebpH 
CDS: complement [7485 - 7961] 
translation: 
MKDPKQREEWLTHFSPQRYSWWCGQVDNYASALVETPEVFKSTQNTYQVMPLVMQASAlNDPLVQLELPVAAVTFLSF 
KEGDNLDFLAPALVVTVASGNKNLlNAlANVPGVKNFYlGQVPTVWMHPDVPHDGYLAEFLMQTRGYCVNSSEDEHSK 
VT 
Gene: ebpI 
CDS: complement [8006 - 8689] 
translation: 
MKVVl IANMl KLI SQGVYQGKHLSVVLE I SVVPWD I GQAQ PAVCD I FDKENAGRLLDVGCG LGLNAHAAAKRGFQVTA 
LDSSSAAlQKCKNEGMSDVRFLlASASNTGLDETFDllLDSALYHALPYDERLTYLKEMRRLAHENTRMHllTFLPAK 
NGMPVPLAlHLSEICSNAENAGWDVISVDRVEYKGNAQAlADFCKKKNLTlLTDEVGFTRLPCWHVVFNlR 
Gene: ebpJ 
CDS: complement [8713 - 10149] 
translation: 
MLRNKMAFFGLCLGFFIIMMDTTTVPLlYTSIlNEYQVTPAMAAWVNNSYLlTYAGFLLFGGRLGDAlNRKTVLYYAL 
I lLAlGALLSGSGQTLIQVlLGRALMGVGAGLLTPQSMAFlSlI FTQGGRGTALGlWGAVAGlATATGPVVTQIFLQT 
lGWRWIIFlYlPVALIALlFAVlCLPGTPGNGAKSKELLSNAIAGlALAAIlLGLELLNGGMQGMTTGLLLLLSGlLL 
FAFMLHGELKNHKQYLLPSSLWKDRAFLRTCLlSGLLGFGLTAFYLPLAYLlELRMGFGPVAISVIMVTlALANALVG 
PFAGHFSDKAAPETLlRWGMCCFAAATMIIGlTGLMTYGGSVAFllIITAMALAGlGTGLAFAPLANQAFSRATFNNF 
APPENDICES 158 
GRAAAFFNVVRQMMSALGSVAIAIFFDYLLHNSEKRSFTNENSLFSSGSPSVAFASFGCFLIITGLLGLGAWLSRTYP 
VVQSVlKETK 
Gene: ebpK 
CDS: complement [10149 10937] 
translation: 
MNTWLISGCSNGLGRCWTESVIHEYGDRVIGITRSVEAAQEMTALYPEHFIPCIADVRDEEYLARILPQLAKDFGIPS 
RVVTSAGYAQFGTLEDLSTEQLRQQFATNVEGTLMYKPELPLMRQLDEARILLVSSMSGVACWPLLGAYQMSKHAIEA 
MGQTLRHELEGTSIQVGVIQPGPYRTGWATTSAQRQPIGSEYDGEALKKRATCGFNIEDPKASLPYFWRMFNTPEMPE 
MLATSAKFVDL I CAQAEEKVKKWRASLA 
Gene: ebpL 
CDS: complement [10948 12084] 
translation: 
LRRWQKAVDILKSSWSEKEQQDSLKQGAQEVLKGSPLLRILDESDLYETGTLREVVAVCRELGKTDASLGWLVGVANS 
AWSMRANFSLPEGVSEDMRENAMLSMVLGRPGKLNAAADGQGWYLNGSWKYASGYPCSSHFFCLAATPSGEVRVVIVP 
SNQLIAVADWQSTGLRGTQSVTVEARDINIPKAFTVAYSPILSGNALSYSGKGSYARYFTGVLMNCLPATLLGATESG 
IRLVLNEFNAPIAGSSYNAMSDSGAARYEIGRLCSTFDLLVRAAEYNASIIDSAAQEGRMLESEERVAIRGRATQIMR 
GCVDIVQALLWLRGSSALEKNSPLEKIWRDVNVGARHGGFAKLVPEELEGISALKGELSSLTQMY 
Gene: ebpM 
CDS: complement [12155 13636] 
translation: 
MMQKLTPRQVRTKLKTINDS INHMLRDNSEAMAVNDGETSLTWKQMYERAVE I I RYFDKAGMLPGQ RLALDAPRSIEL 
YLMVLACLLSGISFISVPRNMNKQQKYQFAISIGCSGICSSLCKFEELQSTYIGEWCLGVTTRECRASYSNEVYCVRT 
SGTTGEPKLVPIHIAQVNAFLQNTHSEIPVKKKINWSWIHDLTFDFSIWELFGALSYGGCLVVISEQIKLDPTKTREI 
LEKSNVHLLSVTPSEFRYI FGSQSPAI FKKLCLKQMVFCGEKLTAETLRVFFP I FNE LKVQLLNTYGPSEATVFCSAW 
KVSQDDLTYDI I PIGKPFPGMVFSLEECRKEGSGNLVLQGGQVFSGYEGRDPIVAGYM TGDICRSDNDGVWHYIGRNE 
GYYKINGFRVDPLEIEEFLQSIPGVFEAVVWMEESSTAPALLKACVNVSRGNNLSTRDLRRACMTMSPWLRPAQYLII 
SQNEWPINSRGKSDRAEIKRKFYGV 
Gene: ebpN 
CDS: [13626 13853] 
translation: 
MECKQKGHQVIVEE I KYMLKEMDVRMDDNFTDLGGNS lMAMI ITDNLQKKYSINIELAQL LGSKIGEIELKPLGK 
Gene: ebpO 
CDS: complement [13995 - 14924] 
translation: 
MAASAARNALEQFHLSSEDVGFIVAGFSGVPDFIGIDLACQVGAELNCNQIRTLNLVEGCATAVSVWKHASSLCTEMP 
EGKFGLVVLAQRMSDTHQDRFGLMNAALSDGAVACVVGKAITYADQPGLRYISTEDISDCRYVDMMRIEYGGGHLPFL 
PEGRDSKKDKLGRERIMDNYCFSSQDLMNFLILRENNSINVIRRVLEKSVSLDTPPFLLHTLEGKQSIENLCNRIGIP 
IERSNISLLSELGHVGCADPLLSFRLMMQRGIISPGSEIVMSTISTGMKWGASLFRYETAISKDNVSYKPERSNN 
Figure AI. The complete DNA sequence of the AGA gene cluster 
BASE COUNT 4076 a 2982 c 3543 9 4323 t 
1 tcaatcaagc gggcagaccc gaataatatg accatctgga tcactaatca aaaaagtgcg 
61 accgaatacg tcagtataag gctcttttat cacaatgatt tgatgtgatt tttgctttgt 
121 ccattcattg aagagtttgt caacatcttc tcctgttggc agcataatgc cgatttcaga 
181 aaaacgtgga atttccgcta ccggttcctc tccgcctgac cagatagcaa aaagagcatc 
241 gccagatgac gggaaagcaa catagcgggg ggtaacgaat acaggttctt tcttaaagat 
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301 aaacctgtag aaatcagttg aacgctcaac atttgaaacg taaaccaatt gcaagtttgg 
361 ggttattgta gggccagcta gatcagtcat gattcctcct tttgtataac aaacgaaaca 
421 ggattttcca ttaacatttt aatccattac ttaaccttaa tggtttgaca gtatttaagc 
481 aatatttttg cagcaaatat acttctgcaa aggattttct ggttattatt gacagttttt 
541 tagctagcaa taatcaataa acttgcttca aaggcgcttt ttccggttta aaaagtattt 
601 attatttccg gaaaatttcc ttttttggaa ttttatagtt attagattat ttagtgatca 
661 acttattttt taaagaaaaa tatattagtg aagttgactc aaacgatttt gaatgttaaa 
721 aaatcgacac attcaacatc ccattaacct acttgaaaca tcatcaattg tggggtttcg 
781 cgttgatcta attaaatgag gtttatatat gtatctgact gatgaagatg caatccgtat 
841 tcgtgaaatt aaccgtcaag tagtatctca gtatttgtca tcgactcgcg gcatagctcg 
901 tcttaaaagg catgagcttt ttgctgaaga tggcgaaggc ggtttatgga ccactgaaac 
961 tggtgagcct ataattatac gcggtattga aaacttagaa aagcatgcta aatggtctct 
1021 tgagtgtttt cctgactggg agtggtataa tattaaaatc ttcaccaccg acaaccctga 
1081 ccatgtttgg gttgaatgtg acggccgagg gttaattcgc ttcccgggat atcctgaaag 
1141 ttattatgaa aatcatttta ttcattcatt tgaattgcgt aatggtctta tcgttcgtaa 
1201 tcgagaattt atgaatcctg ttactcaatt gaaatgttta ggtatagatg ttccacgtat 
1261 caagcgtgag ggtataccca gctaacttct gtaagaattc tatcgccagt attaatactg 
1321 aatttttttc gcgatattta catttatacg aaattaaatt ttctattaat tcatttggca 
1381 cgcgtaataa actttttcag aaaaggccga gttatctgat gtacagaacc ttaaagtctg 
1441 agtcctatag tttatctaat atcattatac ctgatgaaca gcctttggcg tggaatatag 
1501 aaccacaacg tagtgcgcta ttagttcacg atatgcaacg ttattttgtt gatgcgcttc 
1561 catgtgaacc tgtcgacact gttattcatt caatttcact gatactaaag tgggcaagaa 
1621 taaatgagat accggtattt tatagtgcgc agccaggtgg aatgactccg gaacagcgcg 
1681 gcttgctgaa tgatttatgg ggcccaggaa tgaggacgac tgaggatgag cggaagatta 
1741 tcactgagct tacaccttct ccgggtgata cagttttgac taaatggcgc tacagtgctt 
1801 tttatcggtc tccattagcc gaaatgctaa agaacgatca gcgtgactcc ttaattatta 
1861 caggcattta tgcgtcagta ggtatatctg cgaccgctat tgacgctttt acgcaagata 
1921 ttaaaccctt tgtcacagcc gatggaattg ctgatttctc actagccgga catcagcagg 
1981 caatcaatta ccttgctgat aattgcgcca aaataatctc aactgatggg gtggtaaaca 
2041 atgtctgatt ccctgacaca cattctgtca cagccccata aaccttatgc tttactgtat 
2101 cggcccgcag tctcgatgga tagtgttgaa attttgcacc ttacttgcgg aaaaacacac 
2161 tccctggata aagctcttag cgcagatagc catcacggta agcttttagt tgttccattt 
2221 tgccaggtag ccaaacgtgg ctatcacgct atcaatgatg aaacaccgat tctgacgatg 
2281 ccaatcactg cgcgtcaaag cttgccatta tcagaagtaa ttagcaggct accggatttg 
2341 cctatttcgg tcacgaacac taactttaac cttgacgata tacagtttgg gcaacgtatc 
2401 agtcagttaa tcgaacatga aattgggcag ggagcaggtt cgaatttcgt gcttcatcgt 
2461 aagctacgta cctcgcttgt agattatcat cctgaacaac ttcttagcct ttttcgacgc 
2521 cttttgcaga ctgaatcctc cgcatattgg tgttttttaa ttaacactgg tgatgaggct 
2581 tttattggtg tatctccaga gttacatgca tcactagata atggtgagat gtgcatgaac 
2641 ccaatcagcg gaactttacg ttatccagaa cagggcgaaa caatcgaagc tctgcttgaa 
2701 ttcctcacca atcagaaaga aaccaatgag ctttacatgg tggtggatga ggaactaaaa 
2761 gtaatgtcca ggctgtgtga acgtggagcg caggtgagcg acttgcgact caaacaacta 
2821 agtcaggtta ttcacactga atatgtctta aaaggaaaaa cgaaagccag tatttcggat 
2881 atattgactg aaacgttacc agcaccaacg atcattggta gtccagtgca aaatgcctgc 
2941 caggtcattg cccgttacga gccagaaggg cgcagatatt atagcggcgt agtagctctg 
3001 gttgacggta cacatgataa tccccgtctg gactcagcta tttgtattcg tacggctgaa 
3061 gtgactgctg atggaaaagt agagattggc gttggggcaa ctatagttcg tgactctgtg 
3121 cctttggatg aagcggaaga aacgcgcagt aaagcgcaat cactttatgc tgcattgacg 
3181 caagatagtt tgccggccaa aaagaaagtg acacctgcca gccttaaaaa attaaagctt 
3241 ggtgataatc ctaaggttcg ccctttgctg aacgaacgta ataacaggat ttcgaaattc 
3301 tggttaagtg atcctgaaaa gcgtcacaat cgtatatatt ctttcgctga caagaaaata 
3361 ttaatactgg acggtaatga tgcttttact gccatgttta aaacactttt ctcttcactg 
3421 ggcgcacttg ctcatgtgga aaaagtctgt agcggcattg acctccaggg ttgggattta 
3481 gtagtagctg ggccgggccc ggggaatcca cttgatgtta atgatttcag agttaatgca 
3541 atgcgcgaag ccattataaa aatgagagcg actggccagc ctttctttgc tgtatgcctg 
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3601 agccaccaat tgctttgtct gcagctcggc ttaccagtcg cccgcctctc tccacccaac 
3661 cagggagtac aaaaagaaat cctcctggat aggaaccttg aaacagcagg tttttataac 
3721 actttctgtg ccagtattaa tgctgtaacg cactctcaaa tgcggcaaag aggtatagag 
3781 gtttacagcg atccagataa tggaaacgtt catgcgcttc gggctcactc attttcatca 
3841 gttcagtttc atctcgaatc ggtactcact ttaaatggtc aagcgctgct cgaaagattt 
3901 gtcgctcctc ttttccaaaa aaattattca ggaatggctt cttaatggaa ggatatcagg 
3961 ttgattacac ggtattaaat gccttcacac attctcctct tgaaggaaat ccggttgccg 
4021 tttttcatga tacagaaaaa ctctctgaag ctgtcatgca ggcgattgca cgtcagctgc 
4081 agctttcaga aagtactttt atcagtgaaa agactgttga tggtcaggct cgagtgcgaa 
4141 ttttcacgcc cgtcaatgaa ttgccttttg ctggtcatcc actaatggga accgccagtg 
4201 catattcacg gcgccatggt ctggatcaat ttgtatttca tacagctctt ggcgccgtca 
4261 gcatttcggt tgaacaccac accgaaacac tcagtacggt gaaaatcgaa gtgcctctag 
4321 caagaactgt cccttttaag gaagagaagc gtctgcttaa ggcgctgggg ctggaacaaa 
4381 gtgtgcttcc tgtggaaatg tacgatgcag gagccaggca tgtactggtt tccgtcgaca 
4441 gtattgaaac cttacgtgag ctaaggccag accatcaggt cctcgctgaa tttgaaaatc 
4501 ttgcagttaa ctgtttcgcc tggtgtggat ttcaggcgga aaaccggatg ttctcaccag 
4561 cttatggggt aaaagaagat gctggtaccg gttcagttgt cgggccaatt gcacttcacc 
4621 tgatgaaaca cggacagtta aaagctaacg aaaaaatcat gattgagcag gggattttgc 
4681 tcaatcgccg ctgcgtgatg tatggcgaaa tcaaacagga aaatgaaatt gcttctcata 
4741 ttgaactctc cgggcaggtt accttgtttt ctgattgcag ggccttgctg agtaatagcg 
4801 gaaaatgatt cgcttaattt gaatgtgctg ttttaggtat gaaaagtgaa aagactcgaa 
4861 tcgctaaccg gaataacgga tcttccgttt ccgcaatatg acgcgccgcc tgtggtgcct 
4921 tatgaaattt tacataactg gatgcaactg gcgcatcatg aaaatgtacg tgaacctgat 
4981 gcatggaccc tcgcgaccag aagtgacgct ggtatgattt caatgcgcac catatttcca 
5041 gttcgaatga atggagaaga tctatggtgc gctactcatc ttggcagtcg aaagagtctc 
5101 gatatgtgtg ccaacaaagc ggtctcctgc catatttact ggcgtgagct ggggcgacag 
5161 gtgagcttaa ctggtaatgc aaaactgctg tcagatgata tcgccgatca aatctggcac 
5221 agccgtgctt ctgcatatga tcctgtctca gtagcatctc atcaaagtga gccattaaac 
5281 gatcttacta ctttgcaagc gaagatagct ggaataggtt gcggaaagct ggaacgtcct 
5341 gagcgttttg tagtatgggg gctggctttt gacacctatg agttctggtc agcatcgtcc 
5401 tctcgaatcc ataaacgtct gttatataca cgtaatgaac tggggtggaa gcatgaaaga 
5461 ttacagcctt gaaatagatg ctgtcatgaa ggcagcccag ataaatgaca ctaataattt 
5521 tgttcaggca ttaatgcgct ggcacttttc aaaggaaact ggcagtcctt tttggttggg 
5581 aatgcgtgaa caactgaact ttgacccaat caaagacgtt aaaacgatta acgatctgag 
5641 gcagtttagt gatatctcgc actgcctgcg ccaggagccc gtagctaatt tagtgccgca 
5701 aggcctgcct gcggactcgc accctcaggt atatgaaagt gggggtacaa caggcgctcc 
5761 taaatatgtc gtggcttacg atgcttggat agaggcactc atttcctggc gaatgtcagg 
5821 ttatcagcat aggccggggc gtccgtcagg taatacactc gcagctattc ccaccgggcc 
5881 tcacattgtg ggtgccatta ataaagaacg agcgctgcgt ttgggtggga tgtttttttc 
5941 aatcgatata gatcctcgct gggtaaaacg ttctttgagt gaaggtgata cggcaactgt 
6001 tcgcaagtac acacatcatc ttgtggacca ggtccagaat acccttatga atcaggatat 
6061 ccggtttctg gttaccactc cacctgtgct acgtgagttg cttaaacgac cagaagttgt 
6121 gttgcaaatg aaacagtctc tcgctcaaat cacacttggt ggaactgagc tcaaccttga 
6181 tgagattaaa tttatagcga gtgaaattct gcccgactgt gaattcagtg ccagttatgg 
6241 gagcacctca gcattgggcg tatctcggtc cttactgatt acttctgaaa gccaacaagt 
6301 catttatgac agtttctctc cttttataac ctatgacgtt tcactgctca 
6361 aactgtcgaa tatggtgaac gaggaaacgt gattgttacc cacctttcac cttgggcttt 
6421 ttatccacga gtggctgaac gagacacagc tatcagacta ccaggtgtat ccggttttgc 
6481 gggggaccgg ttggctgata ttgaaccttt gaaaatcagc gaaggacgta aggttattga 
6541 aggagtttat tgatgccaaa cattgcgcaa agctgtcctc acgtaaacgc caatgaactg 
6601 cctgttatct ctgctataac gccgttatgc tcaccgcagt ttttgcgtca gcgagaggtg 
6661 gtaaacatat atgaaaagcc catagcttta ctgcagcagt ctcccggcgt atttgcagat 
6721 tacgtaattg cgcatctgag aaaaagtcct gtactggatc gcgcctcacg acaaaaagca 
6781 ttgcaacaag caggtgaatt attcgcaggt tcggtacttt gtggcatgaa tcttacagaa 
6841 tataacacga aagttagctc tcttacgggg ttaccgcgaa cggttgtgga gaatgccagc 
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6901 gataaaattg cacagtcaat ttctcatgca ctgacatttg ctttaaaggg gatccctcta 
6961 caggaaaatc aagcgacaga ccgttacttt tgcgcacaaa gcgtgaggcg tggtgatgtg 
7021 cttactgtaa tagcccctgg taacgggact ggtgttcatg ctctatggcc gcaggcaata 
7081 gcgctgggct atcgagttgt aattcgaccg tcggaacggg aaccgtttac tgctcagcgt 
7141 gtggtaccgg caatggtggc ggcggggttg caggattatg tgacattatt gccctgtaat 
7201 tatgatgtgg tcgaaacact aattgatgct gctgatttaa gtcttattta cggcgctgat 
7261 gaaataactg cccgctatgc tgatcgcaga aatattctgg ttcagggacc tgggcgatcg 
7321 aaagttgtta ttggtgctga ttacccccta gaaaaggctt tggagctgat atttacttcg 
7381 gttgtcggtt tgggtggcgc agcctgtgtt tgtgcaagca gtgttcttgt agaaggggat 
7441 gcggaagctt tagtcggaaa ttctgcgctt ttctgtccaa taaaatgaaa gatccaaagc 
7501 agcgtgaaga atggcttact catttttcac cacagcgtta tagctggtgg tgtggtcagg 
7561 tagataatta cgcctcggct ttagttgaaa ctccagaggt tttcaaatct acccaaaaca 
7621 catatcaagt gatgccacta gttatgcagg catcagcaat caatgatcct ctggtccagc 
7681 tggagttacc tgtggcggca gtgactttct tatcctttaa agaaggggat aatttggatt 
7741 ttcttgcccc tgcgcttgtg gttactgtgg catcgggtaa caagaattta attaatgcaa 
7801 tcgcaaatgt gcctggtgtt aaaaattttt acatcggtca ggtgccaact gtttggatgc 
7861 atcctgatgt accccacgat ggttatctgg ccgaatttct aatgcagact cggggatatt 
7921 gcgtaaatag ttctgaagat gaacatagta aagtaacgta atttttacat ttaaatttac 
7981 ttccaatttt attcaggtgt taaatatgaa agtagtgatc atagcgaata tgataaagct 
8041 gatttcccag ggcgtatatc agggtaaaca cttatcggta gtgctggaaa taagtgtggt 
8101 tccttgggat attggtcaag cgcaaccagc agtgtgtgat atttttgata aagaaaatgc 
8161 tggcaggctt cttgatgttg gatgtggcct gggacttaat gctcatgcag ctgcgaaaag 
8221 aggttttcag gttacagcgt tagacagttc gtctgcggcg attcaaaaat gcaaaaatga 
8281 aggaatgagt gatgttcgtt ttctaattgc cagtgccagt aatacaggac tggatgaaac 
8341 attcgatatc atacttgatt ctgcgctcta tcacgcgctt ccttatgatg aacggttgac 
8401 atatttgaaa gagatgcgtc gcttagcgca tgaaaatacc agaatgcata tcataacatt 
8461 tttacccgcc aaaaatggca tgccagtacc attggccatt catctctcag aaatctgtag 
8521 caatgccgaa aatgccggat gggatgtcat ttccgttgat cgtgttgaat ataaaggaaa 
8581 tgctcaggca attgccgatt tttgcaaaaa gaaaaattta accatactga ctgatgaagt 
8641 gggattcact cgtctacctt gctggcatgt agtgtttaac attagataaa atctctttat 
8701 tcaggtggat taatgttgag aaataaaatg gccttctttg gtctctgtct tggttttttt 
8761 attattatga tggataccac gacagtgccc ttgatttata cctcgataat aaatgaatat 
8821 caggtgacgc ctgccatggc agcgtgggtt aataatagtt atttaattac ctatgcaggc 
8881 ttcttgttgt ttggcggtcg acttggtgat gcaataaatc gtaaaacggt gctttactat 
8941 gctctcatta ttcttgctat tggtgcatta ctcagtggtt ctggtcaaac cctgatacag 
9001 gtcattctgg ggcgtgcgct tatgggggta ggggctggac ttttgacgcc gcaaagcatg 
9061 gcctttattt ccatcatttt tacacaagga ggacgcggta ctgctctggg tatctggggg 
9121 gccgttgctg gcatagcaac ggcaaccggc cccgttgtta cccagatatt tctgcaaaca 
9181 atcggttggc gatggattat ttttatttac atacccgtgg cgctgatcgc actaatattt 
9241 gctgttattt gtcttcccgg cacaccgggt aacggtgcta aaagcaaaga attgctaagt 
9301 aatgctatag cgggcattgc gctcgctgca ataattctgg gattagagct tcttaacggt 
9361 ggcatgcagg gaatgaccac agggctgctt ttattattat ctggtatttt gctcttcgct 
9421 ttcatgctgc acggtgaatt gaaaaatcat aagcagtatc ttttaccatc ttcgctctgg 
9481 aaggatcgag ctttcctgcg tacatgtttg atttccggtt tactcggctt tggcctgaca 
9541 gcgttctacc tgccgctagc ttatttgatt gagctgcgta tgggttttgg accagtagcg 
9601 attagtgtca tcatggtgac aatcgctctg gcaaacgcac tggtgggtcc atttgccgga 
9661 cacttctcgg ataaggcggc tccagaaaca ctgattcgtt gggggatgtg ctgcttcgca 
9721 gctgccacca tgattattgg tattaccgga ttgatgactt atggtggatc tgtagctttt 
9781 attattatta ttaccgcaat ggctcttgca ggtatcggga cgggcctggc atttgccccc 
9841 ttagctaatc aggctttcag ccgtgcaacg tttaacaatt ttggccgtgc agccgctttt 
9901 tttaacgtgg tgcgtcagat gatgagcgca ttgggtagtg tagcaatagc catatttttc 
9961 gattatctgc ttcataactc tgaaaaaaga agtttcacga atgaaaattc cttattttca 
10021 tctggctctc catctgttgc ctttgcttca ttcggctgct tcctgattat taccggactg 
10081 ctgggtttag gtgcctggtt atcacggact tatcctgtcg ttcaatcagt tattaaggaa 
10141 accaaataat gaatacctgg cttatcagtg gatgttcaaa cggactaggt cgatgctgga 
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10201 cggagtctgt tattcatgag tatggtgatc gtgtgattgg aattacccgt tcagtagagg 
10261 ctgcacaaga gatgacagct ctttatccag aacattttat tccttgtatc gctgatgtac 
10321 gagatgaaga gtatctggcc cgtatactac ctcaactggc taaggatttc ggtataccga 
10381 gtcgggtagt aacgtccgcc ggctatgctc agtttggcac acttgaggac ctttctacag 
10441 aacagttgcg acagcagttc gctaccaatg tagaggggac tctaatgtat aaaccagagc 
10501 taccgctgat gcgtcagctg gatgaagctc gcattctact ggtgtcaagt atgagtggcg 
10561 tggcgtgctg gcctcttctg ggagcttatc agatgagcaa gcatgcgatc gaagcgatgg 
10621 gacaaaccct ccgtcatgaa cttgaaggaa cgtctataca ggttggcgta attcagcctg 
10681 gaccttatcg tactggctgg gcaacgactt ctgcgcaacg ccagcctatt ggttctgaat 
10741 atgatggtga ggcattaaaa aaacgagcca cttgtggttt taacatcgaa gatcctaaag 
10801 ctagcttgcc ttacttctgg aggatgttta acacacctga gatgcctgaa atgcttgcaa 
10861 cgtcagcaaa gtttgttgac ctgatttgcg cgcaggcaga agagaaagtt aaaaaatgga 
10921 gagcttctct tgcttaagaa taatgatgtg ctcagacgct ggCaaaaagc tgtcgatatt 
10981 ttgaagtcgt cttggtcaga aaaagaacag caggattctt taaagcaagg tgctcaggaa 
11041 gtattaaagg gttcaccact gttgcgcatc ctggacgaaa gcgatctgta tgagactggt 
11101 acgctacgtg aggtggtcgc tgtatgtcgt gagctcggaa aaacagatgc ttctcttggc 
11161 tggcttgtag gtgttgcgaa ttccgcttgg tcgatgcgcg ccaatttttc tcttcctgag 
11221 ggggtgagtg aagacatgcg tgaaaacgcc atgctatcaa tggtattagg ccgtcccgga 
11281 aagcttaacg ctgcagccga tggtcaaggg tggtatctga acggtagctg gaaatatgca 
11341 tcaggctacc cctgttcttc acatttcttt tgcctcgctg caactccatc tggagaagtg 
11401 cgtgttgtca ttgttccgtc aaatcaattg attgctgtgg ctgattggca atcaaccggc 
11461 ctgagaggaa cacaaagcgt gaccgttgag gcaagggaca tcaacattcc taaagccttt 
11521 actgttgcat attcaccaat tctttcagga aatgcgcttt cgtatagcgg aaagggctct 
11581 tacgcacgct actttaccgg cgtattgatg aactgtcttc ccgccacact cttgggagca 
11641 acagaaagcg gcatcagatt agtacttaat gaatttaacg ctcccattgc tggcagttct 
11701 tataacgcta tgagtgattc tggtgctgca cgttatgaga tcggacggct ctgttcaacc 
11761 ttcgatttgc ttgtgcgggc agccgaatac aacgcctcaa ttattgatag cgcagcgcaa 
11821 gaaggcagga tgcttgaaag tgaagaacga gtagcgattc gcggccgggc tactcagata 
11881 atgcgaggtt gtgttgatat tgttcaggcc ttgttgtggc tgcgaggttc atctgcctta 
11941 gaaaaaaata gccctctgga aaaaatctgg cgtgacgtaa atgtcggggc acgacacggt 
12001 ggcttcgcca aacttgtgcc agaggagcta gaagggataa gtgcattgaa gggagagctt 
12061 tcttcactga cacaaatgta ttgacatatt ggctctgtag ggcgttgtta ctgcgacagc 
12121 gccactacac aaacaattat aggcgagcag gaatatgatg cagaaattaa cccccaggca 
12181 agtccgcaca aagttaaaga ctataaatga ttcaataaat catatgctga gagataattc 
12241 ggaagctatg gcggtaaatg atggtgaaac tagcttaacg tggaagcaaa tgtatgagcg 
12301 tgcagtagaa atcataagat attttgataa agcgggcatg ttgcctggcc agagacttgc 
12361 tcttgatgcg cctaggtcta tagaattata tctgatggtt ttagcatgcc tgctatccgg 
12421 gatttcattt atttctgtac caagaaatat gaataagcag caaaaatacc agtttgctat 
12481 aagcataggt tgctcaggaa tctgctcgtc attatgcaaa tttgaggaat tacaaagcac 
12541 ttacattggc gagtggtgtc ttggtgtaac aacccgagaa tgtagagcct catatagcaa 
12601 tgaggtgtat tgtgtaagga catctggtac cactggagaa cctaaacttg taccaattca 
12661 catcgctcag gttaatgcat ttttgcagaa tacccatagc gaaatcccgg taaagaaaaa 
12721 aattaactgg tcgtggattc acgatctaac ttttgacttt tctatctggg aattgtttgg 
12781 agcactgagt tatggtggat gcctagtagt tattagtgaa cagataaaac ttgatccgac 
12841 caaaactcgt gagatattgg agaaatctaa tgttcacttg ctatctgtca cgccctcaga 
12901 atttcgctac atatttggta gccagtctcc ggcgattttt aaaaaattat gtcttaagca 
12961 gatggtgttt tgcggcgaga aactgacagc tgaaactctt cgtgtatttt ttcccatctt 
13021 taatgagctt aaggttcaat tgctgaatac ttacggccct tcagaagcaa ctgttttttg 
13081 ttctgcctgg aaggtgagtc aggacgactt aacctacgat attataccaa ttggcaagcc 
13141 atttccgggt atggtatttt ctttagagga atgcaggaaa gaagggagtg ggaatctagt 
13201 attacaaggg gggcaggttt tttccggtta tgaaggccgc gaccctatag ttgctggtta 
13261 catgacggga gatatttgcc gcagcgataa cgatggtgta tggcactata taggtcgcaa 
13321 tgaaggctat tataaaataa atggcttccg agttgatcct ctggagatag aggagtttct 
13381 tcaatctata ccgggtgtat ttgaggctgt agtatggatg gaggaatctt ccacagcgcc 
13441 ggcactatta aaagcttgtg ttaacgtttc gagaggaaat aatctaagta ctcgtgatct 
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13501 tagacgcgct tgcatgacaa tgtctccttg gctaaggcct gcacaatatt taattatatc 
13561 ccaaaatgag tggccaataa attcacgtgg aaaatctgat cgcgcagaga taaaaaggaa 
13621 gttttatgga gtgtaagcag aaaggtcatc aagttatagt tgaagaaatt aaatatatgt 
13681 tgaaagaaat ggacgtcagg atggatgaca attttaccga tttaggaggg aactcaatca 
13741 tggctatgat aattacggat aatttgcaga aaaaatattc tattaatata gagttagccc 
13801 aactgctggg tagtaagatt ggtgaaattg aactgaaacc tctgggcaag taaatgaaaa 
13861 tattaagtac agggcataca ttatcgcgag ccgcacatct tgacgaagtt gatcatccta 
13921 atcagttaca gctagaagcg atcaaacgtg cgggttataa gcaattctgg actgaatctc 
13981 agagcgttcg ggaaatggct gcctcagctg cacgaaatgc actggaacaa ttccatttat 
14041 cttccgaaga tgtagggttt attgtcgctg ggttttcggg agttcccgat tttattggta 
14101 tcgacttagc ctgtcaggtt ggagcagaac taaattgtaa tcagattcgt acactcaact 
14161 tagttgaggg ttgtgctacg gctgtcagtg tttggaagca tgcatcttca ctttgtactg 
14221 agatgccaga aggtaaattt gggctggtag tactggcgca gcgcatgagc gatactcatc 
14281 aggacagatt cggacttatg aatgctgcgt taagtgatgg agcagttgct tgcgtggtag 
14341 gaaaggcaat cacatatgca gatcagcccg gattgcgtta tatatctaca gaagatattt 
14401 ctgactgccg ttatgtagat atgatgcgca tagaatatgg tggtggacat ttacctttcc 
14461 tacctgaagg aagagatagc aaaaaagata aattaggtcg agagcgaatt atggataatt 
14521 attgtttctc atctcaggat ttaatgaatt ttttaatttt acgcgaaaat aacagtatca 
14581 atgtcattcg tcgtgtattg gagaaatctg taagcctaga tactcctcct tttctactac 
14641 atactctcga aggaaaacag agcatagaaa atttatgtaa ccgaattggt attccgattg 
14701 agagaagtaa tattagcttg ttatcggagt taggacatgt aggttgcgcc gacccgctgt 
14761 tgtcatttcg attgatgatg cagcgtggga taatcagtcc tggttcagag attgtcatga 
14821 gtactatttc taccggcatg aaatggggag catccctttt ccggtatgaa accgctataa 
14881 gtaaggataa tgtaagctat aaa~cagaaa ggagtaataa ttaa 
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A2.2. Protein sequence similarities of the translated DNA sequence located upstream of 
the AGA gene cluster 
Table A2. Similarities to the region upstream of the AGA gene cluster 
Code Accession no, Putative size score 
PCR (AF336309) probable transposase gene; a low caleium response 244 8e-59 (230) 
plasmid from Yersinia enterocolitica Serotype 0:8 
PBI (NC_OO2142) resolvase (RsvB); adherence factor plasmid pB 171 269 4e-42 (174) 
from Escherichia coli 
PCC (PI8021) resolvase; plasmid pColBM-CI139 from Escherichia 260 6e-42 (174) 
coli 
PCP (NC_002122 resolvase; plasmid pCoIIb-P9 from Shigella sonnei 259 8e-42 (173) 
PF (NC_002483) resolvase; plasmid F from Escherichia coli K-12 268 2e-41 (172) 
PV (NC_002638) Rsd; a 50k virulence plasmid from Salmonella 260 3e-41 (171 ) 
enterica enterica serovar Choleraesuis 
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Blast X alignment of the translated DNA sequence upstream of the AGA gene cluster from 
Ehl087 (EH) with other protein sequences in the GenBank / EMBL / XXX databases: 
EH 
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PCC 
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PV 
EH 
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Figure A2. Sequence alignments upstream of the AGA gene cluster 
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LGSLPRELTQISRSDVTGQNVTGSGAARYFDYESAVALRNLAAAYGTDMPRYLLAPEVAVLLSKVPDLKKRLFIDTLWNTGGR 
L +P E +QISRS +T YF+YE AVALR +A G +PRYLLAPE+ VLL +PDL++R L DTLNNTGR 
LSLIpHENSQISRSAITP---- -YFNYEKAVALRRMALKAGASLPRYLLAPEITVLLDYLPDLRQRLLFDTLWNTGAR 
DY +A+ALR ++ + ++P+YLLAPEV+ LL VPDL++++ + TL1'INTG R 
DYPAALALRQMSMVHD-ELPKYLLAPEVSALLHYVPDLRRKMLLATLNNTGAR 
DY +A+ALR ++ + ++P+YLLAPEV+ LL VPDL++++ + TLWNTG R 
DYPAALALRQMSMVHD-ELPKYLLAPEVSALLHYVPDLRRKMLLATLWNTGAR 
DY +A+ALR ++ + ++P+YLLAPEV+ LL VPDL++++ + TLWNTG R 
DYPAALALRQMSMVHD-ELPKYLLAPEVSALLHYVPDLRRKMLLATLWNTGAR 
DY +A+ALR ++ + ++P+YLLAPEV+ LL VPDL +++ + TLWNTG R 
DYPAALALRQMSMVHD-ELPKYLLAPEVSALLHYVPDLHRKMLLATLWNTGAR 
DY +A+ALR +A + D P+YLLAPEV+ LL VPDL +R+ + TLWNTG R 
DYPAALALRQMAMQHD-DYPKYLLAPEVSALLHYVPDLHRRMLLATLWNTGAR 
LNEILPLTGGGFCAGRSAHRRPAEFTVRQAAHPQAAEAGRGGPQPPARASDKXXXXXXXXXXXGDPGEPPPRAVPLTDPGFVQ 
+NE L LT P +F + GA + + + P R + GE R VPL+DP +v+ 
INECLVLT-------------PGDFELDGAGPFVTLKTLKQRHRGPGRPEN-------------~-GEALKRIVPLSDPAYVR 
+NE L LT G F P F + +A R + PA G+ R VPL+D +v 
INEALALTRGDFSLAP-----PYPFVQLATLKQRTEKAARTAGRTPA- ~~--------------GQQTHRLVPLSDSWYVS 
+NE L LT G F P + . +A R + PA G + R VPL+D +V 
INEALALTRGDFSL-----TPPYPFVQLATLKQRTEKAARTAGRMPA-- -------- GQQTHRLVPLSDSWYVS 
+NE L LT G F P F + +A R + PA G + R VPL+D +v 
INEALALTRGDFSL-----TPPYPFVQLATLKQRTEKAARTAGRMPA-------------------GQQTHRLVPLSDAWYVS 
+NE L LT G F P F + +A R + PA G+ R VPL+D +v 
INEALALTRGDFSLAP-----PYPFVQLATLKQRTEKAARTAGRMPA-- --------- ~GQQTHRLVPLSDSWYVS 
+NE L LT G F P F +A +A R + P+ G P R VPL+D +v 
INEALALTRGDFSLAP- - - - - PYPFVQLATLKQRAEKAARTAGRMPS- - ~~ ~~~ - - - - - - -GSQPHRLVPLSDNQYVS 
RLREWFATAQLPAGSRL----- -WDIRSEDTARSWISQAVASAARDGVTFSIRPVTPKTFRDSFAMHLVQHQVPQKVI 
RI,+E+ AT ++ L W ++S+DTAR+W+ AV A RDGVTF+I P+TP TFR SFAMHL+Q+ +P KV 
RLQEYAATMKITRRKPL-----------WPMKSDDTARNWLKAAVQRAERDGVTFTI-PITPHTFRHSFAMHLLQNGLPFKVL 
+L+ AT++ P +R+- ~~W++ ++ T R+WI +AVA+AA DGVTFS+ PVTP TFR S+AMH++ +P KV+ 
QLQTMVATLKI PLERRNRRNKRTGRTEKI'lEV -TDRTVRTWI GEAVAAAATDGVTFSV - PVTPHTFRlISYAMlIMLYAGI PLKVL 
+L+ AT ++P +R+ W++ ++ T R+WI +AVA+AA DGVTFS+ PVTP TFR S+AMH++ +P KV+ 
QLQTMVATLKIPMERRNKRTGRTEKARII'IEV-TDRTVRTWIGEAVAAAAADGVTFSV-PVTPHTFRHSYAMHMLYAGIPLKVL 
+L+ AT ++P +R+W++ ++ T R+WI +AVA+AA DGVTFS+ PVTP TFR S+AMH++ +P KV+ 
QLQTMVATLKIPMERRNKRTGRTEKARIWEV-TDRTVRTWIGEAVAAAAADGVTFSV-PVTPHTFRHSYAMHMLYAGIPLKVL 
+L+ AT ++P +R+W++ ++ T R+WI +A VA+AADGVTFS+ PVTP TFR S+AMH++ +P KV+ 
QLQTMVATLKIPMERRNRRTGRTEKARIWb~-TDRTVRTWIGEAVAAAAADGVTFSV-PVTPHTFRHSYAMHMLYAGIPLKVL 
L+ AT ++P +RLW+I ++ T R+WI +AV +AA D VTFS+ PVTP TFR S+AMH++ +P KV+ 
ELQMMVATLKIPLERRNRRTGRTEKARLWEI-TDRTVRTWIGEAVEAAAADDVTFSV-PVTPHTFRHSYAMHMLYAGIPLKVL 
KTLMGHKDAKSTEWYTRVFALDVTRQLGVRFTMDPQEAGRLLLPR 1068 
++ ~lGH+D KSTE YTR+FALDV Q GVRF+MD +A LLLP 
QAYMGHQDTKSTEIYTRI FALDVGHQYGVRFBl'IDTLDARALLLP 244 
++LMGHK STE YT+VFALDV + V+F+M +A +L R 
QSLMGHKSISSTEVYTKVFALDVAARHRVQFBMPESDAVTMLKNR 267 
++LMGHK STE YT+VFALDV + V+F+M +A +L R 
QSLMGHKSISSTEVYTKVFALDVAARHRVQFSMPESDAVTMLKNR 25B 
++LMGHK STE YT+VFALDV + V+P+M +A +L 
QSLMGHKSISSTEVYTKVFALDVAARHRVQFSMPESDAVSML 255 
++LMGHK STE YT+VFALDV + V+P M +A +L 
QSLMGHKSISSTEVYTKVFALDVAARHRVQFAMPESDAVAML 264 
+ LMGHK STE YT+VPALDV + V+P M +A +L 
QALMGHKSVBSTb~YTKVFALDVAARHRVQPQMPGADAVAML 256 
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A2.3. Protein seqnence similarities of the translated DNA sequence data located 
downstream ofthe AGA gene cluster 
Table A2. Similarities to the region downstream of the AGA gene cluster 
Code Accession no. Putative sIze 
RR (NC_002575) probable transposase gene; root-inducing plasmid 475 
pRi 1724 from Rhizobium rhizogenes 
AT (AF065242) unknown; soybean-supervirulent chrysopine-type Ti 464 7e_09 
plasmid pTiChry5from Agrobactel'ium tumefaciells 
RN (NC_000914) putative transposase Y 4BF; plasmid pNGR234a from 457 5e_07 
Rhizobium sp. NGR234 
ST (NC _ 002305) putative transposase; IncHl plasmid R27(heat- sensitive 468 2e_06 
transfer) from Salmonella typhi 
SE (AL513383) putative transposase; plasmid pHCMl from Salmonella 465 le_o4 
enterica e/lterica serovar strain CT18 
166 
(45) 
(39) 
(37) 
(34) 
Blast X alignment of the trans1ated DNA sequence downstream of the AGA gene cluster from 
Ehl087 (EH) with other protein sequences'in the GenBank I EMBL I XXX databases. 
Figure A3. Sequence alignments downstream of the AGA gene cluster 
EH 13 INARRGLPGTHRIDETLRYRILTLLDEYYASFGSISTCHRKLLERYEINISTETQRCWMTTYGLWNLHICHQTHIYHPR*NHP 261 
++ +R PRE R L L+ E Y FG + KL+E + 1+++ ET R WMT G+W + ++ PR 
RR 58 VSKKRLQPSNRRHTEEFRNAALDLIRERYLDFGP-TLAREKLIELHRISVAKETLRQWMTEAGIII'VSRRERKK!lVFQPR 135 
G P +RI +R +TL+ E YA FG + KL ER + +S ET R WMT G W 
AT 68 GRPSNNRISAGVRDYAMTLVRERYADFGP· TLATEKLAERNGLRVSRETVRSWMTDAGPW 126 
G P +RI + +R + ++ E YA FG + KL E + +S ET R WM GLVI 
RN 62 GRPSNNRICDGVRDYAMAIVRERYADFGP-TLAAEKLAELDGLTVSRETLRQWf.1ADAGLVI 120 
RRG +++ + L L ++ E Y FG C KL E + ++1S ET R MT 
ST 63 RRGKSSNNQLPQGLAAYALNIIRERYNDFGPTLACE-KLAEVHGVH1SKETVRKLMTQASLVI 123 
N RG G + +L + L+++ E Y FG + KL E + + + ET R M GLW 1+ PR P 
BE 61 NQSRGRTGNRLLPTBLTDQALSllRERYRDFGP-TLAREKLEEVHGLVLGKETIRRLMlKAGLWIPRRQRAPKIHQPRYRRP 141 
EH 248 GEIIQIIGAHHVWFEARTSKYSLLIHVDD 334 
GE++QI G+HH WFE R K +LL+++DD 
RR 142 GELVQ IDGSHHVIWFENRGPKCALLVYIDD 170 
GE++QI G+ H WFE R SLL+ VDD 
AT 146 GELVQIDGSEHR\;FEDRGPSCSLLVFVDD 174 
GE++QI G+ H WFE R SLL+ +DD 
RN 140 GELVQIDGSEHRWFEDRGDPCSLLVFIDD 168 
GE+IQI G H WFE R K + L++VDD 
ST 144 GELIQIDGCDHHWFENRGPKCTALVYVDD 172 
GE+IQI G H WFE R + L++VDD 
BE 144 GELIQIDGCDHHI'IFENRGRPCTALVYVDD 172 
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A2.4. Sequence similarity data for Eh7.1 
Figure A4. DNA sequence flanking the insertion point in Eh7.1 
5' 
TCGAATTCTGCCTAGGCGGCCAGATCTGATCAAGAGACAGTTCCAGGAGAGTTGAGTATGTCCGCTGAA 
CACGTTCTCTCGATGATGAACGAGCATGAAGTTAAGTTTgTTGACCTGCGTTTTACCGATACCAAAGGT 
AAAGAACAGCACGTTACGATCCCTGCTCACCAGGTTAACGCTGACTTCTTCGAAGAAGGCAAAATGTTC 
GATGGTTCGTCTATTGGCGGCTGGAAAGGCATTAACGAATCAGACATGGTGCTGATGCTGACGCACCAC 
GGCGGTCATGGATCTTTCTTCGAGATCTACGCTGATCATCGTGTGACATCTCGAGCAGCACCATGCAGG 
GCTACGACGGATcACGCTCTATCG 
3' 
DNA sequence using primer T3, which anneals to the vector pBluescriptKS-. The sequence 
in italics is mini-Tn5lacZ2, and the transposon insertion point is highlighted in bold. 
Table A3. BlastN alignments of DNA sequence flanking the Eh7.l insertion 
Sequences producing significant alignments: Score E 
Value 
gi1415621emb1X05173.11ECGLN E. coli glnALG operon with gInA ... 232 2e-S8 
gi11461561gb1M13746.1iECOGLNAB E. coli gInA gene encoding gInA ... 228 3e-S7 
gill 540891gb1M14536.1 ISTYGLNA S. typhimurium glnA gene ... 214 Se-S3 
giI3808289IgbIAF072440.1IAF072440 Enterobacter gergoviae ginA ... 188 3e-4S 
gi11551701gb1L08499.11VIBGLNNTR Vibrio alginolyticus glutamine ... 153 le-34 
gi11461581gb1J01618.11ECOGLNACR Escherichia coli K-12 glutamine ... 131 Se-28 
Glutamine but not glutamate was found to restore growth and AGA-production to strain 
Eh7.1 grown in minimal media. Taken with the the sequence similarities presented here it is 
concluded that Eh7.1 possesses a mini-TnSlacZ2 insertion in the Eh1087 glnA gene, the 
product of which is responsible for conversion of glutamate into glutamine. It was further 
demonstrated that the transposon insertion is solely responsible for glutamine auxotrophy by 
transfering the transposon insertion in Eh7.1, via an Ehl087 ginA-encoding cosmid, to 
Eh1 087, recreating a glutamine auxotroph. 
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A2.5. Sequence similarity data for Eh56F2 
Figure AS. DNA sequence flanking the insertion point in Eh56F2 
5' 
CTCCGATAGCACGAAgGCCGGGATAATGAGCNGCATATTGTCGGGGGTGACCGAATCTGCCATTTTCTT 
TGGCCACATACGCTGGGCATTTTCCTGCAGTTCGAAGAGGTCATTACTCAGGTCGCTCGTGACGGCACG 
CCACACGTGATGTGTGCCTATCTCTACGATcTgGCCGGTCTGTTCTCCGGATTCTACGAGCACTGCCCG 
ATTCTCACCGCAGAATCAGACACAACCCGTCTGAGCCGACTGCAGTTCATTGTAACGGTGCACCACAAA 
AAATGAGCTGAGCAGCAGGCCAACCATcAGCGTGGGTGCCAGAATTAAAATCATCATTcGCGCcCGCAG 
GCTGTATTTGGTCATAATAGTCGCCTGGCTCTGTCTCTTGATCAGATCTGGCCGCCTAGGCGAATTCCC 
3' 
DNA sequence using primer T7, which anneals to the vector, pBluescriptKS-. The 
transposon insertion point is highlighted in bold (between bases 375 and 376), and the 
sequence in italics is from mini-Tn51acZ2. A start codon (reverse-complement) for a 
potential E. coli barA homolog is underlined. 
Figure A6. Alignments of the sequence flanking the Eh56F2 insertion point 
A) Translated sequence alignment 
Translated protein sequence similarity: E. coli Sensor protein BarA (Swiss prot: P26607) 
Score 70.6 bits (170) Expect 6e'12 
Identities 54/120 (45%); for first 38 bases: 32/38 (84%) 
Positives 74/120 (61%); for first 38 bases: 36/38 (95%) 
Eh56F2: 360 MTKYSLRARMMILlLAPTLMVGLLLSSFFVVHRYNELQSAQTGCV*FCGENRAVLVESG- 184 
MT YSLRARMMILlLAPT+++GLLLS FFVVHRYN+LQ E AV E G 
BarA: 1 MTNYSLRARMMILILAPTVLIGLLLSIFFVVHRYNDLQRQLEDAGASIIEPLAVSTEYGM 60 
EhS6F2: 183 -----EQTGQIVEI -GTHHVWRA---- -VTSDLSNDLFELQENAQRMWPKKM 
E GQ++ + +RA VTS+ D +Q + +P+++ 
BarA: 61 SLQNRES1GQLISVLHRRHSDIVRAISVYDENNRLFVTSNFHLDPSSMQLGSNVPFPRQL 
EhS6F2: 60 ADSVTPDNMXLIIPAFVLSE 1 
+VT D +1+ ++SE 
BarA: 121 -TVTRDGD1M1LRTP1ISE 138 
B) DNA sequence alignment 
DNA sequence similarity: Escherichia coli argS gene for arginyl-tRNA-synthetase (XI5320.1) 
Score 103 bits (52); Expect = 5e-20; Identities = 85/96 (88%) 
61 
120 
EhS6F2: 127 cgtgacggcacgccacacgtgatgtgtgcctatctctacgatctggccggtctgttct 184 
II ill IIIIII! I II II IIIIIIII II II IIIIIIIIIIIIIIIIIIIIII 
argS: 1782 cgtgaaggcacgccgcatgtaatgtgtgcttacctgtacgatctggccggtctgttct 1839 
EhS6F2: 185 ccggattctacgagcactgcccgattctcaccgcagaa 222 
I II II! IIII ! IIIIIIIIIIII IIII IIIIII1 
argS: 1840 ctggcttctacgagcactgcccgatcctcagcgcagaa 1877 
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A2.6. The Ehl087 recA gene 
Figure A7. DNA sequence of the Ehl087 recA gene 
5' 
CTGCAGAAACTGTATGGCGAATTCTCTCGACAAATTAAACTTGATACTGTATGACTATACAGTATAATT 
GTCGGCAACAGANAGAGTACAGGCACCCTGAGTGCGTGTTTACCCGGCTTGATTAGGAGTTGAAATGGC 
GATTGATGAAAACAAACAGAAGGCTTTAGCTGCCGCGCTTGGCCAGATTGAGAAGCAATTTGGTAAAGG 
CTCCATCATGCGCTTGGGTGAAGACCGCTCAATGGATGTGGAAACTATCTCTACCGGCTCGCTGTCGCT 
GGATATCGCATTAGGCGCAGGTGGTCTGCCAATGGGCCGTATCGTTGAGATCTACGGACCTGAGTCTTC 
AGGTAAAACCACGCTGACTTTGCAGGTTATCGCATCTGCACAGCGTAAAGGTAAAACCTGTGCCTTTAT 
CGATGCAGAACATGCGCTTGATCCGGTTTACGCCAAGAAACTCGGCGTAGACATTGATAACCTGCTCTG 
CTCTCAGCCAGACACTGGTGAGCAGGCGCTGGAAATCTGTGATGCGCTGGCGCGCTCTGGTGCCGTTGA 
CGTGATCATCGTCGACTCCGTCGCGGCGCTGACGCCTAAAGCGGAAATCGAAGGTGAAATCGGTGACTC 
ACACATGGGCCTCGCGGCACGTATGATGAGCCAGGCGATGCGTAAACTGGCCGGTAACCTGAAGCAGTC 
CAATACCCTGCTGATTTTCATCAACCAGATCCGTATGAAAATTGGTGTGATGTTTGGTAACCCGGAAAC 
CACCACTGGTGGTAACGCGCTGAAGTTCTACGCCTCTGTCCGTCTTGATATCCGCCGTATCGGTGCAAT 
CAAAGAGGGCGATAACGTGGTCGGCAGTGAGACCCGCGTTAAAGTGGTGAAAAACAAAATCGCCGCGCC 
ATTCAAACAGGCTGAATTCCAGATCATGTACGGCGAAGGTATCAATACCTTTGGTGAGCTGGTCGACCT 
GGGCGTGAAGCACAAGCTGATTGAAAAAGCGGGTGCATGGTACAGCTACAATGGCGACAAGATTGGTCA 
GGGTAAATCGAATGCCGGCAACTTCCTGAAAGAGAATGCTGCTGTGGCAAACGAGATTGATCTGAAGTT 
ACGTGAGATGTTGCTCAACGGCGCGGATGAAAAACTCGCAGCAGCCGACAAGGCTGCTGAGAAAGAAGA 
CGCGGCTGAAGCGAACGAAGACTTCTAATCTCTGATGCGGGAGGGGCGAAAGCCTCTCCCGTAGTTTTA 
TCCCCCTCTATTATCTTTCTTGCCTTCCCTCTGTCCTGTTCTGTCGCCATAATCTCCCTCTTTTTGTAC 
AAGGTGCGCAGTATGACTGAACCCTCTCAGCCCCAACCTAATGTCGTCTCTTACTCTCGTCTGCTTGAC 
CGTGCGATGCGTATTCTGGGTCAGCGCGATCACAGCCGTGCAGAGTTAGCGCGTAAACTGCAACAATCA 
GCGCAGCGTGCTGCGTGGGCGCAGAAAAAAGAGCCCGAAATTGTTACCGAAGCGTTGCTGGAACAGGTT 
CTTAACTGGTGTCAGGAAAGCGGCTGGTTAAACGACGAGCGTTTCACCGAACGATTTATTCAGAGCCGG 
AGCCGTAAGGGCTTTGGATCGCAGCGCGTACGCCTTGAACTGGCCCAGAAAGGCATTGACCGTGAAGCC 
ATTGATCTTGCAATGGHAGAGACAGAGGTAGACTGGGCGGCGTGTGCGGYTCAGCTGGCTGAACGAAAA 
TTCGGACACCCGCTGCCACAGAGTGGAAAGNGAAAGCGAAAGTACTACGCTATCTGCAG 
3 ' 
DNA sequence of a 1784 bp DNA fragment, bordered by Pstl sites (italics), that encodes the 
Eh1087 recA gene. Predicted codons for translation initiation (ATG) and termination (TGA) 
of the 1068 bp recA gene (respectively) are shown in bold. An nCmR cassette used to create 
recA mutants was inserted in the underlined EcoRI site. 
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A3. Data summary for all A GA gene cluster mini-Tn51acZ2 insertion mutants 
Table A4. Insertion point data for all Ehl087 AGA-minus mutants 
Orientation 1 insertions Orientation 2 insertions 
No. Strain Position l p_ga12 ehp 3 colour4 No. Strain Position p-gal ehp colour 
1 S2.1 1600 (+) A pale 1 M97.l 1700 (-) A pale 
2 M14.1 1800 (-) A pale 2 MI04.2 2300 (-) B pale 
3 M14.5 2000 (+) B pale 3 M54.1 2800 c-) C pale 
4 M14.4 2800 c-) C pale 4 M80.1 3100 c-) C pale 
5 M26.1 2850 c-) C pale 5 M72.1 3200 (-) C pale 
6 M102.1 2900 c-) C pale 6 MIOI.I 3400 c-) C pale 
7 S12:2 3000 (-) C pale 7 S13:3 3500 c-) C pale 
8 S5:1 3200 c-) C pale 8 M62.3 3600 c-) C pale 
9 M34.1 3300 c-) C pale 9 M24.2 3700 c-) C pale 
10 M67.3 3400 c-) C pale 10 M86.1 3750 c-) C pale 
11 S13:2 3600 (+) C pale 11 M24.1 4000 c-) C pale 
12 M62.1 3800 c+) C pale 12 M103.1 4200 C -) D pale 
13 S14:1 4100 c-) C pale 13 M3.2 4800 C -) D pale 
14 M24.3 4400 c-) C pale 14 M97.2 6900 c-) F yellow 
15 M67.1 4800 c-) D pale 15 M35.2 7800 c-) G yellow 
16 M49.1 4900 c+) D pale 16 S1 :1 8350 c-) H yellow 
17 M53.1 4900 (+) 0 pale 17 M104.1 8450 (-) H yellow 
18 S3:4 5200 c-) D pale 18 M62.2 8800 c-) I red 
19 M3.1 5800 (-) E . light yellow 19 M4.1 8800 c-) I red 
20 M70.1 5900 (-) E light yellow 20 M31.1 9000 c-) I red 
21 M103.2 6150 c+) F yellow 21 M55.1 9400 c-) J red 
22 S12:4 6300 (+) F yellow 22 MI01Fl 9500 c-) J red 
23 M28.1 6900 (+) F yellow 23 SI1:l 9600 (-) J red 
24 M88.1 7100 c-) G yellow 24 SIO:l 10000 ( -) J red 
25 M21.3 7500 (+) G yellow 25 M98.1 11200 (-) K red 
26 M53.2 7900 c-) G yellow 26 M104FI 11500 C -) L red 
27 M61.1 8000 (-) G yellow 27 M18.2 11500 (-) L red 
28 M21.1 8200 (-) H yellow 28 S3:1 12700 (-) M orange 
29 M14.2 8400 c-) H yellow 29 M56.1 12950 (-) M orange 
30 M6.l 8800 (-) red 30 M67.2 13100 c-) M orange 
31 M4.2 8800 c-) I red 31 M13.2 13600 (-) M orange 
32 M65.l 8800 (-) I red 32 S13:1 14200 (-) N orange 
33 M30.1 8850 (-) I red 33 M63.1 14200 c-) N orange 
34 M87.l 8900 (+) I red 34 M35.l 14500 (-) 0 orange 
35 M13.4 9100 (+) I red 
36 M23.1 9200 (-) I red Key: 
37 M14.3 9500 (-) J red 1. Number of bases behveen a BamHI site 
38 M52.1 10000 (-) J red upstream of ehpR and each transposon insertion 
39 M20.2 10500 (-) J red 2. p-galactosidase activity resulting from in-frame 
40 M66.1 10900 (-) K red active fusions bet\Veen 'aeZ and an ehp gene 
41 M49.2 12300 (+) L brown 3. The ehp gene interrupted in each mutant 
42 M68.1 13200 (+) M orange 4. The colour of compounds released by each 
43 M26Fl 13300 (+) M orange mutant grown in minimal or Kings A media 
44 M103.3 13700 (-) M orange 
45 SlO:2 13800 c+) M orange 
46 S4:2 14700 (-) 0 orange 
47 M93.1 14900 c-) 0 orange 
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A4. NMR data for D-alanylgriseoluteic acid. 
Figure A8. The chemical structure of AGA with NMR data 
Table AS. l3C NMR data and long range IH_13C correlations (CIGAR) for AGA 
Atomnumbcr 8 IH (ppm, mult, JHz) 8 l3C ppm Correlated carbons 
1 124.9 
2 
3 
4 
4a 
5a 
6 
7 
8 
9 
9a 
lOa 
11 
12 
l' 
2' 
3' 
8.95 (d, 7,5) 
8.05 (dd, 7.5,1.5) 
8,51 (d,8) 
7,92 (d, 8) 
7.16 (d, 7.5) 
5,9 (d, 12.5),5.85 (d, 12.5) 
3.64 (m) 
1.36 (d, 6.5) 
4.18 (s) 
136.8 
130.6 
134.6 
142.7 
142.7 
126,1 
131.5 
107.6 
154.0 
132.9 
138.5 
165.7 
62.0 
176.4 
49.9 
20.6 
56.4 
C-4, C-lOa, C-11 
C-l, C-4a 
C-2, C-lOa 
C-5a, C-9, C-12 
C-6, C-9, C-9a 
C-5a, C-6, C-7, C-l ' 
C-l', C-2' 
C-9 
IData detemuned and provided by Yunjiang Feng, Chemistry Dept., Canterbury University, 
New Zealand. 
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AS. Blossom assay data 
Table A6. Blossom assay data 
Assay A) Populations on stigma first inoculated with Ehl087 or EMAGA 
Ob EMAGA xEMAGA 
Nal Rf Rf+Sm Nal Rf Nal Rf+Sm 
1.6E+04 2.1E+06 9.3E+05 2.8E+03 3.0E+06 2.8E+03 1.IE+07 
2 1.3E+04 9.6E+05 7.8E+05 7.5E+03 I.IE+07 2.9E+03 2.3E+06 
3 8.3E+03 1.6E+06 7.6E+05 3.1E+03 5.2E+06 3.8E+03 2.8E+06 
4 1.3E+04 1.3E+06 5.1E+05 1.3E+03 7.8E+06 5.2E+03 6.8E+06 
5 2.3E+04 1.9E+06 3.6E+05 7.9E+03 4.2E+06 5.2E+03 3.2E+06 
6 2.1E+04 6.3E+05 8.3E+05 2.6E+03 6.2E+06 6.8E+03 1.9E+06 
7 2.0E+04 4.IE+05 2.7E+05 2.6E+03 3.7E+06 4.0E+03 1.5E+06 
8 1.5E+04 2.0E+06 4.5E+05 4.4E+03 1.0E+07 3.5E+03 4.1E+06 
Av 1.6E+04 1.3E+06 6.1E+05 4.0E+03 6.4E+06 4.3E+03 4.2E+06 
SD 
12h 
1.9E+05 1.7E+06 1.9E+06 1.8E+05 8.1E+06 3.5E+03 1.1E+07 
2 3.2E+05 1.7E+06 1.2E+06 5.4E+03 4.1E+06 9.9E+03 4.3E+06 
3 1.5E+05 2.3E+06 1.5E+06 2.4E+03 9.9E+06 5.0E+04 1.9E+07 
4 5.4E+04 1.9E+06 1.9E+06 1.6E+04 7.7E+06 4.8E+04 8.5E+06 
5 3.7E+05 1.8E+06 9.3E+05 1.0E+05 1.3E+07 5.5E+04 8.8E+06 
6 4.7E+05 2.7E+06 2.1E+06 7.0E+02 1.7E+07 6.8E+04 2.6E+06 
7 8.6E+04 4.6E+06 I.1E+06 3.lE+04 1.4E+07 1.1E+04 3.2E+06 
Av 2.2E+05 2.2E+06 1.6E+06 4.2E+04 1.0E+07 3.2E+04 9.9E+06 
SD 
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24 h Ea8862 Eh1087 EMAGA Ea8862 x Eh 1 087 Ea8862 x EMAGA 
Rf Rf+Sm Nal Rf Nal Rf+Sm 
2.5E+06 4.6E+05 8.7E+06 6.9E+02 3.2E+07 8.8E+04 5.4E+06 
2 4.6E+06 2.9E+05 2.9E+06 7.3E+02 1.0E+07 3.6E+03 7.9E+06 
3 1.2E+07 2.2E+05 6.0E+06 3.2E+02 1.7E+07 2.7E+05 4.1E+06 
4 6.IE+06 3.8E+05 3.5E+06 1.4E+04 1.8E+07 6.0E+04 2.IE+07 
5 8.6E+06 1.5E+06 4.5E+06 3. 1 E+02 3.1E+07 4.7E+04 1.2E+07 
6 4.3E+06 2.0E+06 2.6E+06 1.7E+04 2.7E+07 6.5E+04 6.7E+06 
7 1.8E+07 2.5E+06 2.9E+06 l.IE+03 2.4E+07 1.0E+04 7.8E+06 
8 3.8E+06 
Av 8.2E+06 I.4E+06 4.4E+06 5.6E+03 2.1E+07 7.4E+04 8.7E+06 
SD 2.1E+06 8.6E+06 
48h 
5.6E+07 1.1E+07 7.0E+06 2.4E+03 I.4E+07 1.2E+05 
2 7.8E+07 1.0E+07 8.0Et06 2.2E+04 1.4E+07 4.5E+07 
3 1.7E+07 3.6E+06 6.7E+06 4.9E+03 I.3E+07 2.6E+05 1.8E+07 
4 6.3E+07 8.0E+06 1.1E+07 9.6E+05 2.9E+07 1.9E+07 1.6E+07 
5 5.7E+07 5.0E+06 7.7E+06 8.8E+04 2.4E+07 2.7E+05 5.1E+06 
6 3.6E+07 7.3E+06 4.7E+06 5.1E+04 9.2E+06 1.0E+06 3.2E+07 
7 8.6E+07 3.9E+06 3.6E+06 2.1E+04 2.7E+07 1.7E+06 1.6E+07 
8 
Av 5.5E+07 6.7E+06 6.7E+06 I.4E+05 1.8E+07 8.5E+06 I.4E+07 
SD 2.2E+07 2.8E+06 2.4E+06 3.3E+05 7.9E+06 1.6E+07 8.6E+06 
72h Ea8862 Ehl087 Ehl\AGA Ea8862 x Eh1087 Ea8862 x EMAGA 
Nal Rf Rf+ Rf Rf+Sm 
1.9E+08 1.0E+07 1.1E+07 9.0E+04 2.8E+07 7.0E+05 1.9E+07 
2 7.3E+07 1.3E+07 1.7E+07 1.5E+05 2.4E+07 1.9E+05 2.8E+07 
3 8.0E+07 5.6E+06 7.2E+06 2.IE+02 2.3E+07 2.IE+05 3.9E+07 
4 5.6E+08 5.7E+06 2.0E+07 1.2E+04 2.0E+07 5.3E+05 1.7E+07 
5 5.3E+07 8.4E+06 8.2E+06 9.7E+03 2.2E+07 8.7E+04 1.5E+07 
6 6.1E+07 1.2E+07 1.7E+07 3.5E+03 8.9E+06 4.2E+05 2.4E+07 
7 7.4E+07 1.6E+07 1.6E+07 1.4E+04 3.9E+07 2.4E+05 1.5E+07 
8 1.3E+08 5.9E+06 1.7E+07 7.4E+02 1.3E+07 9.0E+05 3.7E+07 
Av 1.5E+08 9.5E+06 1.4E+07 3.5E+04 2.2E+07 4.IE+05 2.4E+07 
SD 1.7E+08 3.8E+06 4.7E+06 5.5E+04 9.2E+06 2.8E+05 9.7E+06 
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Assay B) Populations on stigma inoculated with strains simultaneously 
12h Ea8862 x Eh1087 Ea8862 x EhMGA 24 h Ea8862 x Eh 1 087 Ea8862 x EhMGA 
N R N R R+S N R N R R+S 
1 ! 3.5E+04 3.5E+05 8.6E+04 8.0E+05 7.4E+05 1 9.9E+04 1.7E+06 1.9E+06 2.7E+06 3.9E+06 
2 1.1E+04 1.8E+05 I.4E+05 3.2E+05 4.6E+05 2 I.4E+05 5.3E+06 3.4E+06 4.0E+06 3.4E+06 
3 I.5E+04 2.2E+05 5.8E+04 5.3E+05 5.0E+05 3 1.1E+05 3.7E+06 7.0E+06 6.9E+06 6.4E+06 
4 2.3E+04 2.6E+05 3.5E+04 5.2E+05 4.1E+05 4 6.7E+04 3.1E+06 4.4E+06 3.6E+06 2.7E+06 
5 6.9E+03 7.3E+04 5.4E+04 4.0E+05 4.2E+05 5 1.1E+05 1.7E+06 8.2E+06 5.4E+06 3.7E+06 
6 5.4E+04 3.7E+05 2.7E+04 3.8E+05 2.3E+05 6 3.7E+05 1.5E+06 7.lE+06 6.9E+06 6.2E+06 
7 1.9E+04 2.0E+05 7.0E+04 1.0E+06 8.0E+05 7 1.5E+05 2.lE+06 2.7E+06 3.1E+06 2.6E+06 
8 2.7E+04 3.2E+05 5.8E+04 3.6E+05 3.0E+05 8 7.4E+05 4.2E+06 3.4E+06 1.1E+07 3.6E+06 
Av 2.4E+04 2.5E+05 6.6E+04 5.4E+05 4.8E+05 Av 2.2E+05 2.9E+06 4.8E+06 5.4E+06 4.1E+06 
SD 1.5E+04 9.9E+04 3.5E+04 2.5E+05 2.0E+05 SD 2.3E+05 1.4E+06 2.3E+06 2.7E+06 1.5E+06 
48 h Ea8862 x Ehl087 Ea8862 x EhllAGA 72 h Ea8862 x Ehl087 Ea8862 x EhMGA 
N R N R R+S N R N R R+S 
1 7.3E+04 1.1E+07 1.8E+07 4.8E+06 3.3E+06 I 5.5E+05 4. 1 E+06 2.1E+07 4.7E+06 6.1E+06 
2 2.6E+06 5.2E+06 1.8E+07 4.4E+06 5.8E+06 2 6.4E+07 1.5E+0 1.0E+08 1.0E+07 1.2E+07 
3 3.5E+05 6.4E+06 5.2E+07 1.0E+07 8.6E+06 3 4.6E+06 2.6E+0 5.8E+07 3.8E+06 6.6E+06 
4 I.4E+06 2.0E+07 3.2E+07 6.6E+06 6.5E+06 4 9.4E+06 2.5E+07 4.7E+07 7.2E+06 7.3E+06 
5 4.1E+05 9.9E+06 2.6E+07 5.2E+06 8.6E+06 5 1.5E+05 I.4E+O 4.4E+07 7.3E+06 7.6E+06 
6 5.6E+06 5.1E+06 5.5E+07 4.5E+06 5.0E+06 6 5.6E+05 7.6E+06 7.9E+07 5.1E+06 4.5E+06 
7 2.7E+06 9.0E+06 4.0E+07 1.1E+07 1.1E+07 7 7.0E+07 1.0E+0' 8.0E+07 9.5E+06 8.4E+06 
8 3.4E+06 1.0E+07 1.9E+07 5.0E+06 4.8E+06 8 5.8E+06 1.7E+0' 8.6E+07 3.6E+06 4.2E+06 
Av i 2.IE+06 9.6E+06 3.3E+07 6.4E+06 6.6E+06 Av 1.9E+07 1.5E+0'1 6.5E+07 6.4E+06 7.1E+06 
SD I 1.9E+06 4.8E+06 1.5E+07 2.5E+06 2.4E+06 SD 3.0E+07 7.8E+06 2.7E+07 2.5E+06 2.5E+06 
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Assay C) Populations on stigma first inoculated with Ea8862 
Oh EaSS62 x Eh IOS7 I EaSS62 x Eht,AGA 12h EaSS62 x EhIOS7 EaSS62 x Eht,AGA 
N R N R R+S N R N R R+S 
I l.lE+OS I.SE+OS 1.6E+07 S.5E+04 4.SE+04 I S.7E+07 1.2E+OS 4.7E+07 l.3E+OS 2.SE+OS 
2 6.9E+06 2.SE+04 2.3E+07 l.SE+OS l.lE+OS 2 2.0E+07 3.3E+OS 3.3E+07 I.6E+OS 2.0E+OS 
3 7.9E+06 6.0E+04 l.3E+07 1.2E+OS I.2E+OS 3 S.9E+07 3.SE+OS 4.7E+07 S.OE+OS 6.IE+OS 
4 S.9E+06 7.SE+04 1.3E+07 9.3E+04 S.6E+04 4 2.0E+07 2.SE+05 7.4E+07 3.1E+OS 1.IE+05 
S LlE+07 9.8E+04 IAE+07 S.6E+04 4.3E+04 S 4.6E+07 I.9E+05 S.9E+07 S.SE+05 4.6E+OS 
6 6.0E+07 7.4E+04 4.6E+06 3.SE+OS 2.3E+05 6 6.2E+07 2.7E+OS 4AE+07 4.0E+OS 4.7E+OS 
'7 8.SE+07 6.SE+04 1.4E+07 6.6E+04 S.OE+04 7 3.lE+07 2.0E+OS 6.3E+07 3.5E+05 3.0E+OS 
S 4.3E+07 S.7E+04 S.SE+06 9.7E+04 1.2E+OS 
-:-: S.2E+07 l.SE+OS 2.SE+07 l.SE+06 1.5E+06 Av 4.2E+07 S.OE+04 1.3E+07 l.3E+OS I.OE+OS 4.3E+07 2.4E+05 4.9E+07 4.9E+OS 4.9E+OS 
SD 4.1E+07 4.5E+04 S.SE+06 9.7E+04 6.1E+04 SD 1.7E+07 9.0E+04 I.5E+07 4AE+05 4AE+05 
24 h EaS862 x EhIOS7 EaSS62 x Eht,AGA 48h EaSS62 x Ehl OS7 EaSS62 x Eht,AGA 
N R N R R+S N R N R .R+S 
I 6.6E+07 1.3E+0 4.9E+07 9.1E+05 7AE+OS 2.lE+OS l.5E+O 6.7E+07 2.3E+06 1.5E+06 
2 6.9E+07 2.0E+05 l.lE+OS 1.2E+06 2 1.4E+OS 7.SE+07 4.0E+06 3.2E+06 
3 1.2E+OS 4AE+O 7.SE+07 l.SE+OS l.3E+OS 3 6.9E+07 3.lE+O 7.9E+07 2AE+06 l.SE+06 
4 6.SE+07 SAE+OS 7.2E+07 S.SE+OS 6.3E+OS 4 7,9E+07 6.0E+07 I.2E+06 S.lE+05 
S 6.lE+07 2.9E+OS 6.SE+07 1.7E+OS 1.2E+05 5 1.2E+OS 2.0E+OS 2AE+06 3,9E+OS 
6 9.SE+07 4AE+OS 6,SE+07 l.2E+06 7,OE+OS 6 1.2E+OS 2,8E+OS l.lE+06 2,SE+OS 
7 S.SE+07 2.IE+06 l.lE+OS 2.7E+OS 3.lE+05 7 1.2E+OS 3.2E+OS 6.0E+06 S.6E+OS 
S 4.0E+07 3.9E+OS 6.6E+07 4.6E+06 3.2E+06 S 7.1E+07 6.9E+OS S.OE+06 9.0E+OS 
Av 7,SE+07 1.2E+06 7.SE+07 1.2E+06 S.7E+OS Av I.2E+08 1,2E+06 
SD 2AE+07 1.4E+06 2,2E+07 1.5E+06 1.0E+06 SD 4.7E+07 
nIt Ea8S62 x EhIOS7 Ea8862 x Eht,AGA 
N R N R R+S 
I 4.SE+07 7.7E+06 9.7E+07 S.OE+06 4.3E+06 
2 S.OE+07 7AE+06 9.9E+07 3.6E+06 2.SE+06 
3 1.7E+OS 2.6E+06 I.SE+OS 9.SE+06 6.8E+06 
4 l.5E+08 3.2E+06 IAE+08 S.9E+06 S.SE+06 
S 3.2E+OS 5.2E+05 4AE+07 4.IE+06 4AE+06 
6 l.2E+08 3.2E+06 4.SE+07 4.4E+06 2.7E+06 
7 7.7E+07 5.5E+06 1.9E+08 4.SE+06 4.7E+06 
S l.7E+08 1.7E+06 l.lE+08 4.SE+06 3.6E+06 
Av IAE+OS 4,OE+06 l.lE+08 S.2E+06 4AE+06 
SD 8.9E+07 2,6E+06 4.9E+07 1.9E+06 1.4E+06 
